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Abstract
We have investigated the alkylation of planar chiral cationic ;r-allylmolybdenum complexes
2.1 and 2.2 with a variety of functionalised cc-alkoxyalkylcopper(I) nucleophiles. Complexes
2.1 and 2.2 are readily formed from the corresponding homochiral allylic acetates (S)- and 
{R)-2.12 and a suitable Mo(0) source with retention of facial stereochemistry (Scheme 1). 
Excellent selectivity for attack anti to the metal fragment yields products of overall inversion 
of configuration, 2.3 and 2.4. Good regiocontrol (typically > 8:1) results from steric 
discrimination between the termini of the allyl unit. The selectivity is obtained without the 
need to control central chirahty at the metal, in contrast to literature precedent.
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We have apphed the methodology to natural product synthesis. Cryptophycin 4 (4.110) was 
prepared via the coupling of novel cationic complex 4.1 and homochiral nucleophile 4.2 as 
synthetic equivalents for synthons 4,5 and 4,7 respectively (Scheme 2).
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Chapter 1 - Cationic T^ -^allylmoIybdenum complexes.
1.1 - Introduction.
Extensive investigations over the past three decades have been carried out in the area of 
nucleophilic attack upon allylic ligands TT-bonded to transition metals. The use of palladium 
in catalytic allylic alkylations has been most extensively investigated, with enantioselective 
variants of the reaction being well established since the first report in 1977.^ Catalytic 
applications are not restricted to palladium, with alternative metals including molybdenum, 
nickel, iridium, mthenium, iron, platinum, tungsten, cobalt and rhodium being utihsed.^"  ^In a 
stoichiometric fashion, molybdenum and iron have been the metals of choice,^'^ with 
molybdenum being relatively unexplored in applications to organic synthesis until recent 
years.
The strategy of having a metal bound to an allylic cation equivalent (1.3, Scheme 1.1) is a 
powerful one. The metal serves a dual purpose: stabilising the allylic cation, and directing 
nucleophilic attack upon one face of the planar allyl unit. For the general procedure outlined 
below to be of use to the synthetic chemist, several factors need to be controlled: (a) 
formation of planar chiral electrophilic complexes 1.3 from suitable enantiomeric ally pure 
precursors 1.1 /1.2; (b) subsequent attack on the face of the planar allyl ligand opposite to 
that blocked by the metal; (c) regioselection between the two allylic termini on steric or 
electronic grounds; (d) control of double-bond geometry in products 1.4 /1.5; (e) facile 
removal of the metal from the olefin product.
X 1.2
-  1 + — -------   T  or:
X MLx 1.4 Nu Nu 1.5
1.3
Scheme 1.1.
The above aims can be satisfied by the use of planar chiral cationic Ty^.^Hylmolybdenum 
complexes based on the CpMo(CO)(NO) fragment. Chapter 1 will discuss the development 
of cationic Ti^-allylmolybdenum complexes and examine their potential for use in asymmetric 
synthesis.
1.2 - Preparation of neutral and cationic ij^-allylmolybdenum 
complexes.
1.2.1 - Oxidative addition to zerovalent molybdenum.
The most popular method for formation of neutral T^^-allylmolybdenum complexes 1.9 is the 
oxidative addition of an allylic precursor 1.7 to Mo(CO)3(MeCN)3 (1.6) (Scheme L2).^’ 
Ligand displacement with an anionic spectator group such as cyclopentadienyl (Cp) (or 
hydrotris(l-pyrazolyl)borate (Tp) - see section 1.3) yields 1,9. Neutral complexes 1.9 are 
stable 18-electron species and unreactive towards nucleophiles. Activation to the highly 
electrophilic cationic tetrafluoroborate or hexafluorophosphate complex 1.10 [(r}^ ~ 
allyl)Mo(CO)(NO)Cp]+X- (X = BF4 or PFg) is readily achieved by treatment of neutral 
complex 1,9 with nitrosonium tetrafluoroborate or hexafluorophosphate.
Mo(CO) 6
MeCN
A .3 h
R
1.7
Mo(CO)3 (MeCN) 3
1.6
R2 R*^
BF4 -  or PFb"
X = Halide, 0C (0)R
R2
R3
p 4  1.10
Mo(CO)(NO)Cp
Scheme 1.2.
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Whilst Mo(CO)3(MeCN)3 ^^  is the most common Mo(0) source, other variants include 
Mo(CO)3(DMF)3 /2  Mo(CO)3(py)3 ^^  and Mo(CO)3(PhMe).i4 Mo(CO)3(diglyme) and 
(DME)2Mo2(CO)6 have also been briefly investigated by Liebeskind.^^ An investigation of 
Mo(CO)3(py)3 by Kuhl and K ociensk iand  the subsequent development of the related 
reagent Mo(CO)4(py)2 is discussed below in section 1.2 .2 .
The allylic reagent 1.7 can vary, with allylic acetates or halides being the most widely used. 
Allylic trifluoroacetates, relatively common precursors in palladium-based allylic alkylation 
c h e m is t r y ,h a v e  only limited use in the formation of ;r-allylmolybdenum species.^^ 
Liebeskind has used allylic diphenylphosphinate esters in the preparation of neutral (t? -^ 
allyl)Mo(CO)2Cp complexes.
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1 .2 .2  - The development of Mo(CO)4(py)2  as a reagent for the preparation of rj^- 
allylmolyhdenum complexes.
Mo(CO)3(py)3 ^^  was reported by Pearson to be a superior reagent to other zerovalent 
molybdenum sources for the preparation of -allylmolyhdenum com plexes.A  variety of 
neutral complexes were prepared in good to excellent yield, some of which could only be 
obtained inefficiently using Mo(CO)3(MeCN)3 or Mo(CO)3(DMF)3. Problems encountered 
with the use of Mo(CO)3(py)3 within the Kocienski group stimulated Kuhl to investigate the 
reagent, using ^^Mo NMR^^ to elucidate the reaction pathways involved. Mo(CO)3(py)3 
(1.11) was readily formed from Mo(CO)g by refluxing in pyridine for 4 h (Scheme 1.3). 
Following Pearson's protocol, the oxidative addition of allyl acetate to 1.11 in CH2CI2 was 
investigated. After 4 h, the major component of the reaction mixture was [Mo(CO)4(py)2l 
(1.13, 62%) together with only 2 % of 1.11, Mo(CO)5(py) (1.12, 7%) and the expected 
allylmolybdenum(II) complex 1.14 (29%), A gradual increase in the concentration of 1.14 
was mirrored by a decrease in 1.13, and after a further 20 h, neutral complex 1.15 was 
isolated in 75% yield following Hgand exchange.
Mo(CO}6
Py, A 
4 h
Py,., H2C=CHCH20Ac o c „ 9 ° . .P y
C H aC I..A ,4h
1.11 1.12(7%)
ocrT^co
1.13 (62%)
Py Py
1.11 (2%) 1.14 (29%)
A, 20 h; 
KTp; 75%
Tp(CO)2Mo
1.15
Scheme 1,3.
Mo(CO)4(py)2 (1.13), the reagent apparently responsible for the oxidative addition, was 
quantitatively prepared in THF from Mo(CO)6 and 2 equivalents of pyridine (Scheme 1,4), 
In situ reaction with an allylic acetate followed by displacement of the remaining pyridine and 
acetate ligands with LiCp yielded a variety of neutral ?]2-allylmolybdenum complexes in 
excellent yield and purity, including hindered complexes 1.16a-1.16c which could not be 
obtained with Mo(CO)3(MeCN)3.
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Mo(CO)g
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1.13
Me 
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THF, A, 52-89 h; 
LiCp, rt
8'
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Scheme 1.4.
Kuhl also investigated the influence of the leaving group on the oxidative addition using a 
series of allyl esters 1.17 (Scheme 1.5). A dependence on the donor capacity of the leaving 
group was established. Optimal yield of allyl complex 1.16d and reaction time was obtained 
with the benzoate leaving group. Reaction time continued to decrease as the donor capacity 
increased (R = Ph —> p-MeOPh —> p-Me2NPh) but a detrimental effect upon yield was 
observed.
^  . a  ,R R =
1.17 o
Mo{CO}4(py)2 
THF, A 
LiCp, rt
1.16d
Mo(CO)2Cp
CFgCHg
p-F-Ph
p-CI-Ph
Decreasing reaction time
p-MeOPhp-MegNPh
t
Maximum yield
A
Scheme 1.5.
The trend in donating ability supports the mechanism proposed by Kuhl (Scheme 1.6), 
illustrated for the oxidative addition of enantiopure benzoate (S)-4.17 (see Chapter 4, section 
4.2) to Mo(CO)4 (py)2 . Decarbonylation of Mo(CO)4(py)2 is followed by coordination of 
the transient 16-electron species with the carbonyl group of benzoate 4.17 to give 1.18. 
Following the loss of a further carbonyl ligand from 1.18, and coordination of molybdenum 
to the olefin, intermediate 1.19 collapses to give molybdenum(II) complex 1.20.
i:;;
I
I
■'w;:
(S}-4.17 Ph
Mo(CO)4 (Py)a
-CO (Py)2(CO)3Mo"^^
0C< I^CO 
Py
1.20 (X-Ray)
6
Ph 1.18
-CO
(Py)2(CO)2Mc^^^
Ph
1.19
Scheme 1.6. I
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An X-ray structure of 1.20 was obtained^" '^ and revealed that: (a) the carboxylate and allyl 
ligands were cis; (b) Mo(II) complex 1.20 had been formed with overall retention of 
configuration from benzoate 4.17. Both observations support the above mechanism. The 
Mo(CO)4 (py)2 reagent parallels Mo(CO)3(MeCN)3 in the retentive stereochemistry of 
oxidative addition (see section 1.5.2), but also has distinct advantages in terms of reactivity 
and efficiency, and yields neutral complexes of higher purity. The formation of 1.20 (and 
hence the corresponding CpMo(CO)2-complex) with retention of configuration satisfies one 
of the fundamental requirements of the 77^ -allylmolyhdenum chemistry.
1.2.3 - Alternative routes to neutral and cationic complexes.
A variety of other routes to neutral and cationic 77^ -allylmolybdenum complexes exist 
(Scheme 1.7). McCleverty has reported the direct synthesis of cationic complex 1.22 from 
CpMo(CO)2NO, AgPFg and an allylic h a lid e ,an d  syntheses based on hydride abstraction 
from CpMo(CO)(NO)(?7^-olefin) complexes (e.g. 1.23)^ or protonation of 
CpMo(CO)(NO)(77^-diene) complexes (e.g. 1.24)^"  ^ have also been described. Liu has 
reported the preparation of functionalised complexes 1.30 and 1.31 (as separable mixtures of 
syn and anti isomers) from allylic chlorides 1.26 and 1.27 via halide displacement with 
CpMo(CO)3Na.^^ Me3N(0 ) promoted decarbonylation of the intermediate ?7Lspecies 1.28 
/1.29 produces 1.30 /1.31. The syn / anti product ratio presumably represents the £  / Z ratio 
of the starting allylic chlorides,^^ since the isolated syn and anti ?7^ -complexes 1.30 and 1.31 
were found not to interconvert, even at elevated temperatures.
1.21
CpMo(CO)2 NO
AgPFs
X = Halide M0 (CO){NO)Cp
•^ PFg-
1.22
Mo(CO)(NO)Cp
1.23
PhaCPFs
Mo(CO)(NO)Cp
+ PFa- 
1.22
HPFe, AcgO
lilo(CO)(NO)Cp B eO, 0"C 
1.24
Mo(CO)(NO)Cp
+ BF4 - 
1.25
Cl
1.26, R = OMe
1.27, R = Me
CpMo(GO)3 Na
THF
R
MeaN(O)
Mo(CO)3Cp
1 .2 8 /1 .2 9
CH2CI2
Sy/>1.30, 24% 
Syn-1.31, 30%
Mo(CO)2Cp Cp(CO)2Mo
A/?f/-1.30,19% 
Anf/'1.31, 5%
Scheme 1.7.
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Liebeskind has described the preparation of cyclic and acyclic (77^ -allyl)Mo(CO)2Tp 
complexes 1.33 bearing electi’on-donating substituents by treatment of cyclic and acyclic 
%,6-unsaturated enals and enones 1.32 with Mo(CO)3(DMF)3 and TBSCl (Scheme 1.8).^  ^
Desilylation and alkylation or acylation can be performed on the (rgrf-butylsilyl)oxy- 
substituted complexes 1.33, yielding 1-acetoxy or 1-alkoxy substituted complexes 1.34.
RTMo(CO)2Tp Mo(CO)2Tp
R*! = COMe, Me, APr
Scheme 1.8.
Tp(1.35)
Scheme 1.9.
Cp (1.36)
Liebeskind disclosed a study of the formation of (77^ -allyl)Mo(CO)2Tp complexes 1.36 
(Scheme 1.10) from allylic acetates and Mo(CO)3(DMF)3 in 1995,^  ^building upon earlier 
work by Ipaktschi and Trofimenko.^^'^^ Unlike the related Cp-complexes (see section 1.4.1), 
(?]^-allyl)Mo(CO)2Tp complexes exist solely as exo isomers.^^’
'g o
(N ' ) 3  = Tp ■’
(a) Mo(CO)3 (DMF) 3TBGCI Ry^cZ^OTBS (C) TBAF
1.32 r2 r1 (°) KTp 1 . 3 3  r 2 I pjl (e) AczO or R"l p 2
1.3 - The choice of spectator ligand; Cyclopentadienyl (Cp) vs 
hydrotris(l-pyrazolyl)borate (Tp) - and the complications of Syn- 
Anti and Exo-Endo isomérisation.
The hydrotris(l-pyrazolyl)borate (Tp, 1.35) ligand is isoelectronic with the r\^- 
cyclopentadienyl ligand (Cp, 1.36) (Scheme 1.9), as both are anionic, six-electron donor 
ligands. In recent years, the Tp ligand has increasingly been used in place of Cp and offers 
several advantages:^^ (a) KTp is a readily available, air-stable solid (LiCp readily deteriorates 
unless stored and used under anaerobic and anhydrous conditions, and is best prepared 
freshly); (b) Cp is too basic and nucleophilic to be used with sensitive, functionalised 
systems; (c) Tp-bearing complexes are generally more robust and easy to handle than the 
sensitive Cp-analogues.
-Ï;
H'
Bfo-1.36 R
oc
Scheme 1.10.
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The utility of (?73-ailyI)M o(CO)2Tp and [(r/3-allyl)Mo(CO)(NO)Tp]+ systems is 
complicated by syn-anti isomérisation of terminal allylic substituents (Scheme 1 .11), a 
phenomenon with only very meagre precedent in the analogous Cp-based systems. The 
descriptors syn and anti refer to the configuration of the substituent relative to that at C2 of 
the allyl. Liebeskind observed several general trends: (a) the anti stereoisomer is favoured at 
equilibrium for 1°, 2"^  and 3° alkyl, C0 2 Me and OAc substituents; (b) aryl and OMe 
substituents show a preference for syn stereochemistry at equilibrium; (c) 1-monosubstituted 
complexes (137) require elevated temperatures (100°C, 2 h) to equilibrate; (d) 1,3-di- (138),
1,1,3-tri- (139) and 1,2,3-trisubstituted complexes (1.40) equilibrate at ambient temperature 
in solution.
'Syn
1.37 |^ o(C O )2 Tp Tp(CO)2Mo A^nti
1.39 P*' lilo(CO)2 Tp R' R" K/lo(C0 )2Tp
1.38 M o(C O )2 Tp Tp(CO)2Mo
B'
1.40 M o(C O )2 Tp
Scheme 1.11.
(COjzTp
X-ray studies of several of the above complexes rationalised the observed trends: steric 
hindrance between syn-substituents and two of the pyrazole groups on the Tp ligand render 
the anfï-isomers more stable. The exceptions are the methoxy and aryl substituents, which 
maintain a preference for the ^yn-configuration, as the anrTconfiguration involves a 
significant distortion away from the allyl plane with the resulting impairment of resonance 
delocalisation.
Information regarding syn~anti isomérisation of the corresponding cationic 
Tp(CO)(NO)Mo(?7^ -allyl) systems is sparse. A single report from Liebeskind has disclosed 
the synthesis and characterisation of deuterated complex 1.41a and symmetrically substituted 
systems 1.41b-1.41e (Scheme 1.12).^^ Replacement of the BF4 counterion by BAr4 [Ar = 
3 ,5 -(CF3)2Ph] gave complexes of sufficient stability to enable thorough spectroscopic 
investigation.
Mo(CO){NO)Tp
+ BArr 
1.41
Ar = 3,5-(GF3)2ph
1.41a 1.41b 1.41c 1.41 d 1.41e
Scheme 1.12.
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In contrast to the parent neutral dicarbonyl Tp complexes, acyclic cationic complexes 1.41a 
and 1.41b exhibit both exo and endo isomers (Scheme 1.13). Complex 1.41c existed solely 
as the endo isomer and cyclic complexes 1.41d / 1.41e as purely exo. Complex 1.41b 
showed no change in exoiendo ratio by NMR upon warming to 50°C. Together with other 
NMR evidence, this lead Liebeskind to conclude that the exo and endo isomers did not 
interconvert under the conditions explored.
N0BF4;
1.15 M o(C O )2 Tp KBAr4
N' BArr N' BAr -^
r ' -  ^
Exo-^ .41 b E^do^  ^ .41 b
Exo : Endo = 5 : 1
L = CO or NO, (N ' ) 3  = Tp 
Ar = 3 ,5 -{GF3 )2 Ph
Scheme 1.13.
The formation of endo isomers from acyclic complexes 1.41a-1.41c but not from the cyclic 
systems 1.41d / 1.41e prompted Liebeskind to explore the mechanism of ligand exchange 
and endo isomer formation. Deuterated complex 1.41b was used in the investigation, formed 
from neutral dicarbonyl precursor 1,42 in which the anti-syn deuterium ratio was 66  : 34 
(Scheme 1.14).
(a) NOBF4  ^ BAr4-
M o(C O )2 Tp (b) KBAT4
BfO-1.42
Anti : Syn  = 6 6  : 34
N' BAf4-I + H' BAr4~
S y n / Anti-Exo-'i A lb Syn-Endo-'i.i^b 1 : 1 Anf/-Enc/o-1.41 b
Exo : Endo = 6.7 :1
L = GO or NO, (N% = Tp 
Ar = 3 ,5 -(CF3 )2 Ph
Scheme 1.14.
The anti : syn deuterium ratio in e n d o -lA lh  was approximately 1 : 1 ,  estimated by 
comparing the total integration of anh-protons in the endo isomers to that of the central allylic 
protons (H2) (Scheme 1.14). The 1 : 1 ratio represents a decrease from the 66  : 34 ratio exo- 
anti : exo~syn in the parent neutral complex 1.42.
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Liebeskind drew the following mechanistic conclusions:
(1) The carbonyl-nitrosyl ligand exchange process occurs through an 77! -allyl 
intermediate 1.43 (Scheme 1.15, illustrated for allyl complex 1.41a). Intermediate
1.43 is formed via electrophilic addition of N0+ to neutral dicarbonyl complex 1.15 
with slippage of the aUyl unit from a rf>- to a r^Larrangement.
.3
(2) The endo isomer is formed solely by rotation about the C(l)-C(2) bond in 77L 
intermediate 1.43 (pathway A).
(3) Formation of the endo isomer by rotation about the Mo-C(l) axis in intermediate
1.43 (pathway B) is discounted; since this mode of rotation will not convert a syn- 
substituent to anti or vice-versa, and hence will not explain the deuterium scrambling 
observed in 1.41b.
C(1)-C(2)
rotation
H NO H 
1.44
CO
H2C Jo
1.43
Mo-C(1)
rotation tncio-1.41 a
L = CO or NO 
(N' ) 3  = Tp
NO
1.45
H
Scheme 1.15.
(4) A mixture of pathways A and B was discounted on the grounds that the 1 : 1 syn- 
endo-XA\\> : anti-endo-lAlh  ratio observed is equal to that predicted to arise via 
pathway A alone. Scheme 1.16 below illustrates how pathway A leads to an equal 
ratio of syn and anti substituents, assuming equal population of r]frintermediates 1.46 
/ 1.47. The deuterium is arbitrarily shown as anti in exo-lA2, an analogous process 
would scramble a syn deuterium substituent.
17
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(5) The formation of endo-lAlh exclusively by pathway A accounts for the formation of 
endo cation isomers in acyclic Tp systems alone; cyclic 7]^-allyl analogues of 1.46 / 
1.47 cannot freely rotate about the C(l)-C(2) allyl bond.
N'
,N'
o c 3 ^ c o
 I® "N' C(1}-C(2) rotation
-C O
1.46
D
Ant'hExo-\A2 fvjo+  .1® >"N'o c Â i l ^ c o
NO ^*^2 
1.47
0(1 )-C(2) rotation 
-C O
AnthEnaoA .41b
D
Syn-Endo-'\A1b
L = C O  o r NO 
(N')a = T p
Scheme 1.16,
Similar mechanisms have been proposed for endo-exo isomérisation with
concomitant scrambling of syn-anti substituents in CpM(C0 )(7^ 3_allyl) complexes (M = Fe 
or Ru).^^’ The meagre precedent established by Liebeskind indicates that acyclic cationic 
Tp(CO)(NO)Mo(?73-allyl) complexes are formed as static mixtures of exo and endo 
conformers, presumably in a kinetic ratio. Syn-anti scrambling of the terminal deuterium atom 
in complex 1.42 upon formation of the cation, together with the dynamic equilibration of syn- 
anti isomers in the coiTesponding neutral dicai’bonyl precursors {via a similar rfi
mechanism)^ ^  suggests that acyclic cationic Tp-based systems 1.48 are likely to be of limited 
use in synthesis. Nucleophilic attack upon syn and anti-lA^ (arbitrarily at the terminus) 
would result in geometrical olefin isomers {E)- and (Z)-1.49 respectively (Scheme 1.17).
1+ X-
Mo(CO)(NO)Tp
S/n-1.48
Nu
a -1 .4 9
fYNu
(Z)-1.49
Nu rM +Mo(CO)(NO)Tp
AnM AQ
Scheme 1.17.
The cyclopentadienyl systems popularised by Faller do not generally exhibit syn-anti 
isomérisation, presumably as a result of the lower steric bulk of Cp compared to Tp. In one 
reported case of syn-anti isomérisation in a Cp-system, crotyl complex anti-1.5^ isomerised 
to jyn-1.50 upon heating to 100°C for 3 days (Scheme 1.18). The preference for the syn- 
isomer is the opposite to that favoured by Tp-complexes.^^
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Cp(CO)2Mo
Anti-^l,50
100”C
3 d Mo(CO)2Cp
Syn-1.50
Scheme 1.18.
Cyclic systems cannot undergo syn-anti isomérisation because of geometrical constraints, 
and the Tp ligand can be used without complication. The recent use of enantiopure neutral 
complex 1.51 in a series of [5+2] cycloaddition reactions to form oxabicyclo[3.2.1]octenes 
1.54 illustrates the point (Scheme 1.19).^^
lo(CO)2Tp 
/„4 J  1.51 
R2
©
iy!o(CO)2 Tp
1.52
Tp(CO)aM
1.53
Scheme 1.19.
The work presented in this thesis in chapters 2 and 4 utilises planar chiral acyclic cationic 
(cyclopentadienyl)molybdenum complexes 2.1 / 2.2 and 4.1 (Scheme 1.20) as equivalents for 
the enantiopure, geometrically pure allylic cation synthons 2.121 / 2.122 and 4,5 respectively. 
Whilst the benefits of the analogous Tp systems discussed in this section are acknowledged, 
the possible complications resulting from syn / anti isomérisation of unsymmetrically 
substituted cationic complexes precluded their use in our work.
BFr
NOCp
r  /
ON
BFr
Pr
2.121
BF4-
Cp
00
O^N
BF4 -
2.122
BF4- BF4-'
O N " s CO Cp
00
O^N
Scheme 1.20.
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1.4 - Nucleophilic attack upon cationic CpMo(CO)(NO)(rj3-allyl) 
complexes.
1.4.1 - Mechanism of exo-endo  isomérisation in Cp-based complexes and an 
examination of the factors governing stereo- and regiocontrol in alkylation.
The existence of CpMo(CO)2( a s  a mixture of isomers was first observed by 
King^^ in 1966 and later proposed to result from differing orientations of the allyl group with 
respect to the Cp-ring (Scheme 1,21).'^  ^ The CpMo(CO)(NO)(?;^-C3H5) cation (1.55, R = 
R' = H) was also found to exhibit similar behaviour.^^ In contrast to the Tp-systems, all 
neutral and cationic Cp-based complexes freely interconvert in solution without exchange of 
syn and anri-substituents. The orientational isomers are termed exo and endof^ with the exo 
rotamer defined as that in which the substituent at the central carbon (C2) of the allyl ligand is 
proximal to the cyclopentadienyl ligand, and the endo as that where the allyl ligand has 
rotated through 180 degrees to place the C2 substituent distal to cyclopentadienyl.
NO 
EjfO-1.55
ON^'f^COBF4- 6p
I
BF4-
BF4-
-R'
NO 
Enc/o-1.55
Scheme 1.21.
In contrast to the mechanism observed for the Tp-systems which enables syn and
anri-substituents to interconvert, the mechanism of rotamer interconversion for the 
cyclopentadiene based complexes is one of 'pseudorotation' about the Mo-allyl axis.^ *^"^  ^A 
similar mode of interconversion has been described for the analogous 
C5Me5)Re(CO)2(7?3-C3H5)][BF4] complex.'*’^  Exo-endo isomérisation does not change the 
face of the allyl ligand which is blocked by the metal, only the orientation of the ligand witli 
respect to the Cp-group.
Factors affecting the regio- and stereochemistry of nucleophilic attack upon cationic 
complexes have been analysed by Faller and Kochi. The vast majority of the work was 
carried out with a limited range of nucleophiles; enamines, enolates, hydride, thiophenoxide 
and malonate derivatives. The complicated kinetic pathways have led to much uncertainty and 
contradiction over the years, with many concepts being revised with time. Nevertheless, the 
following conclusions have been drawn:
(a) Nucleophiles attack the face of the planar allylic ligand anti to the metal.^^
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(b) Regiochemistry of attack is governed by the stereochemistry at molybdenum. 
Addition occurs cis to the nitrosyl group, in accordance with attack at the point of 
lowest electron density on the allyl ligand. The selectivity is rationalised by a 
consideration of the electronegativities of C and N, and the different back bonding 
properties of CO and NO. The electronic distribution at the metal is distorted, leading 
in turn to a polarisation of the allyl ligand."^ ’^
(c) Carbonyl-nitrosyl exchange is unselective.^^
(d) The g%c-isomer reacts faster than the endo-isom&r, and as the exo- and endo-homexs 
are in rapid equilibrium under the reaction conditions kinetic selection for the exo- 
isomer can occur."^^’ The isomérisation is generally catalysed by the 
nucleophile.^
The implication of conclusions (b)-(d) for alkylation of an unsymmetrically disubstituted 
complex 1.55 is that the central chirality at molybdenum governs regioselectivity (Scheme 
1 .2 2 ): complexes S'Mo-^-^o-1.55 and RMo-;Gh:o-1.55 giving rise to regioisomeric products 
1.56 and 1.57 respectively. (Priority for assigning the stereochemistry at Mo; NO
> CO )P
Nu 1.56
Nu
Fast
SMo-Bfo-1.55
BF4
00
Nu
ON \f?Mo 'FxO'  ^.55 Nu
Fast
B Fr
00 '
U 
ON R:
H
Smo-& 1C/0-1.55 f?Mo'&iCfo-1.55
Scheme 1.22.
Liebeskind has described the addition of higher order cyanocuprates to functionalised 
complex 1.59 (Scheme 1.23), '^  ^ giving olefinic complexes 1.60 and ultimately a,/3- 
unsaturated ketones 1.61 with a high degree of regioselectivity. NMR spectroscopic data 
for olefinic complexes 1.60 indicated in each case the presence of predominantly a single 
diastereomer, leading Liebeskind to infer that the CO —> N0+ exchange (1.58 —> 1.59) was
21
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highly diastereoselective. Spectroscopic analysis (including the estimation of endo-exo 
rotamer composition) of cationic 77^ -complex 1.59 was not available because of instability in 
solution, but a crystal structure of intermediate 1.60 (R = Me) was obtained. The X-ray 
structure indicated that the observed products had arisen from nucleophilic addition either 
trans to the nitrosyl ligand in exo-1.59 or cis to the nitrosyl in endo~l.59, in stark contrast to 
Faller’s predictions. Liebeskind was unable to rationalise the apparent diastereoselectivity of 
the ligand exchange process. Similarly, the precise rationale for the failure of the nitrosyl to 
control nucleophilic attack was unclear, although a product-like transition state favouring 
conjugated products 1.60 arising from attack at C4 was suggested.
' + PFe- 
OC / X
OC
1.58 O
NOPFb 
DME, 0=C
Exo-1.39 R2 Cu(CN)Ü2
THF, -78°C  
35-91%
PFb- 
ON'"
OC Bndo-1.59
1.60 H - 7 ^ o
CAN, NaOAc 
M82C0; 73-81%
1.61 R
R = n-Bu, s-Bu, Ph, 
2-propenyl, PhaC, 
Me (X-ray obtained)
Scheme 1.23.
Liebeskind also looked at the formation of disubstituted pentenone products 1.65 and 1.66^  ^
(Scheme 1.24). Nucleophilic addition to (rf^-cyclopentadiene)(77^-cyclopentadiene)dicarbonyl 
molybdenum cation 1.62 yielded substituted neutral dicarbonyl complex 1.63. Subsequent 
activation by hgand exchange yielded electrophile 1.64, on which a second nucleophihc attack 
could be performed, more hindered nucleophiles (Me2Cu(CN)Li2 or NaC(Me)(C0 2 Et)2) 
attacking predominantly the less sterically demanding 2 -position.
o o f  ^00 
1.62 O
MeMgCI
THF, -78"C °o /V NOPFa DME, 0°C
1.64 Me
NaCNBDa, Me2Cu(CN)Llg 
NaCH(C0 2 Me)a or 
NaC(Me)(C0 aEt) 2
R 1 .6 5 :1 .6 6
D 1 0 0 : 0
CH(C0 sMe) 2 95 :5
Me 1 5 :8 5
C(Me)(C0 2 Et) 2 0 : 1 0 0
00
1.65 1.66
Scheme 1.24.
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Liebeskind's work is important for several reasons:
(a) Reaction of cationic 773-allylmolybdenum complexes with 'hai*d' nucleophiles is rare.
(b) Nucleophilic attack cis to nitrosyl in exo-1.59 and exo~h64 is not observed.
(c) Carbonyl nitrosyl exchange is appai'ently highly diastereoselective.
(d) Both electronic and steric demands of the ally lie ligand play a role in determining 
regioselectivity, overriding the nitrosyl directing effect. The dependence on steric 
factors is mirrored by precedent from the Kocienski group (section 1.5.3).
(e) The disubstituted cyclopentenone syntheses exemplify an important advantage that 
stoichiometric 7]3-allylmolybdenum complexes have over catalytic allylic alkylations: 
the directing influence of the metal fragment can be multiplied in sequential additions 
to the same substrate.
1.4.2 - Methods for demetallation following nucleophilic attack.
Several procedures have been described for cleavage of the CpMo(CO)(NO) fragment from
product olefins:
(a) Exposure of a chloroform solution of the crude material to air.^ The procedure is 
mild, but slow, reaction times of a day or more generally being required. As described 
in chapters 2 and 4, we have found that bubbling gaseous oxygen through the crude 
solution provides a more rapid alternative.
(b) High pressure CO cleaves the olefin from molybdenum, releasing 
CpMo(CO)2(NO).9
(c) Strong base - if the olefin can withstand the conditions.^
(d) Oxidation by ammonium cerium(TV) nitrate (CAN), often buffered by NaOAc.^^
(e) Pearson has used intramolecular attack upon a cationic Mo(CO)(NO)Cp(??^-allyl) 
system by a pendant acid to effect simultaneous lactonisation and olefin 
décomplexation (Scheme 1.25).^  ^Noteworthy in the sequence below is the excellent 
stability of the Mo(CO)2Tp moiety during functional group manipulations.
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Mo(CO)2Tp 
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(a) NaCH(S0 2 Ph)C0 2 Me
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(c) KOH;77%
1.68 Vo
,M o(CO)2 Tp
OH
NOBF4. EtgN
72%
{±)-1.69 O
Scheme 1.25.
1.5 - Stereochemical issues.
1.5.1 - Asymmetric synthesis via resolved complexes.
The (773-allyl)Mo(CO)2Cp and [(773-allyl)Mo(CO)(NO)Cp]+ BF4-  systems popularised by 
Faller are configurationally stable; the metal moiety cannot migrate from one enantioface of 
the planar allyl ligand to the other. If it can be arranged for one face of the ally! ligand to be 
specifically blocked by the molybdenum fragment, then an incoming nucleophile will 
specifically attack the opposite face, anti to the metal (Scheme 1.26). Herein lies an important 
difference between palladium-catalysed and stoichiometric Mo allylic alkylation reactions: 
palladium forms coordinatively unsaturated 16-electron 77^ -allyl electrophilic complexes 1.71, 
whereas the metal in [(?73-allyl)Mo(CO)(NO)Cp]+ BF4-  complexes is a coordinatively 
saturated 18-electron species. A nucleophile attacking the allyl ligand should therefore only 
be able to do so from the face anti to molybdenum, which acts as a steric shield, blocking the 
jyn-face. In the palladium case however, there is the possibility for nucleophilic attack syn or 
anti to the metal fragment. In general, “soft” nucleophiles (such as stabilised carbanions) 
attack anti, whereas “hard” nucleophiles (organometallic reagents for example) can initially 
attack the palladium, before alkylation via reductive elimination of intermediate 1,72.^
::::AI
X-
^  Nu
.R' Anti attack
1.70
snM .70
-L„Pd Syn
attack
0  R Anti attack
1.72 ©
Nu
1.71 ©Nu (SOFT)
(HARD) 1.70
Scheme 1.26.
Carbonyl-nitrosyl ligand exchange results in a chiral molybdenum centre, a racemic mixture 
if the r^^-ligand is symmetrical. Faller used a neomenthylcyclopentadienyl (NMCp) ligand as
ÿ
I.-II
,
I
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a substitute for Cp to form diastereomeric complexes 1.73 (Scheme 1.27), which were 
subsequently separated by crystallisation.^! Coupling of cation %o-l*73 with enamine 1.74 
yielded optically pure olefin 1.76 following oxidation.
= NMCp
BPh4-
ON
BPh4"I 4- /  orii4 I " y
P?Mo •0X'O1.73
ON"
00
.73
BPh4- 1.74
0
Smo'SW-1.73 MeCN, 0“C: H2 O
^MCp
ON">;Mo
OHO
Scheme 1.27.
"T^cho
1.75 (R)-1.76
1.5.2 - Formation of planar chiral complexes from enantiopure allylic esters.
Enantiofacial control without the need for resolution is possible, as demonstrated by Faller in 
a study designed to elucidate the stereochemical pathway of Mo~catalysed asymmetric 
alkylations (Scheme 1.28).^® Oxidative addition of enantiopure allylic acetate 1.77 to 
Mo(CO)3(MeCN)3 occurred with clean retention of configuration, yielding products of 
overall inversion following nucleophilic attack upon cationic complex 1.78. In line with the 
precedented directing effect of the nitrosyl ligand, nucleophilic attack yielded an equimolar 
mixture of regioisomers 1.79 and 1.80.
AcO'
BF4'
(a) Mo(CO)3 (M0 CN) 3  
/.Pr (b) LiCp ON^oc
1.77
(c) NOBF4  
RETENTION
(d) NaCH(C0 zMe) 2 Nu 1.79
1.78 (0 ) CAN 
INVERSION 
Nu = CH(COgM0 ) 2
/-Pr
1.80
Scheme 1.28.
The retentive oxidative addition of acyclic allylic acetate ent~ l.ll to Mo(CO)3(MeCN)3 
demonstrated by Faller was confirmed by Kocienski in the synthesis of Salinomycin,^^ (see
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section 1.5.3) and complemented by Liebeskind for cyclic acetate 1.81 and bromide 1.83 
(Scheme 1.29).^^’^^
,.‘OAc 
Q - ^ ^ O A c  (b) LICp
(a) Mo(CO)3 (MeCN) 3
1.81 RETENTION
iyio(CO)2Cp
O '^  O' 
1.82
(a) Mo(CO)3 (MeCN) 3
IVleO O'' 
1.83
(b) LiCp 
RETENTION
MeO*
iyio(co)2Cp
'O '
1.84
Scheme 1.29.
Further investigation of cyclic systems by Liebeskind revealed that cleanly retentive oxidative 
addition pathways cannot be universally assumed for alternative Mo(0) systems (Scheme 
1.30).®  ^Dihydropyranone 1.86, when treated with Mo(CO)3(DMF)3 in CH2CI2 gave 1.88, 
the product of overall retention. In contrast, diastereomeric dihydropyranone 1.89 gave a 12 : 
1 mixture of inversion (1.88) and retention (1.90) products with Mo(CO)3(DMF)3. Retentive 
product 1.90 could be prepared independently using Mo(CO)3(PhMe) as the Mo(0) source. 
Mo(CO)3(DMF)3 could be utilised with acetate 1.85 to yield complex 1.87 via inversion.
Mo(CO)2Cp
o
1,87
(a) Mo(CO)3 {DMF) 3
(b)KTp 
INVERSION
OAC
j f l '0 ^ 0 '^R
R = H, 1.85 
R = CHaOAc, 1.86
(a) Mo(CO)3 (DMF) 3
(b) LiCp 
RETENTION
iVlo(CO)2 Cp
1.89
(a) Mo(CO)3 (DMF) 3  or 
Mo(CO)3 (PhMe), CHaCIa
(b) KTp
Mo(CO)3 (DMF) 3  : 
Mo(CO)3 (PhMe) :
OAc OAc
1.88
INVERSION
12
0
1.90
RETENTION
1 • 
100
Scheme 1.30.
Liebeskind concluded that retentive or invertive pathways were both feasible, depending upon 
a number of factors including the nature and effective concentration of the Mo(0) source, 
temperature, and steric constraints imposed by the substrate. Only Mo(CO)3(MeCN)3 ,
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Mo(CO)3(PhMe) and Mo(CO)4 (py)2 appear to be unambiguous sources of Mo(0) for 
retentive oxidative addition pathways, with Mo(CO)3(DMF)3 giving inversion under 
appropriate conditions.
Homochiral allylic esters are readily available, the corresponding alcohols being obtained by 
several methods, including kinetic resolution via Sharpless asymmetric epoxidation, 
enzymatic resolution or from the chiral pool. Coupling with the reliable Mo(CO)3(MeCN)3, 
Mo(CO)3(PhMe) or Mo(CO)4(py)2 reagents should therefore allow access to enantiopure 
-allyImolybdenum complexes. A restriction to the use of allylic acetates is their rather low 
reactivity compared to the corresponding halides, however, as described in section 1 .2 .2 , an 
allylic benzoate provides a more reactive substitute. Liebeskind has used achiral or racemic 
allylic diphenylphosphinate esters in combination with Mo(CO)6 in refluxing MeCN as an 
alternative to the allylic acetate / Mo(CO)3(MeCN)3 combination.^^’ At the time of writing 
(July 2000) nothing further has been reported, and the use of these substrates for the 
formation of enantiopure complexes has yet to be explored.
1.5.3 - Regioselectivity in alkylation of unsynimetrically substituted complexes.
In contrast to Pallet's observations, Kocienski found that attack of cuprate nucleophile 1.91 
upon planar chiral substituted complex 1.92 gave a single regioisomeric product 1.93 
following oxidative décomplexation of the metal (Scheme 1.31).^^’
,0 TB DPS 
1.91 Cu(SPh)Li
1.92 OTBDPS
1.93(b) CHCI3 , Air; 44%
Scheme 1.31.
Further precedent was established^^’ using configurationally stable organocopper(I) 
nucleophiles 1.95 and 1.97,^  ^derived from the corresponding stannanes 1.94 and 1.96^  ^ ^  
at low temperatui’e (Scheme 1.32).
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Scheme 1.32.
Coupling of 1.95 and 1.97 with complexes 1.78 and 1.92 (Scheme 1.33) gave in each of the 
4 cases predominantly the olefin arising from attack at the less sterically hindered terminus of 
the allylic unit (regioselectivity >8:1). X-ray structures of derivatives of olefins 1.98 and 
1.101 established that: (a) the stereochemistry of the a-glucosylcopper(I) reagent was 
retained in the alkylation; (b) the geometry of the double bond was retained from acetate ent~ 
1.77; (c) clean overall inversion had occurred with respect to 1.77.
FeCIa 
AcaO ;72%
1.98, R = Bn OR
RO-
1,99, R = Ac 
(X-ray)
V-Pr
(a) 1.97
(b) CAN; 49%
OBn
BnO"
Bn'
1.100 7-Pr
(a) 1.97
(b) CAN; 54%
CO : '"NO 1.78
(a) 1.95
(b) CAN; 81%
FeCia 
AcaO; 72%
1.101, R = Bn
1.102, R = Ac 
(X-ray)
V-Pr
Scheme 1.33.
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(b) CAN; 75%
.OBn 
BnO-"\^—'R
1.103 7-Pr
I
■'I
1
4
g
The Kocienski precedent established that the electronic directing effect of the nitrosyl ligand 
could be overcome on the grounds of steric differentiation between the methyl and wo-propyl 
allylic termini, negating the need to control central chirality. Furthermore, the work revealed 
the potential for the use of functionalised a-alkoxyalkylcopper(I) nucleophiles in conjunction
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Scheme 1,34.
The regioselectivity complications arising from central chirality in cationic 7t- 
allylmolybdenum systems do not occur with complexes 1.108 /1.109, as the iron is achiral. 
Complete y-regiocontrol is obtained on electronic grounds, directed by the electron- 
withdrawing effect of the sulfone or ester group (Scheme 1.35). Olefins 1.110 are products 
of overall retention of configuration with respect to the starting allylic ether {via double 
inversion), nucleophilic attack occurring anti to the metal.
s .^ ^ ^ x -^ ^ E W G  Nu = silyl enol ethers, amines, arenas,
o c  -  iT silyl ketene acetals, RCu(CN)ZnBr.  k co ). Au' ^  52-99%, 0 0  > 95%
1.108 ,1 .109
Scheme 1.35.
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with planai* chiral cationic complexes, simultaneously creating 2  stereocentres with excellent 
control.
1.6 - Parallels between stoichiometric molybdenum- and iron- 
based 7]3-allyl chemistry.
The stoichiometric use of planar chiral cationic ??^-allyliron complexes has been investigated 
by Enders in recent years (Scheme 1.34), and parallels the molybdenum chemistry discussed 
above.^^ In common with the above strategy, an optically pure allylic substrate (1.104 /
1.105) serves as a precursor to planar chiral complex 1.108 /1.109, In contrast to the 
molybdenum chemistry, inversion of configuration is observed in formation of complexes 
1.108 /1.109. The stereocomplementarity of the Mo- and Fe-systems originates from the 
different roles played by the allylic leaving group. In the molybdenum case, an ester is used 
to tether the metal, directing it to the same face of the allylic unit, resulting in excellent 
retentive formation of the planar chiral allyl complex. In the iron-based systems, the allylic 
ether acts simply as a steric shield, forcing the iron moiety to coordinate to tlie opposite face 
of the olefin (intermediates 1.106 /1.107), before formation of the ty^-array in a subsequent 
step. Cationic complexes 1.108 /1.109 are obtained in good yield and optical purity (>95%) 
following purification by repeated precipitation.
I
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Nakanishi has described the preparation of analogous Fe(CO)2(NO)(ry3-allyl) complexes 
1.112 and 1.113 (Scheme 1.36).^  ^Although formally neutral, the ability of the nitrosyl ligand 
to act as a one, two or three-electron donor allows the complexes to react with nucleophiles 
and electrophiles. Planar chiral complexes 1.112 and 1.113 are formed from allyhc bromides 
1.111 bearing chiral amide or ester auxiliary groups.^^ The diastereomeric complexes are 
readily separable by column chromatography.
Nu
28. 72-95% I
Nu %de = 79->98% Fe(C0 )2(N0 )
1.116 1.112
Nu
R' " 62-82%
F e(C 0)2(N 0) %de = 92->98% Nu
1.113 1.117
Nu = BnNHa, BnNHMe, NaCH{CQ2 Me)2 , NaCH(COM0 )(CO2Et), NaCH(CN) 2
Scheme 1.38.
Monosubstituted complexes 1.118 have also been investigated (Scheme 1.39).® ’^ 
Alkylation with sodiodiethylmalonate gives predominantly substitution at the less hindered 
allyl terminus. Amination is more problematic; phenyl and ester substituents on the allyl give 
complete regioselectivity, but alkyl substituents result in a mixture of regioisomers.
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1-111 1.112 1.113
R1 = H or Me, R2 = (S)-NHCH(Me)Ph,
(f?)-OCH(Me)Ph or (S)-OGH(Me)n-Hex
Scheme 1.36.
Alternatively, complexes 1.115 can be formed from optically active allylic substrates (e.g. 
tosylate 1.114) (Scheme 1.37), the stereoselectivity being highly dependant upon the nature 
of the leaving group and the solvent.^®
Bu4 N[Fe(CO)3(NO)]
OEt --------------------------- >- "OEt
6 7 ^ ,T f% :3  Fe(CO)2 (NO)
1.114 1.115
Scheme 1.37.
As expected, complexes 1,112 and 1.113 are aminated or alkylated with excellent 
regioselectivity as for the analogous Enders systems (Scheme 1.38).®^
'■ '5.,
Nu
Fe(C0 )2(N0 )
1.118
1.119
1.120
n Nu 1 .119:1 .120
Me NaCH(C0 2 et }2 83: 17
Me BnNHa 6 3 :3 7
Ph NaCH(C0 2 Et) 2 1 0 0 : 0
Ph BnNHa 1 0 0 : 0
/7-C 5 H11 BnNHa 8 2 :1 8
COaMe BnNHa 1 0 0  : 0
Scheme 1.39.
1.7 - Conclusions.
The requirements set out in section 1.1 for asymmetric synthesis using planar chiral 
allylmolybdenum complexes have been met. Faller, Liebeskind and Kuhl have shown that 
formation of planar chiral neutral complexes with clean retention from optically active 
precursors is feasible, and that nucleophilic attack occurs anti to the metal. Furthermore, 
Kocienski has shown that good regiocontrol using an unsymmetrically substituted complex 
can be obtained without the need to control central chirality.
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The molybdenum based chemistry mirrors similar iron based work, but has the advantage of 
excellent facial stereocontrol without reliance upon recrystallisation or chi'omatography. The 
Kocienski work with functionalised, configurationally stable chiral organocopper(l) 
nucleophiles demonstrates the potential for the application of planar chiral rj^~ 
allylmolybdenum complexes to asymmetric synthesis.
The work contained in this thesis in chapters 2 and 4 builds upon the knowledge of r}^ ~ 
allylmolybdenum complexes described here in chapter 1, with an ultimate application of the 
strategy to natural product synthesis.
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Chapter 2 - Alkylation of substituted r/^-allylmolybdenum 
complexes.
Chapter 2 will describe an expanded range of nucleophiles compatible with planar chiral 
cationic complexes 2.1 and 2.2 (Scheme 2.1). We show that the good regiocontrol with 
alkylcopper(l) nucleophiles described in the previous chapter is general for a number of 
readily available substrates. The nucleophiles chosen were not aimed at specific synthetic 
targets, but in most cases contain functionality which would allow further elaboration of the 
olefin products.
2.3
4
Nu ' ^
Nu Nu 2.4
A
I  ! Nu
BF4- /-Pn f P BFr
NO
2.1
CO^^^NOCp ON^'ï^COCp
I BF4-
ON
2.2
Scheme 2.1
2.1 - Synthesis of jp-aliyhnoiybdenxun complexes 2.1 and 2.2.
We have used two procedures to secure enantiopure allylic precursors to complexes 2.1 and
2.2. Initial work utilised kinetic resolution via Sharpless asymmetric epoxidation,^^ allylic 
acetate (S)-2.7 being obtained in moderate overall yield in three steps from crotonaldehyde 
2.5 (Scheme 2.2). The enantiomeric ratio at C3 of intermediate alcohol (5)-2.6 was estimated 
as 97:3 via formation of the corresponding (f^)-<%-methoxy-a-trifluoromethylphenylacetate 
ester 2,8 and NMR spectroscopic analysis. The corresponding (R)-alcohol and
acetate were prepared in similar fashion (29%, er = 93:7 and 87% respectively).
:
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(a) /-PrMgCI, EtaO
y  -3 0 “C-^rt, 1.5h; 6 6 %
2.5
AcaO, py, DMAP
OAc (S)'2.7 CHaCIa, rt; 86%
OH 2.6
(b) H-OCDT, TBHP, Ti(0 f-Pr)4 , 4Â MS 
CHaCIa, -20°C , o/n; 26% for (S)-2.6
(fl).PhC(0 Me)(CF3 )C0 ^
DCC, DMAP, CHaCIa, rt; 78% 
(S)-2.6, er = 97 : 3
Scheme 2.2
0 ^ 0  2.8
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The kinetic resolution procedure was reliable in terms of the enantiopurity of allylic alcohol 
{R)~ or (S)-2.6, but as with all resolutions, the sequence is wasteful, the epoxide formed being 
of no use to us. We subsequently turned our attention to an alternative enzymatic resolution, 
which would allow access to either enantiomer of acetate 2.7 from a common precursor.
Novozym 435 is the trade name of the recombinant, immobilised B-component lipase from 
the yeast Candida antarctica, and is particularly efficient and robust, catalysing a diverse 
range of regio- and enantioselective syntheses.^^ The enantiospecificity of the enzyme has 
been predicted based on the crystal structure and modelling of the active site region, 
indicating that only (i?)-enantiomers should be able to form the intermediates required for 
catalysis.U ppenberg and co-workers have resolved the amino acid sequence and three 
dimensional structure of CALB (Candida antarctica B-lipase) and postulated the general 
mechanism shown in Scheme 2.3.^^ The catalytically active serine residue is located at the 
bottom of a deep, narrow pocket approximately 10 x 4Â wide and 12Â deep,^^ and CALB 
exhibits a high degree of substrate selectivity which is related to the limited amount of space 
available in the active-site pocket.
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Attempts to acetylate (±)-2,6 under standard conditions'^"  ^(Novozym 435, vinyl acetate, 4Â 
MS and pentane at ambient temperature) were fruitless, NMR spectroscopy of the crude 
reaction indicating < 5% acétylation after 5 days (Scheme 2.4). Attention then turned to the 
saponification of racemic allylic acetate 2,7, but treatment with Novozym 435 in a 10 : 1 pH 7 
Buffer : f-BuOH mixture^^ similarly failed to produce any alcohol product after 3 days at 
ambient temperature.
Novozym 435 (10 wt%) 
4Â MS (50 wt%)
OH
(±)-2.6
Vinyl acetate (25 eq) 
Pentane, rt, 5 d
■ No reaction
Novozym 435 (10 wt%)
pH 7 buffer : f-BuOH (10:1) 
rt, 3 d
■ No reaction
Scheme 2.4
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As an alternative we decided to investigate the use of allylic alcohol 2.10 which offered 
reduced steric congestion around the hydroxyl group, presumably the cause of the 
incompatibility of 2.6 and 2.7 with CALB. Prepai-ation of racemic alcohol 2,10 (Scheme 2.5) 
was straightforward, but our task was complicated by the commercial availability of enone 2 .9  
in only 75% purity, the remainder being isomer 2.9b. Reduction yielded a mixture of 
inseparable, volatile alcohols 2.10 / 2.11 in the approximate ratio 4.7 : 1. The corresponding 
acetates 2.12 / 2.13 (Scheme 2.6) were also inseparable; however, it was hoped that complex 
formation from a mixture would be possible as 2.13 would not react with the Mo(0) source to 
form an ?73-intermediate. Undesired acetate 2.13 (b.p. 60-62°C / 13 mmHg^^) was judged to 
be volatile enough to be removed upon prolonged drying in vacuo.
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Scheme 2.5
2,12 / (i?)-2,13 allowed the estimation of the enantiomeric excesses of alcohol (S)-2,10 and 
acetate {R)-2A2 as >95% and 92% respectively via (i?)-acetylmandelate ester formation and 
iH NMR analysis.
2 . 1 0  OH
(S)-2 . 1 0  OH \  (S)-2 . 1 1  OH
Novozyme ® (10 wt%) 41 %, 2.10 :2.11 = 5.4 : 1, er^io > 9 7 : 3
Vinyl acetate (25 eq)
2 . 1 1  OH 4Â MS (50 wt%) Pentane, rt, 10 h
Scheme 2.6
Our early studies into the formation and use of 77^ -allylmolybdenum complexes used the 
Mo(CO)3(MeCN)3 based procedure described in Chapter 1.  ^Neutral complex 2.14 was 
formed from allylic acetate {R)-2.1 in 78% yield, and complex ent-2.14 in 73% yield from 
(S')-2.7 (Scheme 2.7). Complex 2.14 was isolated as a dark-red oil after purification by 
column chromatography under inert atmosphere.^^ and i^C NMR spectroscopy indicated 
that the purity of material prepared using the Faller procedure was reasonable, but 
contamination of 2.14 by minor unidentified products was obvious. Nevertheless, conversion 
into complex 2 ,1  by ligand exchange using nitrosonium tetrafluoroborate was 
straightforward, and the cationic species was isolated as a fine yellow solid in 78% yield by 
precipitation in cold ether and filtration under inert atmosphere. The yield of cationic complex
2.1 was capricious, a minimum volume of MeCN being necessary to prevent 2.1 being 
deposited as an oil. Stringent precautions were needed to exclude moisture and air from the 
sensitive solid cationic complexes, which readily decomposed taking on a sticky, green
35
I
NaBH4  (1 . 1  eq)
MeOH, 5°C —> rt, o/n | f
O O 67% OH OH
s
Alcohols (±)-2.10 / (±)-2.11 were subjected to the standard Novozym acétylation conditions 
(Scheme 2.6),^ "^  reaction proceeding quickly and efficiently to yield acetates (R)-2.12 / {R)~ 
2.13 in 45% yield and alcohols (5')-2.10 / (5)-2.11 in 41% yield. The reaction was followed
periodically by NMR spectroscopic analysis of crude reaction samples, >50% conversion 
being attained after 7.5 h at ambient temperature. Saponification of a portion of acetates (R)-
t
(R)-2 . 1 2  O A c \  (fl)-2.13 O A c
45%, 2.12 :2 .13  = 3.8 ; 1, era.iz = 96: 4
appearance. Tetrafluoroborate salts such as 2.1 and 2.2 are well precedented to be sensitive to 
moisture, a suggested decomposition route being decarbonylation promoted by fluoride ion 
liberated from hydrolysis of the BF4 a n i o n . T h e  precedented unselective ligand 
exchange in formation of cationic complex 2.1 was confirmed by and l^C NMR 
spectroscopy. Complex 2.1 initially appeared as a mixture of 2 major isomers in an 
approximately equimolar ratio, along with a further pair of minor isomers. The major isomers 
are assigned as endo conformers, on the basis of observations from Faller that cationic (r? -^ 
allyl)Mo(CO)(NO)Cp species are foimed as kinetically controlled mixtures of isomers."^ *^ 
The mixture gradually proceeds towards thermodynamic equihbrium, eventually favouring the 
conformer which was thermodynamically favoured in the parent neutral complex. Neutral 
complex 2.14 exists in solution as a 5 : 1 exo : endo mixture, assignment based on the 
characteristic upfield exo resonance (<5 -1743) in the ^^Mo spectrum and the existence of 
similarly substituted complexes predominantly in ^o-confbrmations.^^
The use of Mo(CO)4(py)2 ^^  (see Chapter 1, section 1.2.2) provided a viable alternative to the 
original Faller protocol, allowing the formation of neutral complexes 2.14 and gnr-2.14 in 
high yield and excellent purity as judged from NMR spectroscopy (Scheme 2.7).
The use of a mixture of acetate isomers 2.12 / 2.13 did not hamper formation of the neutral 
complex. Periodic analysis of the crude reaction mixture by NMR spectroscopy revealed 
complete consumption of allylic acetate within 58-63 h. LiCp ligand exchange in the normal 
fashion yielded neutral complex 2.14 uncontaminated by acetate 2.13, which was volatile 
enough to be removed by prolonged drying in vacuo.
I
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Mo(CO)e
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A, 12 h
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82% from (S)-2.12
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(S)-2.13 O A c
OAc
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Mo{CO)6
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(a) Mo(CO)3 (MeCN) 3  
MeCN, A, 40 h
(b) LiCp, THF, rt, 1 h; 45%
Mo(CO)s
THF, py (2 eq) 
A, 12 h
(a) Mo(CO)4 (py)g 
THF, A, 63 h
o<yï°^coCp
Enf-2.14
Scheme 2.7
(f?)-2.12 OAc 
+
(b) LiCp, THF, rt, 1 h 
8 6 % from (Fl)-2.12
(R)-2.13 OAc
Similarly, unsubstituted allyl complex 2.16 was prepared in 8 6 % yield from allyl benzoate 
and Mo(CO)4(py)2 (Scheme 2 .8 ). In contrast to the substituted cationic complexes, allyl 
cationic complex 2.17 readily precipitated in cold Et2 0 , and was isolated in 8 6% yield as a 
fine yellow solid.
Mo(CO)e
215
OBz
THF, py ( 2  eq) 
A, 12 h
(à) Mo{CO)4 (Rr)a 
THF, A, 63 h
(b) UCp, THF, rt, 1 h; 8 6 %
■BF.
,Mo. NOBF4
MeCN,0“C, 8 6 %
2.16 
Scheme 2.8
ON'^ f^ ^CO
Cp
2.17
A drawback with using a mixture of acetates 2 .1 2  / 2.13 in combination with Mo(CO)4(py)2 
is the lengthy reaction time for oxidative addition; 63 h compared to 40 h with 
Mo(CO)3(MeCN)3 and acetate 2,7. The greater reactivity of Mo(CO)4(py)2 compared to 
Mo(CO)3(MeCN)3 is illustrated by the reaction times required for oxidative addition of 
benzoate 4.17 (see Chapter 4), 18 h and 28 h respectively. The mechanism for formation of
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773-allylmolybdenum complexes from Mo(CO)4(py)2 is described in Chapter 1 (section 
1.2.2). Coordination of the carbonyl oxygen of an allylic ester occurs prior to departure of a 
ligand from the metal, coordination of Mo to the olefin and collapse of the system to give the 
77^ -arrangement. Competing coordination of a substrate incapable of forming an 773- 
intermediate would inhibit coordination of the allylic acetate and decrease the rate of oxidative 
addition.
To overcome difficulties encountered in the isolation of complexes 2.1 and 2.2, we performed 
the ligand-exchange and alkylation procedures without isolation, minimising the opportunity 
for decomposition of the sensitive tetrafluoroborate salts. In order to ascertain whether the 
strategy was viable, the C-glycoside syntheses described in Chapter 1 (section 1.5.3) were 
r e v i s i t e d . ^ 3 , method previously utilised within the Kocienski group was used to secure 
stannanes 2.20 and 2.21.^^ Procter had found that retention was the dominant mode of 
reaction when substitution of a-chloroether 2.19 using tributylstannyl lithium generated in 
the presence of 0.6 equivalents of excess n-BuLi and 1.5 equivalents of di/^o-propylamine 
was used.^^ A single electron transfer (SET) pathway was tentatively proposed as the most 
likely mechanism. Similar processes have been described in the displacement of halides with 
trimethyltin anions.^ '^^^ Readily separable axial and equatorial stannanes 2.20 and 2.21 were 
prepared in good overall yield from glucal 2.18 (Scheme 2.9), with the axial stannane 2.20 
dominating in an approximate 2.5 : 1 ratio.
Ç1 Sn B u g § n B u 3
HCI(g), PhMe (Bu3 Sn)2 , (1.5 eq). n-BuLi (2.1 eq)
'O B n  O'C.SOmin < S ^ O B n  DIPA (1.5 eq). THF, 0'>C, 2 h ✓ ' ' S ^ Q B n  ^ S ^ O B n  -I : 72%. 2 .2 0 : 2 . 2 1  = 2 .5 : 1 I : I =
O B n O B n O B n O B n O Bn O Bn OBn O Bn
2.18 2.19 2.20 2.21
Scheme 2.9
Coupling of stannanes 2.20 or 2.21 with cationic complex 2.1 via the corresponding 
alkylcopper(I) reagent was performed as previously described.^^ The only procedural 
difference was the addition of complex 2.1 (which had been isolated by precipitation) as a 
solution in a minimal volume of acetonitrile rather than as a solid. Olefins 2.22 and 2.24 
respectively were isolated as the major products after décomplexation using CAN (Scheme 
2.10). Analysis of NMR spectra allowed the regioselectivity to be conservatively 
estimated as 8:1 in each case, as estimated from the differing olefinic signals for each 
regioisomer (see experimental section for details). Comparison of yields and regioselectivity 
with previous work showed that addition of 2.1 as a solution had no detrimental effect upon 
yield or regioselectivity.
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(a) n-BuLi, THF, -7 8 “C, 15 min
(b) CuBr»DMS, DIPS-THF, -78"C, 30 min
(c) Complex 2.1, MeCN, -78°C , 1 h
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OBn OBn
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2.22 :2 .23  = 8 : 1
2,23
OBn OBn
OBn
(a) n-BuLi, THF, -78°C , 15 min
(b) CuBr*DMS, DIPS-THF, -78°C , 30 min
(c) Complex 2.1, MeCN, -78°C , 1 h
(d) CAN, NaOAc. MegCO, rt, 45 min; 33% OBnOBn OBn
+
OBn
OBn OBn
2.24
2.24 : 2 .2 5 = 8  : 1
2.25
Scheme 2.10
It had been established by Procter that alkyllithium nucleophiles were not compatible with 
complexes such as 2 .1 , transmetallation to copper being necessary before alkylation could 
occu r .On e  unknown factor which will determine the synthetic utility of prospective chiral 
nucleophiles is the configurational stability of alkylcopper(I) species. In 1980, Still 
demonstrated that transmetallation of a-alkoxyorganostannanes to the corresponding 
alkyllithium species occurs with retention, as does reaction with electrophiles.^^ In recent 
years, this precedent has been greatly expanded upon.^ '^^  ^In contrast, only meagre precedent 
exists for the configurational stability of cyclic alkoxyalkylcopper(I) reagents at low
temperatiu'e, including that already described for alkylcopper(I) reagents 2.26-2.28 (Scheme 
2.11).
Çu
,Cu(SPh)Li
TBDPSi
2.26
OBn
OBn OBn
OBn
OBn OBn 
2.27
Scheme 2.11
Linderman has shown that the precise nature of the copper species is important. The 
TMEDA-copper reagent 2.30 reacted with ethyl propiolate to yield 2.31 with complete 
retention, but the corresponding higher order cyanocuprate 2.32 resulted in only partial 
retention (Scheme 2.12).^^
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2,32 2.29 2.30
2.31
87%
s-COgEt, TMSCl 
THF, - 7 8 “C
COaEt 
dr = 70 : 30
s-COgEt, TMSCl 
THF, -7 8 ”C
'COaEt 
2.31,92%
Complete retention
Scheme 2.12
The situation for acyclic a-alkoxyalkylcopper(I) reagents is even less well established. 
Linderman described the addition of TMEDA-copper reagent 2.34 (prepared from stannane 
2,33 of 98% ee) to ethyl propiolate to ultimately give lactone 2.36 in only 18%ee (Scheme 
2.13). Similarly, the related higher order cyanocuprate 2.37 led to lactone products with 
widely varying (0-97%) degrees of retention of configuration.^^’
X  —  X  —  Xn - P e n t y r ^ ) 2 Cu(CN)Ua (b) CuCN (0.5 eq) n -P en ty r^ ^ S n B u g  (b) Cul.TMEDA n-Pentyr''^Cu»TM EDA*UMOM (a) BuLi, THF, -78°C OMOM (a) BuLi OMOM
2.37 2.33 2.34
(C) s-COgEt, TMSCl 
THF, -78 'C
( c )
Lil
s-COgEt. TMSCl 
THF, -78°C; 91%
(d) Hg, Pd/C
n-Pentyt'
2.35
"COaEt (e) msOH, H+; 77% n-Pentyi
2.36
0-94% ee
(d) Hg, Pd/c
(e) MeOH, H+; 84% n-Pentyi'
2.3518% 88
'COgEt
Scheme 2.13
With the above precedent in mind, we approached the seai'ch for nucleophiles compatible with 
complexes 2 .1  and 2 .2  with the knowledge that retention of configuration at the nucleophile 
cannot be assumed using chiral alkylcopper(I) nucleophiles.
Î
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2.3 - Alkylation of complexes 2.1 and 2.2.
2.3.1 - Nucleophiles derived by (-)-sparteine-mediated enantioselective 
deprotonation.
(-)-Sparteine (2.38, Scheme 2.14) is a readily available lupine alkaloid which in recent years 
has found widespread use in enantioselective synthesis due to its ability to serve as a chiral 
bidentate ligand in the conformation 2.38a.^^
2.38, H -sparteine 2.38b2.38a
Scheme 2.14
(-)-Sparteine was first used in enantioselective synthesis in 1968 when Nozaki and co­
workers reported the addition of organolithium and organomagnesium reagents to carbonyl 
compounds to yield products with up to 22% ee.^ '^ The chiral ligand has since been 
utilised in a wide variety of enantioselective processes, an area which has been thoroughly 
r e v i e w e d . H o p p e  has described the deprotonation of achiral carbamates 2.39 with 5- 
butyllithium and (-)-sparteine, the carbamate serving to stabilise the a-lithio derivatives by 
chelation.^^’ The deprotonation proceeds with reliable selectivity for the pro-^-proton to 
give enantioenriched products 2.41 of stereoretention after electrophile addition (Scheme 
2.15).
Cb =
s-BuLi pj h p  E-X Hff
------------------- ^  V '" L i* 2 .3 8   ^
H -sparteine QCb
2.40 2.41
Q /  %ee generally > 95%. R = Me, /-Pr, oHeptyl, PhCHaCHa,
Me(CH2 ) i i ,  Mb2 0 H(CH2 }2 ,
2 3 g E = MeaSn, CO2 M0 . PhCHOH, Allyl, Farrocenyl-CHa
PhaCO, MeaSi, MsaPb, Me, PhaP
Scheme 2.15
A series of mechanistic investigations allowed Hoppe to rationalise the mechanism of the (-)- 
sparteine-mediated deprotonation, with the following conclusions:^^’
(1) Lithiated alkyl carbamates 2.40 are configurationally stable in the form of TMEDA or 
(“)-sparteine complexes under the reaction conditions.
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(2) The deprotonation is kinetically controlled, which determines the stereochemical 
course of the reaction.
(3) The pro-S-pioton is abstracted with high selectivity under the influence of (-)- 
sparteine.
It was concluded that prior to the deprotonation occurring, a complex of j-butyllithium, (-)- 
sparteine and the carbamate forms virtually irreversibly. Proton transfer in aggregate 2.42 is 
an intramolecular process in which abstraction of the pro-iS-proton occurs more rapidly than 
abstraction of the pro-R-proton in conformation 2,43, leading to an excess of 2.41 over 
enantiomer 2.46 following retentive electrophile incorporation (Scheme 2.16).
2.39
s-Bus-BuLi
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2.42
s-Bu
2.43
Cb ■ SuHg /cs/frH=»50;1 ■ BuHfl
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E-X
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Scheme 2.16
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Hoppe has also investigated heterosubstituted alkyl carbamates, in which chiral induction is 
possible if a good donor substituent is attached to a stereogenic carbon atom y- or & to the 
carbamate. In a favourable case, substrate directed or (~)“Sparteine mediated hthiation can be 
utilised to produce diastereomeric products. Dicarbamate 2.47 (Scheme 2.17) serves as an 
elegant example of the principle, methylated compound 2.49 being formed with good 
substrate-directed selectivity in the absence of (-)-sparteine.^^ In the presence of (-)- 
sparteine, Hthiation is directed in the opposite fashion, the internal chelate effect being 
overridden by the more powerful chelating effect of the diamine.
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2.47 L 2.48
Mel
Mel Additive :
TMEDA 44%: 2.49 ; 2.51 = 9 8 : 2
H -sparteine 56%; 2.49 : 2.51 = 4 : 96 2.49
Scheme 2.17
In the case of acetonide 2.52 (Scheme 2.18), the inherent substrate-directed selectivity and the 
external selectivity derived from (~)-sparteine form a matched pair, both favouring abstraction 
of the pro-S-proton.^^ Lithiation and substitution in the absence of a chelating ligand returns 
2.54 in excellent (> 95:5) diastereomeric excess, which, in the case of the specific example 
using MegSnCl as electrophile, is further increased to > 99:1 in the presence of (-)-sparteine. 
Use of the enantiomeric (+)-sparteine results in an inversion of selectivity to 28:72, a 
reflection of the now mismatched internal and external inductions. Carbamate 2.52 thus 
forms a synthetic equivalent for the (15',35)-l,3,4-trihydroxybutanide ion 2.57. As is 
described in chapter 4, an equivalent for the related (15,3i?)-l,3,4-trihydroxybutamde ion has 
been utilised in the total synthesis of the natural product Cryptophycin 4.
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2.52
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OH M 
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Scheme 2.18
We were interested in the union of masked triol synthon 2.57 and cationic complexes 2.1 or
2.2, an attractive prospect as the resulting olefin product 2.58 would contain two newly 
formed vicinal stereocentres (Scheme 2.19). The stereochemistry at Cl is fixed as (R)- by the 
lithiation step, the outcome of transmetallation to copper and alkylation was unknown at the 
time. The C2 centre could be fixed as (i?)~ or (S)-, by the choice of planar chiral electrophile
2.1 or 2.2 respectively. Versatile olefin 2.58 offers many possibilities for further elaboration.
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Carbamate 2.52 was derived in four straightforwai'd steps from dimethyl (5)-malate 2.59 
(Scheme 2.20). Selective reduction^^ was followed by protection of the crude diol, reduction 
of ester 2.60 and coupling with chloride 2,63. '^^’ Metallation of 2.52 in the presence
of (-)-sparteine and stannylation yielded stannane 2.64 in good yield as a single diastereomer 
within the limits of and 1% NMR spectroscopy .
(a) BHg'DMS, NaBH4
2.59 OH (b) M0 2 CO, p-TsOH, rt 
83%
O  2.60
UAIH4 , THF, rt
88%
HM nw M02CO,p.TsOHHgl^ p H  PhMe, A c r
2.62
(b) CI3COCOCI 
PhMe, A; 53% 2.63
0  B ugSn O
(a) s-BuLi, (-)-spartelne 
EtaO, -.78°C, 3 h
(b) Bu3SnCI,-78°C->rt 
69%
O 2.61
NaH 
EtzO, rt
91%
' V
Scheme 2.20
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From stannane 2,64, tin-lithium exchange using n-BuLi followed by transmetallation to 
copper using a slight excess of CuBr»DMS as a solution in diwopropylsulfide and THF 
generated the required alkylcopper(I) nucleophile. A freshly prepared solution of electrophilic 
complex 2.2 in MeCN was added directly. Following standard aqueous workup olefin 
product 2.58 was released by oxidative décomplexation of the metal fragment, and was 
obtained in good overall yield from stannane 2.64 (Scheme 2.21), iR NMR spectroscopy 
indicated the dominance of one diastereomeric product, backed up by GCMS data which 
revealed a mixture of 4 isomers in the approximate ratio 95 : 2 ; 2 : 1. The absolute 
stereochemistry of the major olefin isomer is assigned as below and reflects two assumptions 
- firstly, that addition to complex 2 .2  proceeded anti to the metal, ample precedent for which 
is now available. Secondly, the more contentious assumption of overall retention at Cl is 
made (see below). The regiochemistry resulting from alkylation of complex 2.2 is assigned 
as that resulting from nucleophilic attack predominantly at the less hindered allyl terminus of
2.2 on the basis of 2D NMR spectroscopy. The expected chemical shifts of a methyl group 
in an allylic or vinylic position (approximately 1.0 -1.1 and 1.7 ppm respectively) also support 
the assigned regiochemistry.^
(a) n-BuLi, THF, -.78"C
(b) CuBfDMS, DIPS-THF, -7 8 “C
0  BUcSn
2.64
(c) Complex 2.2, MeCN
(d) Ü2 , CHCIa, rt, 44 h; 57%
Scheme 2.21
2.53
= 1 . 0  ppm
Two procedures have been used throughout our work with tî^-allylmolybdenum complexes 
to cleave the metal fragment from the olefin following nucleophilic attack. The first protocol 
is the treatment of an acetone solution of the crude material with ammonium cerium(IV) 
nitrate (CAN), adding CAN portionwise until décomplexation is complete.^^ Progress of the 
cleavage is easily followed by TLC, a characteristic, polar, UV active spot represents the (rp- 
olefin)Mo(CO)(NO)Cp species, typically appearing as a faint-yellow spot in visible light. 
The less polar olefin spot was almost always faintly present following aqueous workup, 
indicating partial décomplexation of material before the oxidation step. An alternative 
procedure was developed from Faller's precedent for décomplexation by exposure of a 
chloroform solution of the crude material to air.  ^As described in Chapter 4, we experienced 
difficulties in the CAN-mediated décomplexation of a substrate containing an acetonide- 
protected diol moiety. We subsequently bubbled gaseous oxygen through a chloroform 
solution of the crude material. Reaction was generally completed overnight, and simplified the 
workup protocol by eliminating a second aqueous extraction stage. The procedure was 
subsequently adopted for most of the systems described in Chapter 2. In the case of the
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crude material obtained from the above coupling reaction, the décomplexation using oxygen 
alone was slow, minimal progress being observed overnight. Discussion with a co-worker in 
the Kocienski group indicated that the rate of décomplexation could be enhanced by visible 
light. Indeed, décomplexation was complete within a further 24 h simply with illumination 
from a 150W household light bulb. The reluctance of the metal fragment to depart the olefin 
can be rationalised by coordination of the neighbouring Lewis-basic carbamate oxygen to the 
metal (Scheme 2.22), providing stabilisation of the (772-olefin)Mo(CO)(NO)Cp species 2.65.
,Mo(CO)(NO)Cp
2.65 7-Pr
Scheme 2.22
To establish the overall effect upon the Cl stereochemistry in the tin hthium —> copper ->
carbon sequence forming olefin 2.58, we needed to relate the Cl stereochemistry to a known 
compound. Using allyl complex 2.17 allowed us to relate the olefin derived from stannane 
2.64 to alcohol 2.67. Alcohol 2.67 and the corresponding (17?)-epimer are known, 2.67 
having been reported as an intermediate in the synthesis of the natural product 
Milbemycin.^^^’ In similar fashion to the preparation of olefin 2.58, stannane 2.64 was 
converted to the corresponding alkylcopper(l) reagent and coupled with complex 2.17, to 
reveal olefin 2.66 after décomplexation as a 98:2 ratio of isomers by GCMS. Reductive 
cleavage of the carbamate g r oupproceeded  uneventfully yielding alcohol 2.67 in 49% 
overall yield from stannane 2.64 (Scheme 2.23). The stereochemistry at Cl was confirmed as 
S by comparison of optical rotation and / l^C NMR spectroscopic data for 2.67 with 
literature values.
'O BugSn O
2.64
(a) n-BuLi, THF, -78°C
(b) CuBfDMS 
DIPS-THF, -78°C
(c) Complex 2.17, MeCN
(d) O2, CHCI3 , M, 19 h
L IA IH 4 , THF
A, 20 h 
49% from 2.64
2.66 2.67
Scheme 2.23
Carbamate 2.66 was contaminated with an inseparable byproduct, tentatively assigned as 2.68 
on the basis of and ^^C NMR spectroscopic data. Hoppe has described the formation of 
olefins (E)- and (Z)-2.72 by deprotonation of carbamate 2.69, transmetallation to copper and 
introduction of oxygen (Scheme 2.24).^®  ^ Copper carbene 2.71 was proposed as an
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-7
7
2.68
(a) s-BuU, TMEDA BngN BngN BPgW
Scheme 2.24
g o c  MTBE. -78"C, 3 h (2.74) J -78=C rt
l-s
2.73, R = H 2.75, R = H 2.77, R = H, 11 -70%, %ee = 36->98%
2.74, R = 01 2.76, R = Cl 2.78, R = Cl. 32-90%, %ee = 0. 73-78%
Scheme 2.25
intermediate. In our system, adventitious oxygen could explain the observance of 2.68, 
formed by a similar process from carbamate 2.64.
.  B „-S  ----------
O WCuCI;02 2.70 OCb 2.71 CuOCb 2.72 NBn,
■With the synthesis of alcohol 2.67 having confirmed overall retention at Cl, by analogy we 
have assumed overall retention in the preparation of olefin 2.58. It can therefore be concluded 
that stannane 2.64 serves as a reliable precursor to the (liS,35)~l,3,4-trihydroxybutanide ion 
2.57 in coupling with ??^-allylmolybdenum complexes 2.2 and 2.17. In principle the 
technique of deprotonation a- to a carbamate group and alkylation with complexes 2 .2  or 
2.17 could be applied to a multitude of other substrates such as those illustrated above in 
Scheme 2.15. The generality of the retentive lithium-copper transmetallation would have to be 
verified for specific substrates, but the meagre precedent provided by carbamate 2.64 is 
encouraging.
Continuing the theme of (-)-sparteine assisted enantioselective deprotonations, we became 
interested in work reported by Beak which allows access to chiral indoline structures. Beak 
described the asymmetric deprotonation of iV-Boc indoline (2.73) and N-Boc 7- 
chloroindoline (2.74) with 5-BuLi and (-)-sparteine, and the subsequent reaction of 
enantioenriched organolithium 2.75 or 2.76 with a range of electrophiles (Scheme 2.25).^^^
s-BuLi, 2.38
Cum ene,-78°C, 6 h (2.73) or [I "I \ — i i Eleclrophiie
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Substituted indoline 2.74 was easily prepared in two steps by standard procedures.^ 
Following A/ -^protection, the C7 position was selectivity lithiated under conditions described 
by Iwao (j-BuLi / TMEDA) and blocked by chlorination. It should be noted that a 
complication with the use of indoline 2.73 is competing lithiation at C7, minimised but not 
eliminated by the use of cumene as a solvent^and for this reason we chose to use the 
chlorinated substrate. Asymmetric lithiation under Beak conditions was followed by 
transmetallation to copper using CuBr»DMS in the fashion described above and coupling 
with cationic complex 2.2 (Scheme 2.26). Oxidative décomplexation (O2 , CHCI3 or CAN, 
Me2C0 ) yielded a mixture of olefins 2,80 in 57% overall yield.
(a) B0 C2 O, THF, rt; 87%
(b) s-BuU, TMEDA 
EI2 O, -78°C . 1 h
2.79
(c) CI3 CCCI3
-78*0  r t ,  1.5 h; 72% Cl
2.74
N
Boc
(d) s-BuLi, (-)-sparteine 
MTBE, -78*0 , 3.5 h
(e) CuBfDMS, DIPS-THF 
-7 8 * 0 ,3 0  min
(f) Complex 2.2, -78*0  -> rt, o/n
( g )  O 2 ,  O H O I 3 ,  r t ,  3.5 h; 57% Boc
2.80
4 i 0.99 ppm
Scheme 2.26
Analysis of the mixture by GCMS revealed the presence of 4 isomers, in the approximate 
ratio 4 : 9 : 8 1  : 6 . The major product will have the absolute stereochemistry depicted above if 
the key assumption of overall retention of configuration at C2 from alkyllithium 2.76 to 
indoline 2.80 is made, as discussed below. Regioselectivity was good, the major diastereomer 
being assigned as 2.80 above on the basis of 2D NMR spectroscopy and on the shift of the 
allylic methyl group. The absolute stereochemistry of the methyl group is based on an 
assumption of anti attack upon complex 2.2. In addition to the expected olefin products, an 
inseparable mixture of ketone product 2.81 and recovered starting material was isolated, as 
was indole 2.82^ ^^  (presumably arising by oxidation of unreacted indoline 2.74 under the 
décomplexation conditions) (Scheme 2.27).
2.74, 6% 2.81, 3% 2.82,10%
inseparable, ketone 2.81 isolated a s  a single diastereomer.
Scheme 2.27
Repeating the coupling reaction using a combination of 5-BuLi and TMEDA for the initial 
deprotonation step resulted in a 52% yield of a mixture of the same 4 olefin isomers by
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GCMS in the approximate ratios 20 : 4 : 29 : 27. Again a trace of ketone 2.81 (<2%, 
apparently a single diastereomer) was observed, together with indole 2.82 (15%) and 2.74 
(4%). The formation of the same 4 diastereomeric compounds under the non-asymmetric 
lithiation conditions indicate that one of the 3 minor diastereomers obtained in the original 
coupling reaction is due to moderate stereocontrol at C2. The remaining two diastereomers 
are tentatively assigned as regioisomeric olefins 2.83 on the basis of the observation of an 
allylic methyl signal resonating at approximately 1.5 ppm (Scheme 2.28). Although the 
overall diastereoselectivity in the original coupling is excellent (81 : 19) it is vexing to note 
that in the coupling of the corresponding racemic alkylcopper(I) nucleophile, regioselectivity 
was poor.
it
¥
Cl
2.74
NBoc
(a) s-BuLi, TMEDA 
EtaO, -78"C, 3.5 h
(b) CuBr*DMS, DIPS-THF, -78°C , 30 min
(c) Complex 2.2, -78°G  rt. o/n
(d) Oz, CHCI3 . rt, o/n; 52% Boc
2.80
1.50 ppm
+
Boc
2.83
Scheme 2.28
As with the previous example there was a need to determine the absolute stereochemistry at 
C2, using allyl complex 2.17 as a model electrophile. Beak had formed indoline 2.84 
(Scheme 2.29) in poor yield and only 10% ee under the j-BuLi / (-)-sparteine conditions and 
regrettably, no optical rotation data was reported. Allylation of the corresponding 
unsubstituted substrate 2.73 gave a sample of (5)-2.85 in 15% yield with a slight excess of 
the (5')-enantiomer (er = 68  : 32). Fortunately, the optical rotation of the sample enriched in 
the (5)-enantiomer was recorded, giving us a basis for comparison.
I
1:
Cl
NBoc
2.74
2.73
NBoc
(a) s-BuLi/(-)-spartein0  
MTBE, -78°C, 3 h
(b) Allyl bromide 
-78=0, 4 h; 32%
(a) s-BuLi / (-)-sparteine 
Cumene, -7 8 “C, 6 h
(b) Allyl chloride / DMPU 
-7 8 “C rt; 15%
Cl
NBoc 
{S )-2 .84 ,10% ee
N
Boc
(S)-2.8S
Scheme 2.29
er = 68 : 32
[ab  = + 2 9 (c  O.OI.CHCb)
Our initial efforts were hampered by the inefficient deprotonation of indoline 2.73 compared 
to the chlorinated analogue. Optimised conditions reported by Beak utilised cumene as
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solvent and a 6  h reaction time at -78°C. Lithiation / substitution sequences in alternative 
solvents such as TBME gave poorer yields and / or a greater proportion of products resulting 
from lithiation and substitution at Cl. Unfortunately, in our hands, lithiation, transmetallation 
to copper and coupling with allyl complex 2.17 failed completely in cumene, returning only 
starting material 2.73 (Scheme 2,30). Similarly, lithiation in cumene and trapping with 
tributyltin chloride was inefficient on a large (25 mmol) scale, only the merest trace of 
stannylation apparent by TLC, despite scaling the concentration appropriately from the Beak 
protocol.
X
(a) S-BuU / H-sparteine 
Cumene, -78°C , 6 h
(b) BusSnCI. -78"C rt
2.73
NBoc
(a) s-BuLi / (-)-sparteine 
Cumene, - 7 8 “C, 5 h
(b) CuBr*DMS, DIPS-THF 
-7 8 “C 30 min
(c) Complex 2.17, -7 8 “C -> rt
X
Scheme 2.30
We decided to turn to TBME as solvent despite the anticipated poor chemoselectivity. 
Lithiation with 5-BuLi / (-)-sparteine, transmetallation to copper, and reaction with 2.17 
yielded an inseparable equimolar mixture of 2- and 7-substituted indolines 2.85 / 2.86 (55%) 
together with 9% of recovered indoline 2.73 (Scheme 2.31). Comparison of the sign of 
optical rotation of the mixture 2.85 / 2.86 [+44.2, (c 0.55, CHCI3)] to that reported by Beak 
[+29 (c 0.01, CHCI3), 36% ee] indicated that the lithiation, transmetallation and allylation 
sequence returned material with predominantly the (25)-configuration we had assumed in the 
original coupling procedure with complex 2 .2 .
2.73
N
Boc
(a) s-BuLI, H-sparteine  
MTBE, -78°C, 3 h
(b) CuBfDMS, DIPS-THF
(c) Complex 2.17
(d) CAN, NaOAc, MegCO; 55% 2.85
NBoc
2.86
Scheme 2.31
N-Deprotection allowed the separation of the regioisomeric amines 2.87 and 2.88, and 2- 
substituted isomer 2.87 was converted into the coiTesponding amide 2.89 under DCC 
conditions in good yield (Scheme 2.32). Only a single diastereomer was apparent by / 
NMR spectroscopy and GCMS, indicating excellent stereocontrol in the retentive 
transmetallation-substitution sequence. It is worth noting that the union of allyl complex 2.17 
with indoline 2.73 represents an improvement in efficiency over the Beak conditions for 
allylation of indohnes 2.73 / 2.74.
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2.85
N
Boc
TFA-CHgClg (1 :4)
N 0 °C -»  rt, 2  h; 73% 
Boc
Scheme 2.32
2.87
(7?)-0-acetylmandeiic acid 
DCC, DMAP 
CHaClz, 0“C. 1 h; 87%
W
2.89 y - f
,OAo
Ph
%
¥
I '
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Further application of (-)-spaiteine mediated enantioselective deprotonation to a nucleophile 
derived from crotyl carbamate 2.90^^^ failed (Scheme 2.33). Hoppe has shown that 
deprotonation of carbamate 2.90 under carefully controlled conditions allowed the selective 
crystallisation of alkyllithium*(-)-sparteine complex 2.91, which could then be trapped with 
an electrophile (e.g. BugSnCl) to yield stannane isomers 2.92 and 2.93 in good yield. 
Unfortunately, we found that deprotonation under the Hoppe conditions, followed by 
transmetallation to copper and reaction with allyl complex 2,17 resulted in a complex mixture 
of products from which nothing of value could be obtained.
■ -1 I
a
(a) n-BuLi, (-)-sparteine
2.90 OCb
Cb = C(0)N/-Pra
(b) Crystallisation 2.91
BUaSnCI
2.92
58%, 90% ee
BUgSn OCb 
2.93
2 2 %, 62% ee
Scheme 2.33
2.3.2 - Further nucleophiles.
We have confirmed the poor regioselectivity described by Faller in the coupling of 
sodiodiraethylmalonate with complex 2.1. In our hands isomers 2.94 and 2.95 were formed 
in 43% yield in a 1.4 : 1 ratio (Scheme 2.34), a slight selectivity for attack at the less hindered 
allyl terminus, but nevertheless greatly reduced regioselectivity compared to other nucleophile 
systems.
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BFr (a) NaCH{COaM0 ) 2  
THF, -78°C  rt, 1 h
CO- ï^^NO
Cp
(b) CAN, NaOAc, MeaCO 
43% MeOgCr COgMe MeOgCT "COglVIe
2.94 2.95
2.94 : 2.95 = 1 .4 :  1
Scheme 2.34
A number of other simple nucleophiles were investigated, and the general trend of good 
regioselectivity continued. Stannane (±)-2.103 was synthesised in straightforward fashion by 
the route below, based on a series of communications by Quayle (Scheme 3.35).^^ '^^^^ 
Deprotonation^^^ of 3,4-dihydro-2iif-pyran (2.97) and stannylation yielded 2.98. Acylation at 
C3 under the reported conditions^ proceeded inefficiently to yield stannane 2,99 which was 
subsequently converted into ester 2.100. Double-bond reduction yielded pyran 2.101, from 
which stannane 2.103 was obtained in a further 2 steps.
I
I
0
2.97
(a) f-BuLi, THF, -78°C , 30 min
(b) BuaSnCI
THF, -7 8 “C ^  0°C, 2 h; 84%
^Q-^SnBug
{±)-2.103
O SnBus 
2.93
(C) DIPEA, CI3 CCOCI
CHgClg, O'C-^rt, 18 b 
24% a COCCIgu  SnBug 
2.99
(d ) NaOMe, MeOH, 
rt, 1 h, 83%
(f) Dibal
THF, O-C, 1 h; 79% (e) EtaSiH, TMSOTf
(g) MOMCI, DIPEA k  A *  CH2 CI2 , -78"C 0 "C, 17 h
BU4 NI, CHaCIa rt. 3  h ^  tonaug 7 9 %
86% (±).2.101
Scheme 2.35
a COjMe 
u  SnBu,
2.100
In the normal fashion, stannane 2.103 was converted into the corresponding alkylcopper(I) 
reagent and coupled with complex 2.1 to yield olefin products 2.104 / 2.105 (Scheme 2.36), 
in low (though unoptimised) yield, both of which were regioisomerically pure within the 
limits of NMR spectroscopy. The maintenance of tmns- relative stereochemistry between C2 
and C3 (and hence by analogy retention of configuration at C2 from stannane (±)-2.103) in 
both olefins is confirmed by the large coupling between H2 and H3 (V 9-9.6 Hz).
'OMOM
O C '"^O'^SnBUg
(±)-2.103
{a) n-BuLI, THF, -78°C , 5 min
(b) CuBr*DMS, DIPS-THF, -78°C, 30 min
(c) Complex 2.1, MeCN, -78°C, 30 min
(d) CAN, NaOAc, MegCO, rt, 12 h 
24%
Scheme 2.36
OMOM 
f-Pr
2.105
OMOM 
f-Pr
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In principle the Quayle route could have been adapted to prepare similar substrates 2,106- 
2.108 (Scheme 2.37). Conversion of tm ns  substrates (±)~2.103 and (±)-2.107 to the 
corresponding cw-isomers is possible by deprotonation a- to the tributylstannyl moiety at 
low temperature, followed by a protic quench.
œ ,'—OMOM /-OMOMOMOM y— ^ y— r_ Bug x ^ ^ S n B u g  C ^ y ^ S n B u g
(±)-2.106 (±)-2.107 (±)-2.103
Scheme 2.37
Chlorinated dihydropyran 2.111 was straightforwardly obtained (Scheme 2.38) from 
dihydropyran 2.97 by chlorohydration,^^^ acétylation and pyrolysis.
o
(a) NaCIO (aq). KHeP0 4  (aq)
0°C, 2.5 h; 46% 200"Ca . ,  e  n r'O AcgO. EtgN, DMAP O OAc 34%
CHgCIa, rt, 14h;81%
2.97 2.110 2.111
Scheme 2.38
Deprotonation of chloride 2.111, transmetallation to copper in the normal fashion and 
reaction with complex 2.1 yielded olefin 2.112 in only 10% yield (Scheme 2.39). Despite the 
poor yield, olefin 2.112 was isolated in excellent regioselectivity (>35 : 1). Only a trace of 
the regioisomeric olefin (2,113) was observed in the IH NMR spectrum, with doublets at 
1.11 and 1.69 ppm being used to assign olefins 2.112 and 2.113 respectively. Stannane 2.98 
was investigated as a similar system to that derived from chloride 2.111. Disappointingly, tin- 
lithium exchange, transmetallation to copper, and reaction with cationic complex 2 .2  failed to 
yield any olefin product.
(a) n-8 uLi, THF, 0°C rt, 2 h
(b) CuBfDMS, DIPS-THF 
-78"C, 30 min
2.111
(c) 2.1, M eCN,-78'’C, 30 min -s ,
(d) CAN, NaOAc, Me-CO; 10% I I ^  1.69 ppm
2.113
2.112 :2 .1 1 3 > 3 5 :1  ^  1.11 ppm
(a) rt'BuLi, THF, -7 8 ”C
(b) CuBfDMS, DIPS-THF, -78°C
' O ' ^ S n B u g  ic) Complex 2.2
2.98
Scheme 2.39
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As will be described in Chapter 4, we have successfully coupled PhCu with substituted r}^ ~ 
allylmolybdenum complex 4.1 and a minor ketone byproduct apparently arising from attack 
upon the carbonyl ligand of 4.1 was observed. PhCu was coupled with complex 2.2 in order 
to see if a similar product would be obtained. The expected olefin regioisomers 2.114 and
2.115 were obtained with excellent (13 : 1) regioselectivity in 25% isolated yield (Scheme 
2.40). The regioisomers were identified by reference to literature d a t a . ^ ^ i ,  1 2 2  Ketone 
regioisomers 2.116 and 2.117 were also isolated in 27% yield, in an 8 : 1 ratio, together with 
isomeric ketone 2.118 (< 2%). The stereochemistry suggested for 2.116 and 2.117 is that 
which would be obtained if the phenyl nucleophile initially attacked the carbonyl ligand and 
then transferred dhectly to the face of the allyl ligand syn to the metal.
1
1I
PhCu
(a) Complex 2.2
(b) Oz, CHCI3, rt O "  P h2.1152.114
25%, 1 3 : 1 27%. 8 : 1
2.118, (<2%)
O^Ph
Scheme 2.40
As an alternative nucleophile to PhCu, higher order cyanocuprate Ph2Cu(CN)Li2 was 
investigated, which has been successfully used by Liebeskind in couplings with cationic or­
ally! molybdenum complexes.^"  ^However, only a trace (<2%) of alkylation products 2.114 /
2.115 were obtained (Scheme 2.41), together with ketones 2.116 / 2.117 in 38% yield and 
almost equimolar ratio, and 2 % of isomeric ketone 2.118.
Ph2Cu(CN)Ü2 (a) Complex 2.2
(b) O2 . CHCI3 . rt
P h  ■ 
2.114, <2%
O '' "Ph 
2.118, <2%
Scheme 2.41
Th
2.116
P h
Y
38%, 1.2; 1
2.117
The absolute stereochemistry and enantiopurity of olefin 2.114 was established by 
dihydroxylation and in-situ  diol cleavage, followed by reduction of the resulting aldehyde 
(Scheme 2.42), Comparison of the sign of optical rotation for alcohol 2.119 with literature 
values allowed the absolute stereochemistry to be identified as R, as expected via  a process of
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retention-inversion from acetate (i?)-2.12. The enantiomeric ratio at Cl was conservatively 
estimated to be > 90 : 10 via formation of the (i?)-0-acetylmandelate ester 2.120 and 
comparison of the integration of the acetate methyl signals at 2.14 ppm and 2.15 ppm (minor 
and major diastereomers respectively) with reference to an authentic sample of esters formed 
from (±)-2.119.
Ph 2.114 Ph 2.115
(a) OSO4 , Nal0 4  
MeOH-HsO, rt, 20 h
(b) UAIH4 , EtaO. rt 
40%
-S
'OH 
Ph (fl)-2.119
(fl)-0-acetylmandelic acid 
DCC, DMAP, CHaCla. rt; 83%
d r > 9 0 : 10
2.120
Scheme 2.42
2A " Conclusions.
We have demonstrated that the good regioselectivity observed by Procter^ ^  in the coupling of 
alkylcopper(I) nucleophiles with substituted complexes 2 .1  and 2 .2  is general for a wide 
range of functionalised substrates. Regioselectivities have typically been > 8 : 1 .  The 
regioselectivity reflects a triumph of steric discrimination over the failure to control central 
chirality inherent in the indiscriminate carbonyl-nitrosyl exchange process. Complexes 2,1 
and 2 .2  have been shown to be reliable synthetic equivalents for cationic synthons 2 .1 2 1  and 
2.122 (Scheme 2.43).
Cp
BF4-
=  00
O^N
+ BF4 -
2.121
' BF4-
Op
T /P r BF4-
ON
Scheme 2.43
2 .122
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The range of substrates we have studied indicates that sp^-hybridised nucleophiles perform 
well, whereas sp^-based systems such as 2.98, 2.111 and phenyl are problematic. The 
variability of success encountered with tliese substrates and tlie presence of products arising 
from attack at the carbonyl ligand of complex 2.1 / 2.2 are interesting factors to note. With 
such systems it is likely that the compatibility of the nucleophile and electrophile will be 
finely balanced, with harmony of the coupling partners dependant upon the precise nature of 
the allylic ligand and nucleophile. For example, arylcopper(I) reagent 2.123 has been used 
within the Kocienski group to alkylate functionalised molybdenum complex 2.125^^^ 
(Scheme 2.44), without complication from carbonylated products. Similarly, the zinc-copper 
based nucleophile 2.124 gave enf-2.126 in good yield using Enders' iron complex 2.127^ '^'' 
as the electrophile.
BFr BFr
EtO
2.125 Cp
OEt
(a) 2.123. THF 
-78°C  -> 0"C
(b) CAN; 72%
OMe
2.123, M = Cu 
2.124, M =Cu(CN)ZnBr
Fe(C0)4
2.127
(a) 2,124, THF 
~78"C -> 0=0
(b) CAN; 64%
Me :
COgEt
2.126
COaEt 
@nF2.126
Scheme 2.44
In contrast to the Enders complex, a variety of zinc-copper based reagents reacted with the 
similar q^-allyltetracarbonyl complexes 2.128 and 2.129 to give carbonylated products 2.131 
as well as olefins 2.132, in varying ratios (Scheme 2.45).^^^ The proposed mechanism was 
one of initial addition to a carbon-monoxide ligand to form metal-acyl intermediate 2.130. 
Ketone 2.131 was subsequently formed via migration of the acyl to the less-substituted 
allylic terminus and loss of Fe(C0 )3.
Fe(C0)4
2.128; R’ = H  
2.129; R i = M e
R2Cu(CN)Znl
{0C)3Fe^ 
2.130 O
R2
2.131
A
■ Fe(C0 ) 3
R2
6  examples, yields 51-68% 
p i  1 . 1 : 1 5 2 . 1 3 2 : 2 . 1 3 3 5 0 : 1
2.132
Scheme 2.45
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In our molybdenum chemistry, yields over the two step alkylation-decomplexation sequences 
remain moderate to poor, though the cases described in this chapter have not been 
individually optimised. The Achilles heel of the process is the oxidative cleavage procedure,^ 
with a need in the future for an exploration of alternative methods. In general, we have found 
that the alkylation procedures are more efficient on a moderate (3-7 mmol) rather than small 
(<1 mmol) scale. We also observed better yields using the higher quality neutral complexes 
formed using the Mo(CO)4(py)2 based preparation procedure.
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Having established the utility of complexes 2.1 and 2.2 where steric bias in the allylic ligand 
allows good regiocontrol, we moved to a system of more complexity. Chapter 3 introduces 
the Cryptophycin series of natural products which provided our next challenge. Chapter 4 
describes our approach to Cryptophycin 4, and describes our investigation of an 77^ - 
allylmolybdenum complex with substituents on the allylic ligand which could have both a 
steric and electronic impact upon regioselectivity.
I
'i.:|
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Chapter 3 - The Cryptophycin series of natural products.
Chapter 3 will describe the isolation and biological activity of the Cryptophycin family of 
natural products, potent antiproliferative compounds which show excellent antitumour 
activity. Previous total syntheses of the Cryptophycins and analogues will be discussed 
briefly, focusing on the control of absolute stereochemistry in a key fragment. The literature 
up to and including May 2000 has been covered.
3.1 -  Isolation of the Cryptophycins.
In 1990, as part of an algae screening program, Schwartz and co-workers reported the 
isolation of a novel depsipeptide from Nostoc sp. ATCC 53789 which was active against 
fungi and yeast of the genus C r y p to c o c c u s The general structure 3,1 was proposed and 
named Cryptophycin. Studies into the use of Cryptophycin as an antifungal agent were 
discontinued due to toxicological concerns.
p
OMe
3.1
Interest in the area was revitalised in 1994, when Moore reported that the lipophilic extract of 
the blue-green alga (cyanobacterium) Nostoc sp. CSV 224 was strongly cytotoxic. The 
major cytotoxin, Cryptophycin 1 (3.1) (initially named Cryptophycin A) was isolated, 
together with 3 minor constituents, Cryptophycins 2-4 (or B, C, D, 3.2-3.4) (Scheme 3,1). 
Mass spectral data and NMR spectroscopic analysis, combined with degradation experiments 
elucidated the relative and absolute stereochemistry of Cryptophycins 1-4. The tyrosine 
portion in Cryptophycins 1 and 3 was initially assigned as L and corrected to D in a later 
publication following total synthesis.
-
3.1, Cryptophycin 1 , X = Cl
3.3, Cryptophycin 3, X = H
R = Pli
3.2, Cryptophycin 2, X = Cl
3.4, Cryptophycin 4, X = H
Scheme 3.1.
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To date, a total of 25 naturally occurring members of the Cryptophycin series have been 
isolated from Nostoc sp. CSV 224, as shown below (Table 1, Scheme 3.2).^27,129-131
Table 1 - Naturally occurring Cryptophycins.
R1A
C ryptophycin R l R2 r 3 r 4 R5 X Y
1 r I A Me Me Me î-Bu Cl H
2 r I A Me Me Me t-Bu H H
3 r I B Me Me Me î-Bu Cl H
4 r I B Me Me Me i-Bu H H
16 r I A Me H Me i-Bu Cl H
1 7 r I B Me H Me /-Bu Cl H
18 r I B Me Me Me (5)-CH(Me)Et Cl H
19 r ib Me Me Me CHMe2 Cl H
2 1 r I A Me Me H i-Bu Cl H
2 3 r I A Me H Me /-Bu Cl Cl
2 4 ^ r I A Me Me H z-Bu H H
2 8 r I B H Me Me z-Bu Cl H
2 9 r I B Me Me H z-Bu Cl H
31 r I A Me Me Me z-Bu Cl Cl
4 0 r I A H Me Me z-Bu Cl H
4 3 r i b Me H Me z-Bu H H
4 5 r I B Me H Me z-Bu Cl Cl
4 6 ^ r I B Me Me Me z-Bu Cl H
4 9 r I B Me Me Me zz-Pr Cl H
5 0 r I A Me Me Me n-Pr Cl H
5 4 r I A Me Me Me (5)-CH(Me)Et Cl H
17 5 r I B Me Me Me z-Bu Cl Cl
1 7 6 r I A Me Me H z-Bu Cl H
 ^Cryptophycin 24 = Arenastatin A,  ^L-Tyr not D-Tyr
.OHPh'
Ph'
OHHN.
OM0OMe
Cryptophycin 26
Cryptophycin 30
Scheme 3,2.
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Cryptophycin 24 has an identical structure to Arenastatin A, which was isolated from the 
marine sponge Dysidea arenaria, and independently reported by Kitagawa and co-workers in
1994.132
3.2 -  Biological activity of the Cryptophycins.
Early investigations by Moore and co-workers revealed cytotoxicity IC50 values as low as 
0.01 nM for the most active member of the Cryptophycin family, Cryptophycin 1. Three 
human tumour cell lines were investigated: KB (nasopharyngeal carcinoma), LoVo (colorectal 
adenocarcinoma) and SK0V3 (ovarian carcinoma) . I n  vivo cytotoxicity data obtained 
from other members of the Cryptophycin family, and from synthetic analogues revealed the 
structure-activity relationships depicted below (Scheme 3.3).^^ ^* 129-131, 133-137
Ph'
Activity
diminished
Styrene or diol - 
Activity diminished
Bromo- or chiorohydrin - 
Activity retained
Lactone acyclic hydroxy methyl 
ether. Activity diminished
or
H
Activity diminished
or
Activity diminished
V  Activity lost
O M e
H-+CI  
Activity diminished
Ci^ H 
Activity diminished
OMe —> NMsg 
Activity retained 
OMe -> OH 
Activity diminished
Me H, Activity diminished 
Activity decreases with diaikyl substitution 
larger than methyl or cyclopropyi
Scheme 3.3.
The Cryptophycins exhibit antitumour activity by the inhibition of tubulin polymerisation into 
microtubules.^^^ Microtubules are dynamic assemblies within cells and are involved in a 
range of cellular activities including the maintenance of cell structure, ceil motility, cell 
proliferation and the regulation of membrane transport processes. The Cryptophycins bind to 
tubulin, inhibit microtubule polymerisation, and depolymerise preformed microtubules in 
v i t r o The mode of action of the Cryptophycins bears similarities to other clinically used 
antimicrotubule agents (Vinblastine, Colchicine and Paclitaxel) although the mode of action is 
most closely related to Vinblastine. In addition, the Cryptophycins are poor substrates
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for the drug-efflux pump P-glycoprotein, a property which may prove useful in the 
chemotherapy of dnig-resistant tumours
3.3 -  Synthetic approaches towards the Cryptophycins.
3.3.1 -  Retrosynthesis
Since the isolation of the first members of the Cryptophycin family and reports of the 
impressive biological activity a great deal of synthetic interest has developed. Several total 
syntheses of Cryptophycins and analogues have been reported to date.^^ ^* 1 3 3 - 1 3 7 , 1 4 0 - 1 4 7
The Cryptophycin skeleton can be viewed in a retrosynthetic fashion as being built up from 
four fragments, A -  D (Scheme 3.4). Fragments B and D (3.6 / 3.8) are easily accessed from 
commercially available D-tyrosine and L-leucic acid respectively. Amino acid fragment C 
(3.7) presents few synthetic problems, being readily available from the chiral pool in a 
minimum number of steps, leaving fragment A (3.5) as the major synthetic challenge.
OH OH
Fragment A, 3.5
3.1 /  3.3 N-^"0
3.2 /  3.4
HO ^O OMe
Fragment B (X = Cl, H), 3.6
Fragment D, 3.8
HO Y  NHa 
Fragment 0 , 3.7
Scheme 3.4.
The following sections deal briefly with the many published synthetic approaches to fragment 
A of the Cryptophycin family, focusing on the key steps involved in securing the C5 and C6 
anti stereochemistry.
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3.3.2 “ The Moore-Tius strategies. 128, 148
The first total synthesis of Cryptophycins 1 and 3 was reported in 1995 by Moore, Tins and 
co-workers .The  route to acid 3.13 is lengthy, though efficient (Scheme 3.5). The C5 and 
C6 stereocentres are introduced via Sharpless asymmetric epoxidation,^^ followed by 
epoxide opening with trimethylaluminium. Protection, benzylic bromination and immediate 
dehydrobromination introduce the styryl double bond into 3.12, from where standard 
manipulation affords 3.13.
(a) (MeO)2 POCH2 COaMe 
_  u  TMG, THF
P h '
3.9 O (b) d ib a l.  THF 3,10
77%
(c) L-(+)-DET, Ti(0 -/-Pr) 4  
TBHP, CHgCIa
(d) MeaAl, Hexane-CHgClz 
89%, er > 95:5
7  steps
3.13 O T B S OH 
E Z  > 95:5
Scheme 3.5.
(e)
(f)
(g)
3.11 OH
(MeO)2CMez 
PPTS, CH2CI2 
NBS, {MeO)2CMez 
CCI4. hv  
DBU; 78%
3.12 %
The efficient and reliable Sharpless asymmetric epoxidation procedure plays a crucial role in 
several of the routes to Cryptophycin fragment A described in this chapter. The mnemonic 
below (Scheme 3.6) serves as a reminder of the general stereofacial selectivity obtained from 
the epoxidation.
H-DET, “ O "
OH
(+)-DET. " O "
Scheme 3.6.
The catalytic cycle below (Scheme 3.7) has been proposed to account for the observed 
enantioselectivity, with dimer 3.15 postulated as the structure of the 'loaded' catalyst at the 
time of oxygen transfer.
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i
Ti(0/-Pr)^
f-BuOOH
(+)-DET
0/-Pr L%Pr
f-BuOOH
0/-Pr
it
3.14 J>0
610
f-BuOH
J > 0  ,  3.15/  f-Bu
E = COaEt
Scheme 3.7.
Opening of epoxide 3.16 proceeds with inversion of configuration and places the methyl 
substituent remote to the primary hydroxyl g r o u p . T h e  mechanism below was proposed, 
with clean inversion of stereochemistry resulting from S^^-type reaction of the tight ion pair 
3.17 (Scheme 3.8). Two equivalents of MegA1 are required; the first generates an aluminium 
alkoxide from the free hydroxyl group, and the second coordinates between the epoxy­
oxygen and the hydroxyl oxygen. The epoxide is subsequently cleaved by a liberated methyl 
anion, yielding diol 3,11.
3.16
R = (CHzlaPh
Mep
Me, Y  * Me, OH 
ÔH 3.11
Scheme 3.8.
A later report by Moore and Tius revealed the formation of fragment A utilising a [2,3]- 
Wittig rearrangement of propargyl ether 3.18 as the key stereodetermining step (Scheme 
3.9).^^^ As described by Nakai and Mikami in their studies of the [2,3]-Wittig 
rearrangement, the reaction occurs with efficient transfer of chirality. The stereoselectivity 
can be predicted by a consideration of the 5-membered transition states T i and T2 below. A
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pseudo-1,3-diaxial interaction between the olefinic proton HjS and the alkyne in transition 
state Tz favours T i and results in the dominance of threo alcohol product 3,19.
3.18
n-BuLi, THF
M a H \ P
Q: ©TTJh epi-3.19 OH
Scheme 3.9.
After silyl protection, selective monohydroboration of the terminal alkyne with 
disiamylborane (prepared in situ from 2-methyI-2-butene) yielded aldehyde 3.20, which 
was further elaborated into ester 3.21 (Scheme 3,10).
(a) TBDPSCI, Im, DMF
(b) 2-methyl-2-butene 
3.19 ÔH BHa.THFiHjOa
KH2 PO4 , KgHP04:76%
5 steps
O T B D P S
Scheme 3.10.
3 . 2 1  OH
Initial attempts to rearrange ether 3,22 were unsuccessful due to competing rearrangement 
pathways, necessitating the introduction of the phenyl group into the molecule at a later 
stage.
3 .2 2
3.3.3 - Kobayashi-Kitagawa routes.
Two synthetic routes reported by Kobayashi and Kitagawa yield protected 1,3-diol 3.25 
(Scheme 3.11) as the fragment A equivalent, relying on a later Wittig-Horner olefination of 
the corresponding aldehyde to elaborate the target molecule. In the first approach the required 
trans stereochemistry is introduced via Sharpless asymmetric epoxidation of allylic alcohol
3,23 and subsequent epoxide opening with Me2CuLi. The outcome of the epoxide opening 
step is not discussed, but judging from the overall efficiency of the conversion of 3.23 to 
protected triol 3.24, selectivity for formation of the 1,3-diol must be good. Chelation of the 
nucleophile to the free hydroxyl group has been proposed in similar systems to account for 
1,3-selectivity.
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3.23 TBDPSO
(a) L-(+)-DET, TBHP 
Ti(0/-Pr)4: 90%
(b) MegCuLi, EtgO
(c) Nal0 4 , EtaO-HjO
(d) PivCI, Pyridine
(e) TESCI, Pyridine
(f) DIBAL, CHjClg: 65%
3 steps
3.24 TESO  OTBDPS
Scheme 3.11.
3.25 OH OTBDPS
The second route (Scheme 3.12) utilises a highly diastereoselective addition of aldehyde 3.26 
to carboximide 3.27 to ultimately reveal protected diol 3.25 after auxiliary cleavage, 
deoxygenation and protecting group manipulation. The excellent diastereoselectivity for this 
boron-mediated aldol reaction can be explained by Zimmerman-Traxler transition state 
3.28.^^^’ Steric hindrance is minimised by placing the aldehyde substituent (RO in an 
equatorial position, and as drawn below the chiral auxiliary substituents are orientated away 
from the centre of the 6-membered transition state.
M 0M 0(C H 2)2C H 0 (3.26)
3  2 7  BuaBOTf, EtsN, CHsCIa
95%, dr >99:1 3.29 OH OMOM 7 steps
R = HC=CHPh 
R = (CHajaOMOM Ph 3.28
3.25 OH OTBDPS
>■ = X c
Scheme 3.12.
3.3.4 - The Lavallée approach.1 4 2
Lavallée uses the commercial availability of (5)-(-)-2-acetoxysuccinic anhydride (3.31) to 
install the C5 stereocentre in hydroxyester 3.38 (Scheme 3.13). Unselective addition of 
lithium phenylacetylide to 3.31 followed by reduction and protection provides separable 
butyrolactones 3.32 and 3.33. Lactone 3.32 was converted into protected triol 3.34, and 
treatment with Me2CuLi installed the required methyl group. Alcohol 3.36 was isolated in 
poor yield from the mixture of Sn2 and Sn2" products, and straightforwardly converted into 
ester 3.38. Epimeric butyrolactone 3.33 was transformed into acid 3.37 by Lindlar reduction 
and treatment with Me2CuLi. The second step is precedented to occur both with retention of 
configuration at the electrophilic centre, and with olefin isomérisation.
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Vv.
A cO
3.31
(a) PhCaCH, f>BuLi, THF
(b) NaBH^, EtOH; NaOH
(c) p-TsOH, PhH; 63%
(d)
(e)
(f)
(g)
DHP, p-TsOH, THF 
LIAIH4 , EtjO 
PvCI, pyr, DMAP; ACgO 
AcOH-HgO; 54%
OAc
3.34 OH
MagCuLI, EtgO; 34%
COof-Bu
3.38 OH
5 steps ,OPv
3.36 OH
Hg, Lindlar cat., quirwline 
EtOAc-MeOH
3.35 
MegCuLI, EtgO
Ph-^  'Y' "COgH
3 .37 ÔH
5 steps
Scheme 3.13.
3,3.5 -  The Sih chemoenzymatic method.
The key step in the Sih synthesis of ester 3.38 is the resolution of racemic ester 3.40 via 
lipase catalysed enantioselective hydrolysis (Scheme 3,14). Utilisation of 2-propanol-treated 
Candida rugosa lipase yielded ester (i?)-3.40 with excellent enantiopurity. Reformatzky 
reaction of corresponding aldehyde 3.42 with f-butyl 4-broraocrotonate promoted by Zn-Pb 
couple produced diastereomers 3.38 and epi-3.3S in poor yield, from which the undesired 
epimer was transformed into 3.38 isomer via Mitsonobu inversion.
Ph''"”' '^ ' ' '^ C 0 2 M e  ^  P(MeO)2SÜ4
Candida rugosa
CO gM e
3.39 92% (±)-3.40 PIT COgM e
(P )-3 .40 ,48%, e s  > 96%
DIBAL, EtaO 
95%
5-ep/-3.38
3.38 OH
f-Butyl 4'bromocrotonate
C O gFBu Zn-Pb; 40%
( 3 .3 8 : 5-P0/-3.38 = 1 : 1 )
Phr 'C H O
3.42
(a) 2 ,4 -(N0 2 )2 PhC0 2 H 
PhaP, DEAD, THF
(b) KaCOa MeOH; 55%
Scheme 3.14.
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3.3.6 -  The Leahy synthesis. 140
Leahy incorporates the means for introducing the epoxide present in Cryptophycins 1 and 2 
into the synthesis of fragment A, as discussed below in section 3.3.12. Aldehyde 3,44 
(derived from (i?)-ethyl mandelate 3,43) yields alcohol 3.47 after reaction with amide 3,45 
under standard Evans aldol conditions (Scheme 3.15).^^^ In common with the Kobayashi- 
Kitagawa route described above (section 3.3.3), transition state 3,46 can be invoked to 
rationalise the observed stereoselectivity of the aldol reaction. Transamidation of amide 3,47 
followed by allylation secured ketone 3,48. Finally, an intramolecular samarium-catalysed 
Tishchenko r e a c t io n w i th  acetaldehyde was used to introduce the final stereocentre with 
concomitant differentiation of the hydroxyl groups.
XPhT^ COgEt
3.43
Q:s^Et
Ç T IPS  3.45 L J
A -'P
3.44
SuzBOTf, DIPEA 
84%
COgf-Bu
TIPSO OH 3.50 3.49 AcO OP MB
Scheme 3.15.
TIPS
3.47 OH O
(a)
(b)
MegAI
MeONHMe^HCl
CHgcCHGHgMgBr
86%
5 steps TIPS (f) MeCHO, Sml2  T IP SO  f
(g) PMB0C(NH)CCl3 
TfOH; 67% a dR n w  n  II
The mechanistic rationale proposed by Evans for the selectivity of the Tishchenko reaction is 
illustrated below (Scheme 3.16).^^  ^Coordination of the aldehyde and hydroxyketone 3.48 to 
samarium is followed by hemiacetal formation. Intramolecular hydride transfer in transition 
state 3.51 yields acetate 3,52.
TIPSO ■
i T n3.48 OH O "
MeCHO, Smla Ml
3.51
R = CH(OTIPS)Ph
TIPS
3.52 OAc OH
Scheme 3.16.
Amine 3.57, an intermediate en route to unit A of an unstable aza-analogue of Cryptophycin 
1 was also synthesised in a broadly similar fashion by Tius from (7?)-methyl mandelate 3.53
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(Scheme 3.17). "^^  ^The chirality of ketone 3.54 dictates the configuration of transition state 
3.55 in the boron-mediated aldol reaction, the bulky silyloxy group being orientated away 
from the 6-membered ring.
OH
Ph'^COgMe
3.53
3 steps
T B S p  I (a) BUgBOTf, DIPEA! J  CH2Cl2.-78“C->0“C -3.54 O (b) (EtO)2CH2CH2CHO, -78°C
6 steps
COaAllyl 
OH NHg 3.57
Scheme 3.17.
LoB"
TBSO’^  "Ph 
3.55
MeOH, HgOg, 0°C 
65%, dr = 10:1
TBS
Ph OEt
3.56 O OH OEt
3.3.7 -  The Georg procedure.160
The stereochemistry required in fragment A is introduced at an early stage in the synthesis 
reported by Georg (Scheme 3.18). Ruthenium catalysed asymmetric hydrogenation of ^ keto 
ester 3.58 yielded hydroxy ketone 3.59 in excellent yield and enantiopurity. Alkylation gave 
ester 3.61 with excellent trans selectivity, presumably via attack upon chelate 3.60 from the 
less hindered upper face.
(S)-BlNAP-RuBr2  Me
O O OBn Hj (50 bar), MeOH 
97%, er = 98 ; 2
3.58
LDA, HMPA, Mel 
O ÔH OBn 74%, dr = 9 6 : 4
3.59
Ph'" ""COgMe
TBSÔ 3.82
Scheme 3.18.
Me—I
3.60 S) A ,,OBn 'LI' 'Li
steps i^g,
0  OH OBn 
3.61
69
3.3.8 -  The White syntheses. 144, 145
White has described two approaches to fragment A. In the first route (Scheme 3,19), one 
stereocentre is derived from the chiral pool, methyl (R)-3-hydroxy-2-methylpropionate (3.63) 
being converted to aldehyde 3.64. The second stereocentre is then secured by the 
diastereoselective addition of allyl tributylstannane, ann'-alcohol 3.66 presumably arising via 
chelated intermediate 3.65. After standard manipulation to aldehyde 3.67, a Takai reaction^^  ^
with iodoform followed by coupling of the resulting (E")-iodoalkene with 
phenyltrimethylstannane under Stille conditions yields ester 3.38.
2 steps
COgMs 
OH 3.63
'CHO
n-Su^ nCH2CH=CH2 
SnCU, CHaCIaOPMB 3.64 76%, dr >20:1 PMBO OH
I 3.66
5 steps
H
PMBQ ,0  
3.es
COgf-Bu 
O OTBS 3.67
CHIg, CfCla, THF 
M egSnPli
PdCIz(MeCN)a, DMF 
TBAF, THF; 31%
‘COgPBu
OH 3.38
Scheme 3.19.
The second White approach utilises an asymmetric crotyiboration protocol to produce key 
allylic alcohol 3.70 (Scheme 3.20). Independently, the same approach was reported by 
researchers at Eli Lilly. The highly enantio- and diastereoselective crotyiboration can be 
rationalised by 6-membered transition state 3.69, the absolute configuration of which is 
determined by the geometry of the isopinocampheyl ligands (L*).^^  ^The White and Eli Lilly 
strategies diverge from alcohol 3.70, standard manipulation allowing White to reveal ester 
3,38 in a further seven steps. The Eli Lilly route ultimately incorporates the versatile terminal 
double bond of 3.71 into the Cryptophycin skeleton, before introduction of the phenyl group 
in a later Pd-catalysed coupling step.
OTBS 
CHO 3.68
BFg'OEta
-78"C rt 
71%, er = 97:3, dr >50:1
7 steps
3.70 OH OTBS
A
COof-Bu
3.38 OH
'COgH
OH 3.713.69
Scheme 3.20.
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3.3.9 -  The Eli Lilly bioreductive strategy. 164
The key to a second approach reported by Eli Lilly is the bioreduction of readily available 
(7?)-carvone 3.72 (Scheme 3.21). Reduction with Trigonopsis variablis produced alcohol 
3.73 without the need for chi'omatographic purification. Two stereocentres are set in place 
with excellent selectivity, which ultimately translate to C5 and C6 in fragment A. Ozonolysis 
followed by Criegee rearrangement^ produced acetate 3.76 which was subsequently 
elaborated into ester 3.62,
(a) Trigonopsis variablis 
pH7 buffer, glucose
(b) TBSCI, DBU, DMF 
44%, dr >99:1
3.72
3.62 O T B S
(c) O3 , MeOH-CHgClg
(d) AOgO, DMAP
3.73
cy
MeO
,0H
3.75 AcO
.OTBS5 steps
3.77
Scheme 3.21.
-  MeOAo
3 steps
3.76 O A c
3.3,10 -  The Shimizu Palladium catalysed route.166
Shimizu reported the elegant palladium-catalysed reductive ring-opening of optically active 
alkenyl oxirane 3.80 (secured via Sharpless asymmetric epoxidation of alcohol 3.79) to 
selectively yield homoallylic alcohol 3.81 (Scheme 3.22). (Z)~Alkenyloxirane 3.80 forms 7Z- 
allylpalladium species 3.82 which isomerises via a ;r~(T-;r interconversion mechanism (3.82 
3.83 -4- 3.84), yielding thermodynamically favoured jyn-;r-allylpalladium species 3.84. 
Intramolecular hydride attack subsequently yields the desired olefin 3,81.
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4 stepsO yO  _ _
p-M eOPh 3.78
3 steps
OH 3.79 OPMB
3.62 OTBS
Pd2(dba)3»CHCl3, n-BujP
3.ao O PM B H“ !H ,E W D ioxane
5 steps'COgMe -------—  Ph-
3.81 OH OPMB
3.80
R = (GHz) gOPMB
,,o'9 o PdLx, HCOgH
-CO,
'tPlp'^ p I
-R
3.82 OH 
-P d L ,
P h
Ph,,
3.83 OH
,R
3.85 ÔH
Scheme 3.22.
3.84 OH
3.81 OH
3.3.11 - MacrocycKsation procedures.
Three main strategies have been used to furnish the macrocyclic Cryptophycins and 
analogues, differing in the position of final ring closure.
(a) - The Moore-Tius approach 128
The strategy pioneered by Moore and Tius in the first reported synthesis of a member of the 
Cryptophycin family featured macrolactamisation at the junction between fragments B and C 
(Scheme 3.23).^^^ Treatment of ester 3,86 with TFA followed by cleavage of the 
trichloroethyl ester revealed the free amine and acid functionalities, Macrolactamisation was 
promoted by pentafluorophenyl diphenylphosphinate (FDPP), giving the cyclised 
Cryptophycin (3.4) in moderate yield over 3 steps.
PI (a) Zn, Sonication 
AcOH-THF
(b) TFA, rt 
‘OMe (c) FDPP, DIEA 
DMF, rt; 40%
CGI.
NHBoc3.86
P
OMe
Cryptophycin 4, 3.4
Scheme 3.23.
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Fray has communicated a similar strategy for the formation of Cryptophycin macrocycles 
under mild conditions (Scheme 3.24).^^*  ^ Following #-deprotection of ester 3.87, 2- 
hydroxypyridine was used to promote ring closure. 2-Hydroxypyridine stabilises tetrahedral 
intermediate 3.89, favouring proton transfer, loss of trichloroethanol and lactamisation. The 
mild Fray conditions minimise byproducts occurring in the Moore - Tius cyclisation 
procedure.
Ph' P
HN. 2-hydroxypyridine
OMe
CCI; Cryptophycin 51 ,3 .90
NHR
4 L '3.87 R = 8oc TFA
3.89
OMe
Scheme 3.24.
(b) - The Kitagawa approach.
In the total synthesis of Arenastatin A (Cryptophycin 24, 3.92), Kitagawa closed the ring 
via formation of the C2-C3 double bond under intramolecular Wittig-Horner conditions 
from phosphonate 3.91 (Scheme 3.25).
.OTBDPS Q;.P
NH
3.91
MeO'
(a) TBAF, AcOH
(b) DMP Ph'
(c) DBU, LiCi; 34%
OMe
H
Arenastatin A, 3.92
Scheme 3.25.
(c) The Lavallée procedure.
Lavallée chose macrolactamisation between units A and B to close the Cryptophycin 
macrocycle (Scheme 3.26), utilising an acid-labile tert-hutyi ester which was removed 
simultaneously with the A-Boc protection in ester 3.93. Cyclisation of the resulting amino 
acid was promoted by 0-benzotriazol-l-yl-A,A,A',A'-bis(pentamethylene) uronium 
hexafluorophosphate (3.94).
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P f f  'Y '  'COgf-Bu
Ar
N ^O
3.93, Ar = 2-CI,3-MeOPh
(a) TFA-CHaCIa
(b)
3.94
PF,0
DIPEA, DMF, 0“C 
85%
Scheme 3.26.
Ph'
Cryptophycin 3, 3.3
3.3.12 - Strategies for the introduction of the Unit A epoxide moiety.
Two general strategies for the introduction of the jS-epoxide pharmacophore present in the 
most active members of the Cryptophycins (e.g. 3.1 and 3.2) have been described. The first 
and most common is the introduction of the epoxide in a final step using 
143,162 Qj dimethyldioxirane (DMDO)^^^* (Scheme 3.27). Diastereoselectivity
for the epoxidation is poor, 3 : 1 in favour of the desired /3-isomer (3.1 / 3.2) at best, with 
isolated yields in the region of 50% following reverse-phase HPLC separation.
p
HN.
Cryptophycin 3 or 4, 3.3 /3 .4
DMDO 
CHaCIa, -3 0 “C
or m-CPBA 
CHaCIa, rt 
dr a  2-3:1
P
Cryptophycin 1 or 2, 3.1 /3 .2
Scheme 3.27.
epÂ-3.1 /3 .2
The second general epoxidation strategy, first applied by L e a h y ( s e c t i o n  3.3.6) draws 
upon precedent from Sharpless for the in-situ conversion of vicinal diols into epoxides 
(Scheme 3.28).^^  ^Formation of a cyclic orthoester 3.96 is followed by the addition of acetyl 
bromide, and the resulting acetoxy halides 3.98 / 3.99 reveal epoxide 3.100 upon acetate 
cleavage and cyclisation using potassium carbonate in methanol
p2 MeC(0Me}3
OH PPTS
3.95
OMe
AcBr A,
3.97
Scheme 3.28
OAc
3.98 Br KgCOg
| r
3.99 OAc
MeOH
3.100
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In the Cryptophycins, the base-sensitive ester linkages present are incompatible with the basic 
transestérification step required to reveal the a-hydroxy halide precursor to the epoxide, 
necessitating a modification of the Sharpless protocol (Scheme 3.29). The use of 4-azido- 
1,1,1-trimethoxybutane in place of trimethyl orthoacetate allowed cleavage of azidobutyrate 
3.102 under reductive conditions via intramolecular lactamisation of intermediate 3.103.^ "^
p (MeC)3(CHa)3N3 Cl
3.101 OH TMSCl
■ p i / Y "  
3.102
PPh3 
Q  HaO
Cl
3.103
Cl
p / y "
3.104 OH
K2CO3 . MeOH 
39%
Ph' 
3.105
Scheme 3.29.
The Leahy strategy was later adapted by Moore and Moher and incorporated into a late stage 
of the original Moore-Tius route (section 3.3.2), using Sharpless Asymmetric 
Dihydroxylation to install the required diol (Scheme 3.30).^^^ Dihydroxylation of styrene 
3.106 under optimised conditions allowed the isolation of j8-diol 3.107 with excellent (29 : 1) 
diastereoselectivity. Macrocyclisation under Fray conditions was followed by conversion via 
the orthoformate to formate ester 3.109. The use of an orthoformate in place of an 
orthoacetate allowed cleavage of the formate ester under mildly basic conditions, leaving the 
other ester linkages intact, and gave epoxide 3.110 in excellent overall yield.
BocHN ^C C Ig  
3.106
K2 0 sO2 (0 H) 4  (2 mol%) 
(DHQD)2 PHAL (2 mol%)
K2 C O 3 , MGSO2NH2 
OMe K3 Fe(CN)8 . f-Bu0 H-H2 0 , rt 3.107 OH 
61%, dr = 2 9 : 1
P
OMe
3.110, Cryptophycin-52
X ÇH+ p ir^ f^  
3.108 OH
X
(a)
(b)(c)
(d)
TFA
2-Hydroxypyridine, MeCN-PhMs 
(MqO)3 CH, PPTS, CHzCIa 
AcBr, CHaCIa
Br A
KaCOs, MeOH-THF; 6 8 % K u
  Y3.109 O
Scheme 3.30
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3.4 -  Conclusions.
The Cryptophycins have stimulated great synthetic interest over the short time since their 
potential as antitumour compounds was revealed in 1994. At the time of writing (May 2000) 
Eli Lilly and Company report that Cryptophycin 52 (LY 355703,3.110) is in Phase II clinical 
trials as a proposed treatment for multiple solid tumours.
p
HN,
OMe
Cryptophycin 52, 3.110 
(LY 355703)
Numerous synthetic routes to the Cryptophycins and analogs, and especially to the key 
Fragment A motif have been published. Many of the routes to fragment A rely heavily upon 
standard, well established methodology, such as the Sharpless asymmetric epoxidation, 
asymmetric boron-mediated aldol or asymmetric crotylboration reactions. The Glasgow route 
to Cryptophycin fragment A, and thence to the total synthesis of Cryptophycin 4 will be 
discussed in the following chapter. We use novel molybdenum-based asymmetric carbon- 
carbon bond forming methodology to control the C5 and C6 stereocentres in fragment A.
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Chapter 4 - The Total Synthesis of Cryptophycin 4,
Chapter 4 will describe the Glasgow approach to (2£,55' ,6i?,7£')-5-(/err- 
butyldimethylsilanyloxy)-6-methyl-8-phenylocta-2,7-dienoic acid 4.3 and from there to the 
total synthesis of Cryptophycin 4. The synthesis of 4.3 provided an opportunity to apply the 
molybdenum-based methodology described in Chapters 1 and 2 to natural product synthesis, 
and utilises a strategy whereby the C5 and C6 stereocentres are introduced in a single 
synthetic operation. Our approach (Scheme 4.1) entails coupling of organocopper(I) 
nucleophile 4.2 with novel planar chiral cationic r]'^ -dlly\ molybdenum complex 4.1.
~ |  + B F 4-  C l
o c '6 > o  4.1 * V Ph" ^  ^  ^  "COgH 4.3 OTBS
Scheme 4.1
4.1 - Retrosynthesis
In common with previous Cryptophycin syntheses described in Chapter 3, our initial target 
molecule was protected hydroxy acid 4.3 as an equivalent for fragment A (Scheme 4.2). With 
a reliable route to 4.3 in hand we planned to complete the synthesis of Cryptophycin 4 mainly 
following precedent established by Moore and co-workers. Hydroxy aldehyde 4.4 was 
envisaged to be a precursor to 4.3, disconnection across the key C5-C6 bond leading to the 
chiral synthons 4.5 and 4.7.
4.3 OTBS
OCT X  CO 4.6 Cp
BF4-
4.1
C p
4.4 OH
©
4.5 OH 4.7
Scheme 4.2
BUfiS OTIPS
O T P S
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We envisaged that cationic synthon 4.5 could be represented by the novel cationic 
molybdenum complex 4.1, which, if available in planar chiral form, would allow the C6 
methyl stereochemistry to be controlled by addition of a suitable nucleophile anti to the face 
blocked by the metal. At the commencement of the work, little guiding precedent was 
available regai’ding the regioselectivity of nucleophilic attack upon complex 4.1. Key issues 
were the electronic effect of phenyl conjugation and the relative steric effects of phenyl vs 
methyl.
As for the nucleophilic coupling partner, we initially envisaged novel organocopper(I) 
nucleophile 4.8 as an equivalent to synthon 4,7. The 1,2-diol array in intermediate 4.9 has two 
key strategic functions: (a) it acts as a stereochemical marker and (b) it serves as a latent 
aldehyde. The strategy outlined in Scheme 4.2 requires the successful synthesis and union of 
complex 4.1 and nucleophile 4.8. Routes to the two key intermediates will be dealt with in the 
following sections.
4.2 - Preparation of allylic alcohol derivatives - precursors to neutral ;7r-allyl molybdenum complex 4.6.
Neutral complex 4.6, the immediate precursor to cationic species 4.1 required the preparation 
of enantiopure allylic alcohol 4.10^^^ (Scheme 4.3). From cheap (~£16 / L) and readily 
available (S)-ethyl lactate (4.11), alcohol 4.10 could be secured in 5 steps. Silyl protection, 
reduction and Wittig reaction of the resulting lactaldehyde^^^ yielded an equimolar mixture 
of (E)~ and (Z)-styryl isomers 4.13. Treatment of the mixture with thiophenol and 1,1'- 
azobis(cyclohexanecarbonitrile) (VAZO® 88) in refluxing to luenesmoothly  isomerised 
the mixture to favour the desired (E)-styrene, presumably via addition of PhS* to the olefin, 
rotation of benzylic radical 4.14 and reformation of the double bond. Similai' isomérisations 
of 2-alkenoic esters, styrenes and non-conjugated olefins using PhSSPh with or without 
AIBN have been d e s c r i b e d . F l u o r o d e s i l y l a t i o n  and recrystallisation secured 
isomerically pure (E)-allylic alcohol 4.10 in 74% yield and >92% ee as estimated via 
NMR analysis of the coiresponding (R)-O-acetyl mandelate ester. Allylic ester derivatives 
4.15-4.17 were subsequently prepared from 4.10 in good yield.
78
4.11 ÔH
(a) TBSCI, EtgN, DMAP 
CHaCIa, A; 92%
(b) DIbal, CHaCIa, -78°C
(c) PhCHaPPha+Br 
n-BuLi, THF, A; 76%
(d) NCCgHioNrrNCeHioCN
4.13 O T B S  
E:Z=1:1
PhSH, PhMe, A; 95%
4.15, R = Ac, 81%
4.16, R =  COCF3, 96%
4.17, R = COPh, 92% OR
(f) AcaO, (CFaCO^aO or 
PhCOCI, EI3N or py
DMAP, CHgClg, rt 4.10 OH
(e) TBAF, THF 
rt; 74%
■SPh*
4.13 OTBS 
E:Z = 6;1
Scheme 4.3
Allylic alcohol 4.10 was prepared on a > 40 mmol scale, but the route was inelegant. Homer- 
Emmons elongation of (5)-0-(rerf-butyldimethylsilyl)lactaldehyde 4.18 '^^  ^ (Scheme 4.4) 
with diethyl benzyIphosphonateyielded styrene 4.13 in only poor yield under standard 
co n d itio n s,an d  the Wittig reaction - isomérisation sequence was more efficient on a large 
scale.
EtOaO^
OTBS
4.12
DIbal, CHaCIa, -78=C
PhCHaP(0)(OEt)2  
NaH or n-BuLI
Q -|-gg THF, —78°C —> rt; 9*35% 
4.18
Scheme 4.4
OTBS
4.13
An alternative preparation of allylic alcohol 4.10 involved the use of Novozym 435^^ to 
resolve the racemate (see Chapter 2, section 2.1). Racemic alcohol 4.10, easily obtained by the 
addition of methyl lithium to cinnamaldéhyde 4.19,^^  ^was treated with Novozym 435 in the 
presence of vinyl acetate (Scheme 4.5). Enantioselective acétylation of the racemate gave 
acetate (R)-4.15 (46% yield) and alcohol (5)-4.10 (45% yield). Saponification of a portion of 
acetate 4.15 allowed the estimation of the enantiomeric ratios of alcohol 4.10 and acetate 4.15 
to be estimated as 97:3 and 96:4 respectively via formation of (R)-O-acetyl mandelate esters 
4,20 and 4.21 and ^H NMR spectroscopic analysis.
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Novozym 435 (10 wt%) 
Vinyl acetate (25 eq)
(±)-4.10 OH
MeLi (1.1 eq) 
THF, -78°C; 77%
4ÂM S{50wt% ) (S)-4.10 OH
Pentane, rt, 10 li 45%
(R)-4.15 OAc
46%
4.19 O
(fl)-0-acetyl mandellc acid 
DCC, DMAP. CHaCIa, rt; 75%
OAc
KaCOs, MeOH, rt; 95% 
(F?)-0-acstyl mandellc acid 
DCC, DMAP, CHaCIa, rt; 79%
Me,
4.20 4.21
O
dr = 97 ; 3  dr = 96 ; 4
OAc
o
Scheme 4.5
4.3 - Synthesis of stannane 4.9.
Isopropylidene-protected stannane 4.9 was initially targeted as a precursor to the nucleophile 
in the key Cryptophycin coupling step, as it was hoped that tin-lithium exchange and lithium- 
copper transmetallation would both proceed retentively at low temperature. A communication 
from Rychnovsky formed the basis of initial attempts to secure stannane 4.9 (Scheme 
4.6).^^^ Dimethyl (»S)-malate 4.22 was converted into aldehyde 4.23, from which thioacetals
4.24 / 4.25 were obtained by treatment of 4.23 with (phenylthio)trimethylsilane (PhSTMS) 
and catalytic trimethylsilyl triflate (TMSOTf), followed by acetone and catalytic TMSOTf. 
Reductive lithiation and stannylation at low temperature concluded the reported route to 
stannane 4.9
CO  M e BH3 «DMS, THF; NaBH4
OH
Dimethyl (S)-malate, 4.22
(b) TIPSOTf, lutidine, CHaCIa, -2 0 “C
(c) TMSCl, B 3 N, DMAP, CHaCIa
(d) DIBAL, EtaO, -7 8 “C
OTIPS 
OTMS
4.23
PhSTMS. TMSOTf 
CHaCIa, -78"C; 
MeaCO, TMSOTf 
CHaCIa, -78°C
BuoS OTIPS (0 L D BB ,TH F,-78X:
VBuaSnCl, -78°C
4.9 4 .2 4 /4 .2 5
Rychnovsky, J. Org. Chem., 1989, 54, 4902.
Scheme 4.6
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In our hands the original Rychnovsky procedure proved unsuccessful: treatment of aldehyde 
4.23 under the above conditions returning none of the desired 0,5'-acetals 4.24 / 4.25, and an 
alternative route was investigated. Justification for this decision arrived after the conclusion of 
the Cryptophycin work when in 1999 Rychnovsky acknowledged that the original procedure 
was unsatisfactory and poorly reproducible, quoting decomposition of the product into the 
phenylthioacetal of the starting aldehyde, the phenylthioacetal of acetone and a variety of 
unidentified products under the reaction c o n d i t i o n s . F o r t u i t o u s l y ,  two alternative 
routes to 4-(phenylthio)-l,3-dioxanes such as 4.24 / 4,25 existed, the second of which was 
modified successfully to secure stannane 4.9.
In the first alternative route (Scheme 4 , 7 ) ,  180-182 f^^xydroxy aldehyde 4.26, which exists as a 
mixture with its unsymmetiical dimer 4.27, is treated with an excess of acetaldehyde under 
DBU catalysis and the resulting hemiacetal 4.28 acetylated in situ to yield acetate 4.29. 
Exchange of acetate for thiophenol under Lewis acidic conditions yielded 4-(phenylthio)-l,3- 
dioxane 4.30. The intermediacy of acetate 4.29 is necessary due to the instability of 
hemiacetal 4.28, which, if isolated, would spontaneously lose acetaldehyde to return (5- 
hydroxy aldehyde 4.26.
P  ___ MeOHO (Excess)Y ^ cho ■
OH 4.26 DBU O x y O  4.28 
Me
AcaO, EtgN
DMAP, CHaCIa V
5 to 10-fold excess of acetaldehyde required
O 4.29
Me
PhSH BFgOEta 
CHaCIa. -78=C
Ol 0  .  Aromatic or unsaturated aldehydes _
jj and ketones - reaction fails.
4.27 L , 0 H  O y O  4.30
R Me
Scheme 4.7
The second r o u t e ( S c h e m e  4.8) relies on the reduction and in situ acétylation of
l,3-dioxan-4-ones 4.32, prepared from )S-hydroxy acids and excess aldehyde under protic or 
Lewis acidic catalysis. DIBAL reduction and in-situ acétylation of the resulting unstable 
hemiacetal yields an a-acetoxy ether which can be converted into 4.33 under Lewis acidic 
conditions as above. The second, more general route is successful for the preparation of 1,3- 
dioxan-4-ones derived from aliphatic or aromatic aldehydes and also from ketones.
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OH
R'CHO or R'2C0
Sc(OTf)3 O yO
(a) DIBAL,-78°C
(b) ACaO, Py, DMAP, ~78“C -»  rt
(c) PhSH, BFaOEta, CHaCIa, -78"C
4.31 4.32 R'
" " T YOyO
4.33 R'
SPh
Scheme 4.8
The second route allowed us to access acetate 4.39 in 5 steps from dimethyl (S^-malate 4.22 
(Scheme 4.9). Reduction of dimethyl (S')-malate by the procedure of Moriwake^^ gave the 
desired 1,2-diol 4.34 together with the 1,3-diol 4.35 (7:1 respectively). The diols were 
identified by comparison of their NMR spectra with literature data.^^"’"^ ®^ The reaction 
was less selective than reported perhaps because the NaBH^ was of inferior quality leading to 
longer reaction times. The contaminant isomer was readily removed chromatographically 
following selective silylation of the primary hydroxyl g r o u p a n d  saponification of the 
methyl ester to yield hydroxyacid 4.37. Dioxanone 4.38 was subsequently prepared using 2- 
methoxypropene and catalytic PPTS.^^^ DIBAL reduction and acétylation proceeded 
uneventfully under Rychnovsky conditions to yield acetate 4.39 exclusively as the (45,659- 
isomer shown.
MeOaCr' '^YOH
4.22
C O ,M e  BHg'DMS, THF, rt;
NaBH4, THF, rt; 89%
COgM©
OH
4.35
OH
Ac
4.34
TIPSCI, tm
DMF, -30°C; 71%
K2COg(aq),M0OH,A:7O%
)T IP S  (d) DIBAL O T IPS (c) HgC=CH(OMe)Me
CHgClg, -78°C; n  ^  J PPTS, CHgClg: 84% .  .
^ --------------------------------------  H O a C r Y '^ ^ O T iP S
CL , 0  4.39 DMAP, ACgO Q, . 0  4.38 OHA  A 4.37
Scheme 4.9
For the Cryptophycin 4 synthesis, the configuration at C4 is irrelevant at this stage (or at that 
of the phenylthio acetal which follows) since the required C4 stereochemistry is only put in 
place by a subsequent reductive lithiation - stannylation step. For convenience however, it is 
useful to note that the relative configurations of acetonides derived from syn- and anti-l,2>- 
diols can be assigned from the NMR shifts of the acetal carbon and acetal methyl 
carbons (Scheme 4.10).^^^’ Rychnovsky correlated the NMR spectra of more than 
200 known compounds of general structure 4.40 or 4.41 and drew the following conclusions:
82
1,3-diol acetonides 4.40 exhibit acetal methyl carbon shifts at approximately 19 
and 30 ppm. The acetonide exists in a well-defined chair conformation with the C4 
and C6  substituents both placed in equatorial positions.
A/îri-1,3-diol acetonides 4.41 exhibit acetal methyl carbon shifts at approximately 25 
ppm. The acetonide exists in a twist-boat conformation 4.44 in order to avoid 1,3- 
diaxial interactions that would be present in chair conformations 4.42 and 4.43.
The acetal methyl carbon shifts are reliable indicators of 1,3-diol acetonide 
stereochemistry, (except where or = CN) but the acetal carbon shift (-98.5
ppm Syn and -100.5 ppm Anr/) is not as reliable and should be used with caution.
-  30 ppm
/  \  H I -9 8 .5  ppm
4.40 " ^ - 1 9  ppm ^
^  4.42 R ’
~ 25 ppm
4.41 ^•43 — 100.5 ppm4.44
Scheme 4.10
The formation of a single acetate diastereomer 4.39 is unsurprising, and in accordance with 
the good syn diastereoselectivity (4:1 ->10:1) observed by Rychnovsky in the reduction and 
in s itu  acétylation of similar dioxanone precursors. Presumably acetate 4,39
represents the kinetic product resulting from axial hydride attack upon the carbonyl group of 
4.38, followed by stereoselective acétylation. Transformation of acetate 4.39 into 0,S- 
acetals 4.24 / 4.25 was problematic (Scheme 4.11), despite precedent from Rychnovsky for 
the conversion of similar acetates, such as 4.45 depicted below, simply using thiophenol and 
stoichiometric BF3«OEt2 as a promoter. In our hands, treatment of acetate 4.39 under the 
literature conditions using stoichiometric BF3«OEt2 yielded 5,5-acetal 4.49 as the sole 
product in 75% yield. A plausible mechanism is proposed below, with desired sulphides 4.24 
/ 4.25 being initially formed via the intermediacy of oxonium ion 4.47, followed by Lewis 
acid mediated departure of acetone and the formation of 5',.S-acetal 4.49 after attack of 
thiophenol upon the stabilised cation 4.48.
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•'Y'V^OAc 
4.45 0 .  , 0
PhSH (2 eq) 
Bp3*OEt2  (1.2 eq)
S P hV''4.46 / \^  CH2 CI2 , -7 8 °C , 1 h; 92%
Rychnovsky and Dahanukar, J. Org. Chem., 1999, 61, 8317.
> 10:1
V Y ^  
° X '
4.39
PhSH (2 eq) 
BF3 *OEt2 (1 . 2  eq) 
CHaCIa, - 7 8 “C 
75% P h
4.49
Scheme 4.11
O T IPS BF3*OEt2 r L ' ^ ' Y ^ O T I P S  PhSHo  "  ©CX.0 --------A  0F3B-0AC4.47
^ y ' Y ^ O T I P S  PhSH
S P h  O H  " -----------------------
P h
P h
° X '
4.24 / 4,25
4.48
O T I P S
— MeaCO BFa'OEta
O T I P S
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A variety of alternative conditions were subsequently investigated, as summarised in the table 
below:
Entry C on d ition s Yield (%) of 
4.24 / 4.25
Yield (%) of 4.49
1 2.0 PhSH, 1.2 BF3*OEt2 
CH2 CI2 , -78°C, 1 h
O(-) 75
2 1.1 PhSTMS, BF3 *OEt2 (cat) 
CH2 CI2 , -78°C, 40 min
3(-) 0
3 1.1 PhSTMS, 5 mol% ZnCl2 
CH2 CI2 , -60°C, 5 min
81 (73 : 27) 0
4 1.1 PhSH, 5 raol% ZnCl2 
CH2 CI2 , -80*^0, 1.5 h
81(81 : 19) Trace by TLC
5 1.05 eq PhSH, 4 mol% ZnCl2  
CH2CI2 , -3 0 “C, 15 min
87 (10 : 90) Trace by TLC
Use of PhSTMS in place of PhSH with BP3*OEt2 promotion gave a trace of the desired 
products 4.24 / 4.25 but the combination of PhSTMS and ZnCl2 at low temperature allowed 
sulphides 4.24 / 4.25 to be isolated in 81% yield. Syn-isomer 4.25 was readily identified by 
the acetal methyl carbon shifts (<5 30.1, 2 0 ,0  ppm) which were in close agreement with 
literature values (Ô 30.0, 19.9 ppm).^^^ The good selectivity for the anti isomer 4.24 at low 
temperature supports predictions made by Deslongchamps for the addition of nucleophiles to 
a cyclic 6-membered oxonium ion (Scheme 4.12).^^^ Attack on oxonium ion 4.50 from the
upper face will result in chair conformation 4.51, which is equivalent to the observed major 
product 4.24. Taking into account the restriction for the antiperiplanar arrangement of an 
oxygen lone pair with the newly formed C-S bond, attack upon the lower face of the oxonium 
ion would result in the sti'ained and unfavourable twist-boat conformation 4.52. Other Lewis 
acids screened in conjunction with PhSTMS include TMSOTf (decomposition), Sc(0 Tf)3 
(decomposition), SnCl4 (decomposition to 4.49) and Ti(0 '^Pr)4 (no reaction).
a . 'ZnCIc
4.39, R = CH,0T1PS
3Jh.h = 12.0, 2.5 Hz
ClaZn-GAc
©
ZnClj
-80°C
30 .1 ,2 0 .0  ppm
Ph
^^h-h -  5.8 Hz 
R
/ \  4 .25, Minor product / \  4.50
28.1, 24.8 ppm 
4.24, Major product /  \   y
Attack on
*■--------------
lower face
© 
r ' y
PhSH
R Attack on
upper face
4.52
PhSH
Scheme 4.12
'V§"
4.51
Subsequent experimentation revealed that the reaction temperature was not critical and neither 
was the use of PhSTMS, more conveniently thiophenol itself could be used (Entries 3-5). An 
alternative preparation of 0,5-acetals 4.24/4.25 was briefly investigated (Scheme 4.13). 
Cohen has reported the one-pot synthesis of 0,S-acetal 4.54 from lactone 4.53 by DIBAL 
reduction and treatment of the crude aluminium salt with thiophenol and BF3*OEt2 at low 
t e m p e r a t u r e , a  route apparently not applied dioxanone systems such as 4.38 by 
Rychnovsky. The original Cohen conditions were applied to dioxanone 4.38 in an attempt to 
avoid the intermediacy of acetate 4.39, but were unsuccessful, as was the use of DIBAL 
followed by ZnCl2 and PhSH.
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(a) DIBAL, PhMe, -7 8 “C, 1 h 
‘Q - ^ Q  (b) PhSH, BFs'OEtg. -7 8 “C, 5 min ' ^ o ' ^ S P h
4.53 4.54
Cohen and Lin, J. Am. Chem. Sac., 1984,106,1130.
0, (a) DIBAL
(b) PhSH. BFa'OEtg or ZnCig
Scheme 4.13
With a viable route to sulphides 4.24 / 4,25 now in place, the key step in the synthesis of 
stannane 4.9 could be addressed. The axial stereochemistry at C4 is set in place by a 
reductive lithiation and stannylation sequence, converting a mixture of diastereomeric 
sulphides to a single stannane diastereomer. Reductive lithiation of a-(phenylthio)ethers 
originated in 1980 when Cohen reported the formation of a-lithioethers from a variety of 
precursors by treatment with lithium l-(dimethylamino)naphthalenide (LDMAN) or lithium 
naphthalenide (LN) (Scheme 4.14).^^^ An advantage of using LDMAN is that the 1- 
(dimethylamino)naphthalene (DMAN) byproduct is readily removed from the reaction 
mixture with a dilute acid wash during workup. Reductive lithiation proceeds via electron 
transfer followed by carbon-sulfur bond cleavage and departure of thiophenoxide anion. The 
resulting carbon radical is further reduced by a second equivalent of the aromatic radical 
anion to give a carbanion. The efficiency of electron transfer from the radical anion increases 
with the steric bulk of the aromatic group, leading to the widespread use of lithium di-tert~ 
butylbiphenylide (LDBB, 4.55).^^^*
Li*
LN
MeoN
LDMAN
L1+
LDBB, 4.55
I .RO SPh _gph_ RO'
Scheme 4.14
XRO-^Li
In the case of a cyclic six-membered a-(phenylthio)ether system, axially substituted products 
are formed with excellent selectivity if lithiation and reaction with an electrophile are carried 
out at low temperature. The selectivity results from the "radical anomeric effect"
illustrated below (Scheme 4.15). The first equivalent of the aromatic radical anion forms 
radical 4.56 which can rapidly interconvert between pseudo axial and pseudo equatorial
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orientations, even at low temperature.Repulsion between the SOMO and the nearby 
oxygen lone pair in radical 4.56Eq results in radical 4.56ax being favoured, and leads solely 
to kinetic organolithium species 4.57ax following donation of a second electron.
Ph OTIPS
X TIPSO
TIPSO
4 .2 4 /4 .2 5
H
4.S6eq
LiDBB
-80=0
- S P h -
-8 0 “C TIPSO
4.56 a x
LiDBB
-80°C
BunSnCI
-80°C  TIPSOTIPSO'
Scheme 4.15
The kinetically formed axial alkyllithium 4.57ax (and the corresponding stannane 4.9) have 
the correct configuration required for the synthesis of Cryptophycin 4; however, thermal 
equilibration of axial organolithium 4.57ax to the diastereomeric species 4.57Eq is possible 
(Scheme 4.16).^^^ The resulting alkyllithium would then be a synthetic equivalent for the 
(15,35)-l,3,4-trihydroxybutanide ion 2.57, an alternative form of which results from 
deprotonation of carbamate 2.52 in the presence of (-)-sparteine as described in Chapter 2,
Rychnovsky has reported the equilibration of the related axial alkyllithium 4.60 by warming 
to -20°C before re-cooling to -78°C and alkylation (Scheme 4.16). Equatorially substituted 
product 4.61 was formed with excellent stereoselectivity, albeit with the penalty of a lower 
yield due to competing protonation of the alkyllithium during equilibration. Later studies 
of the equilibration of a range of 4-lithio-1,3-dioxanes similai* to 4.57 and 4.60 have revealed 
a marked substrate dependence, with unhindered acetals equilibrating rapidly and efficiently, 
but with more hindered substrates such as 4.62 being problematic, steric hindi'ance reducing 
the rate of equilibration and increasing the rate of protonation by the solvent.
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2.52
+ s-BuLi, H-sparteine
©
OH OH
2.57
OH OH
'"'''y^^'Y^OTIPS
4.57sq
-2 0 “C
OTIPS
4.57.,
OH
Li ' P r \ ^ - v A
(a) -»  _20“C, 30 min ^
X0 ^ 0  / \  (b) PhCHO, -78°C
Ph
51%
4.60 Ax 4.61
Rychnovsky, J. Org. Chem., 1989, 54, 4982
E q:A x  
= 9 5 : 5
n-Hex-
20°C, 1 h
(b) MegSO^. -78°C  13% = 3 .4 :1
Rychnovsky eta l, J. Org. Chem., 1999, 64 ,6849
Scheme 4.16
LDBB (as a solution in THF) was prepared by a slight modification to the method of 
Freeman. Reaction of Hthium metal with 4,4Ldi"fôr?-butylbiphenyl (DBB) often proceeded 
slowly and due to the intense dark blue colour of the resulting LDBB solution, it was difficult 
to assess when the lithium had been completely consumed. It was more practical to use an 
excess of Li to DBB in a known volume of THF and essentially perform a 'titration' of the 
LDBB solution by reaction with a small quantity of sulphides 4.24 / 4.25. LDBB solution 
was added dropwise to a mixture of the sulphides in THF at -78°C until the dark blue colour 
of the radical anion persisted, at which time TLC confirmed the absence of sulphide and 
completion of the reductive lithiation. The concentration of the LDBB solution could then be 
calculated and the bulk of the solution used in a larger reaction, scaling the quantity of the 
sulphides appropriately. With this practical modification, stannane 4.9 could be produced 
efficiently, trapping organolithium 4.57ax with BugSnCl at low temperature. Stannane 4.9 
was identified as the desired axially substituted isomer by comparison of the acetal methyl 
carbon shifts (<5 24.9, 24.7 ppm. Scheme 4,17) with those reported by Rychnovsky {5 24.7, 
24.5 ppm).^^^ The epimeric equatorial stannane has significantly different chemical shifts for 
the acetal methyls (ô 29.9,18.6 ppm).^^^ In principle, axial organohthium species 4.57 could 
have been directly transmetallated to the corresponding alkylcopper, but this was not done for 
convenience and also because meagre precedent suggests that the thiophenoxide anion 
formed during reductive lithiation can act as a nucleophile with cationic molybdenum 
complexes.
BuoS TIPS BuoS
V
'OTIPS
4.9
SnBug I 
OTIPS
24.9  
24.7 ppm
'OTIPS
Scheme 4.17
Our final route to stannane 4.9, the immediate precursor to organocopper(I) nucleophile 4.2 
is summarised below (Scheme 4.18),
MeOgC'^ '^ 'Y
OH
4.22
(a) BH3 »DMS. THF, rt; 
CO ^M e NaBH4, THF, rt; 89%
(b) TIPSCI, Im, DMF 
-30°C; 71%
(0)  K 2 C O 3 ,  M e O H  
A; 70%
9 TIPS (d) H2C=CH(0Me)Me ÇTIPS
PPTS, CHaCIa; 84%  a c C
OH (e) DIbal, CHaCIa, -78®C; Py, DMAP, AcaO; 84%
4.37
' V t0 ^ 0  4 .3 9
(f) PhSH
ZnCIa (5 mol%) 
CHaCIa, -3 0 “C; 87%
BUqS
TIPS
0 ^ 0  4.9
(g) LDBB, THF, -78°C;
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4.24 /  4.25(1 ; 9)
Scheme 4.18
4.4 - Preparation of neutral complex 4.6 and initial attempts at 
the key coupling step.
With viable routes to stannane 4.9 and allylic alcohol 4.10 in place, we turned our attention to 
the formation and use of neutral complex 4.6, which proved more difficult than had been 
initially envisaged. Oxidative addition of acetate 4.15 to Mo(CO)3(MeCN)3 was slow 
(Scheme 4.19), requiring 5 days in refluxing acetonitrile for completion by TLC. The isolated 
yield of neutral complex 4.6 following ligand exchange with LiCp was poor (34%). To 
overcome the problem of the low reactivity of 4.6, two approaches were considered, to 
increase the reactivity of the allylic ester or to increase the reactivity of the Mo(0) complex to 
which the allylic ester oxidatively adds.
(a) Mo(CO)3 (MeCN)3  
MeCN, A, 5 d
4.15 OAc (b) LiCp, THF, rt; 34%
Scheme 4.19
4.6Cp
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The second approach was investigated initially, as various systems of the type Mo(CO)3(L)3  
are known, where L = DMF,^^ p y r i d i n e o r  (L)g = PhMe^"^ amongst others. 
Mo(CO)3 (DMF)3  has found wide applicability as a Mo(0) source for the formation of tz~  
allyl molybdenum complexes, but has the practical limitation of being difficult to handle, 
and more seriously for our purposes the stereochemical consequences of the oxidative 
addition of enantiopure allylic acetate systems vary with several factors such as temperature, 
solvent and rate of addition of a c e t a t e . O f  the various possible Mo(0) sources, 
Mo(CO)3 (py)3 , first reported in 1935 by Hieber appeared prom ising .Pearson  has 
compared the rate of reaction of various allylic acetate systems with Mo(CO)3 (py)3  and 
Mo(CO)3 (MeCN)3 , concluding that the pyridine based system is of greatly increased 
reactivity
Mo(CO)3 (py)3  was prepared from Mo(CO)6  by refluxing in pyridine for 3 hours, followed 
by cooling and precipitation with pentane, yielding a yellow crystalline solid in 8 6 % yield.^^ 
As hoped, Mo(CO)3 (py)3  was more reactive than Mo(CO)3(MeCN)3 , oxidative addition with 
acetate 4.15 being complete by TLC within 3 h in refluxing toluene, or 20 h at 90°C, to give 
neutral complex 4.6 in 73% yield. Mo(CO)3 (MeCN)3  is known to react with enantiopure 
allylic acetates with retention of configuration,^®’ but the consequences of oxidative
addition to Mo(CO)3 (py)3  were unknown. It soon became apparent that stereocontrolled 
oxidative addition was not occurring, as coupling of alkylcopper(I) reagent 4.8 with cationic 
complex 4.1 gave a complex mixture of olefin products 4.64 and 4.65 in poor yield (17%), 
following oxidative décomplexation with CAN (Scheme 4.20). The isolation of a trace 
amount of olefins corresponding to diol analogs of 4,64 and 4.65 indicated that the acetonide 
diol protecting group was not stable under the CAN décomplexation conditions. Analytical 
HPLC and GCMS studies revealed a total of 8  diastereomeric olefins 4,64 and 4.65 were 
present, indicating not only that neutral complex 4.6 had been formed without complete facial 
control, but also that nucleophile 4,8 was configurationally unstable and exhibited poor 
regioselectivity in coupling with electrophile 4,1.
BF4-
%
4.1Cp
(a)
(b)
(c)
Mo(CO)3(py)3 
PhMe, 80°C 
LiCp, THF, rt: 73% 
NOBF4 , MeCN, 0°C
4.15 Ô A c
Bu,S
OTIPS
(d) -7 8 “C, 30 min
(0 ) CAN, NaOAc 
/  \  MeaCO, rt; 17%
n-BuLI, THF, -78"C; 
CuBr»DMS 
DIPS-THF, "78°C
TIPS
0 ^ 0  4.9
Scheme 4.20
TIPS
4.64 0 ^ 0
TIPS
4.65
• 8 isomers in totai
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Investigations into the use of Mo(CO)3 (py)3  were discontinued, as it appeared that a lengthy 
investigation of reaction parameters such as temperature, solvent and concentration would 
have been required before a judgement upon its viability as a Mo(0) source could be made, 
and the more attractive option of increasing the activity of the allylic ester component was 
investigated. Kuhl has subsequently investigated the Mo(CO)3 (py)3  system, and established 
that Mo(CO)4 (py) 2  is the main component in solution, as described in Chapter 1, section 
1.2.2. Application of the Mo(CO)4 (py) 2  system to the Cryptophycin investigation is 
described later in this chapter.
4.5 - Alterations to the electrophilic and nucleophilic coupling 
partners used in the Fragment A key step.
The formation of a total of 8 diastereomers in the reaction of cationic complex 4.1 and the 
nucleophile derived from stannane 4.9 indicated that three separate problems were occurring 
in the attempted coupling reaction. The two most serious problems, those involving the failure 
to control the stereochemistiy at both of the newly formed stereocentres are discussed below, 
and the third problem, that of the poor regiocontrol in nucleophilic addition to cationic 
complex 4.1, is dealt with in sections 4.7 and 4.8.
To overcome the problem of the lack of facial selectivity in the formation of neutral complex
4.6 from an enantiopure allylic ester precursor, we returned to tlie Mo(CO)3 (MeCN) 3  
system, as precedent suggested this source of zerovalent molybdenum for stereocontrolled 
oxidative addition to form ÿ -allyl complexes was the most reliable.^®’ The need for
a more activated leaving group in an analogous system to acetate 4,15 was obvious. As an 
extreme alternative, trifluoroacetate 4.16^  ^was synthesised. Trifluoroacetate 4.16 could be 
prepared, purified by column chromatography and used immediately, but was unstable upon 
storage, a neat sample decomposing to a black oil upon storage overnight at ambient 
temperature. Unsurprisingly, oxidative addition of 4.16 to Mo(CO)3 (MeCN)3  was much 
faster than that of the corresponding acetate, addition being complete after 12 h at rt followed 
by 1 h at reflux, or after 2 d at rt. Trifluoroacetate 4,16 was not a viable precursor to planar 
chiral cationic complex 4.1, as coupling of 4,1 with nucleophile 4.67 (derived from stannane 
4,66®^ ) resulted in a complex mixture of products following décomplexation (Scheme 4.21). 
The presence of four C-glycosides was indicated by a complex mixture of signals in the 
vinylic region of the NMR spectrum, and four methyl doublet resonances. The mixture of 
products is presumed to be 4.68 and 4.69 below, as the configurational stability of 
nucleophile 4.67 in coupling with ??^-allylmolybdenum complexes has already been 
established.^^’
91
,^ OBn8nO-7^QBnO-^  4
4.67 Cu
BF4 -
O C ^ Ï ^ N O  4.1 Cp
.^OBn
BnO—  BnO~L--—-A
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Scheme 4.21
The loss of facial control in the formation of 4.6 is probably due to racémisation of 
trifluoroacetate 4.16 under the reaction conditions. When a sample of 4.16 was treated under 
the conditions originally used for the oxidative addition (rt, 0 /11; A, 1 h) in the absence of 
Mo(CO)3 (MeCN )3  and then concentrated in vacuo, NMR spectroscopy indicated 
significant decomposition with multiple peaks in the ô 6.50-5.00 ppm region and the crude 
mixture was optically inactive. Decomposition and loss of optical activity in the absence of 
Mo(CO)3 (MeCN ) 3  ruled out the possibility of a racémisation mechanism involving 
coordination of the carbonyl group of 4.16 to molybdenum and ionisation to form an allylic 
cation and a coordinated trifluoroacetate anion. An ionic, SMl-like mechanism of this type has 
been proposed by Kocovsky and co-workers to explain racémisation in the formation of 
allylic ether 4.70 in an investigation of Lewis-acid type Mo(II) catalysed allylic substitutions 
(Scheme 4.22).^^®
OAc
{FO-4.15, >99% ee
MeOH Me
[Mo(CO)4Br2 ]2 , ( 2  mol%) p  
4 h; 65%
(±)-4.70
Scheme 4.22
The chemical and configurational instability of trifluoroacetate 4.16 obviously precluded its 
use, and an alternative ester with greater reactivity than acetate 4.15 was found in the form of 
crystalline benzoate 4.17 (Scheme 4.23).^®® Oxidative addition of 4.17 to 
Mo(CO)3 (MeCN)3  was complete by TLC after 28 h in refluxing MeCN, and after LiCp 
ligand exchange in the normal fashion, neutral complex 4.6 was isolated in good yield (76%). 
With the precedent that oxidative addition of enantiopure allylic acetates to 
Mo(CO)3 (MeCN)3  is cleanly retentive, it was assumed that the problem of facial control in 
the formation of neutral complex 4.6 was now overcome, and attention turned to the problems 
encountered with the configurational instability of alkylcopper reagent 4.8.
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(a) Mo{CO)3 (MeCN) 3  
MeCN, A, 28 h
(b) LiCp, THF, rt. 1 h; 76%
Scheme 4.23
0 ( f  ; CO 4.6 Cp
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Tin-lithium exchange of stannane 4 . 9  and retentive reaction with electrophile 4 . 7 1  has been 
reported by Rychnovsky (Scheme 4 . 2 4 ) . We confirmed the configurational stability of 
organolithium 4 . 5 ? a x  by reaction with benzaldehyde to return axial alcohols 4 . 7 3  and 4 . 7 4 .  
Retention at C4 was indicated by the characteristic acetal methyl carbon shifts.
BusSPs OTIPS (a) rt-BuLI, THF, -78"C
BFa'OEtg, -78"C; 62%
4.9 4.71 4.72
Rychnovsky, J. Org. Chem., 1989, 54, 4982
BugSn
4.9
(b) PhCHO, -78"C; 72%
Scheme 4.24
OTIPSPh'
25-26 ppm
4 .7 3 /4 .7 4
'OTIPS
i
41
A
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Configurational instability of organocopper(I) reagent 4 . 8  therefore appeared to be the 
problem, and in order to confirm this, 4 . 8  was coupled with simple allyl molybdenum 
complex 4 . 7 7  to yield olefins 4 . 7 8  and 4 . 7 9  in a 6 : 1 ratio (Scheme 4.25). Oxidative cleavage 
of the metal fragment was achieved by bubbling a stream of O2 through a chloroform 
solution of the crude ??^-olefin molybdenum products, an extension of a precedented protocol 
utilising décomplexation by exposure to air.^ The new procedure allowed the isolation of 
olefins 4 . 7 8  and 4 . 7 9  without the complication of cleavage of the acetonide protecting group, 
and was subsequently adopted for all other décomplexation steps in the Cryptophycin 
investigation. The configuration of the major (equatorial) isomer 4 . 7 8  was identified by the 
large diaxial coupling between H6 and H5 (7 11.6 Hz) and confirmed by the acetal methyl 
l^C shifts.
:,iW
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BuoS OTIPS (a) n-BuLI, THF, -78°C(b) CuBp DMS, DIPS-THF, -78=C
(c) [Mo(CO)(NO)Gp(î)3-C3H5)]BF4 (4.77)
(d) OaCHCIa, 17 h 
48%; 4.78 : 4.79 = 6 :  1
OTIPS
°X°
\ /
30.2, 20.0 ppm
OTIPS
25.2 ppm
Scheme 4.25
The origin of the configurational instability of the organocopper(I) species 4.8 is presumably 
an unfavourable steric interaction between the axial methyl group of the acetonide protecting 
group and the axial copper substituent. To minimise this steric interaction, the isopropylidene 
acetal was changed to a benzylidene acetal, with the consequent replacement of the axial 
methyl group by a proton. a-Hydroxy stannanes are reasonably u n s t a b l e , a n d  a one-pot 
transacétalisation strategy was employed, converting stannane 4.9 into a 7 : 1 mixture of 
acetal isomers 4.80 and 4.81 under acidic conditions in the presence of methanol and an 
excess of benzaldehyde dimethyl acetal (Scheme 4.26).^°^ Isomers 4.80 and 4.81 were 
separable by repeated column chromatography. Undesired stannane 4.81 could be recycled 
under the above conditions, yielding an 11 : 1 mixture of isomers 4.80 and 4.81 in 83% yield. 
Major isomer 4.80 was identified as the desired (2i?)-epimer shown below, where the bulky 
phenyl group occupies an equatorial position. The conformation of 4.80 was based upon nOe 
studies, with enhancements of H2 observed upon irradiation of H4, and vice-versa. Similarly, 
minor isomer 4.81 had the (2S)-configuration, the larger than expected 3/ coupling of to 
(13.7 Hz) presumably resulting from the distortion of the ring to alleviate steric strain 
between the diaxial phenyl and tributylstannyl groups at C2 and C6  respectively. nOe studies 
suggested a twist-boat conformation for stannane 4.81, as suggested by Rychnovsky for the 
analogous acetonide protected stannane 4.9.
BUqS
TIPS
4.9
p-TsOH (5 mol%) 
MeOH, PhCH(OMe)a
CHaCIa, rt. 6 h; 77% 
4 .80:4 .81  = 7 : 1
BUqS
TIPS
I 4.80 
Ph
B uoS
0 4 5 .0
ih
TIPS
4.81
ÏU..I
'f'.
J
11:
.OTIPS
'  A ,
BugSnH-
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BUoS
TIPSO L
i
ppm (Hz) nOe ppm (Hz) nOe
H2 5.81 16%-^H'* H2 5.73 , 13%-»HG
4.26 10.7, 6.9, 5.2, 2.4 1Q%->H2 4.17-4.12 - 6% —) H®
H6 5.15 6.4 • 4.59 13.7, 2.3 14% -^H2
Scheme 4.26
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The configurational stability of the alkylcopper(I) reagent 4.2 derived from stannane 4.80 was 
established by coupling with allyl cationic complex 4.77, to yield a single olefin product 4.82 
in moderate yield after décomplexation (Scheme 4,27). Retention of the axial configuration at 
C6 is indicated by the small (3/ = 6.9 Hz) coupling between the C6 -proton and the two 
methylene protons at C5, and confirmed by nOe studies, with a 16% enhancement of H6 
observed upon iixadiation of the acetal proton and a 12% enhancement in the opposite 
direction. Zero enhancement of H6  upon irradiation of H4 and vice-versa was also seen.
BUgS OTIPS
4.80
(a) n-BuLi, THF, -78°G
(b) CuBfDMS 
DIPS-THF, -78°C
(c) 4.77, -78°C
(d) Oa, CHCtg, 1.5 h 
51%
OTIPS
4.82
OTPS
ppm (Hz) nOe
H2 5.84 16% -+ H4
H4 4.18 11.0. 5.9. 2.5 10% -+ H2
H6 4.35 6.9 -
Scheme 4.27
4.6 - Completion of the total synthesis of Cryptophycin 4.
We were now in a position to address the key coupling step in the Cryptophycin fragment A 
synthesis again, with modified electrophilic and nucleophilic coupling partners. Stannane 
4.80 was converted in the normal fashion to organocopper(I) reagent 4.2 and a freshly 
prepared solution of complex 4.1 in MeCN was added at low temperature. After a 1 hr 
reaction time, aqueous workup was followed by décomplexation (O2 , CHCI3) and a mixture 
of olefins 4.83 and 4.84 was isolated in 71% yield (Scheme 4.28). NMR spectroscopy 
revealed a ratio of 4.83 : 4.84 of 1.2 : 1, estimated by integration of the vinylic proton peaks at 
6.51 / 6.28 ppm and 5.64-5.50 ppm respectively. A mixture of a further pair of regioisomeric 
olefins was also obtained in <5% yield, subsequently identified as epimers at 06 as described 
below in section 4.7, indicating that the configurational stability of alkylcopper(I) species 4.2 
was excellent though not perfect.
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Regiosiomeric olefins 4.83 and 4.84 were inseparable, but cleavage of the silyl and acetal 
protecting groups in one step under acidic conditions allowed the isolation of triols 4.85 and 
4.86 which could be separated, albeit with some difficulty, by column chromatography 
(Scheme 4.29).
O TIPS +
ptr " y  " y  "OH 
4.85 OH OH
OTIPS
p-TsOH (15 mol%) 
MeOH, rt; 63%
4.86 OH OH-
Scheme 4.29
Desired triol 4.85 was subjected to sodium periodate-mediated oxidation to reveal ^hydroxy 
aldehyde 4.87 which was isolated and used without further purification (Scheme 4.30). A 
Wadsworth-Horner-Emmons olefination using trimethylphosphonoacetate and 
tetramethylguanidine in THE at low temperature^^^ subsequently yielded ester 4.88. Analysis 
of the NMR spectrum of 4,88 revealed that the newly formed (E)-olefin was 
geometrically pure within the limits of NMR spectroscopy. An initial attempt at the 
olefination using n-BuLi and trimethylphosphonoacetate at was unsuccessful, the
desired olefin product only being isolated in 19% overall yield, and as a 4:1 mixture of E:Z 
isomers. Comparison of spectroscopic data and optical rotation for 4.88 to that of the 
literature compound confirmed the absolute stereochemistry at C5 and C6 , which up to now 
had been assumed in structures 4.83 and 4.85, and by analogy in regioisomeric compounds 
4.84 and 4.86. The comparison of spectroscopic data indicated the key coupling step between 
complex 4.1 and organocopper(I) reagent 4.2 had occurred with overall retention at the
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carbon of 4.2 which originally bore the tributylstannyl moiety, and confirmed the formation 
of neutral complex 4.6 from benzoate 4.17 with retention.
Formation of olefin 4.88 constituted a formal synthesis of Cryptophycin 4, and from here 
onwards precedent established by Moore and Tius was utilised to a large extent to complete 
the total synthesis. The free hydroxyl group in ester 4.88 was efficiently, albeit slowly 
protected as the rgrr-butyldimethylsilyl ether by treatment with an excess of TBSCI and 
imidazole in THF at ambient temperature (Scheme 4.30). The analogous transformation 
using TBSOTf and 2,6-lutidine yielded silyl ether 4.89 in only 63% yield, together with the 
corresponding &hydroxy acid (15%). Lithium hydroxide mediated ester cleavage^^^ yielded 
acid 4.3, from where the elaboration of the remaining 3 fragments of the Cryptophycin 
skeleton could be addressed.
P \ f  ^  OH
4.85 OH OH
NaI0 4 , MeOH-HaO 
rt, 1.5 h 4.87 OH
Me0 2 CCH2 p(0 ){0 Me) 2  (2.2 eq)
TMG (2.2 eq), THF, -78"C rt 
16 h; 83%. E :Z >  2 5 :1
IM UGH 
MeaCO, 6 h 
97%
4.89, R = Me
4.3, R = H
TBSCI, Im'COgR ----------
Ô T B S THF, 5 d; 85%
COglVIe
4,88 OH
Scheme 4.30
D-Tyrosine (4.90) was elaborated to trichloroethyl ester 4.94 in a straightforward four step 
sequence (Scheme 4.31); amino protection, dimethylation, selective cleavage of the methyl 
ester and DCC-mediated estérification of the resulting acid with trichloroethanol.^^^’ 
Treatment of ester 4.94 with neat TFA yielded trifluoroacetate salt 4.96 which was dried in 
vacuo and used immediately without further purification. Cryptophycin fragments C and D 
were prepared according to standard procedures without difficulty. Allylation of 
commercially available L-leucic acid^^  ^yielded ester 4.98 which was coupled under DCC 
conditions with acid 4.103, prepared from (7?)-3-bromo-2-methyl-propanol 4.99 by 
displacement of the bromide with azide, Jones oxidation, azide reduction and Boc-protection 
of the resulting amine. Fd-catalysed allyl cleavage yielded fmgment C-D acid 4.105.
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(a) NaNa, DMF, 100“C, 3 h
(b) Jones oxidation
(e) Alcohol 4 .9 8 , DCC 
P  t)JHBoc DMAP, CHgCia,
0°C rt, 18 h; 87%
4.99
(c) Ha, Pd/C 
EtOAc-EtOH, rt, 2 d; 63%
(d) BocaO, EtaN
1,4-Dioxane-HaO (1:1) 
rt, 18h;86%
HO
4.103
(f) Pd(PPha)4 , Morphoiine 
THF, rt, 28 h; 80%
O^OH
4.105
Scheme 4.31
Amide 4.106 was prepared in 79% yield under conditions reported by Moore and Tins using 
pentafluorophenyl diphenylphosphinate (FDPP) promotion (Scheme 4.32).^^^ Cleavage of 
the f^rf-butyIdimethylsily 1 ether protection proceeded efficiently using pyridinium 
poly(hydrogen fluoride) in THF solution. Attempted cleavage using aqueous acetic acid in 
THF206 was unsuccessful. Coupling of alcohol 4,107 with fragment C-D acid 4,105 then 
yielded ester 4,108 in good yield, from where a cyclisation protocol communicated by 
Fray 1^7 was used to complete the total synthesis of Cryptophycin 4. TFA mediated Boc 
cleavage was followed by basic workup and dissolution of the crude amine in toluene 
(0.02M), to which 2-hydroxypridine (2 eq) was added. A smooth cyclisation occurred (48 h, 
rt) to yield a mixture of Cryptophycin 4 (4.110) and a component subsequently identified as 
dimer 4,111. The ratio of 4.110 to 4.111 was estimated as 4 i 1, based on the integration of 
the tyrosine methoxy singlets at 3.78 and 3.75 ppm respectively in the NMR spectrum. 
The overall combined yield of 4.110 and 4.111 for the Boc cleavage-cyclisation protocol was 
90%, and after separation by preparative TLC pure Cryptophycin 4 was obtained in 48% 
isolated yield from 4.108. Spectroscopic data were in excellent accordance with those 
reported by Moore and Tius, concluding the total synthesis of Cryptophycin 4.^28 increasing 
the dilution of the cyclisation reaction from the 0.02M which had been specified by Fray to
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0.005M increased the ratio of 4.110 to 4.111 to 9 : 1, albeit with a lower overall yield (59%), 
and an extended reaction time (4 d).
COgH
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DMF, rt, 15.5 h 
79%
4.108
4.106
cucr^o
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DCC (1.5 eq), DMAP
4.107 OH
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78%
OMe
CHaCIa 0=C -> rt. 3 h 
82%OMe OMe
NHBoc
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PhMe, rt, 44 h 
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PH
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4.111
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Scheme 4.32
4.7 - Studies directed towards improving regiocontrol in the 
coupling of complex 4.1 and nucleophile 4.2.
Minimal regiocontrol was observed in the addition of organocopper(I) reagent 4.2 to cationic 
complex 4.1 in the synthesis of Cryptophycin 4, in contrast to alkylations described in 
Chapter 2 using complexes 2.1 / 2.2 in which good regioselectivity between the methyl and 
z5o-propyi termini of the allylic unit had been observed. The poor regioselectivity exhibited 
by complex 4.1 is presumably a reflection of the similar steiic requirements of the phenyl and 
methyl termini, allowing the electronic directing effect of the nitrosyl ligand to be the 
dominant factor affecting regioselection.^^ The minimal selectivity in carbonyl - nitrosyl 
exchange was illustrated by NMR spectroscopy of 4.1, the relative ratios of diastereomers
at the metal centre approximately paralleling the observed ratio of olefin products following 
alkylation. Complex 4.1 initially appeared as a pair of 2 major isomers, in the approximate
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ratio 1.2 : 1. Upon standing in CD3CN solution, the mixture isomerised to a mixture of 4 
compounds, presumably 2  pairs of exo and endo isomers, in the ratio 2 .3  : 2  : 1 : 1 .2 , as 
estimated from the intensities of cyclopentadienyl singlets at 5.69, 6.11, 6 .2 2 , and 6.02 ppm 
respectively, indicating minimal selectivity in the hgand exchange step.^^
It was hoped that the diastereoselectivity of carbonyl - nitrosyl exchange, and consequently 
the regioselectivity of nucleophilic attack upon complex 4.1, could be biased by varying the 
temperature at which ligand exchange was performed. Phenylcopper was chosen as a simple 
nucleophile for the investigation (Scheme 4.33). The results of a series of alkylations are 
summaiised in the table below. Interestingly, in each case a significant amount (8-13%) of 
ketone byproduct 4.114 was isolated, apparently arising via attack of the nucleophile upon the 
carbonyl ligand of 4.1 prior to acylation of the 773-ligand. Despite a mixture of regioisomeric 
'normal' alkylation products 4.112 and 4.113 being obtained, ketone 4.114 was isolated as a 
single regioisomer. The (6 )-stereochemisti"y suggested for 4.114 is that which would result 
from attack syn to the metal, though the absolute configuration of 4.114 has not been 
determined.
NOBF4 , MeCN
rMOo,0 0 ^  ; CO Various temps. OC^ 1 NO 
Op Op
4.6 4.1
Ph
Ph' Ph Ph'
(a) PhCu 
THF, 0"C
(b) Ü2 , CHCI3 , rt
4.114 O 4.113
Ph ^  Ph 
4.112
Scheme 4.33
 ^Complex 4.1 prepared in EtCN solution as opposed to MeCN. 
b Cation added to phenyl copper solution at ~80°C as opposed to 0°C. 
c N2(g) bubbled through cation solution before addition to PhCu solution at 0°C.
1 0 0
1
Entry Temperature of 
cation form ation
O verall yield of 
4.112 / 4,113
4.112 ; 4.113 Yield of 4.114
:
1 18°C 73% 1 2.3 8%
2 0°C 59% 1 2.1 10% ■;
3 -40°C 50% 1 1.4 11%
4 -80°C^ 47% 1 1.8 13%
5 18'’C« 56% 1 2.5 10%
6 18°Cb 53% 1 3.8 13%
7 18°CC 62% I 2.1 10%
Several observations were made from the above experiments ;
(a) In all cases the proportion of regioisomer 4.113 aiising from nucleophilic attack upon 
the phenyl terminus of the allylic unit dominates, in contrast to the use of 
Cryptophycin nucleophile 4.2, where a slight (~ 1.2 : 1) preference for attack at the 
methyl terminus is apparent.
(b) As the temperature at which cationic complex 4.1 is formed in MeCN solution 
decreases, the proportion of alkylation product resulting from attack at the methyl 
terminus of the allylic unit increases. (Entries 1-3).
(c) The use of MeCN as a solvent for the formation of cationic complex 4.1 is restricted 
by the freezing point (mp = -48°C) and it was envisaged that the use of EtCN (mp = 
-93°C) would allow a further biasing of the regioselectivity in favour of isomer 4.112. 
However, the use of EtCN as a solvent for cation formation at -80°C resulted in a 
greater proportion of isomer 4.113 than had been observed at -40°C in MeCN, as 
was also the case at rt (entry 5 vj entry 1), indicating that the nature of the solvent as 
well as the reaction temperature plays a role in the carbonyl-nitrosyl exchange 
process.
(d) Lowering the temperature of the nucleophile solution from 0°C to -80°C before 
addition of the electrophile solution resulted in greater selectivity for the 'undesired' 
sense of attack and formation of 4.113. (Entries 1 and 6 ). However, in the 
Cryptophycin case the need for the nucleophile to be kept at low temperature (-80°C) 
precludes operation at 0°C and the apparent favourable effect upon regioselectivity.
(e) Thoroughly degassing the solution of cationic complex before addition to the PhCu 
solution did not reduce the yield of ketone 4.114, allowing dissolved carbon 
monoxide in the reaction medium to be discounted as the origin of the carbonyl 
group. Ketone 4.114 has optical activity, although the absolute configuration of the 
methyl group in 4.114 has not been determined.
The most favourable regiocontrol with PhCu as nucleophile was obtained when carbonyl- 
nitrosyl exchange was performed at -40°C and these conditions were applied to the coupling 
of nucleophile 4.2 with complex 4.1 (Scheme 4.34). The desired regioisomeric dioxane 4.83 
was obtained together with regioisomer 4.84 in approximately a 3 : 1 ratio, a moderate 
improvement over the 1.2 : 1 ratio obtained initially. A minor, inseparable contaminant was 
identified as oxane 4.115 by independent synthesis (n-BuLi, THE, -78°C, 30 min; NH4CI,
=100%) from stannane 4.80.
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As in the initial coupling reaction en route to Cryptophycin 4, a small amount (7%) of a 
mixture of 2 further olefin regioisomers 6-gp*-4.83 and 6-ep/-4.84 was also obtained 
(Scheme 4.35), tentatively assigned as epimers at C6 on the basis of a large (?J 11.0 Hz) 
coupling between H6 and H5 in 6-ep/-4.83. The assignment was confirmed by nOe 
experiments, with large enhancements being observed between H2 and H4 and vice versa, and 
between H2 and H6 and vice versa, indicating that protons at positions 2,4 and 6 all occupy 
axial orientations.
.OTIPS
PhOTIPSP
5h 3.55 ppm (CeDe) 
3J  11.0, 7.2, 2.3 Hz
nOe
H» 9 % ^ H 4 ,1 1 % ^ H 6
12% H2 , 4% -» H6
HG 14% H2, 4% ^  H4
Scheme 4.35
The above studies using complex 4.1 and PhCu or nucleophile 4.2 were carried out with 
neutral complex 4.6 which had been prepared using Mo(CO)4(py)2 as the Mo(0) source, 
rather than Mo(CO)3(MeCN)3 which was used in the initial synthesis of Cryptophycin 4, 
Formation of the same olefin isomers 4.83 and 4.84 which had been observed in the initial 
coupling procedure confiimed that formation of neutral complex 4.6 was cleanly retentive, as 
in the case with Mo(CO)3(MeCN)3 and benzoate 4.17.
The retentive nature of the oxidative addition of benzoate 4.17 to Mo(CO)4 (py)2 was also 
confirmed by derivatisation of olefin 4.112 isolated from the addition of PhCu to neutral
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complex 4.6 (Scheme 4.36). Olefin regioisomers 4.112 and 4.113 were barely separable by 
column chromatography which complicated matters to an extent. Despite this, it was 
envisaged that oxidative cleavage of the olefins followed by reduction would result in a 
mixture of alcohols 4.116, 4.117 and 4.118, which could be further derivatised as (R)~0~ 
acetylmandelate esters in order to identify the absolute stereochemistry of the methyl group in 
olefin 4.112, and estimate the enantiopurity. A mixture of olefins 4.112 and 4.113 (4.112 : 
4.113 = 5 : 1 )  was subjected to dihydroxylation and diol cleavage using OSO4 (10 mol%) 
and NaI0 4  to yield a mixture of crude aldehydes. Reduction using L1A1H4 yielded an 
inseparable mixture of alcohols 4.116, 4.117 and 4.118 in an approximate 4 : 1 : 1  ratio. 
Subsequent estérification with (R)-O-acetylmandelic acid yielded ester 4.121 (and esters
4.119 and 4.120).
Ph
PhT ^  "Ph P 
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(a) OSO4 , Nal0 4  
MeOH-HaO 
rt, 20h
(b) UAIH4 , EtaO, rt
Ph
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4.116 : 4 .117: 4.118 = 4 :  1 : 1
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THF, A, 18 h 
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As described in Chapter 2 (section 2.3), ester 2.120 had been prepared from a sample of (R)-
2.119 (identified as the (R)-enantiomer by comparison of the direction of the optical rotation 
with the literature value), and a mixture of esters (i?5)-4.121 had been prepared from (±)- 
4,116. Comparison of NMR data for ester 4.121 with that for 2.120 and (i?5)-4.121 
allowed the stereochemistry of 4.116 (and by analogy that of olefin 4.112) to be confirmed as 
S. The diastereomeric ratio at the methyl centre of ester 4.121 was conservatively estimated as 
90 : 10 by integration of the acetate methyl singlets at 2.14 and 2.15 ppm (CDCI3 + TMS) 
for the major and minor diastereomers respectively. Acetate singlets from esters 4.119 and
4.120 (at 2.18 and 2.08 ppm) did not interfere with the estimation of the dr of ester 4.121.
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The estimation of the diastereomeric ratio above should be viewed with some caution. Acetate 
methyl singlets from the diastereomeric esters formed from (±)-4.116 and (R)~0~ 
acetylmandelic acid were not completely baseline separated in NMR spectra run in 
CDCI3 , CD3 OD, CôDg or CD3 CN. Attempts to analyse the dr by analytical HPLC or 
GCMS failed, with separation of peaks from the diastereomeric esters not being possible. 
Benzoate 4.17 (from which olefins 4.112 and 4.113 were ultimately derived) was itself 
estimated to have an enantiomeric ratio of 96 : 4. With the caveat that the estimated er of 90 : 
10 for olefin 4,112 incorporates a degree of inaccuracy, it is nevertheless indicative that the 
oxidative addition of benzoate 4.17 to Mo(CO)4 (py)2  and subsequently the addition of PhCu 
to complex 4.1 occurred in each case with excellent stereocontrol, giving olefm 4.112 as the 
product of overall inversion of configuration.
4.8 - Conclusions and future directions.
The synthesis of acid 4.3 and subsequently the total synthesis of Cryptophycin 4 has been 
achieved, utilising the ambitious union of novel cationic complex 4.1 and nucleophile 4.2. 
Excellent control of two newly formed stereocentres has been achieved, albeit with poor 
regiocontrol. Viable routes to the electrophilic and nucleophilic coupling partner precursors
4.6 and 4.80 (Scheme 4.37) have been established, with serious problems encountered in 
both areas successfully overcome. Neutral complex 4.6 is prepared in enantiopure form via 
benzoate 4.17, itself derived cheaply and easily from (5)-ethyl lactate 4.11 or by enzymatic 
resolution of (±)-4.10. Stannane 4.80 is similarly prepared from the chiral pool, with an 
efficient and highly selective reductive lithiation step securing the key (6 R)-stereocentre which 
ultimately translates into C5 of Cryptophycin fragment A. Our synthesis of Cryptophycin 4 
incorporates a high degree of flexibility, either enantiomer of complex 4.6 being available 
from the appropriate benzoate, and the epimeric nucleophile in principle being available via 
equilibration of alkyllithium 4.57, or from carbamate 2.52 (Chapter 2, section 2.3.1). Either 
configuration at C5 and C6  in acid 4.3 could therefore be accessed by our synthetic route if 
desired.
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Regiocontrol in additions to complex 4.1 remains disappointing. Model studies using PhCu 
as nucleophile indicated that slight control over the site of nucleophilic attack could be 
obtained by varying the temperature at which carbonyl - nitrosyl exchange in the formation of
4.1 is performed, and also indicated that the regioselectivity is substrate dependant,
A long term solution to the problem of regiocontrol could possibly be provided by Enders' 
sulfone complex 4.124^^  ^ or the analogous molybdenum version 4.125 (Scheme 4.38). 
Formation of iron complex 4.124 is stereocomplementary to the molybdenum route, as 
oxidative addition occurs with inversion of configuration with respect to the allylic precursor. 
The regioselectivity of attack upon sulfone complex 4.124 is precedented to be excellent, the 
electron withdrawing effect of the sulfone group directing the nucleophile to the other end of 
the rj^-a\ly\ unit, to yield vinyl sulfone 4.126 after decomplexation.^*^^ Nickel or iron 
catalysed coupling of Grignard reagents with vinylic sulfones has been reported to occur with 
a high degree of retention of olefin geometry which would in principle allow access to 
the Cryptophycins or analogs from vinyl sulfone 4.126, and provide a flexible alternative to 
the use of problematic complex 4.1.
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5.1 - Comparison between iron- and molybdenum-mediated stoichiometric allylic 
alkylation procedures.
pl 8u4N[Fe(CO)3(NO)] p1.
O
Scheme 5.1.
Chapter 5 - Summary of results and conclusions.
The following chapter briefly compares and contrasts allylic alkylation using planar chiral 
cationic 773-allylmolybdenum complexes with: (a) stoichiometric iron-mediated allylic 
alkylations; (b) palladium-catalysed allylic alkylations. The achievements described in this 
thesis are summarised.
As described earlier (Chapter 1, Section 1.6) important parallels exist between the 
stoichiometric use of cationic t]3-allylmolybdenum and cationic or neutral iron complexes. 
Enders' complexes 1.108 /1.109 (Scheme 5.1) can be obtained with good control of planar 
chirality from enantiomerically pure allylic ethers 1.104 /1.105, the enantiopurity being 
dependant upon purification by repeated precipitation.^^’ The steric bulk of the allylic 
ether directs the metal fragment in to the opposite face of the olefin, initially forming olefin 
complexes 1.106 /1.107. A second step forms cationic complexes 1.108 /1.109 with overall 
inversion of configuration from 1.104 /1.105.
Control of chirality in formation of Nakanishi's complexes 1.112 / 1.113 relies upon the use 
of an attached chiral auxiliary to facilitate the separation of diastereomeric c o m p l e x e s . j  
The stereoselectivity of an alternative preparation from optically active substrates is highly 
dependant upon tlie leaving group and solvent.^^
,EWG Fe 2 (0 0 ) 9  ,EW G HBF4
BnO BnO + Fe(C0)4
s
Fe(C 0 )2 (N0 ) Ae(CO)g(NO) 1
1.111 1.112 1.113
R1 = H or Me, RS = (S)-NHCH(Me)Ph, S
(F?)-OCH(Me)Ph or (5)-0CH(Me)n-Hex
Control of planar chirality in the formation of neutral (7]3-allyl)Mo(CO)2Cp complexes 5.4 
(precursors to the electrophilic cationic complexes) is highly reliable (Scheme 5.2), 
depending only upon the optical purity of readily available allylic esters. Tethering of
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'M o(C O )3(Py)2 5.3
Scheme 5.2.
The MO"Complexes are coordinatively saturated, 18-electron systems containing non- 
labile ligands, resulting in nucleophilic attack anti to the metal. Anti or syn modes of 
attack are both possible in palladium-mediated alkylations, depending on the nature of 
the nucleophile.
Mo-complexes tolerate both soft and "hard" nucleophiles; the use of hard 
nucleophiles in palladium-catalysed systems is comparatively rare. The combination 
of molybdenum complexes with the functionalised, chiral a-heteroalkylcopper(I) 
nucleophiles described in this thesis has no parallel in Pd-systems.
The directing influence of the molybdenum fragment can be used to direct sequential 
additions to the same substrate.
molybdenum to allylic ester 5.1 directs the metal to the face of the olefin proximal to the 
ester. Neutral complex 5.4 is formed with clean retention of configuration, which 
complements inversion obtained with iron.
Mo(CO)4(Py)2 1 -CO     . / CO
Both the Enders and Nakanishi complexes are achiral at the metal, and as a result
regioselectivity between the allylic termini is controlled by steric or electronic factors alone. In 
.contrast, regiocontrol in the molybdenum chemistry is complicated by a dependence upon 
central chirality, though the effects are subtle, and in favourable cases can be overcome.
:■5,2 - Advantages of stoichiometric molybdenum-mediated allylic alkylation over 
palladium-catalysed procedures.
The stoichiometric nature of the molybdenum chemistry described in this thesis may be 
interpreted as disadvantageous on economic grounds, but the basic feedstock, Mo(CO)g, is 
relatively cheap (25 p / mmol). Several important advantages of the molybdenum 
methodology over palladium-catalysed allylic alkylation procedures should be noted:
i l
CpMo(CO)2(t?^-allyl) and [CpMo(CO)(NO)(773-allyl)]+ systems are not prone to 
rearrangement via 77^  —^ 77! 77^  pathways, which allows the syn-anti isomérisation
of terminal substituents.
1
l i
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5.3 - Summary of results.
We have investigated the alkylation of planar chiral complexes 2.1 and 2.2 with a variety of 
functionalised a-alkoxyalkylcopper(I) nucleophiles (Scheme 5.3). Good regioselectivity 
(typically > 8:1) for attack at the less sterically-hindered methyl terminus of the allyl ligand is 
observed. In contrast to literature precedent,the regioselectivity is achieved without the need 
to control the central chirality at molybdenum. Complexes 2.1 and 2.2 are readily available 
from the corresponding enantiopure allylic acetates (6)- and (i?)-2.12 and Mo(CO)3(MeCN)3 
or Mo(CO)4 (py)2  with clean retention of facial stereochemistry. Nucleophilic attack 
subsequently occurs anti to the metal fragment, yielding olefin products 2.3 and 2.4 with 
overall inversion with respect to the starting acetate.
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Scheme 5.3.
Use of configurationally stable alkylcopper(I) nucleophiles derived from stannanes 2.20, 2.21 
and 2.64, and from chiral alkyllithium 2.76 demonstrates the ability of the methodology to 
simultaneously form two stereocentres with excellent control (Scheme 5.4).
SnBug
OBn OBn
OBn OBn 
2.20
OBn OBn 
2.21
2.64
Scheme 5.4.
The molybdenum-based methodology was extended to the synthesis of Cryptophycin 4 
(4.110) (Scheme 5.5). The key step involved the coupling of nucleophile 4.2 with novel
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planar chiral cationic complex 4 . 1 ,  to secure the absolute stereochemistry at C5 and C6 in 
acid 4 . 3 .  The complete route to Cryptophycin 4 is illustrated in Scheme 5.7.
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Scheme 5.5.
Regioselectivity in the coupling of complex 4 . 1  and nucleophile 4 . 2  was minimal, only a 
slight preference for attack at the methyl terminus (1.2 : 1) being observed. The lack of 
regiocontrol presumably reflects poor steric differentiation between the phenyl and methyl 
termini, and the precedented directing effect of the nitrosyl ligand in complex R5mq-4.1.^^’ 
Using PhCu as a model nucleophile we investigated the effect of temperature upon 
selectivity of CO —> N0+ exchange in forming complex 4 . 1  (Scheme 5.6). We inferred that 
decreasing the temperature resulted in an increasing diastereoselectivity in cation formation, 
as evidenced by an increasing preference for attack at the 'desired' methyl terminus of 4 . 1 .  
The optimum conditions were -40°C in MeCN, poorer selectivity obtained via ligand 
exchange at -78°C in EtCN indicated that the nature of the solvent as well as temperature 
plays a role in ligand exchange selectivity.
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MeCN, -4Q°C
4.113
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Maximum
selectivity
A
Scheme 5.6.
Applying the optimised conditions to the Cryptophycin key step enhanced the regioselectivity 
to 3 : 1 in favour of desired olefin 4 . 8 3  (Scheme 5.7).
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In conclusion, excellent enantiofacial selectivity is achieved in alkylations using 
allyimolybdenunfi complexes, resulting from: (a) reliable control of planar chirality in 
formation of the complexes from enantiomerically pure precursors; (b) subsequent attack 
anti to the metal fragment Regioselectivity in alkylation of unsymmetrically disubstituted 
complexes is more problematic, and governed mainly by central chirality. Ligand asymmetry 
at the metal results in an electronic distortion of the allyl ligand, a subtle effect which can be 
overcome in favourable cases on steric grounds. We have found that solvent and temperature 
effects can affect the diastereoselectivity at the metal in fondation of cationic complexes.
The applicability of the molybdenum-based methodology to stereocontrolled carbon-carbon 
bond formation within the context of a challenging natural product synthesis has been 
demonstrated, and paves the way for future work on more complex target molecules. We are 
optimistic that a combination of the best features of the molybdenum chemistry (reliable 
control of central chirality) and Enders' iron-methodology (excellent regiocontrol on 
electronic grounds) will successfully overcome the problem of regiocontrol in the 
Cryptophycin synthesis.
112
Chapter 6 - Experimental.
6.1 - General experimental details.
Reactions requiring anhydrous conditions were conducted in glassware which had been flame-dried or oven- 
dried overnight, under an atmosphere of dry nitrogen unless otherwise specified. Diethyl ether, tetrahydrofuran 
and ferr-butylmethyl ether (TBME) were freshly distilled from sodium benzophenone ketyl under nitrogen 
prior to use. Dichloromethane, pentane, acetonitrile, cumene and toluene were freshly distilled from CaH2  
under nitrogen. Dimethylformamide (DMF) was distilled from CaH2  under reduced pressure {ca 15 mmHg, 
water aspirator). Methanol was freshly distilled from magnesium methoxide under nitrogen prior to use. 
Hexanes used for column chromatography refers to the fraction of petroleum ether boiling in the range 40- 
60°C and were distilled before use.
Cyclopentadiene (Cp) was cracked freshly from dicyclopentadiene under inert atmosphere and used 
immediately. Mo(CO)6  and NOBF4  were purchased from Acros and Lancaster respectively and used without 
further purification. (-)-Sparteine was purified by Kugelrohr distillation immediately prior to use. CuBr*DMS 
was prepared by the procedure of T a y lo r ^ a n d  purified by recrystallisation before use. All other 
commercially available reagents were purchased from standard suppliers (Aldrich, Acros, Lancaster, Avacado) 
and typically used as supplied or purified by standard methods.^^^ AI2 O3 refers to activated neutral alumina, 
purchased from Acros (Cat. No. 19041-0010) and used as received without deactivation unless otherwise 
specified. Eluants used in the purification of complexes 2.14, 2.16 and 4.6 were degassed with dry nitrogen 
for 20-30 minutes before use. Commercial n-butyllithium, j-butylllthium and phenyllithium solutions were 
titrated against l,3-diphenylacetone-/?-tosylhydrazone prior to use.^ '^^
Organic extracts were dried using magnesium sulphate (MgSOq) unless otherwise specified, and were 
concentrated using a Buchi rotary evaporator at diaphragm pump or water aspirator pressure (5-20 mmHg). 
All aqueous solutions (e.g. NH4 CI, NaHCOg) were saturated unless otherwise specified, the exception being 
aqueous ammonia (35% solution). All reactions were magnetically stirred unless otherwise specified and were 
monitored by Thin Layer Chromatography (TLC) using Macherey-Nagel Alugram Sil G/UV2 5 4  pre-coated 
aluminium foil sheets, layer thickness 0.25 ram. Compounds were visualised by UV (254 nm), 20wt% 
phosphoraolybdic acid (PMA) in ethanol, anisaldehyde, vanillin followed by H2 SO 4 , potassium 
permanganate or eerie sulphate solutions. Flash chromatography was performed on Fisher Scientific 'Matrex 
Silica 60' silica gel (35-70 micron particle size, Code No. S/0683/70). Preparative TLC was performed on 
Macherey-Nagel SIL G-200 UV2 5 4  pre-coated glass sheets, 20 x 20 cm, layer thickness 2  mm.
Melting points were recorded using open capillary tubes (except for complexes 2.14, 2.16 and 4.6 which 
were recorded in sealed capillary tubes) on a Griffin melting point apparatus and are uncorrected. Specific 
optical rotations ( [ cc] d )  were measured at ambient temperature (21±3°C) on an Optical Activity polAAr 2000 
polarimeter using a 5 mL cell with a 1 dm path length or a 0.5 mL cell with a 0.05 dm path length. Infra-red 
(IR) spectra were recorded on a Nicolet Impact 410 FT-IR spectrometer using a thin film supported between 
NaCl plates or a KBr disk, unless otherwise specified. Details are reported as v^ax i» c m '\ followed by an 
intensity descriptor: s = strong, m = medium, br = broad, weak absorbtions are not recorded.
^H and ^^ C NMR spectra were recorded in Fourier Transform mode at the field strength specified, on a Bruker 
AM360 or Bruker DPX 400 spectrometer. All spectra were obtained in CDCI3 , or CD3CN solution in 
5 mm diameter tubes, and the chemical shift in ppm is quoted relative to the residual signals of chloroform
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(%  7.27, ô c  77.2), benzene (%  7.27, ôq 128.4) or acetonitrile (ôh 2.00, ôc  117.7) unless specified
otherwise. Multiplicities in NMR spectra are quoted as; s = singlet, d = doublet, t = triplet, q = quartet, m
-  multiplet, br = broad. Coupling constants (J) are reported in Hz. Numbers in parenthesis following the
chemical shift in the spectra refer to the number of protons attached to the carbon as disclosed by the
Distortionless Enhancement by Phase Transfer (DEPT) technique, with secondary pulses at 90° and 135°.
Signal assignments are based on COSY and HMQC correlations, and / or by reference to standard texts.
The numbering of ^H and ^^C NMR spectroscopic data refers to the illustration of the compound
directly underneath the name. and ^^Mo NMR spectra were recorded on a Bruker WP200SY
spectrometer, operating at 188 MHz and 13 MHz field strengths respectively. ^^F NMR spectra were
referenced externally to FCCI3 at 0°C and ^^Mo NMR spectra were referenced externally to Na2 [Mo0 4 ].^^’ 
2 1 5 ,  2 1 6
Low and high resolution mass spectra were run on a JEOL MStation JMS-700 spectrometer. Ion mass/charge 
(m/z) ratios are reported as values in atomic mass units followed, in parenthesis, by the peak intensity relative 
to the base peak (100%). GCMS was performed on the above spectrometer, using a Chrompack WCOT 
Fused Silica column (25m x 0.25mm, CP-SIL 8 CB-MS stationary phase), initial temperature and heating 
rates are specified for individual cases. Microanalytical data was recorded at the University of Glasgow by 
Mrs. K. Wilson.
6.2 - Experimental Procedures from Chapter 2.
(4£')-2-M ethylhex-4-en-3"O l (2.6).
OH
The title compound was prepared by a modification of the literature procedure^^^: Mg turnings (9.6 g, 397 
mmol) were stirred overnight under N2  at rt before being suspended in Et2 0  (150 mL) and 1,2-dibromoethane 
(0.05 mL) was added. 2-Chloropropane (36 mL, 397 mmol) was added at a rate sufficient to maintain a 
moderate reflux, with slight heating (heat gun) applied to initiate reflux. After the addition of 2-chIoropropane 
was complete, the dark solution was added dropwise to a solution of freshly distilled crotonaldehyde (23.2 g, 
331 mmol) in Et2 0  (150 mL) at -30°C under N2 . After warming to rt over 1.5 h, 2M HCl (200 mL) was 
added cautiously and the phases separated. The aqueous phase was extracted with Et2 0  (2 x 50 mL), and the 
combined organic phases dried, filtered and concentrated in vacuo. Purification by short path distillation (b.p. 
= 58°C / 30 mmHg) yielded the title compound (24.9 g, 220 mmol, 6 6 %) as a clear oil. Spectroscopic data 
were in accordance with literature data.^^^
(3S ,4J?)-2-M ethylhex-4-en-3-ol (2 .6).
OH
The kinetic resolution of allylic alcohol (±)-2.6 was performed on a 45.6 mmol scale using (-)-  
dicyclododecyl tartrate according to the general procedure reported by Sharpless.^^ Purification by Kugelrohr 
distillation (b.p. 150-160°C / 760 mmHg) followed by column chromatography (S1 0 2 , Et2 0  : hexanes = 1 ;
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LRMS (CÏ+ mode, NH3 ): miz = 348.2 [(M+NH4 )+, 100 %], 252.1 (25), 114.1 (63).
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3) yielded the title compound (1.34 g, 11.8 mmol, 26%) as a clear oil. The enantiomeric ratio at C3 was 
estimated as 97:3 via formation of the corresponding (i?)-a-methoxy-a-trifluoromethylphenyIacetate ester as 
described below.
[a]D = +8.5 (c 1.20, CHCI3). Lit. [a]D (enantiomer) = -12.9 (c 4.75, CHCls).^^
In a similar fashion (3R,4£)-alcohol 2.6 ([o:]d = -11.4  (c 4.97, CHCl3 ))was prepared in 29% yield on a 107 
mmol scale using (+)-dicyclododecyl tartrate. The enantiomeric ratio at C3 was estimated to be 93:7 via 
formation of the corresponding (7f)-G:-methoxy-a-trifluoromethylphenylacetate ester.
(2 i? )-3 ,3 ,3 -T riflu oro-2-m eth oxy-2-p h en ylp rop ion ic  acid (1 5 ,2 jE )-l- iso p r o p y ib u t-2 -e n y l  
ester (2 .8 ).
° X °
p A ° F r
DCC (160 mg, 0.78 mmol) was added to a solution of alcohol (5)-2.6 (44 mg, 0.39 mmol), (i?)-a-methoxy- 
a-trifluoromethylphenylacetic acid (136 mg, 0.58 mmol) and DMAP (5 mg) in CH2 CI2  (10 mL) at 0°C 
under N2 . The cloudy white solution was allowed to warm to rt with stirring over 60 h before filtration and 
concentration in vacuo. Et2 0  (20 mL) and 2M HCl (10 mL) were added and the phases were separated. The 
organic layer was washed with 2M HCl (10 mL) and aqueous NaHC0 3  (2 x 20 mL) and the organic phase 
dried, filtered and concentrated in vacuo. Purification by column chromatography (Si0 2 , Et2 0  : hexanes = 1 : 
9) yielded the title compound (100 mg, 0.30 mmol, 78%) as a clear oil. The diastereomeric ratio at Cl was 
estimated as 97 : 3 via  integration of trifluoromethyl singlet peaks in the NMR spectrum: <5p (188 
MHz, CDCI3 ) = -71.9 and -71.8 ppm ((15)- and (IR)-diastereomers respectively), or alternatively via ^H 
NMR spectroscopic analysis, comparing the integration of H4 signals at 5.34 (ddq, J  15.2, 8.2, 1.8, (15)- 
isomer) and 5.47 (ddq, J  15.3, 8.4, 1.7, (IR)-isomer) with reference to a sample of (li?5)-ester formed from 
(±)-2 .6 . 4:
[a]D = +60.0 (c 0.4, CHCI3 ).
IR (film): v  = 2957 s, 2932 s, 2876 m, 2850 m, 1749 s, 1451 m, 1255 s, 1179 s, 1123 s, 1081 m, 1017 m, 
992 m, 967 m cm” ^
^H NMR (400 MHz, CDCI3 ): Ô = 7.52-7.50 (2H, m, Ph), 7.43-7.37 (3H, m, Ph), 5.79 (IH, dq, J  15.3, 6.5,
H3), 5.34 (IH, ddq, J  15.3, 8.2, 1.6, H2), 5.18 (IH, dd, J  8.2, 6.0, HI), 3.56 (3H, d, V c-F  1-k O M e),
1.92-1.86 (IH, m, CHMc2 ), 1.70 (3H, dd, J  6.5, 1.6, H4), 0.94 (3H, d, J 6.7, CH(Me)Me), 0.91 (3H, d, J  
6 .8 , CH(Me)Me).
'I3c NMR (100 MHz, CDCI3 ): d = 166.1 (0, OC(O)R), 132.6 (0, Ph), 132.0 (1, C3), 129.6 (1, Ph), 128.4 
(2C, 1, Ph), 127.8 (2C, 1, Ph), 126.7 (1, C2), 123.6 (0, q, V c_F 288, CF3 ), 84.9 (0, q, ^ q -F 27, 
£(C F 3 )(0 Me)Ph), 83.0 (1, Cl), 55.7 (3, OMe), 32.1 (1, CHMea), 18.3 (2C, 3, CHMs2 ), 17.9 (3, C4).
.|î
Acetic acid (15,2jE)-l-isopropyl-but-2-enyl ester (2.7).
OAc
A mixture of alcohol (5)-2.6 (1.15 g, 10.1 mmol), acetic anhydride (1.3 mL, 14.1 mmol), pyridine (1.1 mL,
14.1 mmol) and DMAP (20 mg) in CH2 CI2  (20 mL) was stirred at rt under N2  for 60 h before the addition 
of 2M HCl (15 mL) and CH2 CI2  (40 mL). The phases were separated and the aqueous phase extracted with 
CH2 CI2  (2 X 20 mL). The combined organic phases were washed with brine (20 mL), dried, filtered and 
concentrated i n  v a c u o .  Purification by column chromatography (Si0 2 , Et2 0  : hexanes = 1:6)  yielded the 
title compound (1.35 g, 8.7 mmol, 8 6 %) as a clear fragrant oil. Spectroscopic data were in accordance with 
literature data.^^^
[ a ] D  = -29.5 (c 1.12, CHCI3 ). Lit. [ « ] d  (enantiomer) = +37.6 (c 4.71, CHCls).^®
5-Methyl-3-hexen-2-ol (2.10) and 5-inethyl-4-hexen-2-ol (2.11).
2.10 OH 2.11 OH
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To a solution of 5-methyl-3-hexen-2-one 2.9 (24.9 g, 222 mmol, Aldrich, 75% pure - remainder 5~methyl-4- 
hexen-2-one (2.9b)) in MeOH (400 mL) at rt was added CeCl3 *7 H2 0  (90.8 g, 244 mmol) and the clear 
solution stirred under N2  for 30 min before cooling to 0°C. NaBH^ (9.22 g, 244 mmol) was added 
portionwise over 30 min maintaining the internal temperature below 5°C. The cloudy white solution was 
stirred at 5°C for 30 min and then at rt overnight before cooling to 5°C and careful addition of aqueous NH4 CI 
(250 mL). The aqueous phase was saturated with NaCl and extracted with Et2 0  (3 x 100 mL), and the 
combined organic phases washed with brine (100 mL), dried, filtered and concentrated i n  v a c u o  to yield a 
fragrant, volatile clear oil which was purified by short path distillation (b.p. = 6 6 °C / 20 mmHg, Lit. b.p. = -1
60-62°C / 16 mmHg (2.10), 57°C I 11 mmHg (2.11)^^' ^^^) to give an inseparable mixture of the title 
compounds (17.0 g, 149 mmol, 67%). ^H NMR spectroscopy revealed a ratio of 2.10 : 2.11 of 4.7 : 1, 
estimated by integration of HI signals at 4.25 ppm (IH, dq, J  6.4, 6.4) and 3.79 ppm (IH, sextet, J  6.1) for 
2 . 1 0  and 2 . 1 1  respectively.
--
IR and ^H NMR spectroscopic data for 2.10^^^ and 2.11^^^ were in accordance with literature data.
13c NMR for 2.10 (100 MHz, CDCI3 ): Ô = 138.2 (1, C4), 131.3 (1, C3), 69.2 (1, C2), 30.7 (1, C5), 23.6 
(3, Cl), 22.4 (2C, 3, C6  and C5-Me).
:13c NMR for 2.11 (100 MHz, CDCI3 ): d = 135.3 (0, C5), 120.3 (1, C4), 68.1 (1, C2), 38.2 (2, C3),
26.1 (3, C5-Me), 22.9 (3, Cl), 18.1 (3, C6 ).
I 
I
(25)-5 -M eth yl-3-h exen-2-o l (2.10), (25)-5-M ethyl-4-liexen-2-ol (2.11), Acetic acid (li?)-
l,4-dim ethylpent-2-enyI ester (2.12) and Acetic acid (lif)-l,4 -d im eth y lp en t-3 “enyl ester
(2 .1 3 ) .
2.12 OAc2.10 OH
2.11 OH 2,13 OAc
A mixture of alcohols (±)-2.10 and (±)-2.11 (14.9 g, 130 mmol, 2.10 : 2.11 = 4.7 : 1), vinyl acetate (60 
mL, 650 mmol), activated crushed 4Â MS (50 wt%, 7.43 g) and Novozym 435 (10 wt%, 1.49 g) in pentane 
(120 mL) was shaken until NMR spectroscopic analysis of the crude reaction mixture indicated a 50% 
conversion (7.5 h). The mixture was filtered and carefully concentrated in vacuo (-15 mmHg, 15-20°C bath 
temp.) to give a clear oil which was purified by column chromatography (SiO^, Et^O : hexanes = 2  : 8 ) to 
yield a mixture of the title acetates (9.18 g, 58.8 mmol, 45%) as a volatile clear oil. ^H NMR spectroscopy 
revealed a ratio of (J?)-2.12 : (i?)-2.13 of 3.8 : 1, estimated by integration of H2 signals at 5.25 ppm (IH, 
dq, J  6.4, 6.4) and 4.82 ppm (IH, sextet, J  6.4) for 2.12 and 2.13 respectively. Further elution yielded a 
mixture of the title alcohols (6.16 g, 52.9 mmol, 41%; [«]%) = -7.5 (c 1.04, CHCI3 ), (5)-2.10 : (S)-2.11 =
5.4 : 1 by ^H NMR spectroscopy as described above).
Data for a 3.8 : 1 mixture of acetates (i?)~2.12 and (R)-2.13:
[a]D = +67.4 (c 1.16, CHCI3 ).
IR and ^H NMR spectroscopic data for the mixture of 2.12 and 2.13 were in accordance with literature 
data.219' ^^0
13c NMR for 2.12 (100 MHz, CDCI3 ): Ô = 170.3 (0, £OM e), 140.0 (1, C3), 126.7 (1, C2), 71.0 (1, 
Cl), 30.7 (1, C4), 22.1 (2C, C5 and C4-Me). 21.4 (3, CQMe). 20.4 (3, Cl-Me).
13c NMR for 2.13 (100 MHz, CDCI3 ): Ô = 170.0 (0, £OMe), 134.4 (0, C4), 119.3 (1, C3), 70.4 (1, 
Cl), 34.5 (2, C2), 25.8 (3, C4-Me). 21.3 (3, CQMe), 19.4 (3, Cl-M s), 17.9 (3, C5).
Acetic acid (lS)-l,4-d im ethyIpent-2-enyl ester (2.12) and Acetic acid (1S)-1 ,4- 
dim ethyipent-3-enyl ester (2.13),
2 , 1 2  OAc 2.13 OAc
A mixture of the title acetates (2.12 : 2.13 = 5.8 : 1, [«Id = -56.4 (c 1.64, CHCI3 )) was prepared from a 
mixture of alcohols (5)-2.10 and (5)-2.11 (2.10 : 2.11 = 5,4 : 1) in 81% yield on a 48.2 mmol scale by 
an analogous procedure to that described above for acetate 2.7. Purification by short-path distillation (b.p. =
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70-71°C / 15 mmHg, Lit. b.p. = 60-62°C / 13 mmHg^^) gave the title compounds as a clear colourless 
fragrant oil. Spectroscopic data were as described above.
(iî)-A cetoxyphenylacetic acid ( liî)-l,4 -d im ethy lpen t-2 -eny l ester (2.10b) and ( R ) ~  
Acetoxyphenylacetic acid (ljR)-l,4-dimethyIpent-3-enyi ester (2.11b).
2.10b 2.11b
A mixture of acetates (J?)-2.12 and (i?)-2.13 (2.12 : 2.13 = 3.8 : 1, 141 mg, 0.90 mmol), K2 CO3 (14 
mg) and MeOH (5 mL) was stirred at rt for 20 h before concentration in  v a c u o . Purification by column 
chromatography (Si0 2 , Et2 Ü : hexanes = 4 : 6 )  yielded a mixture of alcohols (i?)-2.10 and (i?)-2.11 (45 
mg, 0.39 mmol), which were dissolved in CH2 CI2  (10 mL) and cooled to 0°C under N2 . DCC (122 mg, 
0.59 mmol), (R)-O-acetoxyphenylacetic acid (92 mg, 0.47 mmol) and DMAP (2.4 mg) were added and the 
mixture stirred at 0°C for 30 min, and then at rt for 1 h before filtration and concentration i n  v a c u o .  
Purification by column chromatography (Si0 2 , Et2 0  : hexanes = 3:7)  yielded an inseparable mixture of the 
title compounds (102 mg, 0,35 mmol, 90%) in the approximate ratio 2.10b : 2.11b = 3 : 1 .  The 
diastereomeric ratio at Cl for allylic ester 2.10b was estimated as 96 : 4 v i a  integration of the following 
signals in the ^H NMR spectrum: H2 (major isomer of 2.10b) at 5.19 ppm (ddd, J  15.6, 6.4, 1.2) v s  H3 
(major isomer of 2.11b) at 5,68 ppm (dd, J  14.8, 6.4), with reference to a sample of (lR5)-2.10b and 
(lR5)-2.11b formed from (±)-2.10 and (±)-2.11.
[a]D = -58.7 (c 1.02, CHCI3 ).
IR (film): v = 2954 s, 2928 m, 2868 m, 1739 s, 1455 m, 1374 m, 1232 s, 1219 s, 1176 m, 1051 m, 965 m 
cm"k
LRMS (CI+ mode, NH3 ): m / z  = 308.1 [(M+NH4 )+, 100 %], 212.0 (38), 114.1 (30), 97.1 (25).
NMR data for 2.10b:
^H NMR (400 MHz, CDCI3 ): Ô = 7.48-7.44 (2H, m, Ph), 7.41-7.35 (3H, m, Ph), 5.90 (IH, s, 
CH(OAc)Ph), 5.42 (IH, ddd, J  15.6, 6.7, 1.1, H3), 5.36 (IH, pentet, J  6.4, HI), 5.19 (IH, ddd, J  15.6, 6.4, 
1.1, H2), 2.19 (3H, s, CQMe), 2.19-2.08 (IH, m, H4), 1.31 (3H, d, J  6.4, Cl-Me), 0.86 (3H, d, J  6 .8 , H5), 
0.85 (3H, d, J 6 .8 , C4-Me).
13c NMR (100 MHz, CDCI3 ): <5 = 170.5 (0, 0£0R ), 168.2 (0, OCOR), 140.5 (1, C3), 134.0 (0, Ph),
129.2 (1, Ph), 128.8 (2C, 1, Ph), 127.9 (2C, 1, Ph), 125.7 (1, C2), 74.8 (1, £H(OAc)Ph), 72.7 (1, Cl),
30.6 (1, C4), 2 2 .1  (2 C, 3, C5 and C4-Me), 20.9 (3, COMs), 20.4 (3, C1-Mê).
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NMR data for 2.11b:
NMR (400 MHz, CDCI3 ): d = 7.48-7.44 (2 H, m, Ph), 7.41-7.35 (3H, m, Ph), 5.96 (IH, s, 
CH(OAc)Ph), 4.92 (IH, sextet, J 6.4, HI), 4.79 (IH, broad t, J  7.4, H3), 2.19 (3H, s, CQMe). 2.19-2.05 
(2H, m, H2), 1.54 (3H, s, C4-Me), 1.46 (3H, s, H5), 1.25 (3H, d, J  6.4, Cl-Me).
(J?)-Acetoxyphenylacetic acid (15)-l,4-dimethyIpent-2-enyl ester (2.10c) and {R )  
Acetoxyphenylacetic acid (lS)-l,4-dimethylpent-3-enyi ester (2.11c).
2.10c 2.11c O
'1
'
13c NMR (100 MHz, CDCI3 , partial data - some signals obscured by the major diastereomer 2.10b): ô = 
168.6 (0, OCOR), 134.5 (0, C4 or Ph), 118.9 (1, C3), 74.9 (1, CH(OAc)Ph), 72.8 (1, C l), 34.3 (2, C2),
25.8 (3, C^Me), 19.6 (3, Cl-Mg), 17.8 (3, C5).
1
s
-i
A mixture of the title esters (2.10c : 2.11c = 6  : 1) was prepared from a mixture of alcohols (5)-2.10 and 
(5)-2.11 (5.4 : 1) in 83% yield on a 0.68 mmol scale by an analogous procedure to that described above for 
esters 2.10b and 2.11b. The diastereomeric ratio at Cl for 2.10c was estimated as & 97 : 3 via integration 
of the following signals in the ^H NMR spectrum: H3 (major isomer of 2.10c) at 5.68 ppm (dd, J  14.8, 
6.4) vs H2 (minor isomer of 2.10c) at 5.19 ppm (ddd, J  15.6, 6.4, 1.2), with reference to a sample of (1R5)- 
2.10c and (lR5)-2.11c formed from (±)-2.10 and (±)-2.11.
[a]D = - 9 l . 5  (c 1.63, CHCI3 ),
IR (film): v = 2961 s, 2923 m, 2869 m, 1747 s, 1374 m, 1265 m, 1374 m, 1232 s, 1182 m, 1056 m cm-1. 
LRMS (CI+ mode, NH3 ): m/z = 308.1 [(M+NH4 )+, 100 %], 212.1 (30), 114.1 (25), 97.1 (24).
NMR data for 2.10c:
■'f
1h NMR (400 MHz, CDCI3 ): Ô = 7.48-7.45 (2H, m, Ph), 7.41-7.27 (3H, m, Ph), 5.91 (IH, s, 
CH(OAc)Ph), 5.68 (IH, dd, J  14.8, 6.4, H3), 5.43-5.32 (2H, m, HI and H2), 2.35-2.23 (IH, m, H4), 2.19 
(3H, s, OCOMe), 1.17 (3H, d, J  6.0, Cl-Me), 0.97 (6 H, d, J  6 .8 , H5 and C4-Me). |
13c NMR ( 1 0 0  MHz, CDCI3 ): Ô = 170.3 (0, OCOR), 168.2 (0, OCOR), 140.8 ( 1 , C3), 134.1 (0 , Ph),
129.2 (1, Ph), 128.8 (2C, 1, Ph), 127.7 (2C, 1, Ph), 125.8 (1, C2), 74.8 (1, CH(OAc)Ph), 72.9 (1, C l), |
30.7 (1, C4), 22.1 (2C, 3, C5 and C4-Me). 20.8 (3, COMe). 20.0 (3, Cl-Me). |.'x
NMR data for 2.11c: I
iH  NMR (400 MHz, CDCI3 ): 6  = 7.48-7.45 (2H, m, Ph), 7.41-7.27 (3H, m, Ph), 5.89 (IH, s, 
CH(OAc)Ph), 5.08 (IH, broad t, J 7.4, H3), 4.92 (IH, sextet, J  6.4, HI), 2.35-2.23 (2H, m, H2), 2.19 (3H, 
s, OCOMe). 1.69 (3H, s, C4-Me), 1.61 (3H, s, H5), 1.08 (3H, d, J 6.4, Cl-Me).
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NMR (100 MHz, CDCI3 , partial data - some signals obscured by the major diastereomer 2.10c): ô ~ 
170.3 (0, OCOR), 168.4 (0, OCOR), 134.8 (0, 0 4  or Ph), 127.7 (1, Ph), 118.9 (1, 03), 74.8 (1, 
CH(OAc)Ph), 72.8 (1, 01), 34.3. (2, 02), 25.9 (3, 04-M e). 19.1 (3, 01-Mê), 18.0 (3, 05).
(2iî,45)-(?7^”Cyclopentadienyl)(5-methyl-2,3,4-ï7-hex-3-en-2-yl)(dicarbonyl)inolybdenum 
(2.14).
/ P  /Pr
«0  ==ON"": "C O  OCCp
Exo Endo
The title compound was prepared in 73% yield as a dark-red oil by the procedure of Kocienski on a 6.7 mmol 
scale,^^ or alternatively as below;
To a solution of Mo(0 0 ) 5  (1.70 g, 6.44 mmol) in THF (80 mL) under N2  was added pyridine (1.04 mL,
12.9 mmol) and the solution brought to reflux. After refluxing for 12 h a solution of acetates (i?)-2.12 and 
(R)-2.13 (2.12 : 2.13 = 3.8 : 1, 1.21 g, 6.12 mmol of 2.12) in THE (5 mL + 2 x 1  mL) was added 
dropwise via  syringe to the red-orange solution, which was refluxed for a further 63 h before cooling to rt 
over 1 h. LiCp (21 mL of a 0.33M solution in THF (prepared immediately before use from freshly cracked 
Cp (1.03 g, 15.6 mmol) and n-BuLi (6.7 mL of a 2.32M solution in hexanes, 15.6 mmol) in THF (40 mL), 
rt, 15 min under N2 ) was added and the dark red-brown solution stirred at rt under N2  for 1 h. The solution 
was transferred via syringe to a round-bottomed flask and concentrated in vacuo to a volume of approximately 
20 mL, before purification by column chromatography (AI2 O3 , degassed hexanes-Et2 0 , 1:1, under N2 ) and 
prolonged (3 h, 30°C, -5  mmHg) concentration in vacuo. The title compound (1.66 g, 5.27 mmol, 8 6 % 
from 2.12) was obtained as a red-yellow oil which solidified upon drying in vacuo overnight. Complex
2.14 was generally used without further purification, but for analytical purposes purification by 
recrystallisation from pentane under an atmosphere of N2  gave fine yellow needles. ^H NMR spectroscopy 
indicated an approximate exo : endo ratio of 5 : 1, as Judged by the integration of H3 signals at 3.95 and 3.45 
ppm respectively. Spectroscopic data for the title compound has previously been reported.^^
m.p. = 65-67®C (dec, pentane). Lit. m.p. = 65-6T C  (hexane).^^
[a]D = -20.6  (c 2.10, CHCI3 ). Lit. [aJo = -150.0 (c 0.08, CHCIs).^'^
IR (KBr): v  = 2954 m, 1936 s, 1848 s, 1377 m, 1006 m cm”  ^ - in accordance with literature data.^ "^
In  and l^C NMR data for the major (Exo) isomer were in accordance with literature data.^^
*-H and ^^ C NMR data for the minor {Endo) isomer;
1h NMR (400 MHz, CDCI3 ); Ô = 5.20 (5H, s, Cp), 3.45 (IH, t, J  10.0, H3), 2.63 (IH, dq, J 10.0, 6.0, 
H2), 2.37 (IH, t, /  9.6, H4), 2.02 (IH, ddt, J  13.2, 9.2, 6 .6 , H5), 1.88 (3H, d, J 6.0, HI), 1.22 (3H, d, J
6.4, H6 ), 1.13 (3H, d, 7 6 .8 , H6 ').
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13c NMR (100 MHz, CDCI3): 6  = 240.4 (2C, 0, CO), 90.6 (5C, 1, Cp), 90.5 (1, C3), 67.6 (1, C4), 51.0 
( 1, C2), 33.7 (1, C5), 28.1 (3, C l), 25.3 (3, C6 ), 20.5 (3, C6 ').
95mo NMR (13 MHz, THF): Ôexo =  -1743, ô^ndo = -1559. Exo : endo = 5 : l.^^l
By an analogous procedure, enantiomeric complex enr-2.14 was prepared in 82% yield from a mixture of 
acetates (5)-2.12 / (5)-2.13 (5.8 : 1) on a 6.1 mmol scale, or in 45% yield on a 5.2 mmol scale by the 
literature procedure.^^
(25,4iî)-(ï7^-CyclopentadienyI)(S-inethyl-2,3,4-î7-hex-3-en-2-yl)(carbonyl)(nitrosyl) 
molybdenum tetrafluoroborate (2.1).
ON^ °^"'CO Cp
BF4-BF4“ yCp yCp
ON
Exo-2.1 Endo-2.1
t f
n
Cationic complex 2.1 (or 2.2) was routinely prepared in a minimum volume {ca 2-3 mL / mmol) of freshly 
distilled MeCN at 0°C under N2  by the addition of NOBF4  (1.1 eq) and transferred directly via cannula to a 
solution of the nucleophile. For characterisation purposes the title compound was prepared in 78% yield on a
4.9 mmol scale from neutral complex (25,4R)~2.14 according to the published procedure.^  ^ Complex 2.1 
was isolated as a mixture of 2  major isomers (presumably a pair of endo i s o m e r s ) , i n  the approximate
ratio 1 : 1 , a minor pair of exo-isomers was also observable.
'
IR (solution in CD3CN):v = 2076 s, 1716 s cm“ ^
iH NMR (400 MHz, CD3CN) Data for endo isomers: Ô = 6.09 (5H, s, Cp), 6.05 (5H, s, Cp), 5.24 (IH, t, J  
12.6, H3), 5.12 (IH, br t, J  13.0, H3), 4.36-4.28 (IH, m, H2), 3.93 (IH, dd, J  13.0, 9.8, H4). 3.64 (IH, dd, 
713.2, 4.8, H4), 3.31 (IH, dq, J  12.0, 6.1, H2), 2.82-2.62 (2H, m, H5), 2.39 (3H, d, J  6.4, Me), 2.13 (3H, 
d, J  6.4, Me), 1.44 (3H, d, J  6.4, Me), 1.38 (3H, d, J  6 .8 , Me), 1.23 (3H, d, J  6.4, Me), 0.96 (3H, d, J  6.9, 
Me). Partial data for the exo isomers: ô -  6.21 (5H, s, Cp), 6.19 (5H, s, Cp), 3.83-3.74 (2H, m), 2.57-2.48 
(2H, m), 2.22 (3H, d, J  6.0, Me), 1.38 (3H, d, J  6 .8 , Me), 1.34 (3H, d, J  6 .8 , Me), 1.32 (3H, d, J 6 .8 , Me), 
1.29 (3H, d, J  6 .8 , Me), 1.26 (3H, d, J  6 .8 , Me), remaining peaks obscured by the major isomers.
^^C NMR (100 MHz, CD3 CN, mixture of endo and exo isomers): <5 = 215.8 (0, CO), 215.0 (0, CO), 211.3 
(0, CO), 211.0 (0, CO), 110.1 (1), 109.7 (1), 108.6 (1), 106.7 (1), 102.8 (5C, 1), 101.6 (5C, 1), 101.5 (5C,
1), 100.6 (5C, 1), 94.4 (1), 94.1 (2C, 1), 93.9 (1), 89.4 (1), 87.2 (1), 78.1 (1), 75.6 (1), 35.3 (1), 34.4 (1),
30.9 (1), 30.4 (1), 26.4 (3), 25.5 (3), 25.3 (3), 24.4 (3), 23.9 (3), 22,7 (3), 21.3 (3), 21.1 (3), 20.7 (3), 19.4 
(3), 18.7 (3), 18.2 (3).
LRMS (CI+ mode, NH3 ): m/z = 318 [(M+H)+ (^% o), 100 %], 316 [(M+H)+ (^^Mo), 73 %], 287 (14), 286 
(11). The expected Mo isotope patterns are present.
HRMS (El mode): found [M+*], 317.0310. C i3 H i7 0 2 ^^Mo requires 317.0316. Found [M+'j, 315.0296. 
C i3H i7 0 2 *^^ Mo requires 315.0312. The expected Mo isotope patterns are present.
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Benzoic acid aiiyl ester (2,15).
,OBz
(i7^ -C ycIop en tad ien yI)(î7^ -p rop en yl)(carb on yI)(n itrosy l)m oïyb d en u m  tetraflu orob orate  
(2.17 / 4.77)
BFr
ON^l^CO
<|P BF4- <|P BF4-
Cationic complex 2.17 was routinely prepared in a minimum volume (ca 2-3 mL / mmol) of freshly 
distilled MeCN at O^ C under N% by the addition of NOBF4  (1.1 eq) and transferred directly via cannula to a
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■I1
Benzoate 2.15 was prepared on a 258 mmol scale by the procedure of Tamaru.^^^ Purification by short-path 
distillation (b.p. = 112-114°C / 10 mmHg, Lit. b.p. = 109-1ITC  / 15 mmHg^^^) gave the title compound 
(41.0 g, 253 mmol, 98%) as a clear oil. Spectroscopic data were in accordance with literature data.^ '^ ’^
(ï7^ -C yclop en tad ien yI)(77^-propenyl)(dicarbonyl)m olybdenum  (2.16 / 4.76)
Op
To a solution of Mo(CO)g (3.0 g, 11.4 mmol) in THF (140 mL) under N2  was added pyridine (1.8 mL, 22.7 
mmol) and the solution brought to reflux. After refluxing for 12 h a solution of benzoate 2.15 (1.75 g, 10.8 
mmol) in THF (5 mL + 5 mL) was added dropwise via syringe to the red-orange solution, which was refluxed 
for a further 12 h before cooling to rt over 1 h. LiCp (31.0 mL of a 0.40M solution in THF (prepared 
immediately before use from freshly cracked Cp (1.29 mg, 19.6 mmol) and n-BuLi (8.4 mL of a 2.32M 
solution in hexanes) in THF (40 mL), rt, 15 min under N2 )) was added and the dark red-brown solution stirred 
at rt under N2  for 1 h. The solution was transferred via syringe to a round-bottomed flask and concentrated in 
vacuo to a volume of approximately 20 mL. Purification by column chromatography (AI2 O3 , degassed 
hexanes-Et2 0 , 1:1, under N2 ) yielded the title compound (2.39 g, 9.26 mmol, 8 6 %) as a yellow fine 
crystalline solid. Spectroscopic data were in accordance with literature data.^^ ^H NMR spectroscopy 
indicated that 2.16 existed as a mixture of exo and endo isomers (3.3 : 1) in good agreement with literature 
data.^ '^
J |
Complex 2.16 was generally used without further purification, but for analytical purposes purification by 
recrystallisation from Et2 0  / pentane under an atmosphere of N2 gave fine yellow needles.
m.p. = 136-139°C (dec, Et2 0  / pentane). Lit. m.p. = 135-138^'C (Et2 Û / heptane).
^^Mo NMR (13 MHz, THF): ô^xo = -1856, = -1648. Exo : endo ~ 2 : 1,^ ^^  in good agreement with
literature data.^^
Cp ^
Exo Endo
j::'
I■i
solution of the nucleophile. However, for characterisation purposes the title compound was prepared in 92% 
yield on a 6.2 mmol scale in an analogous fashion to complex 2.17 above.
[a]D (2.20) = +31 (c 6.6, CHCI3 ). Lit. [«]d = +26 (c 5.5, CHCls)^^
[a]D (2.21) = -9 .4  (c 1.9, CHCI3 ). Lit. [«]d = -9.3 (c 1.8, CHCls)^^
(2JÎ,3/?,4ÜL,65)-2,3-Bisbenzyloxy-4-benzyloxymethyI-6-[(liî,2£')-l,4-dimethyIpent-2- 
enyljtetrahydropyran (2.22).
'OBn
OBn OBn
The title compound was prepared in 69% yield on a 1.3 mmol scale from stannane 2.20 according to the 
method previously described.^^ Spectroscopic data were in accordance with those reported p rev io u sly T h e
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I r  NMR spectroscopy indicated that 2.17 existed as a mixture of exo and endo isomers, in an initial ratio 
of endo : exo = 5 : 1 ,  equilibrating to endo ; exo = 1 : 5.5 after 27 h in CD3 CN at rt. The endo and exo 
resonances were assigned by reference to and NMR spectroscopic data for the corresponding 
hexafluorophosphate analogue of 2.17,^^^ and the ratio was estimated via  integration of H2 peaks at 5.47 
and 5.09 ppm for endo and exo respectively.
iR NMR (400 MHz, CD3 CN): Endo isomer: Ô = 6.24 (5R, s, Cp), 5.47 (IR, ddt, J  14.0, 12.6, 7.1, H2), 
4.83 (IR, dd, y 7.1, 3.4, HI or H3), 4.15 (IR, ddd, 7 7.3, 3.5, 0.5, HI or R3), 3.54 (IR, dd, J  12.5, 1.0, HI 
or R3), 3.00 (IR, d, J  14.0, HI or R3); Exo isomer : à = 6.09 (5R, s, Cp), 5.09 (IR, tt, J  14.0, 7.6, H2), 
4.92 (IR, dd, J  7.5, 3.3, HI or R3), 4.70 (IR, dd, J  7.9, 3.2, HI or H3), 3.42 (IH, d, J  13.4, HI or H3),
3.15 (IR, d, y  13.4, HI or R3).
13c NMR (100 MHz, CD3 CN): Endo isomer: Ô = 207.7 (0, CO), 113.8 (1, C2), 101.5 (5C, 1, Cp), 67.8 
(2, Cl or C3), 59.8 (2, Cl or C3); Exo isomer: 6  = 210.7 (0, CO), 100.5 (6 C, Cp + C2), 67.9 (2, Cl or 
C3), 64.1 (2, Cl or C3).
(2JS,4jR,5S,6j?)-(4j5-Bisbenzyloxy~6-benzyloxymethyltetrahydropyran-2-yl)tributyi 
stannane (2.20) and (25,4iî,55,6iî)-(4,5-BisbenzyIoxy-6"benzyloxymethyltetrahydro 
pyran-2-yl)tributylstannane (2,21)
SnBUg
OBn 
2.20
The title compounds were prepared over 2 steps from tri-O-benzyl D-giucal (2.18) on a scale of 4.8 mmol 
according to the procedure described by Procter.^^ Purification by column chromatography allowed the 
isolation of stannanes 2.20 (3.47 g, 4.91 mmol, 51%) and 2.21 (1.41 g, 1.99 mmol, 21%) as clear oils. 
Spectroscopic data for both compounds were in accordance with literature data.^
■
'S;
regioselectivity in formation of olefin 2 .2 2  was estimated as 8  : 1 , based on the integration of the following 
vinylic proton resonances in the NMR spectrum; <5 5.45-5.31 (2H, m, major isomer, IH m, minor 
regioisomer) vs 5.12 (IH, dd, J  15.3, 8.9, minor isomer).
(2/2,3/î,4iî,6/?)-2,3-Bisbenzyloxy-4-benzyloxymethyI-6-[(liî,2£)-l,4-dimethylpeiit-2- 
enyijtetrahydropyran (2.24).
'OBn
OBn OBn
[(4S)-2,2-Dimethyl[l,3]dioxoIan-4-yl]acetic acid methyl ester (2.60)
2-[(4S)-2,2-Dimethyl[l,31dioxolan-4-yl]ethanol (2.61).
,0H
'II
The title compound was prepared in 33% yield on a 0.24 mmol scale from stannane 2.21 according to the 
method previously described.^ ^  Spectroscopic data were in accordance with those reported previously.^^ The 
regioselectivity in formation of olefin 2.24 was estimated as 8  : 1, based on the integration of the following 
vinylic proton resonances in the %  NMR spectrum: Ô 5.43 (IH, dd, 15.5, 6 .6 , major regioisomer) + 5.46- 
5.33 (2H, m, minor regioisomer) vs 5.25 (IH, 15.5, J  , 8.0, 1.0, major regioisomer).
3
3The title compound was prepared by a procedure adapted from the l i t e r a t u r e : M e t h y l  (3S)-3,4- 
dihydroxybutanoate (prepared from dimethyl (S)-malate 2.59 on a scale of 153 mmol according to the 
procedure of Moriwake^^ as a clear oil and used crude) was dissolved in acetone (300 mL) and /p-TsOH'H^O 
(1.46 g, 7.65 mmol) was added. The cloudy white suspension was stirred at rt for 2.5 d before the addition of 
EtgN (0.5 mL) and concentration in vacuo. The residue was partitioned between CH2 CI2  (150 mL) and 
aqueous NaHCO) (150 mL) and the phases separated. The aqueous phase was extracted with CH2CI2  (3 x 50 
mL) and the combined organic phases dried, filtered and concentrated in vacuo to give a pale yellow oil which 
was purified by column chromatography (S1 0 2 , Et2 0  : hexanes = 1 : 1) to yield the title compound as a clear 
oil (16.1 g, 92.2 mmol, 60% over two steps from 2.59). Spectroscopic data were in accordance with 
literature data.^^^
[«Id = +9.05 (c 10.4, Me2 C0 ). Lit. [«Jd = +8.69 (c 10, Me2 C0 ).^^^
The title compound was prepared in 8 8 % yield on a 83.6 mmol scale by the method of Luk.^^^ 
Spectroscopic data were in accordance with literature data.^^^’
[«Id = -2.72 (c 4.97, MeOH). Lit. [c£]d (enantiomer) = +2.49 (a 5.12, MeOH).^^^
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2,2,4,4-Tetramethyloxazoïidine-3-carbonyl chloride (2.63).
The title compound was prepared in 70% yield on a 46.0 mmol scale by the method of Hoppe^ "  ^and purified 
by short-path distillation (b.p. = 79-8r c  / 1.5 mmHg, Lit. b.p. = 73-74 / 3 mmHg '^^). Spectroscopic data 
were in accordance with literature data.^ "^
2,2,4,4-TetramethyloxazoIidine-3-carboxyIic acid [(4S)-2-(2,2-dimethyl[l,3]dioxolan-4- 
yl)]ethyl ester (2.52).
The title compound was prepared in 91% yield as a clear colourless oil on a 32.0 mmol scale by the method 
of Hoppe.^“^ NMR spectroscopic data were in accordance with literature data.^^
[a]D = -9.47 (c 5.08, MeOH) Lit. [aJo = -11 .4  {c 5.3, MeOH).^®
IR (film): v = 2982 s, 2937 s, 2871 m, 1700 s, 1457 m, 1410 s, 1353 s, 1262 m, 1211 m, 1158 m, 1097 
m, 1069 m cm“ .^
13c NMR (100 MHz, CDCI3 ): <3 = 153.4 (0.55C, 0, 0 ££0 )NR2 ), 152.8 (0.45C, 0, Q£fO)NR2 ), 109.1 (0,
02), 96.0 (0.55C, 0, N£M e20), 94.9 (0.45C, 0, N £M e20), 76.5 (0.55C, 2, 0£H2CM e2), 76.2 (0.45C, 2, 
OCH2 CMe2 ), 73.4 (1, 04), 69.5 (2, 05), 61.6 (2, CH20C(0)N), 60.7 (0.450, 0, N£M e2 ), 59.8 (0.550, 0, 
N £M e2), 33.3 (2, ÇH2 CH2 ÜC(0 )N), 27.1 (2C, 3, Me), 26.7 (3, Me), 25.8 (3, Me), 25.4 (3, Me), 24.3 (3, 
Me).
13o NMR (100 MHz, CDOI3 , 52"0): Ô = 138.4, 109.2, 76.6, 73.6, 69.6, 61.7, 33.5, 27.2, 26.8, 25.8,
25.6,24.4, 3 quaternary signals were not observed.
2,2 ,4 ,4-Te trame thy Ioxazolidine-3-car boxy lie acid ( lS )-2 -[(4 S )-2 ,2 -d im eth y i-
[l,3]dioxolan-4-yl]-l-(tributylstannanyl)ethyl ester (2.64),
O B usSn O
j-BuLi (22.9 mL of a 1.28M solution in cyclohexane : hexane (92:8), 29.4 mmol) was added dropwise to a 
solution of carbamate 2.52 (8.04 g, 26.7 mmol) and (-)-sparteine (6 .8 8  g, 29.4 mmol) in Et2 0  (140 mL) at
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-78°C under N2 . The clear yellow solution was stirred at -78°C for 3 h before the dropwise addition of 
tributyltin chloride (10.9 mL, 40.0 mmol) and the solution was allowed to warm gradually to rt overnight 
( ~ 1 2  h). IM HCl (100 mL) and Et2 0  (50 mL) were added and after stirring for 10 min the phases were 
separated. The aqueous phase was extracted with Et2 Û (2 x 50 mL), and the combined organic phases washed 
with brine (50 mL), dried, filtered and concentrated in vacuo. Purification by column chromatography (Si0 2 ,
Et2 0  : hexanes = 1 : 4 )  gave the title compound (10.8 g, 18.3 mmol, 69%) as a clear colourless oil.
[«Id = +15.3 (c 0.85, CHCI3 ).
IR (film): v  = 2953 s, 2922 s, 2877 m, 1680 s, 1399 s, 1382 s, 1261 m, 1208 m, 1070 s c m 'l
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1h NMR (400 MHz, CDCI3 ): d = 4.76 (IH, dt, J  9.6, 4.1, HI), 4.17 (IH, septet, J  6.2, H3), 4.10 (IH, dd,
/  6.0, 6.0, H4), 3.72 (2H, s, OCH2 CMe2 ), 3.55 (IH, dt, J  3.1, 7.4, H4), 2.31-2.20 (IH, m, H2), 1.95 (IH,
ddd, J  14.4, 6 .8 , 4.1, H2'), 1.55-1.26 (30H, m, SnBus, Me), 0.92-0.85 (15H, SnBus).
13c NMR (100 MHz, CDCI3 ): Ô = 153.3 (0.6C, 0, 0 £ ( 0 )NR2 ), 152.6 (0.4C, 0, 0 £ ( 0 )NR2 ), 109.1 (0, 
CMe2 ), 96.1 (0.6C, 0, NCMezO), 94.8 (0.4C, 0, N£M e2 0 ), 76.5 (0.6C, 2, 0 £ H 2 CMc2), 76.2 (0.4C, 2, 
0£H 2C M e2C ), 74.7 (1, C3), 69.6 (2, C4), 67.7 (1, C l), 60.8 (0.4C, 0, N £M c2 CH2 ), 59.6 (0.6C, 0, 
N £ M e 2 C H 2 ), 38.5 (2, C2), 29.3 (3C, 2, Sn(CH2 C H 2 £ H 2 M e )3 , 3 jc -S n  9.8), 27.7 (3C, 2, 
Sn(CH2£ H 2 CH2 Me)3 , V c-Sn 28.8), 27.2 (3, Me), 26.9 (0.5C, 3, Me), 26.7 (0.5C, 3, Me), 25.8 (3, Me), 
25.5 (2C, 3, Me), 24.4 (0.5C, 3, Me), 24.3 (0.5C, 3, Me), 13.9 (3C, 3, Sn(CH2 CH2 CH2Mfi)3 ), 10.1 (3C, 
2 , Sn(£H2 CH2 CH2 Me)3 , Vc-Sn 162.9, 155.9).
LRMS (Cl mode, isobutane): m/z = 592.0 [(M+H)+, 11 %], 590.1 (10), 534.0 (100), 532.0 (75), 476.0 (8 ),
474.0 (6 ), 291.0 (6 ), 289.0 (5).
Found: C, 54,99; H, 9.04; N, 2.28. C2 7 H5 3 N 0 5 Sn requires: C, 54.92; H, 9.05; N, 2.37 %.
2,2,4,4-Tetramethy Ioxazolidine-3-car boxy lie acid (IR ,2 5 ,3£ ')-l-(2 ,2 -d im eth y l-
[l,3]dioxolan-4-ylmethyl)-2,5-dimethylhex-3-enyl ester (2.58).
n-BuLi (4.6 mL of a 1.42M solution in hexanes, 6.5 mmol) was added dropwise to a solution of stannane 
2.64 (3.49 g, 5.92 mmol) in THF (100 mL) at -78°C under N2 . The light-yellow solution was stirred at 
-78*’C for 30 min before cooling to approximately -9 0 °C and the dropwise addition of a solution of 
CuBr'DMS (1.46 g, 7.10 mmol) in diwopropylsulfide (2.5 mL) and THF (10 mL). The brown-orange 
solution was allowed to warm to -7 8 °C over 45 min before re-cooling to approximately -90°C and the 
dropwise addition of a solution of cationic complex 2 .2  (which had been freshly prepared from neutral 
complex 2.14 (1.55 g, 4.93 mmol) and NOBF4  (633 mg, 5.42 mmol) in MeCN (10 mL) at 0°C for 10 
min). After warming to -78°C and stirring for 1.5 h, aqueous NH4 CI (40 mL), Et2 0  (30 mL) and aqueous ■
NH3 (5 mL) were added and the mixture warmed to rt. After filtration of the mixture through celite, and 
thorough washing of the celite with EtaO (2 x 30 mL) the phases were separated and the aqueous phase 
extracted with Et2 0  (3 x 30 mL). The combined organic phases were washed with brine (50 mL), dried, 
filtered and concentrated in vacuo. The resulting yellow-brown oil was dissolved in CHCI3 (250 mL) and 
stirred at rt with O2  bubbling through the solution for 44 h, and illumination from a standard household 
light-bulb (150W) for the last 26 h. The dark-brown mixture was concentrated in vacuo, dissolved in CH2 CI2  
(5 mL) and flushed through a plug of S1 0 2  (4 cm depth, Et2 0 ) before purification by column 
chromatography (Si02, Et2 0  : hexanes, 0  : 1 1 : 1) to yield the title olefin (1 .1 2  g, 2.28 mmol, 57%) as
a pale yellow oil. Stannane 2.64 (93 mg, 0.23 mmol, 4%) was also recovered.
[aJo = +10.3 (c 1.3, CHCI3 ).
IR (film): y  = 2978 s, 2939 s, 2872 m, 1694 s, 1399 s, 1377 s, 1259 m, 1209 m, 1094 m, 1064 s c n rK
NMR (400 MHz, CDCI3 ): Ô = 5.45 (IH, dd, J 15.6, 6.3, H4), 5.31 (IH, dd, J  15.6, 7.9, H3), 4.83 (IH, 
dt, J  9.9, 3.9, HI), 4.15-4.07 (2H, m, CH0 CMe2 , CÏÏAHB0 CMe2 ), 3.75 (2H, s, OCH2 CMe2 ), 3.58-3.52 
(IH, m, CHAHB0 CMe2 ), 2.44-2.34 (IH, m, H2), 2.25 (IH, octet, J  6 .8 , H5), 1.98 (IH, dt, J  9.9, 4.7, 
CH(OAllyl)CHAHB), 1.70-1.63 (IH, m, CH(OAllyl)CHAHB), 1.55 (6 H, br s, Me), 1.41 (3H, s. Me), 1.40 
(3H, s, Me), 1.38 (3H, s. Me), 1.32 (3H, s, Me), 1.03 (1.5H, d, J  6 .8 , C2-Me), 1.02 (1.5H, d, J  6 .8 , C2- 
Me), 0.96 (6 H, d, J  6 .8 , H6 , C5-Me).
GCMS (160°C, 1 min, 3°C min“  ^ -> 200°C, 5°C 250°C) showed 4 isomers in the ratio 1 : 95 : 2 : 2,
13c NMR (100 MHz, CDCI3): d = 152.7 (0.6C, 0, 0 £ ( 0 )NR2), 152.6 (0.4C, 0, 0 £ ( 0 )NR2 ), 139.4 (1,
C3 or C4), 127.9 (0.6C, 1, C3 or C4), 127.8 (0.4C, 1, C3 or C4), 108.9 (0, 0 £ M c 2 0 ), 96.1 (0.6C, 0,
0 £M e2N), 95.0 (0.40, 0, 0 £M e2 N), 76.6 (0.6C, 2, 0 £ H 2 CMe2 ), 76.2 (0.4C, 2, 0 £ H 2 CMc2 ), 74.9 (1,
Cl or £ H 0 CMe2 ), 73.7 ( 1, Cl or £ H 0 CMe2 ), 69.7 (2 , £ H 2 CMe2 ), 60.8 (0.4C, 0, N£Me2 CH2), 59.9 
(0 .6 C, 0, N £M e2 CH2 ), 41.0 (1, C2), 36.3 (2, CH(0 Allyl)£H2 ), 31.2 (1, 05), 27.1 (3, Me), 26.8 (3, Me), «
25,8 (3, Me), 25.7 (0.50, 3, Me), 25.6 (0.50, 3, Me), 25.4 (3, Me), 24.4 (3, Me), 22.7 (3, 06), 22.6 (3,
C5-Me), 17.0 (C2-Me).
1 —> 7 D O T ' —3. « h n w p ft A in  th p  r a tin  1 • O'ï ■ 2  ' 2 %retention times 9.32, 10.03, 10.19, 10.36 respectively.
LRMS (Cl mode, isobutane): mfz = 398.2 [(M+H)+, 95 %], 340.2 (100), 225.2 (62), 167.2 (59). 
Found; C, 66.56; H, 9.83; N, 3.47. C2 2 H3 9NO5  requires: C, 66.47; H, 9.89; N, 3.52 %.
2,2,4,4-Tetramethy Ioxazolidine-3-car boxy lie acid ( 15) - l - [ (45) -2 , 2 -d imethyl -
[l,3]dioxolan-4-ylinethyl]but-3-enyl ester (2.66).
%
-If■"I
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To a solution of stannane 2.64 (4.09 g, 6.93 mmol) in THF (100 mL) at -78°C under %  was added n-BuLi 
(5.4 mL of a 1.42M solution in hexanes, 7.6 mmol) dropwise and the resulting light-yellow solution stirred 
at -78°C  for 20 min before cooling to approximately -90°C and dropwise addition of a solution of 
CuBr»DMS (1.71 g, 8.32 mmol) in dizjopropylsulfide (3 mL) and THF (10 mL). After stirring at -78°C for 
30 min the orange-brown solution was re-cooled to -90°C and a solution of cationic complex 2.17 (which 
had been freshly prepared from neutral complex 2.16 ( 1 .1 2  g, 4.34 mmol) and NOBF4  (558 mg, 4.77 
mmol) in MeCN (12 mL) at 0°C for 10 min) was added via cannula keeping the internal temperature below 
-75°C. The brown solution was stirred at -7 8 °C for 1 h before aqueous work-up and décomplexation (O2, 
light, rt, 19 h) as described above for olefin 2.58. Concentration in vacuo and purification by column 
chromatography (Si0 2 , Et2 0  : hexanes = 1 : 4 )  yielded the title compound (1.45 g, 4.25 mmol, 61%) as a 
pale yellow oil. Alkane 2.52 (103 mg, 0.34 mmol, 5%) was also isolated by column chromatography. ^H 
NMR spectroscopy indicated that olefin 2.66 had been isolated as a 11 : 1 mixture with impurity 2.68, 
estimated by comparison of the integration of the following peaks: 5.84-5.72 (IH, m, H3 (2.66)) vs 5.57- 
5.49 ppm (2H, m, 2.68).
M o  = + 2 2 .1  (c 1 .0 2 , CHCI3 ).
IR (film): v = 2984 s, 2938 m, 2873 m, 1696 s, 1399 s, 1379 s, 1334 m, 1259 m, 1210 m, 1159 m, 1095 
s, 1064 s cm” l.
^H NMR (400 MHz, CDCI3 ); Ô = 5.84-5.72 (IH, m, H3), 5.10 (IH, d, J  17.9, H4), 5.09 (IH, d, J 9.5, 
H4'), 4.99-4.93 (IH, m, HI), 4.15 (IH, br pentet, J  6.4, CH 0C M e2) ,  4.09 (IH, dd, J 7.6, 5.8, 
CHAHB0 CMe2), 3.72 (2H, s, NC(Me)2 CÏÏ2 0 ), 3.56 (IH, t, J 7.6, CHAHB0 CMe2 ), 4.47-2.37 (2H, m, 
H2), 2.03-1.93 (IH, m, CH(OAllyl)CHACHB). 1.81-1.71 (IH, m, CH(OAllyl)CHACHB), 1.55 (3H, s. 
Me), 1.53 (3H, s, Me), 1.51 (3H, s, Me), 1.41-1.33 (12H, m. Me).
^3c NMR (100 MHz, CDCI3 ): Ô = 152.4 (0.6C, 0, 0£(0 )N R 2), 151.6 (0.4C, 0, 0C (0)N R 2), 133.8 (1, 
C3), 118.3 (2, C4), 109.1 (0, N £(M e)2 0 ), 96.1 (0.6C. 0, 0 £(M e)2 0 ), 95.0 (0.4C, 0, 0 £(M e)2 0 ), 76.5 
(0.6C, 2 , NC(Me)2£ H 2 ), 76.2 (0.4C, 2 , NC(Me)2 £ H 2 ), 73.3 ( 1 , £ H 0 CM e2 ), 71.1 (1 , C l), 69.6 (2 , 
£H20CM e2), 60.8 (0.4C, 0, N£(M e)2 CH2 ), 59.9 (0.6C, 0, N£(M e)2 CH2 ), 39.5 (0.6C, 2, £ H 2 CH=CH2 ),
3 9 .4  (0.4C, 2 , £H 2 CH=CH2 ), 38.0 (0 .6 C, 2 , CH(0 Allyl)CIi2 ), 37.9 (0.4C, 2 , CH(0 Allyl)CH2 ), 27.2 (3 , 
Me), 26.9 (3, Me), 25.8 (3, Me), 25.7 (0.5C, 3, Me), 25.6 (0.5C, 3, Me), 25.5 (0.5C, 3, Me), 25.4 (0.5C, 
3, Me), 24.4 (3, Me).
LRMS (El mode GCMS, 150°C, 2 min, 5°C min"! -> 200°C, 10°C -> 250°C, rt = 6.31 min): m/z = 341 
[(M"''*), 2%], 326 (100), 158 (85), 156 (35), 101 (87). A minor diastereomer (2%) was observed, with a 
retention time of 6.47 min.
HRMS (Cl mode, isobutane); found [M+H]"*", 342.2283. C 18H3 2O5N requires 342.2280. 
(2 5 )-l-[(4 S )-2 ,2 -D im eth y l-[ l,3 ]d io x o Ia n -4 -y l]p en t-4 -en -2 -o I  (2 .67).
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A solution of olefin 2.66 (1.08 g, 3.16 mmol) in THF (25 mL) was added dropwise over 5 min to a 
suspension of LiAIH4  (480 mg, 12.7 mmol) in THF (35 mL) at 0°C under N2 . The mixture was then 
refluxed for 4 d (with the addition of a further 480 mg of LiAlH^. after 44 h) before cooling to 0°C and the 
addition of H2 O (0.9 mL), followed by 15% aqueous NaOH (0.9 mL) and H2 O (2.7 mL). The mixture was 
brought back to reflux for 30 min before cooling to rt and filtration through celite, washing the celite 
thoroughly with THF (3 x 15 mL). The filtrate was concentrated in vacuo and purification by column 
chromatography (Et2 0  : hexanes = 3 : 7 1 ; 1) yielded the title compound (475 mg, 2.55 mmol, 81%) as
a clear oil. Spectroscopic data were in accordance with literature data.^*^’
[a]D = +11.9 (c 3.20) Lit. [aJo = +14.6 (c 3.33, CHCls).^^'^
2,3-D ihydroindoIe-l-carboxylic acid /err-butyl ester (2.73)
N  1 
7  Bog
The title compound was prepared on a 75.6 mmol scale according to the procedure of Iwao.^^^ Purification 
by short-path distillation (b.p. = 95-97°C / 0.1 mmHg, Lit. b.p. = 83-84°C / 0.1 mmHg^^^) gave the title 
compound (14.4 g, 65.8 mmol, 87%) as a clear oil which solidified upon standing and was purified further by 
recrystallisation from hexanes. ^H NMR and IR spectroscopic data were in accordance with literature data.^^  ^
NMR spectroscopic data (CDCI3 , rt) were in accordance with the partial data reported by Meyers, and in 
common with the literature report not all quaternary carbons were visible.^^^
m.p. -- 43-45°C (hexanes). Lit. m.p. = 42-45°C (from the melt).^^^
13c NMR (100 MHz, CDCI3 , 52°C): Ô = 152.8 (0), 142.9 (0), 131.4 (0), 127.5 (1), 124.8 (1), 122.3 (1),
115.0 (1), 80.9 (0), 47.8 (2), 28.7 (3C, 3), 27.5 (2).
7-C hIoro-2,3-d ihydroindole-l-carboxyIic acid te r t-h u ty l ester (2.74)
The title compound was prepared in 72% yield on a scale of 14.8 mmol according to the method of Iwao. 1 ^  
Purification by column chromatography yielded the title compound as a pale yellow solid which was purified 
further by recrystallisation from pentane. 1h  NMR and IR spectroscopic data were in accordance with 
literature d a ta is
m.p. = 84.5-85.5°C (pentane) Lit. 84.5-85°C (pentane). 110
13c NMR (100 MHz, CDCI3 ): d = 153.4 (0, £ 0 2 ^Bu), 140.7 (0, Ph), 137.2 (0, Ph), 129.1 (1, Ph), 125.3 
(1, Ph), 124.2 (0, Ph), 122.9 (1, Ph), 81.6 (0, QMqj), 51.5 (2, C2), 30.1 (2, C3), 28.3 (3C, 2, CMeO.
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(2jR)-7-Chloro-2-[(15,3£)-l,4-dimetliyIpent-2-enyl]~2,3-dihydroindole-l-carboxylic acid 
fgrf-butyl ester (2.80).
s
6
Boc
j“BuLi (4.3 mL of a 1.28M solution in cyclohexane : hexane (92:8), 5.54 mmol) was added dropwise to a 
solution of (-)-sparteine (1.30 g, 5.54 mmol) in /erf-butyl methyl ether (70 mL) at -TB^ ’C under N2 . The 
solution was stirred for 10 min before the slow addition of a pre-cooled (~78°C) solution of indoline 2.74 
(1.17 g, 4.62 mmol) in ?erf-butyl methyl ether (50 mL) via  cannula, ensuring the internal solution 
temperature did not rise above -75°C. The solution was stirred at -7 8 "C for 3.5 h before cooling to 
approximately -8 5 “C and addition of a solution of CuBr*DMS (1.23 g, 6.01 mmol) in diisopropyl sulfide (4 
mL) and THF (6  mL) ensuring the internal solution temperature did not rise above -7 5 “C. The orange 
solution was stirred at -78°C for 30 min before cooling to approximately -85°C and adding a solution of 
complex 2.2 (which had been freshly prepared from neutfal complex ent-2,14  (1.21 g, 3.85 mmol) and 
NOBF4  (495 mg, 4.24 mmol) in MeCN (10 mL) at 0°C for 10 min) via cannula. The brown solution was 
allowed to gradually warm to rt over 14 h before aqueous work-up in an identical fashion to that described 
above for olefin 2.58. The crude material following aqueous work-up was dissolved in Me2C0  (250 mL) and 
NaOAc*3 H2 0  (7.5 g) added, followed by CAN (2.5 g). The orange-brown mixture was stirred at rt for 3 h 
before concentration in vacuo and addition of Et2 0  (100 mL) and H2 O (100 mL). After stirring for 10 min 
the mixture was filtered through celite, the phases were separated and the aqueous phase extracted with Et2 0  
(2 X 50 mL). The combined organic phases were washed with brine (50 mL), dried, filtered and concentrated in 
vacuo to yield a brown oil. Purification by column chromatography (S1 0 2 , Et2 0  : hexanes = 5 : 95 10 :
90) yielded the title olefin (766 mg, 2.19 mmol, 57% from neutral complex ent-2,14') as a pale yellow oil. 
Further elution yielded an inseparable mixture of ketone 2.81 and indoline 2.74 (111 mg, 2.81: 2.74 = 1 
: 3, approximately 3% and 6 % respectively, Rf (Et2 0  : hexanes = 1:9) :  2.80 = 0.40, 2.74 / 2.81 = 0.23). 
Indole 2.82^ ®^  (165 mg, 0.66 mmol, 14%) was also isolated. NMR indicated that 2.80 was obtained as 
a mixture of isomers, GCMS (150°C, 2 min, 5°C min"  ^ ~> 200°C, 10°C min“  ^ -*  250°C) showed 4 
isomers in the ratio 4 : 9 : 81 : 6 , retention times 8 .6 6 , 9.11, 9.50, 9.78 min respectively. NMR data is 
quoted for the major isomer.
[alD = +9.42 (c 1.38, CHCI3 ).
IR (film)v = 2961 s, 2931 m, 1702 s, 1454 s, 1366 s, 1327 s, 1244 m, 1162 s cm“ l.
NMR (400 MHz, CDCI3 ): d = 7.15 (IH, d, J 8.0, Ph), 7.01 (IH, d, J  7.2, 0.4, Ph), 6.93 (IH, t, J 7.6, 
Ph), 5.30 (IH, ddd, J  15.3, 6.4, 0.8, CH=CHCHMe2 ), 5.06 (IH, ddd, J  15.3, 8 .2 , 1.4, CH=CHCHMe2 ), 
4.45 (IH, ddd, J  8.5, 5.4, 1.2, H2), 3.35 (IH, dd, J 16.0, 8.5, H3), 2.61 (IH, d, J  16.0, H3'), 2.24 (IH, ddq, 
J  13.2, 1.2, 6.7, CEMe), 2.08 (IH, dseptet, J  1.1, 6.7, CEMe2 ), 1.54 (9H, s, CMe3 ), 0.99 (3H, d, J  6 .8 , 
CHMe), 0.82 (3H, d, J 6 .8 , CHMg(Me)), 0.80 (3H, J  6 .8 , CHMe(Me)).
13c NMR ( 1 0 0  MHz, CDCI3 ): d = 153.8 (0, £ 0 2 ?-Bu), 140.9 (0, Ph), 138.3 (1, CH=£HCHMe2 ), 136.9 
(0, Ph), 128.8 (1, Ph), 127.7 (1, QH=CHCHMe2 ), 125.2 (I, Ph), 124.3 (0, Ph), 122.7 (1 , Ph), 81.4 (0,
130
CM es), 66.9 (1, C l), 42.2 (1, CHMe), 33.4 (2, C2), 31.0 (1, £H M e2 ), 28.4 (3C, 3, CMeg), 22.6 (3, 
CHMe(Me)), 22.3 (3, CHMe(Me)), 16.7 (3, CHMe).
LRMS (El mode): m/z = 349 [(M+*), 2 %], 276 (3), 252 (6), 152 (100), 117 (11), 57 (97).
Found: C, 68.50; H, 7.89; N, 3.96. Calc, for C2 0 H2 8CINO2 : C, 68.65; H, 8.07; N, 4.00%.
Spectroscopic data for 8 -C hloro-2-(2 ,5-d im ethyIhex-3-enoyl)"2 ,3-d ihydroindole-l-carb oxylic  
acid ferf-butyl ester (2.81):
1h NMR (400 MHz, CDCI3): <5 = 7.19-6.94 (3H, m, Ph), 5.24 (IH, dd, J  15.7, 6.0, CH=CHCHMe2), 5.17 
(IH, dd, J  15.7, 7.8, CH =CH CH M c2 ), 4.93 (IH, dd, J  1 0 .0 , 2 .0 , H2 ), 3.82 (IH, dq, J 7.0, 7.1, 
C(O)CHMe), 3.48 (IH, dd, J  16.4, 10.0, H3), 3.19 (IH, dd, J  16.4, 2.0, H3'), 1.99-1.91 (IH, m, CHMc2 ), 
1.17 (3H, d, J  6 .8 , C(O)CHMe), 0.71 (3H, d, J  6 .8 , CHMe(Me)), 0.70 (3H, d, J  6.7, CHMe(Me)).
13c NMR (100 MHz, CDCI3): d = 211.8 (0, C(O)CHMe), 153.6 (0, CÛ2 ^Bu), 140.5 (1, CH=CHCHMe2 >,
139.9 (0, Ph), 135.0 (0, Ph), 129.4 (1, Ph), 125.7 (1, CH=CHCHMc2  or Ph), 124.7 (1, CH=CHCHMe2  or 
Ph), 124.1 (0, Ph), 123.0 (1, Ph), 82.6 (0, £M e 3), 69.3 (1, C2), 44.2 (1, C(O)CHMe), 33.0 (2, C3), 30.8 
( 1 , CHMC2 ), 28.3 (3C, 3, CMeiL 2 2 .2  (3, CHMs(Me)), 22.0 (3, CHMe(Ms)), 17.4 (3, C(O)CHMe).
LRMS (El mode GCMS, 150°C, 2 min, 5°C min“ l 200°C, 10°C ^  250°C, rt = 11.87 min): m/z = 377 
[M+*, 3 %], 304 (4), 277 (7), 152 (100), 151 (11), 117 (17), 57 (79).
HRMS (GCMS, EI+ mode): found [1VI+'], 377.1756. C2 iH2g0 3 N3 5 c i requires 377.1758.
(2S )-2 -A Ily l-2 ,3 -d ih yd ro in d oIe-l-carb oxy lic  acid  tert-butyl ester (2.85) and 7-Ally 1-2,3- 
d ih yd roindole-l-carboxylic  acid terf-butyl ester (2 .8 6 ).
A5
N 1 
8 0 c
2.85 ^  2.86
5-BuLi (6.4 mL of a 1.30M solution in cyclohexane : hexane (92:8), 8.25 mmol) was added dropwise to a 
solution of indoline 2.73 (1.39 g, 6.4 mmol) and (-)-sparteine (1.93 g, 8.25 mmol) in ïerr-butyl methyl 
ether (65 mL) at -78°C under N2 . The light yellow solution was stirred at -78°C for 3.25 h before cooling to 
approximately -90°C and addition of a solution of CuBr*DMS (1.83 g, 8.89 mmol) in diwopropyl sulfide (5 
mL) and THF (7 mL) dropwise, ensuring the internal solution temperature did not rise above -7 5 “C. After 
stirring for 40 min at -78°C the solution was cooled to approximately ~85°C and a solution of cationic 
complex 2.17 (which had been freshly prepared from neutral complex 2.16 (2.69 g, 10.4 mmol) and 
NOBF4  (1.34 g, 11.4 mmol) in MeCN (20 mL) at 0°C for 10 min) was added dropwise over 10 min. The 
dark-brown solution was allowed to warm slowly to rt under N2  overnight, before aqueous work-up in an
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identical fashion to that described above for olefin 2.58. Décomplexation was performed using the CAN 
mediated procedure described above for olefin 2.80. Purification by column chromatography (Si0 2 , PhMe : 
hexanes = 1 : 1 “> 100 : 0 followed by Et^O : hexanes = 1 : 9 )  yielded a mixture of the title compounds as a 
pale yellow oil (901 mg, 3.47 mmol, 55%; Rf = 0.39 in PhMe) and recovered indoline 2.73 (130 mg, 0.59 
mmol, 9%; Rf = 0.24 in PhMe). NMR spectroscopy revealed an approximately equimoiar ratio of 2.85 
and 2.86. and NMR spectroscopic data for 2,85 and NMR data for 2.86 were in accordance 
with literature data.^^^
[a]D = +44.2 (c 0.55, CHCI3 ).
IR (film, 1 : 1 mixture of 2.85 / 2.86): v = 2975 m, 1703 s, 1484 s, 1453 m, 1391 s, 1333 m, 1293 m, 
1168 s, 1139 m cm” .^
13c NMR (2.86) (100 MHz, CDCI3 ): Ô = 154.0 (0, CO^^Bu), 142.3 (0, Ph), 138.3 (0, Ph), 137.1 (1, 
£H = C H 2 ), 134.8 (0, Ph), 128.8 ( 1 , Ph), 124.7 (1, Ph), 116.0 (2, CH=CH2 ), 115.4 (1 , Ph), 80.8 (0, 
£M e3 ), 51.2 (2 , C2 ), 37.9 (2 , CH2 CH=CH2), 29.8 (2 , C3), 28.6 (3C, CMêg).
(25 )-2 -A Ily l-2 ,3 -d ih y d ro -l£ r-in d o le  (2,87) and 7-AHyl-2,3-dihydro«li3^-mdole (2.88).
2.87 2.88
Trifluoroacetic acid (2 mL) was added to a solution of indoUnes 2.85 and 2.86 (« 1 : 1, 742 mg, 2.86 
mmol) in CH2 CI2  (8  mL) at 0®C under N2 . The orange-brown solution was stirred at 0°C for 30 min and 
then at rt for 1.5 h before concentration in vacuo to give a purple-red oil which was dissolved in Bt2 0  (25 
mL) and washed with 0.5M NaOH (2 x 25 mL). The combined aqueous phases were extracted with Et2 0  (2 x 
25 mL) and CH2CI2  (3 x 25 mL) and the combined organic phases washed with brine (25 mL), dried, filtered 
and concentrated in vacuo. Purification by column chromatography (Si0 2 , Et2 0  : PhMe = 2 : 98 5 : 95)
yielded indoline 2,87 (233 mg, 1.46 mmol, 51%; Rf = 0.51 in Et2 0  : PhMe = 5 : 95) and indoline 2.88 
(100 mg, 0.63 mmol, 22%; Rf = 0.34 in Et2 0  : PhMe = 5 : 95) as clear oils. Spectroscopic data for 
2 .8 7 2 3 0  = -54.3 (c 1.18, CHCI3)) and for 2.88^^^ were in accordance with literature data.
Acetic acid 2 -[(2 S )-2 -a lly I-2 ,3 -d ih yd ro in d o l-l-y l]-2 -oxo-l-p h en y leth y l ester (2.89).
4
1
7
2.89 Ph
A solution of DCC (87 mg, 0.42 mmol) and (i?)-(9-acetoxyphenylacetic acid (82 mg, 0.42 mmol) in CH2 CI2  
(5 mL) was cooled to 0"C under N2  and stirred for 15 min before the addition via cannula of a solution of 
indoline 2,87 (56 mg, 0.35 mmol) in CH2 CI2  (10 mL). The cloudy mixture was stirred at O^’C under N2  for
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1 h before concentration in vacuo. EtOAc (25 mL) was added to the residue and the mixture filtered before the 
addition of 0.5M HCl (15 mL). The phases were separated and the organic phase washed with 0.5M HCl (15 I
mL) and aqueous NaHCOa (2  x 15 mL). The two aqueous phases were extracted separately with EtOAc (2  x 
15 mL) and the combined organic phases dried, filtered and concentrated in vacuo. Purification by column 
chromatography (Si0 2 , Et2 0  : hexanes = 4 : 6 )  yielded the title compound (102 mg, 0.30 mmol, 87%) as a 
colourless oil. ^H and ^^ C NMR spectroscopic analysis indicated the presence of a single diastereomer within 
the limits of detection.
[a]D = -121.9 (c 2.04, CHCI3 ).
IR (film): v = 1739 s, 1670 s, 1599 m, 1481 s, 1458 m, 1411 s, 1371 m, 1229 s, 1184 m, 1045 s, 956 m,
919 m, 755 s cm“ .^
iH NMR (400 MHz, CDCI3 ): d = 8.24 (IH, d, J 8.1, Ph), 7.52 (2H, t, J  2.9, Ph), 7.46-7.38 (3H, m, Ph), :1
7.23 (IH, t, J  7.7, Ph), 7.15 (IH, d, J  7.2, Ph), 7.05 (IH, t, J  7.4, Ph), 6.18 (IH, s, CH(OAc)Ph), 5.79
(IH, ddt, J  17.0, 10.0, 7.0, CH=CH2 ), 5.19 (IH, d, J  17.0, CH=CE2 ), 5.16 (IH, d, J  10.0, CH=CÜ2 )» 4.32
(IH, br t, J  8.5, H2), 3.02 (IH, dd, J 15.8, 8.5, H3), 2.86-2.72 (2H, m, CHaHbCH=CH2 , H3'), 2.49 (IH,
dt, J  14.4, 7.9, CHaCHbCH=CH2 ), 2.24 (3H, s, OC(O)Me).
13c NMR (100 MHz, CDCI3 ): ô = 171.0 (0, 0 £ (0 )R ), 165.8 (0 , 0 £ (0 )R ), 142.1 (0, Ph), 133.9 (0, Ph),
133.0 (1, £H =C H 2 ), 130.3 (0, Ph), 129.9 (1, Ph), 129.4 (2C, 1, Ph), 128.9 (2C, 1, Ph), 127.8 (1, Ph),
125.0 (1, Ph), 124.7 (1, Ph), 119.0 (2, CH=£H2 ), 118.2 (1, Ph), 75.0 (1, £H(OAc)Ph), 58.3 (1, £2), 39.1 
(2 , £H 2 CH=CH2 ), 33.7 (2 , C3), 2 1 .0  (3, OC(O)Ms).
MeOgC' COgM© MsOgC”"^ COgMs 
2.94 2.95
NaH (382 mg, 9.55 mmol) was washed with THF ( 2 x 5  mL), suspended in THF (100 mL) and cooled to 
0°C under N2 , before the dropwise addition of dimethyl malonate (1.09 mL, 9.55 mmol) over 10 min. After 
warming to rt and stirring for 15 min the solution was cooled to -78"C and a solution of cationic complex
2.1 (which had been freshly prepared from neutral complex 2.14 (1.50 g, 4.76 mmol) and NOBF4  (613 mg, 
5.25 mmol) in MeCN (15 mL) at 0"C for 10 min) was added dropwise. After warming to rt over 1 h and 
stirring at rt for 2 h the mixture was concentrated in vacuo and re-dissolved in Mc2 C0  (100 mL). 
NaOAc»3 H2 0  (5.0 g) was added and rapid stirring commenced before the addition of CAN (2.87 g, 5.24
■I
LRMS (EI+ mode): m/z = 335.4 [M+', 24 %], 294.3 (26), 177.2 (17), 149.2 (44), 118.2 (100), 84.0 (49).
GCMS (150°C, 1 min, 5°C rain"  ^ 250°C, rt = 14.73 min) indicated the presence of a single amide 
diastereomer, within the limits of detection.
HRMS (EI+ mode): found [M+*], 335.1521. C2 1 H2 1 NO3 requires 335.1521.
2-((liR,2£^)-l,4-Dimethylpent-2-enyl]malonic acid dimethyl ester (2.94) and 2-[(lS,2E)-l- 
Isopropylbut-2-enyl]maIonic acid dimethyl ester (2.95).
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mmol). The dark-brown solution was stirred for 17 h with the addition of further portions of CAN (1.30 g, 
2.38 mmol) after 30 min, 1 h and 2 h. Following aqueous work-up in the fashion described above for olefin 
2.80, purification by column chromatography (SiO^, EtzO : hexanes = 1 : 9 )  yielded an inseparable mixture 
of the title compounds (470 mg, 2.06 mmol, 43%) as a pale yellow oil. Spectroscopic data were in 
accordance with literature data.^^^ The regioisomeric ratio was estimated as 2.84 : 2.85 = 1.4 : 1 by 
NMR spectroscopy, comparing the integration of H2 doublets at 3.51 ppm {J 9.8) and 3.25 ppm (7 3.25) for 
2.85 and 2.84 respectively.
[a]D = +15.6 (c 1.40, CHCI3 ).
TributyI(5,6-dihydro-4Fir-pyran-2-yl)stannane (2.98).
O 2 SnBu3
f-BuLi (12.1 mL of a 1.7M solution in pentane, 20.6 mmol) was added to a solution of 3,4-dihydro-27/-pyran 
(1.98 g, 20.6 mmol) in THF (5 mL) at -78°C under N2 . The flask was transferred to an ice-bath, and stirred 
at 0°C for 30 min before cooling to -78°C and adding tributyltin chloride (6.15 mL, 22.66 mmol). The 
solution was allowed to warm to room temperature with stirring under N2  over 2  h, before pouring into ether 
(50 mL) and aqueous NH4 CI (1 mL). After rapid stirring for 5 min the phases were separated and the organic 
phase washed with brine (2 x 50 mL), dried, filtered and concentrated in vacuo to give a clear oil. Purification 
by distillation (b.p. 101°C / 0.1 mmHg, Lit. b.p. = 105-110°C / 0.1 mmHg^^^) gave the title compound 
(13.9 g, 37.3 mmol, 84%) as a clear oil. IR and ^H NMR spectroscopic data were in accordance with 
literature data.^^^
13c NMR (100 MHz, CDCI3 ): d = 162.9 (0, C2), 112.5 (1, V c-Sn  31.7, C3), 66.2 (2, ^Jc-Sn 10.3, C6 ),
29.2 (3C, 2, 37c-Sn 10.1, Sn(CH2 CH2£ H 2 Me)3 ), 27.4 (30, 2, V c-Sn 27.7, Sn(CH2 CH2 CH2 Me)3 ), 23.4 
(2, 05), 21.4 (2, 3 jc-sn  16.1, C4), 13.8 (30, 3, 8n(0H2CH2CH2Ms)3), 9.6 (30, 2, Vc-Sn 171.8, 164.4, 
Sn(£H2CH2£H2Me)3).
2,2,2-TrichIoro-l-[2-(tributylstannanyl)-5,6-dihydro-4Ff-pyran-3-yI]ethanone (2.99).
'CCI3 
'O'^ a'SnBUs
Trichloroacetyl chloride (0.30 mL, 2.72 mmol) was added dropwise over 5 min to a solution of stannane
2.98 and MA-diisopropylethylamine (0.05 mL, 0.27 mmol) in OH2 CI2  (9 mL) at 0°O under N2 . The 
solution was allowed to warm to rt over 2 h, and stirred for a further 16 h. The red-orange solution was then 
poured into 5% aqueous NaHOOs (20 mL) and the phases separated. The organic phase was washed with H2O 
(2 X 25 mL), dried, filtered and concentrated in vacuo. Purification by column chromatography (Si0 2 , 
hexanes) gave the title compound (335 mg, 0.65 mmol, 24%) as a clear oil.
IR (film): v = 2954 s, 2922 s, 1662 m, 1464 m, 1252 m, 1168 s, 812 m, 722 s c m ' l
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iH NMR (400 MHz, CDCI3 ): d = 4.14 (2H, t, J  5.2, H6 ), 2.75 (2H, t, J  6.4, H4), 1.92-1.86 (2H, m, H5), 
1.59-1.47 (6 H, m, Sn(CH7CH9 CH2 Me)3 ). 1.31 (6 H, apparent sextet, J  7.2, Sn(CH2 CH2 CH2 Me)3 ), 1.03- 
0.99 (6 H, m, Sn(CH2 CH2 CH2 Me)3 ), 0.89 (9H, t, J  7.2, Sn(CH2 CH2 CH2Me)3).
13c NMR ( 1 0 0  MHz, CDCI3 ): d = 197.9 (0 , COCCI3 ), 182.2 (0, C2 ), 116.2 (0 , C3), 97.3 (0 , C0 £ C l3 ), 
68.5 (2, 3 /c-Sn  9.8, C6 ), 29.2 (30, 2, ^JQ.Sn 10.1, Sn(CH2 CH2 £ H 2 Me)3 ), 27.8 (3C, 2, V c-S n  30.4, 
Sn(CH2£ H 2 CH2 Me)3 ), 23.2 (2, 7.8, C4), 21.3 (2, C5), 13.7 (3C, 3, Sn(CH2 CH2 CH2M e)3 ), 11.7
(30, 2, l/c-S n  183.1, 175.1, Sn(£H2 CH2 CH2 Me)3 ).
LRMS (01 mode, NH3): m/z = 536.1 [(M+NH4 )+, 36 %], 519.1 [(M+H)+, 29 %], 461.1 (100), 427.0 (6 6 ),
359.1 (60).
HRMS (01 mode, isobutane): found [M+H]+, 519.0638. C1 gH3 4 3 5 oig0 2 1 requires 519.0632.
2-(Tributylstannanyl)-5,6-dihydro-4JÏ-pyran-3-carboxyiic acid methyl ester (2.100).
O 2  SnBug
Na (30 mg) was added to a solution of stannane 2.99 (325 mg, 0.63 mmol) in MeOH (5 mL) at rt under N2 . 
After stirring at rt for 1 h, the solvent was removed in vacuo. Purification by column chromatography (Si0 2 , 
OH2 CI2  : hexanes = 1 : 5 )  gave the title compound (226 mg, 0.52 mmol, 83%) as a clear oil.
IR (film): v  = 2954 s, 2922 s, 2872 m, 2852 m, 1690 s, 1560 s, 1290 s, 1264 s, 1156 m, 1096 s, 1076 m 
cm“ l.
iH NMR (400 MHz, ODOI3 ): d = 3.96 (2H, t, /  5.1, H6 , H6 '), 3.69 (3H, s, OMe), 2.29 (2H, t, J  6.4, H4, 
H4'), 1.87-1.81 (2H, m, H5, H5'), 1.54-1.46 (6 H, m, Sn(OH2 CH2 CH2 Me)3), 1.31 (6 H, apparent sextet, J
7.3, Sn(OH2 C H 2 C H 2 M e)3 ), 0.99-0.95 (6 H, m, Sn(OH2 C H 2 C H 2 M e)3 ), 0.89 (9H, t, J  7.3. 
Sn(OH2CH2CH2Me)3).
13o NMR (100 MHz, ODOI3 ): d = 184.5 (0, CÜ2 Me), 170.2 (0, 02), 113.9 (0, 03), 67.1 (2, Vc-Sn 10 6 , 
06), 51.2 (3, OOoMe). 29.2 (30, 2, ^Jc~Sn 10.2, Sn(CH2 CH2 CH2 M e)3 ), 27.5 (30, 2, ^ c - S n  30.2, 
Sn(OH2£ H 2 CH2 Me)3 ), 21.6 (2, 04), 21.0 (2, 05), 13.9 (30, 3, Sn(OH2CH2CH2Me)3), 1L5 (30, 2, V c-  
Sn 183.9, 173.9, Sn(£H2 CH2 CH2 Me)3 ).
LRMS (01 mode, NH3 ): m/z = 433.2 [(M+H)+, 6  %], 392.2 (33), 375.1 (100), 373.1 (77).
Found: 0 , 53.00; H, 8.48. Oi9H3 6 0 3 Sn requires: 0 , 52.92; H, 8.42 %.
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r r a « 5'-2 -(TributyIstannanyl)tetrahydropyran-3 “CarboxyUc acid m ethyl ester (2.101).
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To a solution of stannane 2.101 (316 mg, 0.73 mmol) in THF (5 mL) at 0°C under N2  was added 
diisobutylaluminium hydride (0.26 mL, 1.46 mmol). The solution was stirred at 0°C for 1 h before adding 
dropwise a solution of sodium potassium tartrate (2.0 g) in H2O (5 mL). The mixture was stirred at rt for 3 h 
before the addition of ether (50 mL) and separation of phases. The aqueous phase was extracted with ether (2 x 
15 mL), and the combined organic phases washed with brine (25 mL), dried, filtered and concentrated in 
vacuo. Purification by column chromatography (S1 0 2 , ether : hexanes = 1 : 9 )  gave the title compound (234 
mg, 0.58 mmol, 79%) as a clear oil.
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Trimethylsilyl trifluoromethanesuifonate (1.62 mL, 8.94 mmol) was added dropwise to a solution of stannane 
2.100 (1.29 g, 2.98 mmol) and triethylsilane (4.76 mL, 29.8 mmol) in CH2 CI2  (100 mL) at -7 8 “C under 
N2 . After stirring at -7 8 “C for 30 min the solution was allowed to warm to rt before adding aqueous 
NaHC0 3  (50 mL). The phases were separated, the aqueous phase extracted with CH2 CI2  ( 2  x 25 mL), and 
the combined organic phases washed with brine (50 mL), dried, filtered, and concentrated in vacuo. 
Purification by column chromatography (S1 0 2 , ether : hexanes = 5 : 95) gave the title compound (1.19 g,
2.74 mmol, 92%) as a clear oil.
■IR (film): v = 2954 s, 2930 s, 2872 m, 2852 m, 1732 s, 1462 m, 1436 m, 1150 m, 1074 s, 1016 m cm"I
^H NMR (400 MHz, CDCI3 ): <5 = 3.88 (IH, ddd, J  11.2, 3.6, 2.0, H6 ), 3.61 (IH, d, J  11.2, H2), 3.64 (3H, 
s, COoMe). 3.26 (IH, dt, J  2.0, 11.2, H6 '), 2.82 (IH, ddd, J  11.2, 11.0, 3.5, H3), 2.10-2.06 (IH, m, H4), 
1.69-1.61 (3H, m, H4', H5, H5'), 1.53-1.45 (6 H, m, Sn(CH2 CH2 CH.2 Me)3 ), 1.31 (6 H, apparent sextet, J
7.3, Sn(CH2 CH.2 C H 2 M e )3 ), 0.92-0.84 (6 H, m, Sn(CH.2 C H 2 C H 2 M e)3 ), 0.89 (9H, t, J  7.4, 
Sn(CH2CH2CH2Ms)3)-
13c NMR (100 MHz, CDCI3 ): 0 =  174.6 (0, £ 0 2 Me), 75.3 (1, Vc-Sn 199.9, 189.9, C2), 70.3 (2, '^Jc-Sn 
19.5, C6 ), 51.7 (3, COoMe). 46.9 (1, C3), 29.2 (4C, 2, 3/c-Sn 9.9, Sn(CH2 CH2£ H 2 Me)3 , C4), 27.6 (3C, 
2, V c-S n  27.8, Sn(CH2 CH2 CH2 M e)3), 25.8 (2, C5), 13.9 (3C, 3, Sn(CH2 CH2 CH2 M&)3), 9.0 (3C, 2, 
Vc-Sn 160.9, 153.8, Sn(£H2 CH2 CH2 Me)3 ).
LRMS (Cl mode, NH3): m/z = 452.3 [(M+NH4 )+, 50 %], 450.3 (35), 394.2 (57), 377.1 (100).
Found: C, 52.45; H, 8.91, CigHggOgSn requires; C, 52.68; H, 8.84 %. 
7’ran^-[2-(T ribu tylstan nanyl)tetrah ydropyran-3-yi]m ethanol (2.102).
IR (film): V = 3404 br m, 2954 s, 2926 s, 2872 m, 2850 m, 1464 m, 1074 s, 1024 m, 8 6 8  m cm~l.
iH NMR (400 MHz, CDCI3 ): Ô = 3.86-3.82 (IH, m, H6 ), 3.60 (IH, d, J  10.0, H2), 3.51-3.46 (IH, m, 
CH aH bO H ), 3.42-3.37 (IH, m, CH aH bO H ), 3.26 (IH, dt, J  4.0, 10.4, H6 ), 2.01-1.89 (3H, m, H3 and 
H4, H4 or H5, H5'), 1.69-1.61 (2H, m, H4, H4 or H5, H5'), 1.55-1.47 (6 H, m, Sn(CH2 CH2 C a 2 Me)3 ), 
1.32 (6 H, apparent sextet, J  7.4, SnlCH^CH^CH^Me)^). 0.92-0.88 (6 H, m, Sn(CH2 CH2 CH2 Me)3 ), 0.90 
(9H, t, J  7.4, SnfCH?CH?CH2 Me)3 ).
13c NMR (1 0 0  MHz, CDCI3 ): d = 77.7 ( 1 , Vc-Sn 205.0, 196.0, C2), 70.8 (2 , 3yc_Sn 19.4, C6 ), 65.7 (2 , 
^■/C-Sn 4.7, £H 20H ), 43.2 ( 1, C3), 29.4 (3C, 2, ^C -Sn  9.8, Sn(CH2 CH2£ H 2 Me)3 ), 28.5 (2, 3jc-Sn 18.2, 
C4), 27.6 (3C, 2, 2/c.Sn 27.4, Sn(CH2£H 2 CH2 Me)3 ), 26.1 (2, C5), 13.9 (3C, 3, Sn(CH2CH2CH2Ms)3),
9.4 (3C, 2 , Vc-Sn = 157.9, 150.9, Sn(£H2 CH2 CH2Me)3 ).
LRMS (Cl mode, isobutane): m/z = 405.2 [(M+H)+, 20 %], 353.2 (25), 347.1 (100).
Found: C, 53.33; H, 9.34. CigH3g0 2 Sn requires: C, 53.35; H, 9.45 %.
ïra7iï-T r ib a ty l(3 -m ethoxym ethoxym etliy l-tetrahydropyran-2 -yI)stannaiie (2.103).
2 SnBug
Chloromethyl methyl ether (0.09 mL, 1.15 mmol) was added to a solution of stannane 2.102 (234 mg, 0.58 
mmol), A,A-diisopropylethylamine (0.20 mL, 1.15 mmol) and tetrabutylammonium iodide (11 mg, 0.03 
mmol) in CH2 CI2  (5 mL) at rt under N^. The solution was stirred at rt for 3 h before the addition of aqueous 
NaHCOs (20 mL) and separation of phases. The aqueous layer was extracted with CH2 CI2  (2 x 20 mL) and 
the combined organic layers washed with brine (20 mL), dried, filtered and concentrated in vacuo. Purification 
by column chromatography (Si0 2 , ether : hexanes = 1 : 49) gave the title compound (225 mg, 0.50 mmol, 
8 6 %) as a clear oil.
IR (film): v = 2954 s, 2926 s, 2872 m, 2850 m, 1464 m, 1154 m, 1114 m, 1074 s, 1044 s, 922 m cm-1
1h NMR (400 MHz, CDCI3 ): d = 4.56 (2H, s, OCHaOMe), 3.85 (IH, br d, J  10.8, H6 ), 3.58 (IH, d, J  
10.4, H2), 3.34 (3H, s, OCH?QMe). 3.33-3.26 (2H, m, CE2 OMOM), 3.23 (IH, dt, J  10.8, 3.1, H6 '), 2.12-
2.03 (IH, m, H3), 1.96-1.88 (IH, m, H4), 1.74-1.58 (2H, m, H5, H5'), 1.56-1.42 (7H, m, H4', 
Sn(CH2 CH2 CH2 M e)3 ), 1.31 (6 H, apparent sextet, J  7.3, Sn(CH2 CEaCH2 M e)3 ), 0.92-0.86 (6 H, m, 
Sn(CH2 CH2 CH2 Me)3 ), 0.89 (9H, t, 7 7.2, SnlCHaCHgCHgMe)!).
13c NMR (100 MHz, CDCI3 ): Ô = 96.6 (2, 0 £ H 2 0 Me), 78.0 (1, Vc-Sn 208.5, 199.1, C2), 70.7 (2, ^Jq - 
Sn 20.1, C6  or CHaOMOM), 70.4 (2, ^fc-Sn 3.8, C6  or £ H 2 0 MOM), 55.3 (3, CH^OMe). 41.1 (1, C3),
29.4 (3C, 2, 3 jc -sn  9.8, Sn(CH2 CH2£ H 2 M e)3 ), 29.2 (2, ^Jc-Sn 18.6, C4), 27.7 (3C, 2, y c - S n  27.4, 
Sn(CH2£ H 2 CHaMe)3 ), 26.3 (2, C5), 13.9 (3C, 3, Sn(CH2 CH2 CH2 M&)3 ), 9.4 (3C, 2, V c-Sn 158.3,
151.2, Sn(£H2 CH2 CHaMe)3 ).
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LRMS (CI mode, NH3 ): mtz = 468.3 [(M+NH4 )+ 31 %], 408.2 (100), 391.2 (96). 
Found: C, 53.23; H, 9.32. C2 oH4 2 0 3 Sn requires: C, 53.47; H, 9,42 %.
tetrahydropyran (2.104 / 2 ,105 ).
3 O OMe
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n-BuLi (0.44 mL of a 2.33M solution in hexanes, 1.03 mmol) was added to a solution of stannane 2.103 
(424 mg, 0.94 mmol) in THF (10 mL) at -78°C under N2 . The solution was stirred at -78°C for 10 min 
before cooling to ~90“C and adding via cannula a precooled (~90°C) solution of CuBr»DMS (232 mg, 1.13 
mmol) in diisopropyl sulfide (0.8 mL) and THF (1.0 mL), maintaining the reaction temperature below 
-75°C. The orange-brown solution was allowed to warm to -78°C over 30 min before cooling to -90°C and 
adding a solution of complex 2.1 in MeCN (3 mL) via cannula. After warming to -7 8 °C and stirring for 30 
min aqueous work-up and décomplexation using the CAN mediated procedure were performed as described 
above for olefin 2.80. Purification by column chromatography (Si0 2 , Et2 0  : hexanes = 5 : 95) gave the 
title compounds as clear oils.
Data for the less polar isomer (Rf = 0.43, ether : hexanes = 1 :9 ):
[a]D = +63.0 (c 0.47, CHCI3 ).
-
IR (film): v  = 2956 s, 2928 s, 1464 m, 1154 m, 1110 s, 1042 s, 1004 m, 976 m, 920 m cm“ .^
.
%  NMR (400 MHz, CDCI3 ): ô = 5.45-5.36 (2H, m, CH=CH), 4.59 (2H, s, OCEzOMe), 3.99 (IH, ddt, J 
4.0, 2.0, 10.9, H6 ), 3.46 (IH, dd, J  9.6, 3.6, CEaHbOM OM ), 3.39 (IH, dd, J  9.6, 6.4, CHaEbOM OM ),
3.36 (3H, s, OMe). 3.32 (IH, dd, J  10.9, 3.4, H6 '), 3.11 (IH, dd, J  9.6, 2.4, H2), 2.42-2.33 (IH, m,
CEMe), 2.31-2.23 (IH, m, CEMe2 ), 1.93-1.87 (IH, m, H4 or H5), 1.71-1.54 (3H, m, H3, H4, H4' or H3,
H5, H5'), 1.50-1.40 (IH, m, H4' or H5'), 1.07 (3H, d, J  6.9, CHMe). 0.98 (3H, d, J  6.7, CH(Me)Me), 0.98 
(3H, d ,7 = 6 .7 , CH(Me)Mê).
13c NMR (100 MHz, CDCI3 ): 6  = 138.6 (1, £H=CH), 128.0 (1, CH=CH), 96.7 (2, 0 £ H 2 0 Me), 83.2 (1,
C2), 6 8 .8  (2, C6  or CHiOMOM), 6 8 .6  (2, C6  or £ H 2 0 MOM), 55.3 (3, OMe), 38.8 (1, £HMe), 38.5 (1,
£ H M e 2 ), 31.3 (1, CHM e2 ), 27.7 (2, C4 or C5), 26.4 (2, C4 or C5), 23.0 (3, CH(Me}Me), 22.9 (3, 
CH(Me)Me), 19.0 (3, CHMe).
LRMS (EÎ+ mode): m/z: = 256.2 [(M+*), 5%], 159.0 (12), 129.1 (10), 97.0 (100), 81.0 (9), 55(12).
Found: C, 70.14; H, 10.92. C15H2 8 O3 requires: C, 70.27; H, 11.01 %.
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Data for the more polar isomer (Rf = 0.35, ether ; hexanes = 1 :9 ):
[a]D = -9 .0  (c 0.72, CHCI3 ).
IR (film): v = 2956 s, 2930 s, 2868 m, 1464 m, 1380 m, 1152 m, 1110, s, 1042 s, 994 m, 970 m, 922 m 
cm“l,
1h NMR (400 MHz, CDCI3 ): 5 = 5.48 (IH, ddd, J  15.6, 7.1, 0.8, CH=CHCHMe2 ), 5.37 (IH, dd, J  15.6,
6.3, CH=CHCHMe2 ), 4.60 (2H, s, OCEzOMe), 3.93 (IH, ddt, J 3.6, 1.6, 10.8, H6 ), 3.47 (IH, dd, J  9.7,
4.6, CEaHbOMOM), 3.40 (IH, dd, J  9.7, 6.0, CHaEbOMOM), 3.37-3.31 (IH, m, H6 '), 3.36 (3H, s, 
OMe), 3.08 (IH, dd, J  9.0, 3.1, H2), 2.39 (IH, dquintet, J  3.1, 7.1, CEMe), 2.25 (IH, octet, J  6.7, 
CEMe2 ), 1.91 (IH, ddq, J  12.8, 4.0, 1.6, H4), 1.80-1.71 (IH, m, H3), 1.63-1.56 (2H, m, H5, H5'), 1.47- 
1.37 (IH, m, H4), 0.98 (3H, d, J  7.1, CHMe), 0.97 (6 H, d, J  6.7, CHMe?).
13c NMR ( 1 0 0  MHz, CDCI3 ): Ô = 136.7 ( 1 , CH=£HCHMe2 ), 131.4 (1, £H =C H C H M e2 ), 96.8 (2 , 
0 £ H 2 0 Me), 83.2 (1, C2), 69.4 (2, C6  or £H 2 0 MOM), 67.9 (2, C6  or £ H 2 0 M0 M), 55.4 (3, OMe), 37.9 
( 1 , C3 or CHMe), 37.3 (1, C3 or £HM e), 31.1 (1, £ H M e 2 ), 27.3 (2, C5), 26.0 (2, C4), 22.9 (3, 
CH(Me)Me), 2 2 .8  (3, CH(Me)Ms), 14.1 (3, CHMe).
LRMS (EI+ mode): m/z\ = 256 [(M+*), 6 %], 159 (9), 129 (8 ), 97 (100), 81 (9), 69 (11), 55 (15).
Found: C, 70.10; H, 10.94. C15H2 8 O3 requires: C, 70.27; H, 11.01 %.
3-C hlorotetrahydropyran-2-ol (2.109)
The title compound was prepared in 46% yield on a 120 mmol scale according to the general procedure of 
Descotes and Soula.^^^ Purification by recrystallisation (Et2 0  / hexanes) gave the title compound as white 
crystals. ^H NMR and IR data have been previously reported.^ '^^
m.p. = 59-61 °C (Et2 0  / hexanes) Lit. m.p. 60-62°C.^^^
IR (KBr): v  = 3321 br s, 2962 s, 2930 m, 2876 s, 1432 ra, 1350 s, 1294 m, 1180 s, 1152 s, 1105 s, 1063 
s, 943 s, 770 s cm"k
iH NMR (400 MHz, CDCI3 ); Ô = 4.93 (IH, d, J  1.9, H2), 4.77 (IH, d, J  5.8, H2), 4.12-4.08 (IH, m, H3),
4.04-3.98 (2H, m, H6 , H6 ), 3.94 (2H, s, OH), 3.76 (IH, ddd, J  4.3, 5.8, 8 .6 , H3), 3.60-3.52 (IH, m, Hô'), 
3.59 (IH, ddd, J  3.2, 8.7, 11.6, H6 '), 2.35-2.29 (IH, m, H4), 2.23-2.14 (IH, m, H4), 2.04-1.97 (IH, m, 
H4'), 1.91-1.76 (3H, m, H4', H5, H5), 1.66-1.50 (2H, m, H5', H5').
13c NMR (100 MHz, CDCI3 ): Ô = 97.1 (1, C2), 92.9 (1, C2), 64.2 (2, C6 ), 63.0 (2, C6 ), 59.7 (1 , C3),
58.5 (1, C3), 30.9 (2, C4), 29.2 (2, C4), 24.0 (2, C5), 22.4 (2, C5).
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LRMS (EI+ mode): m/z = 136.01 (M+, 40%), 119.00 [(M-OH)+, 33%], 107.98 (47), 90.05 (100), 75.43 
(56), 62.55 (100), 54.29 (85).
Acetic acid 3-chlorotetrahydropyran-2-yl ester (2.110)
f ï "0 '"^0 Ac
To a solution of lactol 2.109 (814 mg, 5.96 mmol) in CH2 CI2  (20 mL) at rt under N2  was added acetic 
anhydride (0.7 mL, 7.15 mmol), triethylamine (1.0 mL, 7.15 mmol), and DMAP (10 mg). The solution was 
stirred at rt for 14 h before addition of IM HCl (50 mL) and separation of the phases. The aqueous phase was 
extracted with CH2 CI2  (2 x 20 mL) and the combined organic phases were washed with brine (50 mL), dried 
and concentrated in vacuo. Purification by column chromatography (Si0 2 , Et2 Û : hexanes = 1 : 9 )  gave the 
title compound (891 mg, 4.99 mmol, 84%) as a clear oil. ^H NMR (CCI4 ) and IR data have been previously 
reported.^ ^^
IR (film): v = 2960 m, 1760 s, 1438 m, 1372 m, 1228 s, 1204 s, 1144 m, 1072 s, 1040 ra, 1008 m, 950 s 
cm~^.
^H NMR (400 MHz, CDCI3 ): (Approximately 4 : 1 ratio of trans : cis isomers^36^ Trans isomer: ô = 5.82 
(IH, d, J  5.2, H2 ), 3.99 (IH, ddd, J  11.6, 7.6, 3.9, H6 ), 3.94 (IH, dt, J  7.2, 4.6, H3), 3.70 (IH, ddd, J 11.6,
6 .6 , 3.9, H6 '), 2,42-2.34 (IH, m, H4), 1.89-1.82 (2H, m, H4', H5), 1.69-1.59 (IH, m, H5'); Cis isomer: Ô 
= 6.13 (IH, d, J  3.2, H2), 4.14-4.09 (IH, m, H3), 3.92-3.84 (IH, m, H6 ), 3.73-3.69 (IH, m, H6 '), 2.20-
2.06 (IH, m, H4'), 2.42-2.34 (IH, m, H4), 1.89-1.82 (2H, m, H5, H5').
13c NMR (100 MHz, CDCI3 ): Trans isomer: Ô = 169.2 (0, £OMe), 94.3 (1, C2), 64.2 (2, C6 ), 55.3 (1, 
C3), 29.5 (2, C4), 22.3 (2, C5), 21.0 (3, COMe): Cis isomer: <5= 169.5 (0, £OM e), 91.0 (1, C2), 61.2 (2, 
C6 ), 55.5 (1, C3), 28.5 (2, C4), 25.2 (2, C5), 20.9 (3, CQMe).
LRMS (Cl mode, isobutane): m/z = 179 [(M+H)+, 5%], 136 (7), 119 (100).
HRMS (Cl mode, isobutane): found [M+H]+", 179.0472. CyHi2^^C1 0 3  requires 179.0475.
5-C hIoro-3 ,4-d ihydro-2H -pyran  (2.111)
&
The title compound was prepared in 34% yield on a 39.8 mmol scale according to the procedure of 
Summerbell and L u n k .P u r ifica tio n  by short-path distillation (b.p. 54°C / 30 mmHg, Lit. b.p. = 140- 
142°C / 760 mmHgl^l^) gave a clear oil. ^H NMR data has been previously rep orted .^ 37
IR (film): v = 2936 m, 2876 m, 1760 m, 1654 m, 1272 m, 1222 s, 1158 s, 1092 m, 1054 m, 1028 m, 986 
m, 922 m, 854 m cm” .^
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iH NMR (400 MHz, CDCI3 ): Ô = 6.58 (IH, s, H6 ), 3.93 (2H, dd, J  5.2, 5.2, H2), 2.31 (2H, dt, J  6.4, 1.6, 
H4), 1.97 (2H, tt, J  6.4, 5.2, H3).
13c NMR (100 MHz, CDCI3): 6  = 141.7 (1, C6 ), 110.9 (0, C5), 65.3 (2, C2), 27.9 (2, C4), 23.2 (2, C3).
LRMS (EÏ+ mode): mfz: 120 [(M+, C5 H7 3 7 CIO], 42%), 118 [(M+, C5 H7 3 3 CIO], 92%), 89 (40%), 83 
(100%), 62 (44%), 53 (53%).
HRMS (EI+ mode): found [M+1, 118.0186. C5H7 3 5 CIO requires 118.0185. 
5-C hloro-6-[(lJ? ,3 jE ')-l,4 -d im eth ylp en t-2 -en yn -3 ,4 -d ih yd ro-2H -p yran  (2.112)
«-BuLi (3.0 mL of a 2.23M solution in hexanes, 6.62 mmol) was added to a solution of pyran 2.111 (747 
mg, 6.30 mmol) in THF (10 mL) under N?. The solution was allowed to warm to rt and stirred for 2 h before 
cooling to -80°C and addition of a solution of CuBr*DMS (1.69 g, 8.19 mmol) in diisopropylsulfide (5.2 
mL) and THF (6.7 mL) dropwise over 10 min, keeping the internal temperature below -75°C. The brown 
solution was stirred at -80°C for 30 min before cooling to -90°C and addition of complex 2.1 (1,27 g, 3.15 
mmol) in MeCN (3 mL) dropwise. After warming to -78°C and stirring for 30 min aqueous work-up and 
décomplexation using the CAN mediated procedure were performed as described above for olefin 2.80, 
Purification by column chromatography (810%, Et2 0  : hexanes = 5 : 95) gave the title compound (65 mg, 
0.30 mmol, 10%) as a clear oil.
[a]D = +50.4 (c 0.83, CHCI3 ).
IR (film): V = 2958 s, 2931 m, 2868 m, 1249 m, 1092 s, 1078 m, 1020 m, 1007 m, 971 m, 944 m cm -k
^H NMR (400 MHz, CDCI3 ): <3 = 5.47 (IH, dd, J  15.5, 5.8, CH=CHCHMe2  or CH=CHCHMe2 ), 5.39 
(IH, dd, J  15.5, 6.4, CH=CHCHMe2 or CH=CHCHMe2 ), 3.94 (2H, t, J  5.1, H2 , H2'), 3.57 (IH, pentet, J 
6.9, CHMe or CEMe?), 2.35-2.31 (2H, m, H4, H4'), 2.26 (IH, dq, J  9.7, 6.5, CEMe or CHMe?), 1.96-
1.89 (2H, m, H3, H3'), 1.11 (3H, d, J  7.0, CHMe). 0.98 (6 H, d, J 6 .8 , CHMe?).
13c NMR (100 MHz, CDCI3 ); <5 = 153.9 (0, C6 ), 137.4 (1, £H=CHCHMe? or CH=CHCHMe2 ), 128.0 (1, 
£H=CHCHMe? or CH=£HCHMe?), 105.1 (0, C5), 66.2 (2, C2), 37.6 (1, £HM e or CHMe?), 31.0 (1, 
CHMe or CHMe?), 29.2 (2 , C3 or C4), 24.0 (2 , C3 or C4), 22.7 (2C, 2, CHMez), 17.8 (3, CHMe).
LRMS (Cl mode, NH3): m/z = 232.0 [(M+NH4 )+, 45 %], 215.0 [(M+H)+, 100 %], 179.0 (30).
HRMS (EI+ mode): found [M+*], 214.1122. C i?H i9 3 5 ciO  requires 214.1124.
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2.114
A
13c NMR (100 MHz, CeDe, referenced to added TMS): 6  = 146.7 (0, Ph), 136.3 (1, C3), 132.5 (1, C2),
128.6 (2C, 1, Ph), 127.5 (2C, 1, Ph), 126.2 (1, Ph), 42.5 (1, C l), 31.3 (1, C4), 22.8 (3, C5), 22.7 (3, C4- 
Me), 21.8 (3, Cl-Me).
(lS,2£^)"(l,4-Dimethylpent-2-enyI)benzene (2.114) and (lR ,2£')-(l-lsopropylbut-2-  
enyl)benzene (2.115).
Ph
2.115
To a solution of phenyllithium (2.0 mL of a 1.81M solution in cyclohexane / ether, 3.54 mmol) in THF (60 
mL) at 0°C under N? was added a solution of CuBr*DMS (850 mg, 4.13 mmol) in diijo-propyi sulfide (2 
mL) and THF (4 mL) via  cannula. The dark green-black solution was stirred at 0°C under N? for 30 min 
before cooling to -78°C and the addition of a solution of cationic complex 2.2 (which had been freshly 
prepared from neutral complex ent-2.14  (928 mg, 2.95 mmol) and NOBF4  (379 mg, 3.25 mmol) in MeCN 
(15 mL) at 0°C for 10 min) dropwise. After stirring at -78°C for 2 h, aqueous work-up and décomplexation 
using the O? mediated procedure were performed as described above for olefin 2.58 (without illumination). 
Purification by column chromatography (SiO?, Et?0 : hexanes = 5 : 95) gave an inseparable mixture of the 
title compounds (128 mg, 0.73 mmol, 25%) as a clear oil in the approximate ratio 13 : 1, as estimated by 
comparison of the integration of H5 (2.114) and H4 (2.115), at 3.33 ppm (IH, ddq, J 6.9, 6,9) and 2.78 
ppm (IH, t, J  9.0) respectively. Further elution yielded ketones 2.116 and 2.117 (164 mg, 0.81 mmol, 
27%) in the approximate ratio 2.116 : 2.117 = 8 : 1 ,  followed by a trace (<2%) of isomeric ketone 2.118. 
( R f  (Et?0 : hexanes = 5 : 95): 2.114 / 2.115 = 0.79, 2.116 / 2.117 = 0.50, 2.118 = 0.34).
[a]D = + 4.42 (c 0.86, CHCI3 , 13 : 1 ratio of 2.114 : 2.115).
Î
IR (film, 13 : 1 mixture of olefins 2.114 / 2.115): v = 3017 m, 2959 s, 2930 m, 2868 m, 1496 m, 1454 
m, 972 m cm“ .^ (IR data for 2.115 has been previously reported).
LRMS (EI+ mode): m/z = 174.1 [M+\ 40 %], 131.1 (100), 118.1 (49), 105.1 (42), 91.0 (32).
■
NMR Data for 2.114: (Undetailed ^H NMR data has been reported previously^^^)
1h NMR (400 MHz, CeDe, referenced to added TMS): ô = 7.16-7.04 (5H, m, Ph), 5.57 (IH, ddd, J  15.4,
6 .6 , 0.9, H2), 5.40 (IH, ddd, J 15.4, 6 .6 , 1.2, H3), 3.33 (IH, dq, J  6.9, 6.9, HI), 2.19 (IH, apparent octet, J
6.7, H4), 1.28 (3H, d, J  7.2, Cl-Me), 0.94 (3H, d, J  6.4, H5), 0.93 (3H, d, J  6 .8 , C4-Me).
NMR Data for 2.115: (^H NMR data were in accordance with literature data^^ )^
13c NMR (100 MHz, CgDg, referenced to added TMS): 6 = 145.2 (0, Ph), 134.5 (1, Ph, C2 or C3), 128.5 
(2C, 1, Ph), 128.2 (2C, 1, Ph), 126.1 (1, Ph, C2 or C3), 125.4 (1, Ph, C2 or C3), 57.7 (1, C l), 33.3 (1, 
CHMe?), 21.3 (3, CHMe(Me)), 21.0 (3, CHMe(Me)), 18.0 (3, CHMe).
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An analogous coupling procedure was performed as detailed above using 4.7 mmol of Ph2 Cu(CN)Li2  
(prepared as described by Liebeskind^'^) and 3.2 mmol of neutral complex ent~2,l4. Aqueous work-up and 
décomplexation using the O? mediated procedure were performed as described above for olefin 2.58 (without 
illumination). Purification by column chromatography (SiO?, Et2 0  : hexanes = 2 : 98) gave ketones 2.116 
and 2 .117  (2.116 : 2 .117 = 1.2 : 1 , 240 mg, 1.19 mmol, 38%), <2% of ketone 2.118 and <2% of 
olefins 2 .114  / 2.115.
Data for: (2jR,3E)-2,5-DimetliyI-l-phenylhex-3-en-l-one (2.116) and (2S,3.E)-2-Isopropyl-l- 
phenyIpent-3-en-l-one (2.117).
2.116
O '' Ph 
2.117
IR (film):v = 2950 s, 2924 m, 2876 m, 1677 s, 1455 m, 1202 m, 976 s, 706 s cm 'l 
[ct]D = -50.7 {c 1.34)
NMR (400 MHz, CDCI3 ): 6 = 8.00-7.79 (2H, m, Ph (2.116 / 2.117)), 7.57-7.53 (IH, m, Ph (2.116 
/ 2.117)), 7.48-7.44 (2H, m, Ph (2.116/2.117)), 5.61-5.47 (2H, m, H3, H4 (2.116/2.117)), 4.10 
(IH, pentet, J  6 .8 , H2 (2.116)), 3.71 (IH, t, J  8 .6 , H2 (2.117)), 2.29-2.217 (IH, m, H5 (2.116), CHMe? 
(2.117)), 1.60 (3H, d, J  6.0, H5 (2.117)), 1.30 (3H, d, J  6 .8 , C2-Me (2.116)), 0.95 (3H, d, J  6.7, H6
(2.116)), 0.94 (3H, d, J  6.7, C5-Me (2.116)), 0.83 (6 H, d, J  6 .6 , CHMe? (2.116)).
13c (100 MHz, CDCI3 ): Ô = 202.3 (0, Cl (2.117)), 202.0 (0, Cl (2.116)), 140.1 (1, C3 or C4 (2.116)),
137.8 (0, Ph), 136.7 (0, Ph), 133.0 (1, Ph, C3 or C4), 132.9 (1, Ph, C3 or C4), 129.3 (I, Ph, C3 or C4),
129.1 (1, Ph, C3 or C4), 128.7 (3C, 1, Ph, C3 or C4), 128.6 (2C, Ph), 128.5 (1, Ph, C3 or C4), 128.3 (1, 
Ph, C3 or C4), 127.2 (1, Ph, C3 or C4), 127.1 (1, Ph, C3 or C4), 58.3 (1, C2 (2.117)), 44.8 (1, C2
(2.116)), 31.2 (1, C5 (2.116)), 30.8 (1, CHMe? (2.117)), 22.4 (2C, 3, C6 , C5-M& (2.116)), 21.5 (3, 
C5 or CHMe? (2.117)), 20.0 (3, C5 or CHMê2  (2.117)), 18.2 (3, C5 or CHMe? (2.117)), 17.9 (3, C5).
LRMS (EI+ mode): m/z = 202 [M+*, 19 %], 159.1 (44), 105.0 (100), 77.0 (100), 55.0 (45).
Data for: (2E)-2,5-DimethyI-l-phenyiIiex-2-en-l-one (2.118).
IR (film):v = 2955 m, 2929 m, 1654 s, 1446 m, 1319 m, 1277 s, 912 m cm~^.
^H NMR (400 MHz, CDCI3 ): Ô = 7.70-7.34 (5H, m, Ph), 6.37 (IH, td, J  7.4, 1.3, H3), 2.24 (2H, t, J 6 .8 , 
H4), 2.02 (3H, s. Me), 1.80 (IH, septet, J  6.7, H5), 0.86 (6 H, d, J  6 .6 , H6 , C5-Me).
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î
13c NMR (100 MHz, CDCI3 ): 6  = 199.3 (0, £OPh), 146.0 (1, C3), 139.0 (0, Ph or C2), 137.2 (0, Ph or
C2 ), 131.5 (1, Ph), 129.4 (2C, 1, Ph), 128.2 (2C, 1, Ph), 38.4 (2, C4), 28.6 (1, C5), 22.7 (2C, 3, C6 ),
12.8 (3, C2).
LRMS (EI+ mode): mtz = 202 [M+‘, 41 %], 159 (54), 145 (59), 105 (100), 91 (19), 77 (6 8 ).
HRMS (EI+ mode): found \M +*l 202.1359. C14H18O requires 202.1358.
(iK)-Acetoxyplienylacetic acid (2R)-2-phenylpropyl ester (2.120).
2 Ph
îi
To a mixture of olefins 2.114 and 2.115 (87 mg, 0.50 mmol, 2.114 : 2.115 = 13 : 1) in MeOH (6  mL) 
and H ?0 (6  mL) was added OSO4  (0.66 mL of a O.IM solution in H?0, 0.07 mmol) and sodium periodate 
(538 mg, 2.52 mmol) and the dark solution stirred at rt for 15 h. Et?0 (20 mL) and H?0 (20 mL) were added 
and the phases were separated. The aqueous phase was extracted with Et?0 (2 x 20 mL) and the combined 
organic phases were dried, filtered and concentrated in vacuo to yield a black oil which was dissolved in 
MeOH (20 mL), cooled to 0“C, and NaBHa (238 mg, 6.0 mmol) added. The solution was stirred at 0°C for 5 |
min and at rt for 15 min before concentration in vacuo and the addition of Et?0 (20 mL) and H?0 (20 mL).
The phases were separated and the aqueous phase extracted with Et?0 (2 x 20 mL). The combined organic 
phases were dried, filtered and concentrated in vacuo. Purification by column chromatography (SiO?, Et?0 : 
hexanes = 3 : 7 )  yielded (R)-2-phenylpropan-l-ol (2 .119, 27 mg, 0.20 mmol, 40%) as a clear oil. 
Spectroscopic data for 2 .119  ([a ]g  = +5.9 (c 2.7, CHCI3 ), Lit. [aJo = +16.5 (c 1.47)^38^ were in 
accordance with literature data.^^^’ ^39
Alcohol 2.119 (27 mg, 0.20 mmol) was dissolved in CH^Cl? (10 mL) and (i?)-0-acetoxyphenyIacetic acid 
(46 mg, 0.24 mmol), DMAP 12 mg, 0.01 mmol) and DCC (61 mg, 0.30 mmol) were added. The cloudy 
mixture was stirred at rt for 2 h before filtration and addition of 0.5M HCl (10 mL). The phases were 
separated and the organic phase washed with aqueous NaHCOg (10 mL), before extraction of both aqueous 
phases separately with CH2 CI? (2 x 5  mL). The combined organic phases were dried, filtered and concentrated 
in vacuo. Purification by column chromatography (SiO?, Et?0 : hexanes = 5 : 95 1 : 9) yielded the title |
compound (52 mg, 0.17 mmol, 83%) as a clear oil.
The dr at C2 for ester 2.120 was conservatively estimated as a 90 : 10 from the integration of acetate 
methyl singlets at 2.14 and 2.15 ppm (minor and major isomers respectively) with reference to an authentic 
sample of (2J?5)-2.120.
[«Id = -73.8 (c 0.4, CHCI3 ).
IR (film): v  = 3031 m, 2966 m, 1744 s, 1454 m, 1273 m, 1231 s, 1176 m, 1056 m, 699 m cm~K
1H NMR (400 MHz, CDCI3 ): d = 7.40-7.34 (5H, m, Ph), 7.26-7.19 (3H, m, Ph), 7.09-7.07 (2H, m, Ph),
5.89 (IH, s, CH(OAc)Ph), 4.26-4.17 (2H, m, HI, HI'), 3.03 (IH, sextet, J 7.0, H2), 2.15 (3H, s, COMe),
1.20(3H, d, 7 7.0, C2-Me).
3'
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13c NMR (100 MHz, CDCI3 ): d = 170.5 (0, CO?R), 168.9 (0, CO?R), 142.8 (0, Ph), 134.0 (0, Ph),
129.3 (1, Ph), 128.9 (2C, 1, Ph), 128.6 (2C, 1, Ph), 127.8 (2C, I, Ph), 127.4 (2C, 1, Ph), 126.8 (1, Ph),
74.7 (1, PhCH(OR)CO?R), 70.5 (2, OCH?), 39.0 (1, CH(Me)Ph), 20.9 (3, C(O)Me), 17.9 (3, CH(Me)Ph).
LRMS (CI+ mode, isobutane): m/z = 313.1 [(M+H)+, 70 %], 253.0 (48), 225.1 (100), 207.1 (37), 118.1 
(33).
6.3 - Experimental Procedures from Chapter 4.
(35)-3,4-Dihydroxybutyric acid methyl ester (4,34).
OH
Diol 4.34 was prepared in 89% yield on a 89.3 mmol scale by the method of Moriwake and co-workers.^^ 
Spectroscopic data were in accordance with literature data.
[a]D = -23.2 (c 1.22, CHCI3 ). Lit. [aJo = -24.6 (c 1.00, CHC^).^^^
(3S)-3-Hydroxy-4-(triisopropylsilanyloxy)butyric acid methyl ester (4.36),
OH
To a solution of diol 4.34 (12.0 g, 89.3 mmol) and imidazole (12.2 g, 178.6 mmol) in N,N~ 
dimethylformamide (100 mL) at 0°C under N? was added triisopropylsilyl chloride (20.1 mL, 93.8 mmol). 
The solution was stirred at rt for 30 h before pouring into hexanes (250 mL) and H?0 (75 mL). The phases 
were separated and the organic phase washed with H?0 (2 x 50 mL), dried, filtered and concentrated in vacuo. 
Purification by column chromatography (SiO?, ethyl acetate : hexanes = 1 : 9 )  gave the title compound (18.5 
g, 63.6 mmol, 71%) as a clear oil.
[ a ] D  = -7 .2 (c  1.06, CHCI3 ).
IR (film): v = 3481 br m, 2944 s, 2867 s, 1736 s, 1463 m, 1439 m, 1123 m, 1066 m, 883 m cm~K
1h NMR (400 MHz, CDCI3 ): 0 = 4.11 (IH, ddq, J  7.6, 5.8, 4.8, H3), 3.72 (IH, dd, J  9.8, 4.9, H4), 3.71 
(3H, s, CO?Me), 2.91 (IH, d, J  4.8, OH), 3.66 (IH, dd, J 9.8, 5.8, H4 ), 2.58 (IH, dd, J 16.0, 4.8, H2), 
2.52 (IH, dd, J  16.0, 7.6, H2 ), 1.06 (18H, d, J  5.6, Si(CHMê2 )3 )- 1-15-1.04 (3H, m, SKCHMe?)?.
13c NMR (100 MHz, CDCI3 ): Ô = 172.7 (0, C l), 6 8 .8  (1, C3), 6 6 .6  (2, C4), 51.9 (3, CO^Me). 38.0 (2,
C2 ), 1 8 .1  (6 C, 3 , Si(CH(Me)2 )3 ), 1 2 .0  (3 C, 1 , Si(CH(Me)?)3).
LRMS (Cl mode, isobutane): m/z = 291.2 [(M+H)+, 100 %], 247.1 (15).
Found: C, 57.81; H, 10.37. Calc, for C i4 H3 oÛ4 Si: C, 57.89; H, 10.41%.
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(35)-3 -H ydroxy-4-(triisopropylsiIanyioxy)butyric  acid (4.37).
'  ^ 3 "HOaCA^Y^OTlPS
OH
To a solution of ester 4.36 (38.6 g, 132.9 mmol) in MeOH (600 mL) was added 10% aqueous potassium 
carbonate solution (270 mL) and the mixture refluxed for 1.5 h. After cooling to rt, the mixture was acidified 
to pH 2 with 2M HCl. After extraction with Et?0 (2 x 250 mL) and washing with brine (200 mL), the 
organic phase was dried, filtered, and concentrated in vacuo. Purification by column chromatography (SiO?, 
ethyl acetate : hexanes = 2 : 8 - *  1:1) gave the title compound (27.1 g, 98.1 mmol, 74%) as a clear oil.
[a]D = -7 .2  (c 0.83, CHCI3 ).
IR (film): v  = 3460 br w. 2937 m, 2861 m, 1713 s, 1469 s, 1123 m, 1062 w, 884 m, 798 m, 681 m cm“l
iH NMR (400 MHz, CDCI3 ): 6  = 6.50 (IH, br s, OH), 4.17-4.07 (IH, m, H3), 3.73 (IH, dd, J  9.8, 4.9, 
H4), 3.68 (IH, dd, J  9.8, 5.7, H 4), 2.63 (IH, dd, J  16.2, 4.6, H2), 2.56 (IH, dd, J  16.2, 7.9, H2'), 1.05 
(18H, d, J  5.7, SKCHMe?)?). 1.15-1.05 (3H, m, SifCHMe?)]).
13c NMR (100 MHz, CDCI3 ): d = 177.6 (0, C l), 68.7 (1, C3), 66.4 (2, C4), 38.1 (2, C2), 18.0 (6 C, 3, 
Si(CHMe2 )3 ), 1 2 .0  (3 C, 1 , Si(£HMe2)3 ).
LRMS (Cl mode, isobutane): m/z = 277 [(M+H)+, 100 %], 259 (14), 233 (23), 173 (19).
Found: C, 56.22; H, 10.03. Calc, for C i3 H2 s0 4 Si: C, 56.48; H, 10.21%. 
(6 S )-2 ,2 -D im eth y l-6 -(tr iiso p ro p y ls ila n y Io x y m eth y l)-[l,3 ]d io x a n -4 -o n e  (4 .38).
3 0 ^ 0  1 OTIPS
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I
To a solution of acid 4.37 (7.45 g, 27.0 mmol) and 2-methoxypropene (3.10 mL, 32.3 mmol) in CH2 CI2  
(250 mL) at rt under N? was added pyridinium / 7-toluenesulfonate (339 mg, 1.35 mmol). The clear solution 
was stirred at rt for 3 h before concentration in vacuo. Purification by column chromatography (SiO?, ether : 
hexanes = 4 : 6 )  gave the title compound (7.15 g, 22.6 mmol, 84%) as a clear oil. Further elution yielded 
acid 4.37 (730 mg, 2.64 mmol, 10%).
S'[alD = -38 .4  (c 1.10, CHCI3 ).
IR (film): v  = 2945 s, 2864 s, 1746 s, 1464 m, 1387 m, 1295 m, 1142 m, 883 m cm“ l.
I
1h NMR (400 MHz, CDCI3): <5 = 4.20 (IH, tt, /  7.1, 4.8, H6 ), 3.81 (IH, dd, J  10.4, 4.8, CH2 OTIPS),
3.74 (IH, dd, J  10.4, 4.8, CH2 OTIPS), 2.59 (2H, d, J  7.1, H5, H5% 1.59 (3H, s, CMe(Me)), 1.57 (3H, s, 
CMe(Me)), 1.05 (18H, d, J  5.2, SKCHMez)]), 1.14-1.03 (3H, m, Si(CHMe2 )3 ).
NMR (100 MHz, CDCI3 ): 6  = 168.1 (0, C4), 106.1 (0, C2), 68.7 (1, C6 ), 65.6 (2, CH2 OTIPS), 31.8 
(2, C5), 29.1 (3, CMe(Me)), 25.0 (3, CMe(Me)), 18.0 (6 C, 3, SKCHMe?)?). 12.0 (3C, 1, Si(£HMe2 )3 ).
LRMS (Cl mode, isobutane): mfz = 317.3 [(M+H)+, 100 %], 259.2 (16).
Found: C, 60.71; H, 10.07. Calc, for C i6 H3 2 0 4 Si: C, 60.72; H, 10.19%.
Acetic acid (4 S ,6 S )-2 ,2 -d im eth y l-6 -(tr iiso p ro p y lsila n y lo x y m eth y i)-[l,3 ]d io x a n -4 -y I ester  
(4 .3 9 ) .
AcC------------- 'OTIPS
3 Oi^O 1
To a solution of dioxanone 4.38 (19.1 g, 60.4 mmol) in CH2 CI2  (180 mL) at -78°C under N2  was added 
neat DIBAL (11.3 mL, 63.4 mmol) dropwise. After stirring ™78°C for 1 h, pyridine (14.6 mL, 181 mmol),
4 -dimethylaminopyridine (8.11 g, 66.4 mmol) in CH2 CI2  (50 mL) and acetic anhydride (22.8 mL, 241 
mmol) were added and the clear solution stirred at -78°C for a further 1.5 h before the addition of aqueous 
NH4 CI (100 mL) and aqueous sodium potassium tartrate (100 mL). The solution was allowed to warm to rt 
with vigorous stirring over 1 h. The phases were separated, and the aqueous phase extracted with CH2 CI2  (3 
X 100 mL). The combined organic phases were washed with ice-cold IM NaHS0 4  (3 x 100 mL), aqueous 
NaHCOs (2 X 100 mL) and brine (100 mL), dried, filtered and concentrated in vacuo to yield the crude product 
as a clear oil. Purification by column chromatography (S1 0 2 , ether : hexanes = 1 : 9 )  gave the title 
compound (18.3 g, 50.7 mmol, 84%) as a clear oil. ^^C NMR spectroscopy indicated that acetate 4,39 was 
a single diastereomer, identified as the syn 1,3-dioI acetonide isomer by reference to the shifts of the acetonide 
methyl signals, and to the coupling constants of H4.^^ '^
[a ]D = -5 .1  (c 1.26, CHCI3 ).
IR (film): v = 2941 s, 2893 m, 2865 s, 1757 s, 1466 m, 1385 m, 1364 m, 1225 s, 1144 s, 1039 s, 996 m 
cm'k
iH NMR (400 MHz, CDCI3): d = 6.18 (IH, dd J  10.0, 3.0, H4), 4.01 (IH, dddd, J  11.7, 6.3, 4.8, 2.5, H6 ), 
3.81 (IH, dd, J  9.8, 5.0, CH2 OTIPS), 3.61 (IH, dd, J  9.6, 6.4, CH2 OTIPS), 2.11 (3H, s, COMe), 1.96 
(IH, dt, J  12.4, 2.8, H5), 1.56-1.43 (IH, m, H5'), 1.52 (3H, s, CMâ(Me)), 1.44 (3H, s, CMe(M&)), 1.13-
1 .01  (3H, m, Si(CHMe2 )3 ), 1.05 (18H, d, J4 .8 , SKCHMe?)?).
13c NMR (100 MHz, CDCI3 ): <3 = 169.6 (0, COMe), 100.7 (0, C2), 89.6 (1, C4), 69.5 (2, CH2 OTÎPS),
6 6 .8  (1, C6 ), 33.1 (2 , C5), 29.8 (3, CMe(Me)), 21.4 (3, COMe), 20.9 (3, CMe(M&)), 18.1 (6 C, 3, 
Si(CHMe2 )3). 12.1 (3 C, I, Si(CHMe2 )3 ).
LRMS (Cl mode, NH3 ): m/z = 378.3 [(M+NH4 )+, 67 %], 318.3 (100), 301.2 (92).
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■Found: C, 59.95; H, 9.88. Calc, for CigHagOgSi: C, 39.96; H, 10.06%.
(4S,6/!)-(2,2-Dim ethyl-6-phenylsulfanyI-[l,3]dioxan-4-ylmethoxy)triisopropylsiIane 
(4.24) and (45,65)-(2,2-Dimethyl-6-phenylsulfanyl-[l,3]dioxan-4-ylmethoxy) 
triisopropylsilane (4.25),
Ph&  G ^  4
O T P S
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4.24 4.25
To a solution of acetate 4.39 (9.90 g, 27.5 mmol) in CH2 CI2  (110 mL) at -70“C under N2  was added 
phenylthiotrimethylsilane (5.5 mL, 28.8 mmol) and ZnCl2  (0.82 mL of a 1.0 M solution in ether, 0.82 
mmol) dropwise. The light brown solution was stirred at -70'*C for 17 h before addition of IM NaOH (50 
mL) and warming to rt. The phases were separated, and the aqueous phase extracted with CH2 CI2  (3 x 50 
mL). The combined organic phases were washed with IM NaOH (50 mL) and brine (50 mL), dried, filtered 
and concentrated i n  v a c u o . Purification by column chromatography (SiÜ2 , ether : hexanes = 2 : 98 4: 96)
gave a mixture of the title compounds (9.74 g, 23,7 mmol, 8 6 %) as a clear oil. and NMR 
spectroscopy indicated a ratio of 4.24 : 4.25 of approximately 7:3.^^^’ For analytical purposes, a 
sample of isomers 4.24 and 4,25 was separated by careful column chromatography.
' 1Alternative procedure: ZnCl2  (1.9 mL of a l.OM solution in ether, 1.9 mmol) was added dropwise to a |
solution of acetate 4.39 (17.4 g, 48.4 mmol) and thiophenol (5.2 mL, 50.8 mmol) in CH2 CI2  (240 mL) at 
~30®C under N2 . After stirring for 15 min at -30°C, IM NaOH (100 mL) was added and the mixture allowed 
to warm to rt. Work-up and purification as above yielded a mixture of the title compounds (17.3 g, 42.1 
mmol) as a clear oil, ^H and NMR indicated a ratio of 4.24 ; 4.25 of approximately 1:9.^® ’^ ,3
Spectroscopic data for sulphide 4.24: (Rf = 0.85, Et2 0  : PhMe = 2 : 98)
.
[ « I d  = +85.0 (c 0.22, CHCI3 ). 1
■I
IR (film): v = 2942 s, 2859 s, 1586 w, 1461 m, 1382 m, 1215 w, 1137 m, 1114 m, 873 m, 6 8 8  m c n r K
I
iH NMR (360 MHz, CDCI3 ): Ô = 7.52-7.47 (2H, m, Ph), 7.33-7.22 (3H, m, Ph), 5.50 (IH, t, J  5.8, H6 ),
4.17 (IH, ddt, J  10.2, 4.7, 5.5, H4), 3.80 (IH, dd, J  10.2, 5.5, CH2 OTÏPS), 3.64 (IH, dd, J  10.2, 5.7, 
CH2 OTIPS), 2.08 (IH, ddd, J  13.5, 10.1, 6.0, H5), 1.99 (IH, ddd, J  13.5, 5.7, 4.7, H5'), L61 (3H, s,
Cm(Me)), 1.38 (3H, s, CMe(Me)), 1.14-1.04 (3H, m, Si(CHMe2)3), L07 (18H, d, J  4.5, Si(CHMe2 )3 ). |
NMR (90 MHz, CDCI3 ): d = 135.6 (0, Ph), 131.0 (2C, 1, Ph), 129.0 (2C, 1, Ph), 127.1 (1 , Ph),
101.1 (0, C2), 78.6 (1, C4 or C6 ), 67.8 (1, C4 or C6 ), 66.5 (2, CH2 OTIPS), 34.0 (2, C5), 28.1 (3,
CMe(Me)), 24.6 (3, CMe(Mg)), 18.1 (6 C, 3, SKCHMe.?)?), 12.1 (3C, 1, Si(CHMe2 )s).
LRMS (FAB+ mode): m / z  = 433.4 [(M+Na)+, 22 %], 335.4 (14), 301.4 (47), 243.3 (82), 173.2 (100), 157.2 ■
(73), 115.3 (43).
HRMS (FAB+ mode, PEG): found [M+Na]+, 433.2210. C2 2H3s 0 3 SSiNa requires 433.2209.
Spectroscopic data for sulphide 4.25: (R f = 0.78, Et2 Û : PhMe = 2 : 98)
Compound 4.25 has been previously described, with only the following l^C NMR data reported: <3 = 30.0 
(Me), 19.9 (Me) ppm.^^^
[c£]d = -54.2 (c 0,36, CHCI3).
IR (film): v =  2938 s, 2859 s, 1462 w, 1379 w, 1138 m, 1117 m, 955 m, 881 m, 689 m cm” l.
1h NMR (400 MHz, CDCI3): <5 = 7.50-7.48 (2H, m, Ph), 7.32-7.23 (3H, m, Ph), 5.31 (IH, dd, J  12.0, 2.5, 
H6), 4.02 (IH, dddd, J  11.3, 6.4, 4.9, 2.4, H4), 3.76 (IH, dd, J  9.8, 4.9, CH2OTIPS), 3.54 (IH, dd, J  9.8,
6.4, CH2OTIPS), 1.98 (IH, dt, J  12.9, 12.5, H5), 1.61-1.52 (IH, m, H5'), 1.55 (3H, s, CMe(Me)), 1.52 
(3H, s, CMe(Ms)), 1.12-1.04 (3H, m, Si(CHMe2)3), 1.04 (18H, d, 7 4.5, Si(CHM£2)3)-
13c NMR (100 MHz, CDCI3 ): Ô = 134.3 (0, Ph), 131.4 (2C, 1, Ph), 129.0 (2C, 1, Ph), 127.3 (1, Ph),
100.3 (0, C2), 77.7 (1, C4 or C6 ), 70.5 (1, C4 or C6 ), 66.9 (2, CH2 OTIPS), 34.0 (2, C5), 30.1 (3, 
CMe(Me)), 20.0 (3, CMe(Me)), 18.1 (6 C, 3, SiCCHMe^)?), 1 2 .1  (3C, 1, Si(£HMe2 )3 ).
LRMS (Cl mode, NH3): m/z = 428.2 [(M+NH#)^, 34 %], 370.2 (39), 318.2 (69), 301.2 (100), 283.2 (81),
260.2 (31), 151.1 (39).
HRMS (Cl'*’ mode, isobutane): found [M+H]+, 411.2389. C2 2 H3 9 0 3 SSi requires 411.2389.
Found (for a mixture of isomers): C, 64.36; H, 9.41. Calc, for C2 2 H3g0 3 SSi: C, 64.34; H, 9.33%.
4,4-Bis-phenylsulfanyl-l-(triisopropyIsilanyloxy)butan-2-ol (4,49)
SPh OH
The title compound was obtained in an initial attempt to synthesise sulphides 4.24 and 4.25 by the 
following procedure: A solution of acetate 4.39 (57 mg, 0.16 mmol) and thiophenol (0.03 mL, 0.32 mmol) 
in CH2 CI2  (5 mL) was cooled to -78"C under N2  and BF3*OEt2  (0.02 mL, 0.19 mmol) was added dropwise. 
After stirring at ~78"C for 1 h, IM NaOH (2 mL) was added, the mixture was warmed to rt and the phases 
were separated. The aqueous phase was extracted with CH2 CI2  ( 3 x 1 0  mL), and the combined organic phases 
washed with IM NaOH (2 x 10 mL), brine (10 mL), dried, filtered and concentrated in vacuo. Purification by 
column chromatography (S1 0 2 , Et2 0  : hexanes = 1 : 9 )  gave the title compound (55 mg, 0.12 mmol, 75%) 
as a clear oil.
[ a ] D  = -8.1 (c 0.42, CHCI3).
IR (film): v = 2569 w, 3491 w, 2943 s, 2866 s, 1582 m, 1477 m, 1464 m, 1117 m, 882 m, 791 m cm"!.
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OTIPS
[ a ] D  = -1 7 .2 (c  1.02, CHCI3 ).
NMR (400 MHz, CDCI3 ): 6  = 4.20 (IH, dd, J 11.3, 6.3, H6 ), 3.90 (IH, dq, J 8 .8 , 5.9, H4), 3.75 (IH, 
dd, J  10.0, 5.8, CH2 OTÏPS), 3.62 (IH, dd, J 10.0, 5.8, CH2 OTIPS), 2.11 (IH, dt, J  5.9, 12.1, H5), 1.69 
(IH, ddd, J  12.7, 8.9, 6.2, H5'), 1.58-1.46 (6 H, m, Sn(CH2 CH 2 CH.2 Me), 1.36-1.26 (6 H, m.
- . j
iH NMR (400 MHz, CDCI3 ): ô = 7.53-7.50 (2H, m, Ph), 7.46-7.43 (2H, m, Ph), 7.33-7.23 (6 H, m, Ph),
4.74 (IH, dd, J  10.5, 4.1, H4), 4.16-4.11 (IH, m, H2), 3.70 (IH, dd, J  9.8, 3.7, HI), 3.50 (IH, dd, J  9.8,
6.4, HI'), 2.50 (IH, d, J  4.8, OH), 2.09 (IH, ddd, J  14.2, 9.9, 4.1, H3), 1.79 (IH, ddd, J  14.2, 10.5, 3.1, 
H3'), 1.07-0.99 (3H, m, Si(CHMe2)3), 1.03 (18H, d, 7  4.8, SifCHMe?)?).
13c NMR (100 MHz, CDCI3 ): a = 134.3 (0, Ph), 134.0 (0, Ph), 133.0 (2C, 1, Ph), 132.7 (2C, 1 , Ph),
129.1 (4C, 1, Ph), 127.9 (1, Ph), 127.8 (1, Ph), 69.5 (1, C2), 67.3 (2, C l), 54.8 ( 1 , C4), 39.6 (2, C3),
18.1 (6 C, 3, Si(CHMe?)3). 12.0 (3C, 1, Si(£HM e2 )3 ).
LRMS (Cl mode, NH3 ); m/z = 480.0 [(M+NH4 )+, 3 %], 370.1 (23), 335.1 (100), 174.1 (9).
(4S,6/î)-[2,2-Dimethyl-6-(tributylstannanyl)-[l,3]dioxan-4-ylmethoxy]triisopropyIsilane 
(4,9).
BUgSlK®.
LDBB was prepared by a modification to the method of Freeman and Hutchinson: 1^ ® A mixture of Li (3.24
g, 467 mmol), DBB (12.5 g, 46.7 mmol) and THF (160 mL) was stirred at 0°C for 48 h under a static Ar
atmosphere. A mixture of sulphides 4.24 / 4.25 (188 mg, 0.46 mmol) in THF (20 mL) was cooled to
-78°C under N2  and LDBB solution (5.8 mL) added dropwise until lithiation was complete, as apparent by
the maintenance of a dark-blue solution colour and TLC analysis. Bu^SnCl (0.13 mL, 0.48 mmol) was added
dropwise and the solution stirred at -7 8 "C for 10 min before the addition of H2 O (3 mL) and removal of the
cold bath. The remaining LDBB solution was added dropwise to a solution of sulphides 4.24 / 4.25 (4.23 g,
10.3 mmol) in THF (100 mL) at -7 8 "C and the resulting dark-blue solution stirred at -78°C for 10 min
before the addition of Bu3SnCl (2.9 mL, 10.8 mmol) dropwise. After stirring for 10 min, HgO (100 mL) and
Et2 0  (100 mL) were added and the cold bath removed. The two reaction mixtures were combined and the
phases separated. The aqueous phase was extracted with Et2 Û (3 x 50 mL) and the combined organic phases
washed with 0.5M NaOH (3 x 50 mL), dried, filtered and concentrated in vacuo. Purification by column
chromatography (Si0 2 , hexanes ether : hexanes = 1 : 99) gave the title compound (4.96 g, 8.38 mmol,
81%) as a clear oil. ^^C NMR spectroscopy indicated the presence of a single isomer, identified as the
expected axially substituted isomer by reference to the chemical shifts of the acetonide methyl signals.
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7;
Compound 4.9 has been previously described, with only the following NMR data reported: <5 = 24.7 
(Me), 24.5 (Me) ppm.^^^
IR (film): V = 2949 s, 2928 s, 2870 s, 1465 m, 1382 m, 1225 m, 1143 m, 1101 m, 1068 w, 1002 m, 878 
m, 692 m cm L
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Sn(CH2 CH2 CH2 Me), 1.32 (3H, s, CMe(Me)), 1.29 (3H, s, CMe(Mfi)), 1.13-1.05 (3H, m, Si(CIiMe2 )3 ),
1.07 (18H, d, J  4.4, Si(CHMe2 )3 ), 0.93-0.84 (15H, m, Sn(CH2 CH2 CH2 Me)3 , Sn((CH2 )3M s)3).
13c NMR (100 MHz, CDCI3 ); <5 = 100.4 (0, C2), 68.1 (1, C4), 66.7 (2, CH2 OTIPS), 59.8 (1, C6 ), 34.1 
(2, C5), 29.3 (3C, 2 , 3 7 c -S n  10.4, Sn(CH2 C H 2 iQ.H2 M e) 3 ), 27.8 (3C, 2, ^ / c - S n  25.2, 
Sn(CH2£ H 2 CH2 Me)3 ), 24.9 (3, CMe(Me)), 24.7 (3, CMe(Ma)), 18.1 (6 C, 3, Si(CH M e?hl 13.9 (3C, 3, 
Sn((CH2 )3M s)3 ), 1 2 .2  (3 C, 1 , Si(CHMe2)3 ), 8 .8  (3 C, 2 , Vc-Sn 1 6 1 .0 , 150.9, Sn(£H2 CH2 CH2 Me)3).
LRMS (EI+ mode): m/z = 591.2 [M+% 0.1%], 535.2 (19), 477.2 (40), 291.1 (100), 243.2 (75), 157.1 (74),
115.0 (38).
Found: C, 56.90; H, 9.98. Calc, for C2 8 H6 0 O3 SiSn: C, 56.85; H, 10.22%.
[(4S,65)-2,2-Dimethyl-6-(triisopropylsilanyloxyniethyï)-[l,3]dioxan-4-yl]-(JîS)- 
phenylmethanol (4.73 and 4.74).
OTIPS
To a solution of stannane 4.8 (171 mg, 0.29 mmol) in THF (15 mL) at -78"C under N2  was added n-BuLi 
(0.14 mL of a 2.29 M solution in hexanes, 0.35 mmol) dropwise. The light yellow solution was stirred at 
-78"C for 10 min before adding dropwise a solution of benzaldehyde (0.03 mL, 0.32 mmol) in THF (1 mL), 
which had been dried by standing with freshly activated 4Â sieves for 10 min. The clear solution was stirred 
at -78°C for 25 rain before the addition of aqueous NH4 CI (10 mL) and Et2 0  (10 mL) and warming to rt.
The phases were separated and the aqueous phase extracted with Et2 0  (3 x 20 mL), dried, filtered and 
concentrated in vacuo. Purification by column chromatography (3102, Et2 Ü : hexanes = 2 : 8 )  gave the title 
compounds (85 mg, 0.21 mmol, 72%) as a clear oil. ^H NMR spectroscopy revealed that 4.73 and 4.74 
were formed as an approximately equimolar mixture. Careful column chromatography allowed separation of 
the isomers for characterisation purposes.
Data for the less polar isomer: (Rf = 0.45, Et2 Û : hexanes = 2 : 8 )  t
[ a ] D  = -3 3 .5 (c  0.60, CHCI3 ).
IR (film): v  = 3462 br m, 2946 s, 2871 s, 1458 m, 1378 m, 1222 m, 1112 m, 1022 m, 882 m, 696 m, 681 
m cm“ .^
iH NMR (400 MHz, CDCI3 , referenced to added TMS): Ô = 7.37-7.24 (5H, m, Ph), 4.92 (IH, t, J  2.3, 
CE(OH)Ph), 4.03 (IH, ddd, 9.6, 6.0, 3.6, H4), 3.90-3.83 (IH, m, H6 ), 3.64 (IH, dd, J  10.4, 16.4, 
CH2 OTIPS), 3.54 (IH, dd, J  10.4, 4.8, CH2 OTIPS), 2.58 (IH, d, J  2.2, OH), 1.94 (IH, ddd, J  13.2, 10.0,
6.4, H5), 1.39 (3H, s, CMe(Me)), 1.37 (3H, s, CMe(Me)), 1.14 (IH, ddd, J 13.0, 9.0, 6.0, H5'), 1.06-0.98 
(3H, m, Si(CHMe2 )3), LOO (1 8H, d, 7  2 .0 , Si(CHMe2 )3)-
13c NMR (100 MHz, CDCI3 ): Ô = 139.6 (0, Ph), 128.3 (2C, 1, Ph), 127.6 (1, Ph), 126.3 (2C, 1, Ph),
100.7 (0, £ M e 2 ), 74.6 (1, £H(OH)Ph), 70.5 (1, C4), 68.7 (1, C6 ), 66.5 (2, CH2 OTIPS), 26.9 (2, C5),
25.6 (3, CMe(Me)), 25.0 (3, CMe(Me)), 18.1 (6 C, 3, SKCHMe?)?), 12.1 (3C, 1, Si(CHMe2)3).
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1LRMS (CI+ mode, isobutane): m/z = 409.3 [(M+H)+, 6 ], 351.2 (100), 333.2 (80), 307.2 (32), 289.2 (22),
177.1 (72), 159.1 (14).
Found: C, 67.66; H, 9.89, Calc, for C2 3H4 o0 4 Si: C, 67.60; H, 9.87%.
Data for the more polar isomer: (Rf = 0,35, EtaO : hexanes = 2 : 8 )
[ a ] D  = -6 .5 (c  1.55, CHCI3 ).
(5): (/î) = 6 :  1
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IR (film): V = 3466 br m, 2939 s, 2865 s, 1464 m, 1381 m, 1223 m, 1136 m, 1108 m, 1020 m cm~l.
_
I r  NMR (400 MHz, CDCI3 , referenced to added TMS): ô = 7.38-7.26 (5H, m, Ph), 4.49 (IH, dd, 78.0, 1.6, 
CH(OH)Ph), 3.95-3.87 (2H, m, H4, H6 ), 3.64 (IH, dd, 7 10.4, 6.0, CH2 OTIPS), 3.52 (IH, dd, 7 10.4, 5.2, 
CH2 OTIPS), 3.03 (IH, d, 7 2.0, OH), 1.62 (IH, ddd, 7 13.0, 9.9, 6.4, H5), 1.42 (3H, s, CMâ(Me)), 1.40 
(3H, s, CMe(Ms)), 1 .2 2  (IH, ddd, 7 13.0, 9.1, 5.7, H5'), 1.08-0.97 (3H, m, Si(CHMe2 )3 ), LOO (18H, d, 7
2 .0 , Si(CHMê2)3).
13c NMR (100 MHz, CDCI3 ): Ô = 139.3 (0, Ph), 128.6 (2C, 1, Ph), 128.4 (1, Ph), 127.5 (2C, 1, Ph),
101.0 (0, £M 6 2 ), 77.5 (1, £H(OH)Ph), 71.8 (1, C4 or C6 ), 68.1 (1, C4 or C6 ), 66.4 (2, CH2 OTIPS), 30.8 
(2 , C5), 25.4 (3, CMe(Me)), 25.0 (3, CMe(Me)), 18.1 (6 C, 3, Si(CHMS2)3), 12.1 (3C, 1 , Si(CHMe2)3).
LRMS (CI+ mode): m/z = 426.2 [(M+NHq)^, 4], 368.2 (37), 351.2 (100), 333.2 (9), 194.1 (15). 
(4S,6jRS)"(6-Allyl-2,2-dimethyl-[l,3]dioxan-4-yImethoxy)triisopropyIsiIane (4.79).
J J ..Mr.
yi<y^0<
«-BuLi (0.15 mL of a 2.29 M solution in hexanes, 0.35 mmoL) was added to a solution of stannane 4.9 
(190 mg, 0.32 mmol) in THF (20 mL) at -78"C under N2 . The solution was stirred at -78"C for 5 min 
before cooling to -90"C and adding via cannula a solution of CuBr*DMS (79 mg, 0.39 mmol) in diisopropyl 
sulfide (0.3 mL) and THF (0.3 mL) maintaining the reaction temperature below -80"C. The orange solution 
was stirred at -78°C for 30 min before cooling to -90"C and dropwise addition of a solution of complex 
4.77 (which had been freshly prepared from neutral complex 4.76 (91 mg, 0.35 mmol) and NOBF4  (45 mg, 
0.39 mmol) in MeCN (4 mL), 0"C, 20 min). The brown solution was allowed to warm to -78"C over 30 
min before addition of aqueous NH3 (5 mL), aqueous NH4 CI (10 mL) and Et2 0  (25 mL) and removal of the 
cooling bath. After warming to room temperature the mixture was filtered through celite, rinsing with Et2 0  
(3 X 25 mL). The phases were separated, the aqueous phase was extracted with Et2 0  (3 x 25 mL) and the 
combined organic phases were washed with brine (50 mL), dried, filtered and concentrated in vacuo. The crude 
products were dissolved in analytical grade chloroform (50 mL), and stirred at rt with a stream of O2  bubbling 
through the solution for 17 h. The solvent was removed in vacuo to give a brown oil. Purification by 
column chromatography (Si0 2 , Et2 0  : hexanes = 2 : 98) gave the title compound (53 mg, 0.15 mmol, 48%) 
as a clear oil.
I
1h NMR spectroscopy indicated that olefin 4.79 was present as a mixture of epimers at the C4 position. 
(Isomers inseparable by column chromatography). The major isomer was determined to be the (65)-epimer by 
the large 11.6) coupling of H6  to H5 (CgD^). NMR spectroscopic data confirmed the assignment, 
acetonide methyl carbon shifts at 30.2 and 20.0 ppm being indicative of the stereochemistiy.^^^’ The 
minor (6 i?)-isomer exhibited acetonide methyl carbon shifts at 25.2 ppm (2C, 3). The ratio of equatorial : 
axial isomers was estimated from NMR spectroscopy (CDCI3 ) comparing the integration of signals at; 
3.79-3.72 (2 overlapping dd, 1 each from ( 6 R ) -  and (65)-isomers) and 3.63 (IH, dd, (6 /?)-isomer).
[a]D = - 12.8 (c 1.06, CHCI3).
IR (film): v = 2943 s, 2866 s, 1642 w, 1464 m, 1379 m, 1261 m, 1200 m, 1172 m, 1114 s, 994 m, 883 
m, 681 w cm“ ^
1h NMR (400 MHz, data for the (6 S)-isomer): a = 5.90-5.80 (IH, m, CH=;CH2 ), 5.06-5.01 (2H, m, 
CH=CE2 ), 3.88 (IH, ddt, J  11.6, 2.5, 5.5, H4), 3.80 (IH, dd, J  9.7, 5.2, CH2 OTIPS), 3.69 (IH, ddt, J
II.6, 2.4, 6.0, H6 ), 3.57 (IH, dd, 7 9.7, 2.2, CH2 OTIPS), 2.34-2.27 (IH, m, CHaHbCH=CH2 ), 2.14-2.07 
(IH, m, CHaHbCH=CH2 ), 1.50 (3H, s, CMs(Me)), 1.45 (IH, dt, 7 12.8, 2.6, H5), 1.30 (3H, s, CMe(M£»,
1.26-1.17 (IH, m, H5'), 1 .1 1  (18H, d, 72.8, Si(CHMS2 )3 )> 1.15-1.08 (3H, m, Si(CHMe2 )3 ).
13c NMR (100 MHz, CDCI3 , (65)-isomer): a = 134.4 (1, £H=CH2 ), 117.2 (2, CH=£H2 ), 98.6 (0, CMe2 >,
70.2 (1, C4), 68.7 (1, C6 ), 67.4 (2, CH2 OTIPS), 41.1 (2, £ H 2 CH=CH2 ), 33.9 (2, C5), 30.2 (3, 
CMe(Me)), 20.0 (3, CMe(Me)), 18.1 (6 C, 3, SKCHMe?,)?). 12.2 (3C, 1, Si(£HMe2 )3).
13c NMR (100 MHz, CDCI3 , (65)-isomer): Ô = 134.7 (1, £H=CH 2 ), 117.0 (2, CH=£H2 ), 100.3 (0, 
£M c2 ), 68.1 (1, C6  or C4), 66.7 (2, CH2 OTIPS), 66.5 (1, C6  or C4), 40.4 (2, £H 2 CH=CH2 ), 34.4 (2, 
C5), 25.2 (2C, 3, CMe?). 18.1 (6 C, 3, Si(CHMe?)i), 1 2 .2  (3C, 1, Si(£HMe2 )3 )-
LRMS (CI+ mode): m / z  = 343.2 [(M+H)+, 5], 285.2 (100), 267.2 (26), 241.2 (20), 217.2 (7), (173.1 (13),
III.1 (32).
Found: C, 66.75; H, 11.09. Calc, for CipHsgOgSi: C, 66.61; H, 11.18%,
(2if,4S,6/?)"TriisopropyI[2-phenyI-6-(tributylstannanyl)-[l,3]dioxan-4-yImethoxy]siIane 
(4.80) and (2S,4S,6/J)-TriisopropyI(2-phenyl-6-(tributyistannanyl)-[l,3]dioxan-4- 
ylmethoxyjsilaiie (4.81).
BuoSns.^ GOTIPS TT OTIPSBUgSns
4.80
To a solution of stannane 4.9 (4.32 g, 7.30 mmol), methanol (0.9 mL, 21.9 mmol) and benzaldehyde 
dimethylacetal (5.5 mL, 36.5 mmol) in CH2 CI2  (120 mL) at rt under N2  was added f-TsOH (69 mg, 0.37 
mmol). The solution was stirred at rt for 7 h before concentration in  v a c u o .  Purification by column 
chromatography (S1 0 2 , Et2 0  : hexanes = 2  : 98) gave the title compounds (4.17 g, 6.52 mmol, 89%) as a
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clear oil. NMR spectroscopy indicated a mixture of 4 .8 0  /  4 .8 1  in the approximate ratio 7 : 1, based on i
the integration of H2 singlets at 5.81 and 5.73 ppm respectively. Separation of isomers was possible by i
careful repetitive column chromatography (Si0 2 , PhMe : hexanes = 1: 3) .  The major isomer was identified 
as the 2 R  isomer 4 .8 0  by nOe studies.
Data for the 2i?-isomer (4 .8 0 ):  (R f  = 0.13, PhMe : hexanes = 1 : 3 )  i
[o:]d = +20.6 (c 1.61, CHCI3).
IR (film): v = 2922 s, 2860 s, 1460 m, 1378 w, 1107 m, 1004 w, 883 w, 796 w, 755 m, 687 m, 595 w 
cm~l.
iH NMR (400 MHz, CgDg): Ô = 7.93-7.90 (2H, m, Ph), 7.36-7.22 (3H, m, Ph), 5.81 (IH, s, H2), 5.15 
(IH, apparent d, J  6.4, H6 ), 4.26 (IH, dddd, J  10.7, 6.9, 5.2, 2.4, H4), 4.18 (IH, dd, J  9.7, 5.0, 
CH2 OTIPS), 3.89 (IH, dd, /  9.7, 7.2, CH2 OTIPS), 2.56 (IH, ddd, J  13.3, 10.8, 6.4, H5), 2.07 (IH, br dd, J  
13.3, 1.4, H5'), 1.76-1.63 (6 H, m, Sn(CH2 CH2 CH2 Me), 1.49 (6 H, sextet, J  7.3, Sn(CH2 CH2 CH2 Me),
1.27-1.12 (12H, m, Sn(CH2CH2 CH2Me + Si(CHMe2 )3 ), 1 .2 2  (18H, d, J  2 .8 , SKCHM e^hl  1.04 (6 H, t, J
7.2, Sn(CH2 CH2CH2Me).
13c NMR (100 MHz, CDCI3): ô = 139.1 (0, Ph), 128.8 (1, Ph), 128.4 (2C, 1, Ph), 126.2 (2C, 1, Ph),
100.6 (1, C2), 77.4 (1, C4), 74.4 (1, C6), 66.6 (2, CH2OTIPS), 33.9 (2, C5), 29.3 (3C, 2, = 10.2,
Sn(CH2CH2£ H 2Me)3), 27.7 (3C, 2 , ^Jc-Sn = 27.8, Sn(CH2£ H 2CH2Me)3), 18.2 (6C, 3, Si(CHMe2)3),
13.8 (3C, 3, Sn((CH2)3M e)3). 12.1 ( 1, 3C, S i(£ H M e2)3), 10.3 (3C, 2 , U c -S n  150.1, 143,6, 
Sn(£H2 CH2 CH2 Me)3).
LRMS (CI+ mode): m/z = 641.2 [(M+H)+, 35], 583.1 (100), 581.1 (76), 533.2 (32), 475.1 (18), 291.1 (44),
289.1 (34), 243.2 (22), 107.1 (8 6 ).
Found: C, 60.17; H, 9.41. Calc, for C3 2 Hôo0 3 SiSn: C, 60.09; H, 9.46%.
Data for the 2S-isomer (4 .8 1 ) :  (R f  = 0.22, PhMe : hexanes = 1 : 3 )
M o  = -2 .14  (c 1.54, CHCI3).
IR (film): v  = 2960 s, 2864 s, 1460 s, 1380 m, 1114 m, 1073 m, 1018 m, 881 m, 798 m cm"!.
^H NMR (400 MHz, CDCI3 ): d = 7.46-7.44 (2H, m, Ph), 7.36-7.28 (3H, m, Ph), 5.73 (IH, s, H2), 4.59 
(IH, dd, J  13.7, 2.3, H6 ), 4.35 (IH, t, J  9.0, CH2 OTIPS), 4.17-4.12 (IH, m, H4), 4.01 (IH, dd, J  9.5, 5.2, 
CH2 OTIPS), 2.59 (IH, dt, J  6.1, 13.8, H5), 1.85 (IH, ddd, J  13.8, 2.3, 1.1, H5'), 1.61-1.51 (6 H, m, 
Sn(CH2 CH2 CH2 Me)3), 1.31 (6 H, sextet, J  7.2, Sn(CH2 CH2 CH2 Me)3 ), 1.18-1.08 (3H, m, Si(CHMe2)3),
1 .1 0  (18H, d, J  5.2, Si(CHMs.2 )3 ), 0.99-0.94 (6 H, m, Sn(CE2 CH 2 CH2 M e)3 ), 0.90 (9H, t, J  7.4, 
Sn(CH2CH2CH2Me)3).
15c NMR (100 MHz, CDCI3 ): Ô = 140.0 (0, Ph), 128.5 (1, Ph), 128.2 (2C, 1, Ph), 126.2 (2C, 1, Ph),
97.9 (1, C2), 73.1 (1, C4), 68.1 (1, C6), 61.8 (2, CH2OTIPS), 30.1 (2, C5), 29.3 (3C, 2, 5jc-Sn 10.2, 
Sn(CH2 CH2 £ H 2 Me)3 ), 27.9 (3C, 2 , 2 6 .8 , Sn(CH2£ H 2 CH2 M e)3 ), 1 8 .2  (6C, 3, Si(CHMe2)3),
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13.9 (3C, 3, Sn((CH 2)3M e)3), 12.1 (3C, 1 , S i(£ H M e 2 )3 ), 8 .6  (3C, 2 , V c -S n  160.6, 153.6, 
Sn(£H2CH2CH2Me)3).
LRMS (CI+ mode): mtz = 641.0 [(M+H)+, 49%], 583.0 (100), 581.0 (75), 533.0 (31), 351.1 (42), 291.0 
(69), 289.0 (53).
Found: C, 60.07; H, 9.36. Calc, for C3 2 H6 o0 3 SiSn: C, 60.09; H, 9a 
(2 S ,4 S ,6 jî)-(6 -A Ily l-2 -p h en y I-[l,3 ]d io x a n -4 -y lm eth o x y )tr iiso p ro p y ls ila n e  (4.82).
OTIPS
Olefin 4.82 was prepared in an analogous fashion to olefin 4.79 on a scale of 0.25 mmol of stannane 4.80 
and 0.28 mmol of neutral complex 4.76. Purification by column chromatography (SiÜ2 , Et2 0  : hexanes = 
3 : 97) gave the title compound (50 mg, 0.13 mmol, 51%) as a clear oil. and NMR spectroscopy 
indicated the presence of a single isomer, identified as the (65)-isomer on the basis of the small (J 6.9) 
coupling between H6  and H5. nOe experiments confirmed the assignment, with large (12-16%) enhancements 
observed between H6  and H2, and no enhancement observed between H4 and H6  when either position was 
irradiated.
[ a ] D  = +17.5(c 0.59 CHCI3 ).
IR (film): v = 2866 s, 1463 m, 1383 m, 1216 m, 1118 s, 1069 m, 1027 m, 995 s, 918 m, 883 s, 754 s, 
697 m cm 'k
iH NMR (400 MHz, CDCI3 ): Ô = 7.51-7.48 (2H, m, Ph), 7.38-7.30 (3H, m, Ph), 5.88 (IH, ddt, J 16.8,
10.0, 7.3, CH-CH2 ), 5.84 (IH, s, H2), 5.21-5.13 (2H, m, CH=CH2 ), 4.35 (IH, m, apparent q, J  6.9, H6 ),
4.18 (IH, ddt, J  11.0, 2.5, 5.9, H4), 3.93 (IH, dd, J  9.9, 5.4, CH2 OTIPS), 3.69 (IH, dd, J  9.9, 6.4, 
CH2 OTIPS), 2.87 (IH, dt, J  14.4, 7.3, CHaHbCH=CH2 ), 2.55 (IH, dt, J  14.4, 7.3, CHaEbCH=CH2 ),
2.00 (IH, ddd, J  13.8, 11.2, 6.2, H5), 1.74 (IH, ddd, J  13.5, 2.5, 1.3, H5'), 1.15-1.03 (3H, m, 
Si(CHMe2 )3), 1 .0 8  ( 18H, d, J  5 .2 , Si(CHM&2 )3 ).
13c NMR (100 MHz, CDCI3 ): à = 139.1 (0, Ph), 134.7 (1, CH=CH2 ), 128.8 (1, Ph), 128.3 (2C, 1, Ph),
126.3 (2C, 1, Ph), 117.6 (2, CH=£H2 ), 94.4 (1, £HPh), 73.2 (1, C4), 72.3 (1, C6 ), 66.9 (2, CH2 OTIPS),
35.6 (2, £H 2 CH=CH2 ), 30.3 (2, C5), 18.2 (6 C, 3, Si(CHMc2)3), 12.1 (3C, 1, Si(£HMe2)3).
LRMS (CI+ mode): mlz = 391.1 [(M+H)+, 100], 347.1 (8 ), 285.1 (50), 261.1 (11), 241.1 (11), 111.1 (13),
107.1 (12).
Found: C, 70.65; H, 9.73. Calc, for C2 3 H3 g0 3 Si: C, 70.72; H, 9.81%.
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(25)-2-(/^r^-Butyldimethylsilanyloxy)propionic acid ethyl ester (4.12).
EtOgC^
ÔTBS
A solution of (5)-ethyl lactate 11 (12.2 g, 104 mmol), fôrt-butyldimethyisilyl chloride (15.6 g, 104 mmol), 
triethylamine (15.2 mL, 109 mmol) and 4-dimethylaminopyridine (500 mg) In CH2 CI2  (200 mL) was 
refluxed under N2  for 1 d. After cooling to rt the mixture was filtered through celite, and the celite washed 
with hexanes (50 mL). The filtrate was washed with 2M HCl (100 mL) and H2O (100 mL), dried, filtered and 
concentrated in vacuo. Purification by short-path distillation (b.p. 102°C / 15 mmHg) yielded the title 
compound (22.2 g, 95.5 mmol, 92%) as a clear oil. Spectroscopic data were in accordance with literature 
data.^ "^ ®
[a]D = -25.0 (c 1.05, CHCI3 ). Lit. [gJd = -30.0 (c 2.50, C H C lg).^
(15,2J5)-ferf-Butyldimethyl(l-methyl-3-phenylallyloxy)silane (E)-4.13 and {IS,2Z)-tert- 
Butyldimethyl(l-methyl-3-phenylaUyloxy)silane (Z)-4.13.
 ^ OTBS
To a solution of silyl ether 4.12 (23.3 g, 100 mmol) in CH2 CI2  (400 mL) at -78"C under N2  was added 
diisobutylaluminiura hydride (102 mL of a l.OM solution in hexanes, 102 mmol) dropwise. After stirring for 
10 min at -78 "C, acetone (12 mL) and aqueous Na2 S0 q (60 mL) were added and the cooling bath removed. 
After vigorous stirring at rt for 1 h, solid Na2 S0 q (90 g) was added and stirring continued for a further 1 h. 
The mixture was filtered through celite and the residue washed thoroughly with CH2CI2  (3 x 100 mL) before 
concentration in vacuo yielded crude (5)-<9-(ferr-butyldimethylsilyl)lactaldehyde (4.18) as a clear oil which 
was immediately used without further purification.
n-BuLi (62 mL of a 2.03M solution in hexanes, 125 mmol) was added to a suspension of 
benzyltriphenylphosphonium bromide (52.2 g, 121 mmol) in THF (200 mL) at rt under N2 . After stirring at 
rt for 10  min the dark red solution was brought to reflux before the dropwise addition of a solution of crude 
aldehyde 4.18 in THF (20 mL). Reflux was continued for 30 min before the orange suspension was cooled 
to rt and aqueous NH4 CI (100 mL) and H2O (100 mL) were added. The phases were separated and the aqueous 
phase was extracted with CH2 CI2  (3 x 100 mL). The combined organic phases were dried, filtered and 
concentrated in vacuo to yield a pale yellow suspension of crude olefins (£)-4.13 and (Z)-4.13 and 
triphenylphosphine oxide. The mixture was suspended in hexanes (150 mL) and filtered, washing with 
hexanes (2 x 50 mL). The filtrate was concentrated and purification by column chromatography (Si0 2 , ether : 
hexanes = 5 : 95) gave the title compounds (20.1 g, 76.7 mmol, 76%) as a pale yellow oil. ^H NMR 
spectroscopy indicated an approximately equimolar mixture of geometrical isomers.
[a]D = -48.65 (c 1.11, CHCI3 ).
IR (film): v = 2960 s, 2932 s, 2848 m, 1466 w, 1378 w, 1255 s, 1063 s, 834 s, 778 s cm rK
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iH NMR (400 MHz, CDCI3): Ô = 7.30-7.18 (lOH, m, Ph), 6.50 (IH, d, J  15.6), 6.37 (IH, d, J  12.0), 6.21 
(IH, dd, J  15.6, 5.6), 5.68 (IH, dd, J  12.0, 8 .8 ), 4.77 (IH, dq, J  8 .8 , 6.0), 4.47 (IH, dq, J  6.0, 6.2), 1.34 
(3H, d, J  6.3), 1.30 (3H, d, J 6.3), 0.92 (9H, s), 0.82 (9H, s), 0.10 (3H, s), 0.09 (3H, s), -0 .07  (3H, s), 
-0.12 (3H, s).
Isomérisation of olefins (£Z)-4.13.
A solution of olefins 4.13 {E : Z <=* 1:1, 30.8 g, 117 mmol), thiophenol (1.2 mL, 11.8 mmol) and 1,1'- 
azobis(cyclohexanecarbonitrile) (865 mg, 3,54 mmol) in PhMe (600 mL) was brought to reflux under N^. 
After refluxing for 2 d the pale yellow solution was cooled to rt, and washed with 0.5M NaOH (2 x 100 mL). 
The aqueous phase was extracted with Et2 0  (2 x 50 mL) and the combined organic phases dried, filtered and 
concentrated in vacuo. Purification by column chromatography (SiÜ2 , ether : hexanes = 5 : 95) gave 4,13 
(29.1 g, 111 mmol, 95%) as a pale yellow oil. ^H NMR spectroscopy indicated an approximate ratio of E : 
Z Isomers of 6:1, based on the integration of H4 doublets at 6.50 and 6.37 ppm respectively.
(25,3£^)-4-PhenyIbut-3-en-2-ol (4.10).
OH
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1
:
13c NMR (100 MHz, CDCI3 ): Ô = 137.7 (1 , Ph, C2 or C3), 137.4 (0, Ph), 137.3 (0, Ph), 135.0 ( 1, Ph, I
C2 or C3), 128.8 (2C, 1, Ph), 128.7 (2C, 1, Ph), 128.3 (2C, 1, Ph), 128.1 (1, Ph, C2 or C3), 127.5 (1, Ph, ;
C2 or C3), 127.4 (1, Ph, C2 or C3), 127.0 (1, Ph, C2 or 03), 126.6 (20, 1, Ph), 69.6 (1, 01), 65.3 (1, |
01), 26.1 (30, 3, SiMe?OMe^). 26.0 (30, 3, SiMe2 CM&3 ), 24.8 (3, 01-Me), 24.6 (3, 01-Me), 18.5 (0, 
SiMe2£ M e 3 ), 18.3 (0, SiMe2£M e3), -4.3 (20, 3, SiMe2 CMe3 ), -4 .6  (20, 3, SiMe^OMe?).
J
-r
Tetrabutylammonium fluoride trihydrate (22.0 g, 69.7 mmol) was added to a solution of olefins 4.13 (15.3 
g, 58.1 mmol, E : Z - 6 :  1) in THE (200 mL) at rt under N2 . The dark red-brown solution was stirred at rt 
under N2  for 4.5 h before addition of aqueous NH4 CI (100 mL) and Et2 Û (100 mL). The phases were 
separated, and the aqueous phase extracted with Et2 0  (2 x 50 mL). The combined organic phases were washed |
with brine (50 mL), dried, filtered and concentrated in vacuo to give a yellow-brown oil. Purification by 
column chromatography (Si0 2 , ethyl acetate : hexanes = 1 : 9 2 : 8 ) gave a mixture of alcohols (EZ)-
4.10 (7.71 g, 52.0 mmol, 90%) as a light yellow oil which solidified upon standing. Further purification by 
recrystallisation from hexanes-CH2 Cl2  (6:1) yielded (E)-4.10 (6.38 g, 43.1 mmol, 74%) as a pale yellow |
crystalline solid. Spectroscopic data were in accordance with literature data.^^^’
m.p. = 29-30"0 (hexanes-CH2 Cl2 ) Lit. m.p. = 3 1-33"C.
[«]d  = -24.8 (c 0.87, OHOI3 ). Lit. [«]d = +34.2 (enantiomer) (c 1.77, OHOls).^^^
5
j
(jî)-Acetoxyphenylacetic acid (15)-l-methyi-3-phenylalIyl ester (4.20)
“ OH 3 oAc
A suspension of Novozym 435 (6 6  mg), crushed activated 4Â molecular sieves (330 mg), (±)-4.10 (660 mg, 
4.45 mmol) and vinyl acetate (10.3 mL, 111 mmol) in pentane (20 mL) was shaken gently at rt for 10 h, 
NMR analysis of the crude reaction mixture indicated a 50% conversion. After filtration and concentration in
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To a solution of alcohol 4.10 (41 mg, 0.28 mmol), (R)-O-acetoxyphenylacetic acid (59 mg, 0.30 mmol) and 
DMAP (2 mg, 0.01 mmol) in CH2 CI2  (10 mL) at 0"C under N2  was added DCC (8 6  mg, 0.41 mmol). The 
cloudy solution was stirred at 0°C for 10 min and at it for 50 min before filtering through celite and washing 
with Et2 0 . After drying, filtration and concentration in vacuo, purification by column chromatography 
(S1 0 2 , ether : hexanes = 3 : 7 )  gave the title compound (76 mg, 0.23 mmol, 84%) as a clear oil.
. :
1The diastereomeric ratio at Cl was estimated as 97 : 3 via  integration of the H3 signals in the NMR 
spectrum: d = 6.56 (d, J  16.0, (15)-diastereomer), d = 6.26 (d, J  16.0, (lE)-diastereomer), with reference to a 
sample of (li?5)-ester formed from (±)-4.10.
[ a ] D  = -107.7 (c 2.32, CHCI3 ).
IR (film): V = 3054 w, 3030 m, 2978 m, 2930 w, 1755 s, 1492 w, 1448 w, 1368 m, 1225 s, 1173 s, 1049 
s, 970m cra“ .^
NMR (400 MHz, CDCI3 referenced to added TMS): d = 7.50-7.19 (lOH, m, Ph), 6.58 (IH, d, J  16.0, 
H3), 6.16 (IH, dd, J  16.0, 6.4, H2), 5.95 (IH, s, CE(OAc)Ph), 5.55 (IH, ddq, J  6.4, 1.1, 6.5, HI), 2.17 
(3H, s, OCOMe), 1.27 (3H, d, J 6.5,C1-Me).
13c NMR (100 MHz, CDCI3 ): d = 170.3 (0, 0 £ 0 R ) , 168.2 (0, 0 £ 0 R ), 136.3 (0, Ph), 134.0 (0, Ph),
131.9 (1, C3), 129.2 (1, C2 or Ph), 128.8 (2C, 1, Ph), 128.6 (2C, 1, Ph), 128.0 (2C, 1, C2 and / or Ph),
127.7 (2C, 1, Ph), 126.7 (2C, 1, Ph), 74.8 (1, £H(OAc)Ph), 72.6 (1, C l), 20.8 (3. GOMe), 20.0 (3, C l- 
Mê).
■i.
LRMS (EI+ mode): m/z = 324.2 [M+% 2%], 264.2 (7), 131.1 (100), 118.1 (40), 107.1 (32), 91.1 (20), 43.0 
(17).
HRMS (El'*' mode); found [M'*'*], 324.1359. C20H20O4  requires 324.1362.
Alternative procedure for the preparation of (2S,3E)-4-Phenylbut-3-2-oI (4.10) and (li?,2E)-Acetic 
acid l-methyi"3-phenylallyl ester (4.15):
. a
The enantiomeric ratio at C2 for alcohol 4 .1 0  was estimated as 97:3 via formation of the corresponding (/?)- 
0 -acetoxyphenylacetic ester 4 .2 0  by an analogous procedure to that detailed above.
The enantiomeric ratio at Cl for acetate 4 .1 5  was estimated as 96:4 by cleavage of the acetate (10 wt% 
K2 CO3 , MeOH, rt, 15 h) and formation of the corresponding (E)-O-acetoxyphenylacetic ester 4 .2 1  by an 
analogous procedure to that detailed above.
(Jï)-Acetoxyphenylacetic acid (l/?)-l-methyI-3-phenylalIyl ester (4.21)
.0
[a]D = -2 .6 (c  1.40, CHCI3 ).
Ph OAc
13c NMR (100 MHz, CDCI3 ): 6  = 170.5 (0, 0 £ 0 R ), 168.2 (0, 0 £ 0 R ), 136.3 (0, Ph), 134.0 (0, Ph),
131.4 (1, C3), 129.4 (1, C2 or Ph), 128.9 (2C, 1, Ph), 128.6 (3C, 1, Ph), 128.0 (3C, 1, Ph), 127.9 (1, C2 
or Ph), 126.6 (1, Ph), 74.8 (1, CH(OAc)Ph), 72.4 (1, C l), 20.9 (3, CQMe). 20.4 (3, Cl-Me).
■s
.;f:
vacuo, purification by column chromatography (Si0 2 , ether : hexanes = 2  : 8  -> 4 : 6 ) gave acetate 4 .1 5  
(390 mg, 2.05 mmol, 46%) as a clear oil, and alcohol 4 .1 0  (300 mg, 2.02 mmol, 45%) as a clear oil which 
solidified upon standing.
Data for alcohol 4 .1 0 :
[«Id = -34.1 (c 2.34, CHCI3). Lit. [a ]o  = +34.2 (enantiomer) (c 1.77, CHClg).^^^
Spectroscopic data were in accordance with literature data.^^’
Data for acetate 4 .1 5 :
[a]D = +143.1 (c 3.38, CHCI3 ). Lit. [o]d  = +151.1 (c 5.27, CHCls).^"^^
^H and IR spectroscopic data were in accordance with literature data.^'^
13c NMR (100 MHz, CDCI3 ): â = 170.5 (0, £OMe), 136.5 (0, Ph), 131.7 (1, Ph, C2 or C3), 129.0 (1, 
Ph, C2 or C3), 128.7 (2C, 1, Ph), 128.0 (1, Ph, C2 or C3), 126.7 (2C, 1, Ph), 71.1 (1, C l), 21.5 (3, 
COMe), 20.5 (3, Cl-Me).
IR (film): v  = 3054 w, 3034 m, 2974 m, 2930 w, 1763 s, 1743 s, 1492 m, 1448 m, 1372 s, 1225 s, 1173 
s, 1049 s, 970 s, 926 m cm~l.
1h NMR (400 MHz, CDCI3 referenced to added TMS): Ô = 7.49-7.18 (lOH, Ph), 6.26 (IH, d, J  16.0, H3),
5.98 (IH, dd, J  16.0, 6.2, H2), 5.95 (IH, s, CH(OAc)Ph), 5.55 (IH, ddq, J  6.4, 1.2, 6.2, HI), 2.19 (3H, s, 
OCOMe). 1.42 (3H, d, J  6.4, Cl-Me).
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LRMS (CÏ+ mode, NH3): mlz = 342.1 [(M+NH4 )-*-, 14%], 212.1 (14), 131.1 (100). 
(lS,2E)-Trifluoroacetic acid l-methyl-3-phenylaUyl ester (4,16).
Freshly distilled trifluoroacetic anhydride (2.5 mL, 11.5 mmol), was added to a solution of alcohol 4.10 (854 
mg, 5.76 mmol), triethylamine (1.8 mL, 12.7 mmol) and DMAP (10 mg) in CH2 CI2  (5 mL) at 0"C under 
N2 . The solution was allowed to warm to rt with stirring over 3 h and H2 O (30 mL) added. The phases were 
separated, and the aqueous phase was extracted with CH2 CI2  (3 x 30 mL), The combined organic phases were 
washed with aqueous K2 HPO4  solution (2 x 30 mL) and H2 O (30 mL), dried, filtered and concentrated in 
vacuo. Purification by column chromatography (Si0 2 , Et2 0  : hexanes = 1 : 9 )  gave the title compound 
(1.15 g, 4.70 mmol, 82%) as a clear oil.
Trifluoroacetate 4.16 has previously been described, but no data reported.
■
[a]D = -94.8 (c 0.83, CHCI3 ).
IR (film): v = 3058 w, 3031 w, 2987 m, 2934 w, 1781 s, 1377 w, 1222 m, 1160 s, 1027 m, 969 w crrrK
'
iH NMR (400 MHz, CDCI3 ): ô = 7.43-7.29 (5H, m, Ph), 6.72 (IH, d, J  15.9, HI), 6.20 (IH, dd, J  15.9,
7.4, H2), 5.70 (IH, dq, J  6.7, 6.5, H3), 1.57 (3H, d, J  6.5, H4).
13c NMR (100 MHz, CDCI3 ): Ô = 157.0 (0, q, V c -F  42.0, COCFg), 135.7 (0, Ph), 134.4 (1, Ph, Cl or 
C2), 128.9 (2C, 1, Ph), 128.8 (1, Ph, Cl or C2), 127.0 (1, Ph, Cl or C2), 126.1 (1, Ph, Cl or C2), 114.8 
(0 , q, V c-F  286.0, COCFs), 76.6 ( 1, C3), 2 0 .1  (3, C4).
■LRMS (El mode): m/z = 244.2 [M+*, 60 %], 149.1 (28), 131.1 (100), 115.1 (50), 91.1 (49), 57.2 (29). 
(lS,2£')-Benzoic acid l-methyl-3-phenylaIiyI ester (4.17).
ÔBZ
To a solution of alcohol 4.10 (3.82 g, 25.8 mmol) and DMAP (10 mg) in CH2 CI2  (30 mL) at rt under N2  
was added benzoyl chloride (3.3 mL, 28.4 mmol) and triethylamine (4.0 mL, 28.4 mmol). The solution was 
stirred at rt for 18 h before the addition of 2M HCl (30 mL). The phases were separated and the aqueous phase 
extracted with CH2CI2  (3 x 30 mL). The combined organic phases were washed with brine (50 mL), dried, 
filtered and concentrated in vacuo to give a pale-yellow solid. Purification by recrystallisation from hexanes 
gave the title compound (5.89 g, 23.3 mmol, 90%) as a white solid.
Optical rotation and b.p. data for benzoate 4.17 have been previously reported.^^^
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m.p. = 79-80"C (hexanes).
1h NMR (400 MHz, CDCI3  referenced to added TMS): ô = 8.10-8.06 (2H, m, Ph), 7.55-7.21 (8 H, m, Ph), 
6.69 (IH, d, u
6.5, Cl-Me).
(ljR,3 S)-(?7^-Cyclopentadieny I) (1-phenyl-1,2,3-J7-but-3 -enyl)(dicarbonyl)molybdenum 
(4.6).
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[ oj] d  = +1.46 (c 7.56, CDCI3 ). Lit. [ a ] D  = +0.42 (c 8.16 CHCls).^®®
IR (KBr): v = 3057 w, 3028 m, 2979 w, 2921 w, 1709 s, 1633 m, 1450 m, 1327 m, 1274 s, 1147 m, 1070 
m, 974m cm ~^.
J  16.0, H3), 6.30 (IH, dd, J  16.0, 6 .6 , H2), 5.79 (IH, ddq, J  6.5, 1.1, 6.5, HI), 1.54 (3H, d, J  f
13c NMR (100 MHz, CDCI3 ): d = 165.9 (0, £OPh), 136.5 (0, Ph), 133.0 (1, Ph, C2 or C3), 131.8 (1, Ph, 
C2 or C3), 131.1 (0, Ph), 129.7 (2C, 1, Ph, C2 or C3), 129.0 (1, Ph, C2 or C3), 128.7 (2C, 1, Ph, C2 or 
C3), 128.5 (2C, 1, Ph, C2 or C3), 128.0 (1, Ph, C2 or C3), 126.7 (2C, 1, Ph, C2 or C3), 71.7 (1, C l),
20.6 (3, Cl-Me).
ocrï°^coCp
0
Procedure 1) - A solution of molybdenum hexacarbonyl (4.20 g, 15.9 mmol) in acetonitrile (140 mL) was 
brought to reflux under N2  and refluxed for 3 h to give a clear yellow solution. A solution of benzoate 4 .1 7  7
(3.35 g, 13.3 mmol) in MeCN (50 mL) was added via cannula and reflux was continued for 28 h before the 
solution was cooled to rt. A solution of cyclopentadienyllithium (freshly prepared by the addition of n-BuLi 
(8.9 mL of a 1.71M solution in hexanes) to freshly cracked cyclopentadiene (965 mg, 14.6 mmol) in THF L
(35 mL) at 0°C under N2  followed by stirring of the light-yellow solution at 0"C for 15 min) was added via 
cannula and the red solution stirred at rt for 1 h before concentration in vacuo. Purification by column 
chromatography (AI2 O3 , degassed CH2 CI2 , under N2  atmosphere) gave the title compound (3.53 g, 10.1 |
mmol, 76%) as a red-orange crystalline solid which was dried in vacuo overnight before use. 7
Procedure 2)^^ - To a solution of Mo(CO)6  (512 mg, 1.94 mmol) in THF (25 mL) under N2  was added 
pyridine (0.31 mL, 3.88 mmol) and the solution brought to reflux. After refluxing for 12 h a solution of 
benzoate 4 .1 7  (465 mg, 1.84 mmol) in THF (1 mL + 0.5 mL) was added dropwise via syringe to the red- 
orange solution, which was refluxed for a further 18 h before cooling to rt over 1 h. LiCp (7.1 mL of a 
0.29M solution in THF (prepared immediately before use from freshly cracked Cp (328 mg, 5.0 mmol) and 
«-BuLi (2.27 ml of a 2.19M solution in hexanes) in THF (15 mL), rt, 15 min under N2 )) was added and the 
dark red-brown solution stirred at rt under N2  for 1 h. The solution was transferred via  syringe to a round- 
bottomed flask and concentrated in vacuo to a volume of approximately 10 mL, before purification by 
column chromatography (AI2 O3 , degassed hexanes-Et2 0 , 2:1, under N2) and concentration in vacuo. The 
title compound was obtained as a fine yellow crystalline solid (597 mg, 1.71 mmol, 8 8 %).
Complex 4.6 was generally used without further purification, but for analytical purposes it could be purified 
further by recrystallisation from pentane to give fine yellow needles.
13c NMR (100 MHz, CDCI3 ): ô = 239.7 (0, CO), 239.6 (0, CO), 142.1 (0, Ph), 128.6 (2C, 1, Ph), 125.9
LRMS (El mode): m/z = 350.2 [(M(98Mo)+% 25 %], 322.2 [(M(98mo)-CO)+, 20%], 292.2 (100). The 
expected Mo isotope patterns are present.
(lE,3S)-(?7^-Cyclopentadienyl)(l-phenyl-l,2,3-i7“but-3-enyl)(carbonyl)(nltrosyl) 
molybdenum tetrafiuoroborate (4.1)
- 8F4+
OC'I^NO
IR (solution in CD^CN):^ = 2080 s, 1720 s cm' -1
m.p. = 85-88°C. (Et2 0  / Pentane).
M d = +8 .0  (c 0.67, CHCI3) 'f
IR (KBr): v  = 1917 s, 1839 s, 812 m, 757 m, 695 m c m 'l
iH NMR (400 MHz, CDCI3 referenced to added TMS): ô = 7.30-7.19 (3H, m, Ph), 7.12-7.08 (2H, m, Ph),
5.10 (5H, s, Cp), 4.88 (IH, t, J 9.6, H2), 2.35 (IH, d, J  10.0, HI), 1.86 (3H, d, J  6.0, H4), 1.78-1.73 (IH, 
m, H3).
%
(1 , Ph), 125.1 (2C, 1, Ph), 93.9 (5C, 1, Cp), 68.5 (1, C2), 58.8 (1, C3), 58.4 (1, C l), 21.2 (3, C4).
93Mo NMR (13 MHz, THF): ~ -1617, ô^ncio " -1412. exo : endo -  13 : 1.^ ^^
Found: C, 58.60; H, 4.69. Calc, for C17H 1 6O2 M0 : C, 58.63; H, 4.63%. I
Cationic complex 4.1 was routinely prepared in a minimum volume (ca 2-3 mL / mmol) of freshly distilled 
MeCN at 0°C under N2  by the addition of NOBF4  (1.1 eq) and transferred directly via cannula to a solution of 
the nucleophile. However, for characterisation purposes the title compound was prepared on a 3.4 mmol scale 
and transferred to Et2 0  (200 mL) at 0°C under N2  to yield a light-brown solid after cooling to -60"C for 15 
min. Cationic complex 4.1 (518 mg, 1.20 mmol, 36%) was isolated by filtration under an atmosphere of 
N2.
1h (360 MHz, CD3 CN): Complex 4.1 was initially isolated as a mixture of 2 major isomers (presumably a 
pair of endo i s o m e r s ) , i n  the approximate ratio 1.2 : 1 which equilibrated to a mixture of 4  isomers 
upon standing in CD3 CN for 24 h, in a ratio of approximately 2.3 : 2  : 1 : 1.2, as estimated by the 
integrations of Cp singlets at 5.69, 6.11, 6.22 and 6.02 ppm respectively.
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NMR data for the initial {endo) isomers; ô -  7.54-7.35 (lOH, m, Ph), 6.11 (5H, s, Cp), 5.69 (5H, s, 
Cp), 6.23-5.93 (2H, m, H2), 5.28 (IH, d, J  11.7, HI), 5.20 (IH, d, J  13.4, HI), 3.95 (IH, dq, J  12.9, 6.2, 
H3), 3.76 (IH, d, dq, J  12.3, 6.2, H3), 2.47 (3H, d, J  5.9, H4), 2.30 (3H, d, J  6.3, H4); partial data for the 
exo-isomers: ô = 6.22 (5H, s, Cp), 6.02 (5H, s, Cp), 4.77 (IH, d, J  13.8, HI), 4.51-4.44 (2H, m, H3), 4.40 
(IH, d, J 13.0, HI), 2.42 (3H, d, J  6.4, H4). Signals for H2 and the second H4 doublet obscured by major 
isomer peaks at 6.23-5.93 ppm and 2.30 ppm respectively.
^3c NMR (100 MHz, CD3 CN, equilibrium mixture of 4  endo and exo isomers): Ô = 214.9 (0), 213.9 (0),
211.0 (0), 209.5 (0), 136.8 (0), 135.8 (0), 135.4 (0), 134.0 (0), 131.4 (2C, 1), 130.7 (2C, 1), 130.0 (2C, 1), 
129.8 (2C, 1), 129.7 (2C, 1), 129.5 (2C, 1), 129.4 (2C, 1), 128.0 (2C, 1), 127.7 (2C, 1), 127.6 (2C, 1), 
106.7 (1), 106.5 (1), 104.2 (1), 103.3 (5C, 1), 102.5 (5C, 1), 102.4 (5C, 1), 101.8 (5C, 1), 101.0 (1), 94.6 
(1), 93.4 (1), 92.3 (1), 88.0 (1), 83.3 (1), 80.6 (1), 76.8 (1), 74.6 (1), 21.1 (3), 19.6 (3), 18.9 (3), 18.2 (3).
9^Mo NMR (13 MHz, MeCN): ô = -1293, -1339, -1383 ppm, in the approximate ratio 1 : 2.5 : 4, with 
approximate line widths 210 Hz, 206 Hz, 290 Hz respectively.^^^
LRMS (FAB mode, nitrobenzyl alcohol matrix): m/z = 352.1 [M(98mo)+*, 98%], 324.1 [(M(9^Mo)-CO)+, 
100%], 289.1 (30). The expected Mo isotope patterns are present.
HRMS (FAB mode, nitrobenzyl alcohol matrix): found [M"***], 352.0235. CigHi^OiN^^Mo requires 
352.0238. Found [M"^ *], 350.0246. CigHi^OzN^^Mo requires 350.0235. The expected Mo isotope patterns 
are present.
(2ü)-2-r^rr-Butoxycarbonylamino-3-(4-methoxyphenyI)propionic acid methyl ester 
(4.92).
MeO'
OMe 
NHBoc
Ester 4.92 was prepared as a clear oil in 53% yield over two steps from D-Tyrosine on a scale of 6.0 mmol 
according to literature procedures.^^’ Spectroscopic data were in accordance with literature data.^^
[a]o  = -4 .7  (c 2.4, MeOH) Lit. [c£]d (enantiomer) = +5.9 (c 2.5, MeOH).^®'^
(22?)-2-rerr>Butoxycarbonylamino-3-(4-methoxyphenyI)propionic acid 2,2,2- 
trichloroethyl ester (4.94).
MeO'
O' CCI3 
NHBoc
Ester 4.94 was prepared in 65% yield over 2 steps from ester 4.92 on a scale of 3.08 mmol according to 
literature procedures. The title compound was purified by column chromatography (SiÜ2 , Et2 0  :
hexanes = 1 : 4 )  and recrystallisation from EtOAc. Spectroscopic data were in accordance with literature
data.^ ^^
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m.p. = lll-112"C(EtOAc) Lit. m.p. =
[a]D = -8.60 (c 6.3, CHCI3 ) Lit. [g ]d  = -12.0 (c 12.0,
(2i?)-3-Amino-2-methylpropionic acid (4.102).
HO T  NH,
Acid 4.102 was prepared in 63% yield over 3 steps on a 9.28 mmoi scale by the method of Lavallée and co­
workers. Spectroscopic data were in accordance with literature data.^ "^ ^
m.p. = 184-185"C (MeOH / EtOAc). Lit. m.p. = 179-181°C.^'^^ (MeOH / EtOAc)
[a]D = -14.2 (c 3.4, H2 O) Lit. [«]d  = -14.7 (c 2.6, H20).^42
(2jR)-3-fcrf-Butoxycarbonylaraino-2-methylpropionic acid (4.103).
HO Y  NHBoc
A solution of amino acid 4.102 (601 mg, 5.83 mmol), di-tert-butyl dicarbonate (1.46 g, 6.70 mmol) and 
triethylamine (1.22 mL, 8.75 mmol) in 1,4-dioxane (10 mL) and H2 O (10 mL) was stirred at rt for 18 h. The 
mixture was concentrated in vacuo and diluted with H2 O (50 mL) and EtOAc (50 mL). The phases were 
separated and the aqueous phase washed with EtOAc (3 x 25 mL). The aqueous phase was acidified to pH 1 
with IM HCl and re-extracted with EtOAc (3 x 25 mL). The organic phases were washed with brine (25 mL), 
dried, and concentrated in vacuo to give the title compound (619 mg, 3.04 mmol) as a clear oil which slowly 
solidified. A further batch of acid 4.103 (397 mg, 1.95 mmol) was isolated from the first organic phase after 
solvent removal in vacuo to give a total crude mass of the title compound of 1 .0 2  g (5.00 mmol, 8 6 %) 
which was used without further purification. A sample was purified for analytical purposes by 
recrystallisation from Et2 0 . Spectroscopic data were in accordance with literature data.
m.p. = 67-68"C. (Et2 0 ). Lit. m.p. = 69.5-70.5"C. (Et%0)^^^
[a]D = -20 .4  (c 1.39, MeOH). Lit. [a ]o  -18.4 (c 2.0, MeOH).^^^
(2S)-2-Hydroxy-4-methylpentanoic acid allyl ester (4.98).
The title compound was prepared as a pale yellow oil in 62% yield on a scale of 8.04 mmol by the procedure 
of Moore, Tins and co-workers. Spectroscopic data were in accordance with literature data.^^^
[alD = -8.7 (c 0.91, CHCI3 ) Lit. [ « b  = -8 .4  (c 1.1, CHCl3 ).^^^
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(25)-2-[(3/?)-3-fer^Butoxycarbonylamino-2-methylpropionyloxy]-4-methylpropionic acid 
allyl ester (4.104).
NHBoc
Ester 4.104 was prepared as a clear oil in 87% yield on a scale of 2.36 mmol by the method of Moore, Tins 
and co-workers. Spectroscopic data were in accordance with literature data.^^^
[a]D = -43.8 (c 3.47, CHCI3 ) Lit. M d  = -51.3 (c 3.41, CHCls).^^^
(2S)-2-[(3i?)-3-^crt-Butoxycarbonylamino-2-methylpropionyloxy]-4-inethyIpropionic acid 
(4.105)
r\  n u
O IT NHBoc
The title compound was prepared as a clear oil which solidified upon standing in 80% yield on a scale of 1.87 
mmol by the method of Moore, Tins and co-workers. Recrystallisation from Et2 0  gave clear needles. 
Spectroscopic data were in accordance with literature data.^^^
m.p. = 73-74.5“C (Et2 0 ).
[cî]d  = -51.9  (c 3.77, CHCI3) Lit. [ « ] d  = -47.9 (c 4.70, CHCl3).^28
Triisopropyl[(2S,4S,6S)-6-[(li?,2E)-l-methyI-3"phenylallyl]-2-phenyI-[l>3]dioxan-4- 
ylmethoxy]silane (4.83) and TriisopropyI-[(2S,4S,6S)>2-phenyI-6-[(lS)-l"phenylbat-2- 
enyl]-[l,3]dioxan-4-yImetlioxy]silane (4.84).
OTIPS OTIPS
n-BuLi (5.4 mL of a 1.71M solution in hexanes) was added dropwise to a solution of stannane 4.80 (5.40 g, 
8.45 mmol) in THE (150 mL) at -80°C under N2 . After the light-yellow solution was stirred at -80°C for 1 
h, a solution of CuBr*DMS (2.08 g, 10.14 mmol) in diwo-propylsulfide (7 mL) and THE (8.5 mL) was added 
via cannula, maintaining the internal solution temperature below -80°C. The orange-brown solution was 
stirred at -80°C for 1 h under N2  before the addition of cationic complex 4.1 (freshly prepared: nitrosonium 
tetrafiuoroborate (1.28 g, 11.0 mmol) was added to a solution of neutral complex 4.6 (3.53 g, 10.1 mmol, 
prepared by procedure 1 above) in MeCN (20 mL) at 0°C and the yellow solution stirred at O'^ C under N2  for 
15 min) via  cannula. The light-brown solution was stirred at -80°C for 1 h before the addition of aqueous
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NH 4 CI (40 mL) and aqueous NH3 (10 mL) and removal of the cooling bath. After reaching room 
temperature, the mixture was filtered through celite, washing thoroughly with EtgO (50 mL). The phases 
were separated, and the aqueous phase extracted with Et2 0  (2 x 50 mL), and the combined organic phases 
washed with brine (100 mL), dried, filtered and concentrated in vacuo. The crude material was dissolved in 
CHCI3 (250 mL) and stirred at rt for 17 h with a stream of O2  bubbling through the brown solution. 
Removal of solvent in vacuo yielded a dark brown oil which was purified by column chromatography (Si0 2 , 
Et2 0  : hexanes = 2 : 98) to give a mixture of the title compounds (2.90 g, 6.03 mmol, 71% from stannane 
4.80) as a pale yellow oil. NMR revealed a ratio of 4.83 : 4.84 of approximately 1.2 : 1 (in favour of 
the desired isomer), estimated by integration of the vinylic proton peaks at 6.51 and 6.28 ppm (4.83) and 
5.64-5.50 ppm (4.84).
[aJo = +23.3 (c 1.50, CHCI3 ) (1.2:1 mixture of 4.83 : 4.84).
IR (film)v = 2942 s, 2866 s, 1462 m, 1382 w, 1117 s, 1069 m, 1028 m, 1014 m, 995 m, 882 m, 795 w, 
748 m, 696 s, 660 m cm~^.
iH NMR (400 MHz, CDCI3 ): <3 = 7.53-7.17 (19H, m, Ph), 7.05-7.04 (IH, m, Ph), 6.51 (IH, d, J  15.9, 
PhCH=CHR (4.83)), 6.28 (IH, dd, J  15.9, 8.4, PhCH^CKR (4.83)), 5.85 (IH, s, CHPh, (4.83)), 5.76 
(IH, s, CHPh (4.84)), 5.64-5.50 (2H, m, MeCH=CHR (4.84)), 4.44 (IH, dd, 7 11.1, 5.0 (4.84)), 4.27- 
3.90 (6 H, m), 3.72 (2H, ddd, J  10.0, 6 .6 , 1.4 (4.83)), 3.19 (IH, q, J  8.3), 2.11 (IH, ddd, J  13.5, 2.5, 1.5 
(4.84)), 2.02-1.90 (3H, m), 1.66 (3H, dd, J  5.6, 0.8 (4.84)), 1.13 (3H, d, J  6.4, Me (4.83)), 1.12-1.00 
(42H, m, Si(CHMe2)3).
^3c NMR (100 MHz, CDCI3 ): à = 141.9 (0, Ph), 139.1 (0, Ph), 138.9 (0, Ph), 137.8 (0, Ph), 133.5 (1, 
PhCH=£HR (4.83)), 132.2 (1, CH=CH, (4.84)), 130.1 (Ph£H=CHR (4.83)), 128.8 (2C, 1, Ph), 128.7 
(2C, 1, Ph), 128.6 (1, Ph or CH=CH, (4.84)), 128.4 ( 1 , Ph or CH=CH, (4.84)), 128.3 (2C, 1, Ph), 128.2 
(2C, 1, Ph), 128.1 (2C, 1, Ph), 127.9 (1, Ph or CH=CH, (4.84)), 127.2 (1, Ph or CH=CH, (4.84)), 126.6 
(1, Ph or CH=CH, (4.84)), 126.3 (2C, 1, Ph), 126.2 (2C, 1, Ph), 125.9 (2C, 1, Ph). 94.8 (1, £H P h  
(4.83)), 94.3 (1, CHPh, (4.84)), 76.6 (1), 74.8 (I), 73.3 (1), 73.1 (1), 6 6 .8  (2C, 2), 50.0 (1), 37.6 (1, 
PhCH=CHCHM eR, (4.83)), 28.9 (2), 28.7 (2), 18.2 (14C, 3, Me + Si(CHM^2 ) 3 ), 12.2 (6 C, 1, 
Si(CHMe2)3).
LRMS (Cl mode, isobutane): m/z = 481 [(M+H)+, 17 %], 393 (21), 375 (58), 351 (100), 307 (25), 245 (44). 
Found: C, 74.86; H, 9.41. Calc, for C3oH4 4 0 3 Si: C, 74.95; H, 9.22.
Olefins 4.83 and 4.84 were also prepared in 56% yield (4.83 : 4.84 = 3 : 1) on a scale of 0.56 mmol of 
stannane 4.80 by an analogous procedure to that described above using neutral complex 4.6 prepared by 
procedure 2 above. The mixture of the title compounds was contaminated by oxane 4.115, identified by 
independent preparation by an analogous procedure to that detailed for alcohols 4.73 and 4.74 above, using 
aqueous NH4 CI solution in place of benzaldehyde as the electrophile.
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.0 
Ph
[a ir , = -1.96 (c 1.02, CHCI3).
cm“ l.
1h NMR (400 MHz, CDCI3 ): Ô = 7.52-7.51 (2H, m, Ph), 7.40-7.32 (3H, m, Ph), 5.56 (IH, s, H2), 4.33 
(IH, dd, 7 11.1, 4.5, H6 ), 4.04-3.97 (2H„ m, H4, H6 '), 3.94 (IH, dd, 7 9.7, 5.2, CH2 OTIPS), 3.71 (IH, dd, 
7 9.7, 6.7, CH2 OTIPS), 1.86 (IH, ddt, 7  11.8, 5.3, 12.1, H5), 1.74 (IH, br dd, 7 13.3, 1.2, H5'), 1.18-1.11 
(3H, m, Si(CH(Me)2 )3 , 1.09 (18H, d, 7  5.2, Si(CH(Ms)2)3).
OH OH
Data for isomer 4.85:
[ a i r  = +103.6 (c 1.10, MeOH).
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" Ï
Data for (25 ,4S )-T riisop rop yl-(2 -p h en yI-[l,3 ]d ioxan -4-y lm eth oxy)silan e (4.115):
‘rH^oTips
IR (film): v = 2943 s, 2863 s, 1465 m, 1385 w, 1236 w, 1147 m, 1109 s, 1029 m, 881 m, 758 w, 694 vv
13c NMR (100 MHz, CDCI3): ô = 138.8 (0, Ph), 128.9 (1, Ph), 128.3 (2C, 1, Ph), 126.3 (2C, 1, Ph), 
101.4 (1, C2), 77.9 (1, C4), 67.2 (2 , C6), 66.6 (2, CH2OTIPS), 28.8 (2, C5), 18.1 (6C, 3, Si(CH(Me)2)3),
12.1 (3C, 1, Si(CH(Me)2)3).
LRMS (Cl mode, isobutane): m/z = 351.3 [(M+H)+, 85 %], 307.2 (53), 245.3 (100).
Found: C, 68.49; H, 9.65. Calc, for C2 oH3 4 0 3 Si; C, 68.32; H, 9.78%.
(2 /? ,4S ,5 i? ,6£)-5 -M etliy l-7 -p h en yl-h ep t-6 -en e-l,2 ,4 -tr ioI (4.85) and (2 R ,4 S ,5 S ,6 E )-S -  
P h en y l-o c t-6 -en e -l,2 ,4 -tr io l (4 .86),
5 E j 'OH 
OH OH
4.86
To a solution of oxanes 4.83 and 4.84 (4.83 : 4,84 = 1.2:1, 2.77 g, 5.76 mmol) in MeOH (100 mL) at rt 
was addedp-toluenesulfonic acid monohydrate (164 mg, 0.86 mmoi). The pale yellow solution was stirred at 
rt for 1 d before solvent removal in vacuo. Purification by column chromatography (Si0 2 , EtOAc) yielded a 
mixture of the title compounds (861 mg, 3.64 mmol, 63%) as a pale yellow oil. Careful repetitive column 
chromatography allowed the separation of isomers. Triol 4.86 solidified upon standing and was recrystallised 
from Et2 0  to give fine needles.
IR (film): v  = 3465 br s, 2935 m, 2873 m, 1452 m, 1388 m, 1365 m, 1329 m, 1082 m, 992 m, 972 m 
cm“ .^
Ï
COgMe
To a solution of trlol 4.85 (125 mg, 0.53 mmol) in MeOH (15 mL) and H2 O (5 mL) at rt was added 
sodium periodate (170 mg, 0.79 mmol). The clear solution was stirred at rt for 1.5 h, after which time a 
white precipitate was present. Methanol was removed in vacuo and H2O (30 mL) and CH2CI2  (20 mL) were 
added. The phases were separated and the aqueous phase extracted with CH2CI2  (2 x 20 mL). The combined 
organic phases were dried, filtered and concentrated in vacuo to afford crude aldehyde 4.87 as a clear oil (103
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1h NMR (400 MHz, CDCI3 ): 6  = 7.38-7.23 (5H, m, Ph), 6.49 (IH, d, J  16.1, H7), 6.12 (IH, dd, J  16.1,
8.7, H6 ), 4.05-3.99 (IH, m, H2), 3.80-3.76 (IH, m, H4), 3.67 (IH, dd, J  11.1, 3.6, HI), 3.54 (IH, dd, J  
11.1, 7.0, HI'), 2.41 (IH, br sextet, 7 7.3, H5), 1.75 (IH, ddd, 7 14.4, 8.7, 2.5, H3), 1.60 (IH, ddd, 7 14.4,
9.3, 3.5, H3'), 1.12 (3H, d, 7 6 .8 , C5-Me). i
13c NMR (100 MHz, CDCI3 ): Ô = 137.1 (0, Ph), 132.3 (1, C6  or C7), 131.6 (1, C6  or C7), 128.8 (2C, 1,
Ph), 127.7 (1, Ph), 126.4 (2C, 1, Ph), 72.3 (1, C2 ), 69.6 (1, C4), 66.9 (2, C l), 44.2 (1, C5), 36.4 (2, C3),
16.9 (3, C5-Me). g
LRMS (Cl mode, NH3 ): m/z = 254.2 [(M+NH4 )+, 100 %], 237.1 (28), 219.1 (22).
Found: C, 71.15; H, 8.70. Calc, for C14H2 0 O3 : C, 71.16; H, 8.53%. IData for isomer 4.86: 
m.p. = 110-1 i r c  (Et2 0 ).
[a]D -  -69.1 (c 1.65, MeOH).
ÎIR (KBr): V = 3397 br s, 2959 w, 2940 w, 2917 w, 2890 w, 1112 m, 1082 m, 1070 s, 1025 s, 963 m, 702 
m cm"*.
^H NMR (400 MHz, CDCI3 ): Ô = 7.53-7.30 (2H, m, Ph), 7.26-7.17 (3H, m, Ph), 5.65-5.53 (2H, m, H6  
and H7), 4.13 (IH, dt, 7 2.5, 8 .8 , H4), 4.07-4.01 (IH, m, H2), 3.65 (IH, dd, 7 11.1, 3.5, HI), 3.53 (IH, dd,
7 11.1, 7.0, HI'), 3.30 (IH, t, 7 8.2, H5), 2.94 (IH, br s, OH), 2.18 (IH, br s, OH), 1.88 (IH, ddd, 7 14.5,
8.7, 2.6, H3), 1.68 (3H, d, 7 5.0, H8 ), 1.63 (IH, br s, OH), 1.55 (IH, ddd, 7 14.5, 9.1, 3.5, H3'). I
13c NMR (100 MHz, CDCI3): Ô = 141.4 (0, Ph), 130.8 (1, Ph, C6  or C7), 129.2 (2C, 1, Ph), 128.5 (2C,
1, Ph), 128.4 (1, Ph, C6  or C7), 127.2 (1, Ph, C6  or C7), 72.1 (1, C4), 69.7 (1, C2), 67.1 (2, Cl), 56.7 (1,
C5), 36.8 (2, C3), 18.3 (3, C8 ).
LRMS (Cl mode, NH3 ): m/z = 254.2 [(M+NH4 )+, 100 %], 236.2 (30), 219.2 (8 ), 116.1 (12).
Found: C, 71.27; H, 8.73. Calc, for C14H2 0 O3 : C, 71.16; H, 8.53. 
(2£,5S,6jR ,7.E)-S-H ydroxy-6-m ethyl-8-phenyIocta“2,7-dienoic a d d  m ethyl ester (4,88), '9
f
mg, 0.50 mmol) which was azeotroped with PhMe (2 x 20 mL) and used without further purification after 
further drying in vacuo for 1.5 h.
To a solution of aldehyde 4.87 in THF (17 mL) and trimethylphosphonoacetate (0.17 mL, 1.17 mmol) at 
-7B'’C under was added TV'-tetramethy 1 guanidine (0.15 mL, 1.17 mmol) in THF (5 mL) dropwise 
over 2 min. The clear solution was allowed to warm to rt with stirring over 16 h and stirred at rt for 42 h 
before the addition of H2O (20 mL) and Et%0 (20 mL). The phases were separated and the aqueous phase was 
extracted with Et^O (3 x 25 mL). The combined organic phases were dried, filtered and concentrated in vacuo 
to afford a pale-yellow oil. Purification by column chromatography (SiOa, EtgO : Cyclohexane = 2 : 8  -> 4 
: 6 ) yielded the title compound (114 mg, 0.44 mmol, 83%) as a clear colourless oil. Spectroscopic data were 
in accordance with literature data.
[ a ] r  = +71.7 (c 1.20, CHCI3 ). Lit. [«]d  = +55.2 (c 0.31, CHCl]).^"^^
(2£’,5 S ,6 iü ,7 £ )-5 -(ferN B u ty ld im eth y ls ila n y lo x y )-6 -m eth y l-8 -p h en y lo c ta -2 ,7 -d ien o ic  acid  
m ethyl ester (4.89).
COoMo
To a solution of alcohol 4.88 (85 mg, 0.33 mmol) in DMF (15 mL) at rt under N2  was added tert- 
butyldimethylsilyl chloride (198 mg, 1.32 mmol) and imidazole (98 mg, 1.32 mmol). The clear solution was 
stirred at rt under N2  for 5 d before the addition of Et2 0  (30 mL) and IM HCl (40 mL). The phases were 
separated and the aqueous phase was extracted with Et2 0  (3 x 15 mL). The combined organic phases were 
dried, filtered and concentrated in vacuo. Purification by column chromatography (Si0 2 , Et2 0  : Cyclohexane 
= 2 : 8 )  yielded the title compound (104 mg, 0.28 mmol, 85%) as a clear colourless oil. Spectroscopic data 
were in accordance with literature data.*^^
[alD = +64.0 (c 0.50, CHCI3 ), Lit. [ a ] r  = +68.2 (c 1.50, CHCb).^^^
(2£',SS,6jR ,7£')-S”(rerr-B iity ld im eth yls iIan y loxy)-6 -m eth y l-8 -p h en ylocta -2 ,7 -d ien o ic  acid  
(4 .3 ) .
OTBS
To a solution of methyl ester 4.89 (236 mg, 0.63 mmoi) in acetone (10 mL) at rt was added IM LiOH (8  
mL). The cloudy light-yellow solution was stirred at rt for 6  h before the addition of Et2 0  (20 mL). After 
washing with IM HCl (2 x 20 mL) and brine (20 mL) the combined aqueous phases were extracted with 
Et2 0  (2 X 20 mL). The combined organic phases were dried, filtered and concentrated in vacuo. Purification 
by column chromatography (Si0 2 , EtOAc : Cyclohexane = 3 : 7 + 1 %  AcOH) yielded the title compound 
(219 mg, 0.61 mmol, 97%) as a clear colourless oil. Spectroscopic data were in accordance with literature 
data.*128
[ a ] r  “  +90.8 (c 1.13, CHCI3 ). Lit. [ a ] r  = +87.0 (c 1.40, CHCg).*^»
-!■V!
. . . f t
1g
I
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(2/?)-2-[(2Ê,5S,6iî,7£')-5-(^erï-ButyIdimethylsiIanyIoxy)-6-methyI-8-phenyl-octa-2,7- 
dienoylamino]-3-(4-inethoxyphenyl)-propionic acid 2,2,2-trichloroethyl ester (4.106).
OTBS H
CUC^ OMe
Amide 4.106 was prepared according to the method of Moore, Tins and c o -w o r k e r s o n  a scale of 0.6 
mmol of acid 4.3 and 0.6 mmol of TFA salt 4.96. Salt 4.96 had been freshly prepared from ester 4.94 
(263 mg, 0.6 mmol) by dissolution in neat trifluoroacetic acid (5 mL) at 0®C, followed by standing at rt for 
1.5 h before concentration in vacuo, addition of PhMe (5 mL) and concentration in vacuo. Purification by 
column chromatography (S1 0 2 , Et2 0  ; Cyclohexane = 1 : 9 3 : 7) yielded the title compound (297 mg,
0.44 mmol, 79%) as a viscous clear oil. Spectroscopic data were in accordance with literature data.^^^
1
[ a ] D  =+17.1 (c 2.28, CHCI3 ). Lit. [a]D = +18.2 (c 2.00, CHCls).^^^
(2iî)-2-[(2£',5S,6iî,7j&)-5-Hydroxy-6-methyl-8-phenyl-octa-2,7-dienoylamino]-3-(4- 
methoxyphenyi)-propionic acid 2,2,2-trichloroethyl ester (4.107).
cucr^ OMe
To a solution of amide 4.106 (189 mg, 0.28 mmol) In THF (20 mL) at 0°C under N2  in a polypropylene 
reaction vessel was added pyridinium poly(hydrogen fluoride) (5 mL) and the clear solution stirred at 0“C for 1 
h then at rt for 3 h. The solution was diluted with Et2 0  (20 mL), washed with H%0 (2 x 30 mL), aqueous 
NaHCOg (2 x 30 mL) and brine (2 x 20 mL), dried, filtered and concentrated in vacuo to give a pale yellow 
oil. Purification by column chromatography (Si0 2 , Et2 0  ; hexanes = 1 : 1 -* 100 : 0 ) yielded the title 
compound (122 mg, 0.22 mmol, 78%) as a colourless clear oil. Spectroscopic data were in accordance with 
literature data.^^^
[ a ] D = - 1 . 1 4 ( c  1.75, CHCI3). Lit. [a]D = -1.50 (a 1.70, CHCI3 ) 128
(25)-2-[(2i2)-3-^cri-Butoxycarbonylamino-2-methylpropionyloxy]-4-niethylpentanoic 
(15,2i?,3£)-l-{3-[(2i?)-2-(4-raethoxyphenyl)-l-(2,2,2-trichloroethoxycarbonyl)“ 
ethyIcarbamoyi]-allyl}-2-methyl-4-phenylbut-3-enyi ester (4.108).
acid
Ph"
‘OMe
NHBoc
170
■S-
:
Ester 4.108 was prepared according to the method of Moore, Tins and co-workers on a scale of 0.15 
mmol of alcohol 4.107 and 0.23 mmol of acid 4.105. Purification by column chromatography (Si0 2 , 
Et2 0  : hexanes = 6 : 4 )  yielded the title compound (105 mg, 0.12 mmol, 82%) as a colourless clear oil. 
Spectroscopic data were in accordance with literature data.
[ccJd = -9 .8  (c 0.53, CHCI3 ). Lit. [a]D = -10.5 (c 0.56, CHCls).^^®
(3S,6iî,10JÏ,13jB,165)-3-Isobutyl-10-(4-methoxybenzyI)-6-methyl-16-[(lJÎ,2£)-l-methyl" 
3-phenylanyl]-l,4-dioxa-8,ll-diazacyclohexadec-13-ene-2,5,9,12-tetraone (4.110) 
Cryptophycin 4.
OMe
Ester 4,108 (29.8 mg, 0.04 mmol) was dissolved in trifluoroacetic acid (2 mL) at 0°C and stirred at rt for 25 
min before concentration in vacuo. PhMe (5 mL) was added and the clear solution concentrated in vacuo 
before dissolution in Et2 0  (5 mL) and washing with 0.5M NaOH ( 2 x 5  mL). The aqueous phase was 
extracted with Et2 0  (2 x 5  mL) and the combined organic phases washed with brine (5 mL), dried, filtered and 
concentrated in vacuo. The crude amine was then dissolved in toluene (1.75 mL) and 2-hydroxy pyridine (6 .6  
mg, 0.070 mmol) added in one portion. The clear solution was stirred at rt under N2  for 44 h before being 
diluted with Et2 0  (5 mL), dried, filtered and concentrated in vacuo. Purification by column chromatography 
(SÎO2 , EtOAc : hexanes = 1 : 1 )  followed by preparative TLC (Si0 2 , EtOAc : hexanes = 6 : 4 )  gave 
Cryptophycin 4 (4.110) (10.2 mg, 0.017 mmol, 48% over 2 steps) as a clear semi-solid, which was further 
purified by crystallisation from EtOAc : hexanes (1:1) to give clear fine needles, (m.p. = 176-178®C) A minor 
component was also isolated by preparative TLC (0.7 mg, white amorphous solid), which was established to 
be dimer 4.111 on the basis of mass spectroscopic data.
[a]D = +51.5 (c 0.20, CHCI3) Lit. [a ]^  = + 22.8 (c 0.2, CHCls).^^^ |
IR (CHCI3 ): V = 3403 w, 3273 w, 3003 s, 2956 s, 1743 s, 1727 s, 1676 s, 1519 s, 1249 s, 1182 s, 1123 
m, 970 m cm“  ^ - in accordance with literature data.^^^ '■1=
IR (KBr): v  = 3425 m, 3315 m, 2960 w, 2934 w, 1744 s, 1667 s, 1618 m, 1514 s, 1463 w, 1248 m, 1194 
m, 1177 ra, 1126 w, 1068 w, 1032 w, 973 w cm“ l.
LRMS (EI+ mode): m/z = 604.4 [M+*, 7%], 378.2 (100), 227.2 (42), 161.1 (100), 121.1 (55), 44.0 (48).
HRMS (EI+ mode): found [M+’], 604.3148. C2 9 H4 2O5N requires 604.3149.
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NMR data comparison for 4. 110: (Numbering system as specified by Moore et
V  ’
OMe
1h NMR (CDCI3 , 400 MHz):
Literature data^^^ Experim ental data
Proton Ô 7  (Hz) Ô 7  (Hz)
A Ph 7.35-7.20 5H, m - 7.35-7.21 5H, m -
B H5, H9 7.12 2H,d 8 .8 7.12 2H,d 8 .8
CNH 7.02 lH,dd 5.8, 4.3 7.05 IH, t 6 .0
B H6 , H8 6.81 2H,d 8 .8 6.82 2H,d 8.4
A H3 6.71 lH,ddd 15.3, 10.3, 5.0 6.72 lH,ddd 15.2, 10.2, 5.0
A H8 6.41 lH ,d 15.8 6.41 lH ,d 15.6
A H7 6 .0 1 lH,dd 15.8, 8.9 6 .0 2 lH,dd 16.0, 8 .8
A H2 5.74 lH,dd 15.3, 1.2 5.75 lH ,d 15.2
SN H 5.62 lH ,d 8.3 5.65 lH ,d 8 .0
A H5 5.02 lH,ddd 11.0, 6.3, 1.8 5.03 lH,ddd 11.1, 6.3, 1.7
D H 2 4.84 IH, dd 9.9, 3.6 4.85 lH,dd 9.8, 3.4
B H 2 4.80 lH,ddd 8.3, 7.0, 5.5 4.83-4.78 IH, m -
g  OMe 3.78 3H, s - 3.79 3H, s -
CH3 3.41 lH,ddd 13.5, 4.3, 4.3 3.41-3.38 2H, m -
CH3' 3.36 lH,ddd 13.5, 7.5, 5.8
BH3 3.14 IH, dd 14.4, 5.5 3.15 lH,dd 14.4, 5.2
BH3' 3.08 IH, dd 14.4, 7.0 3.08 lH,dd 14.4, 7.2
C H 2 2.69 IH, m - 2.73-2.66 IH, m -
A H6 , H4' 2.54 2H, m - 2.59-2.51 2H, m -
A H4 2.36 lH,ddd 14.5, 11.0, 10.3 2.38 lH,ddd 14.4, 10.8, 10.6
D H3, H4 1.65 2H, m - 1.70-1.59 2H, m -
DH3' 1.35 IH, m - 1.38-1.32 IH, m
C2-Me 1 .2 2 3H,d 7.5 1.23 3H,d 7.2
A 6 -Me 1.13 3H,d 6.5 1.14 3H,d 6 .8
D5-M e 0.76 3H,d 6.5 0.77 3H,d 6 .8
D4-Me 0.72 3H,d 6.5 0.73 3H,d 6.4
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13c (CDCI3 , 100 MHz):
Literature data^^^ Experimental data
Carbon Ô Multiplicity a Multiplicity
C Cl 175.9 - 176.0 0
B Cl 171.2 - 171.2 0
D C l 170.8 - 170.8 0
A Cl 165.3 - 165,3 0
B C 7 158.6 - 158.5 0
A C3 141.5 - 141.6 1
A C 9 136.7 - 136.7 0
A C8 131.8 - 131.8 1
B C5, C9 130.2 - 130.2 1
A C 7 130.1 - 130.1 1
A C ll ,  C13 128.6 - 128.6 1
B C4 128.5 - 128.4 0
A C 12 127.6 - 127.5 1
A CIO, C14 126.2 - 126.1 1
A C 2 125.1 - 125.0 1
B C6, C8 114.1 - 114.1 1
A C 5 77.1 - 77.2 1
D C 2 71.6 - 71.6 1
BOMe 55.2 - 55.2 3
B C 2 53.8 - 53.9 1
A C 6 42.3 - 42.3 1
C C3 40.8 - 40.7 2
D C 3 39.5 - 39.5 2
C C2 38.1 - 38.1 1
A C 4 36.5 - 36.5 2
B C3 35.3 - 35.3 2
D C 4 24.5 - 24.4 1
D C 5 22.7 - 22.7 3
D 4-Me 2 1 .1 - 2 1 .2 3
A 6 -Me 17.3 - 17.3 3
C2-M e 14.2 - 14.2 3
I
-
I
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(35,6/î,10iî,13jE,165,195,22i?,26i?,29E,325)-3,19-DiisobutyM0,26-bïs-(4- 
methoxybenzyl)-6,22-dimethyl-16,32-bis-[(liî,2£^)-l-methyl-3-phenylalïyl]-1,4,17,20- 
tetraoxa~8,ll,24,27-tetraazacycIotriaconta-13,29-dien-2,5,9,12,18,21,25,28-octaone 
(4.111):
OMe
NHMet
NH
•Ph
[a]D = +57.1 (c 0.04, CHCI3 ).
IR (CHCI3 ) V = 3297 m, 2955 s, 2925 s, 2853 m, 1746 s, 1632 s, 1553 m, 1514 s, 1458 m, 1247 m, 1179 
m, 1 1 1 0  m cm~^.
iH NMR (400 MHz, CDCI3 ): d = 7.43 (2H, br s), 7.35-7.20 (lOH, m), 7.10 (4H, d, J  8 .6 ), 6.76 (4H, d, J  
8 .6 ), 6.77-6.70 (2H, m), 6.53 (2H, br s), 6.41 (2H, d, J  15.8), 6.02 (2H, dd, J  15.8, 8.7), 5.85 (2H, d, J  
15.8), 5.18 (2H, br q, J  7.4), 5.08 (2H, ddd, J  9.9, 6.5, 3.3), 4.78 (2H, dd, J  9.9, 3.7), 3.76 (6 H, s), 3.49- 
3.42 (4H, m), 3.11 (2H, dd, J  13.9, 5.7), 2.91 (2H, dd, J  13.9, 7.3), 2.67 (2H, br q, J  5.0), 2.56 (2H, dd, J
15.0, 6 .6 ), 2.52-2.34 (6 H, m), 1.44 (2H, ddd, J  14.2, 8 .8 , 3.7), 1.12 (6 H, d, J  7.3), 1.08 (6 H, d, J  6 .8 ), 
0.94-0.87 (2H, m), 0.78 (6 H, d, /  6.5), 0.73 (6 H, d, J  6 .6 ).
13c NMR (90 MHz, CDCI3): Ô = 174.7 (2C), 172.3 (2C), 171.2 (2C), 165.5 (2C), 158.4 (2C), 139.4 (2C),
137.1 (2C), 131.8 ( 2 0 ,  130.7 (4C), 130.5 (2Q , 129.3 (2C), 128.8 (4Q , 127.7 (2Q , 126.4 (4C), 113.9 
( 4 0 ,  76.3 ( 2 0 ,  71.7 ( 2 0 ,  55.3 (2C), 54.1 ( 2 0 ,  42.3 ( 2 0 ,  41.1 ( 2 0 ,  39.7 ( 2 0 ,  39.6 ( 2 0 ,  38.3 (2C),
35.2 ( 2 0 ,  29.9 ( 2 0 ,  24.8 ( 2 0 ,  23.1 ( 2 0 ,  21.7 ( 2 0 ,  17.1 ( 2 0 ,  14.1 (2 0 -
LRMS (+ve ion FAB): m/z = 1232 [(M+Na)+, 31%], 1046 (12), 844 (100), 804 (25), 801.7 (22), 745 (22), 
743 (21), 705 (11).
HRMS (+ve ion FAB): found [(M+Na)+], 1231.6187. C7 oH8 8 0 i 4 N4Na requires 1231.6195.
( l i î ,2 E )- l ,3 -D ip h e n y l- l-b a te n e  (4.112) and (E )-l,l-D ip h en y lb u t-2 -en e  (4.113).
Ph
Pif Ph Ph'^
4.112 4.113
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Representative experimental procedure: To a solution of phenyllithium (1.47 mL of a 1.81M solution in 
cyclohexane / ether, 2.65 mmol) in THF (30 mL) at 0°C under N2  was added a solution of CuBr»DMS (636 
mg, 3.10 mmol) in diwo-propyl sulfide (1.5 mL) and THF (4 mL) v i a  cannula. The dark green-black solution 
was stirred at 0®C under N2  for 30 min before the addition of cationic complex 4.1 (formed immediately 
before use: NOBF4  (284 mg, 2.43 mmol) was added to a solution of neutral complex 4.6 (770 mg, 2.21 
mmol) in MeCN (10 mL) at 0°C under N%, and the solution stirred at 0°C for 10 min before transfer). After 
stirring at O'^ C for 1 h after the addition of cationic complex 4.1, aqueous NH4 CI (20 mL) and aqueous NH3  
(5 mL) were added and the solution allowed to warm to room temperature. Et2 0  (30 mL) was added and the 
phases were separated, extracting the aqueous phase with Et2 0  (2 x 30 mL). The combined organic phases 
were washed with brine (30 mL), dried, filtered and concentrated i n  v a c u o  to give a brown oil which was 
dissolved in CHCI3 (300 mL) and stirred at rt with a stream of O2  bubbling through the solution for 17 h. 
Concentration i n  v a c u o  and adsorbtion of the crude material onto silica was followed by purification by 
column chromatography (Si0 2 , hexanes) to yield a mixture of the title compounds (272 mg, 1.31 mmol, 
59%) in the approximate ratio 4.112 ; 4.113 = 1 : 2.1, as estimated from ^H NMR spectroscopy v i a  
integration of the corresponding vinylic proton resonances: ô  6.39 (IH, d, J  5.2) and 6.35 (IH, d, J  4.8) for 
4.112 and <5 5.92 (IH, ddq, J  15.1, 7.7, 1.7) and 5.44 (IH, ddq, J  15.2, 1.2, 6.4) for 4,113. Further elution 
yielded ketone 4.114 (53 mg, 0.22 mmol, 10%) as a clear oil.
^H and NMR data for olefin 4.112 were in accordance with literature data.^^^
^H NMR data (CCI4 ) for olefin 4.113 has previously been reported. '^^^
iH NMR (400 MHz, CDCI3 , referenced to added TMS, 4.113): 6  = 7.38-7.18 (lOH, Ph), 5.92 (IH, ddq, J
15.1, 7.7, 1.7, H2), 5.44 (IH, ddq, J  15.1, 1.2, 6.4, H3), 4.67 (IH, d, J  7.6, HI), 1.73 (3H, d, J  6.4, H4).
13c NMR (100 MHz, CDCI3 ): Ô = 144.4 (2C, 0, Ph), 133.7 (1, C2), 128.7 (4C, 1, Ph), 128.5 (4C, 1, 
Ph), 127.1 (1, C3), 126.3 (2C, 1, Ph), 54.3 (1, Cl), 18.2 (3, C4).
LRMS (EI+ mode, isobutane): m / z  = 208.2 [M+*, 100 %], 193.2 (65), 165.1 (28), 115.1 (50). 
(25,3£')-2-Methyl-l,4-diphenylbut-3-en-l-one (4.114)
[a]D -  +25.3 (c 0.88, CHCI3 )
IR (film):v= 3054 w, 3025 w, 2971 w, 2927 w, 1677 s, 1589 m, 1443 s, 1244 w, 1205 m, 961 s, 747 m, 
703 s cm“ .^
iH NMR (400 MHz, CDCI3 , referenced to added TMS): Ô = 8.03-8.00 (2H, m, Ph), 7.57-7.21 (8 H, m, Ph), 
6.52 (IH, d, J  16.0, H4), 6.36 (IH, dd, J  16.0, 8.0, H3), 4.32 (IH, br quintet, 7 7.1, H2), 1.42 (3H, d, J  6 .8 , 
Me).
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13c NMR (100 MHz, CDCI3 ): 6  = 201.2 (0, C l), 137.1 (0, Ph), 136.6 (0, Ph), 133,2 (2C, 1, Ph, C3 or 
C4), 131.8 (1, Ph, C3 or C4), 129.9 (2C, 1, Ph, C3 or C4), 128.8 (2C, 1, Ph, C3 or C4), 127.7 (4C, 1, 
Ph, C3 or C4), 126.4 (1, Ph, C3 or C4), 45.1 (1, C2 ), 17.9 (3, Me).
LRMS (Cl mode, NH3): mtz = 254.2 [(M+NH4 )+, 100 %], 237.1 [(M+H)+, 93 %], 200.1 (5).
HRMS (CI+ mode): found [M+*], 236.1200. CnHi^O requires 236.1201.
(iï)-Acetoxyphenylacetic acid (2S)-2-phenylpropyl ester (4.121).
A
P h ' Y  1  ^ Ph  O
To a mixture of olefins 4.112 and 4.113 (89 mg, 0.43 mmol, 4.112 : 4.113 = 5 : 1) in MeOH (6  mL) 
and H2 O (6  mL) was added OSO4  (0.45 mL of a O.IM solution in H^O, 0.04 mmol) and sodium periodate 
(366 mg, 1.7 mmol) and the dark solution stirred at rt for 20 h. Et2 0  (5 mL) and H2 O (5 mL) were added and 
the phases were separated. The aqueous phase was extracted with Et2Û ( 3 x 5  mL) and the combined organic 
phases were washed with aqueous Na2 S2 0 3  solution (2 x 10 mL) and brine (10 mL), dried, filtered and 
concentrated in vacuo. The resulting crude mixture of aldehydes was dissolved immediately in Et2 0  (3 mL) 
and LÎA1H4  (65 mg, 1.7 mmol) added. The grey suspension was stirred at rt for 10 min before the dropwise 
addition of a 10% aqueous solution of KOH (10 mL) and Et2 0  (5 mL). The mixture was stirred vigorously 
for 10 min before separation of the phases and extraction of the aqueous phase with Et2 0  ( 2 x 5  mL). The 
combined organic phases were dried, filtered and concentrated in vacuo. Column chromatography (S1O2 , Et2 0  
: hexanes = 3 : 7 )  yielded a mixture of alcohols 4.116, 4.117 and 4.118 (40 mg) which were dissolved in 
CH2 CI2  (10 mL) and (R)-O-acetoxyphenylacetic acid (84 mg, 0.44 mmol), DMAP (2 mg, 0.01 mmol) and 
DCC (90 mg, 0.44 mmol) added. The cloudy mixture was stirred at rt for 2 h before filtration and purification 
by column chromatography (Si0 2 , Et2 0  : hexanes = 1 : 3 )  to yield a mixture of esters 4.119-4.121 (6 6  
mg, 4.121 : 4.120 : 4.119 = 3.5 : 1 : 1).
The dr at C2 for ester 4.121 was conservatively estimated as 90 : 10 from the integration of acetate methyl 
singlets at 2.14 and 2.15 ppm (major and minor isomers respectively) with reference to an authentic sample 
of (R5)-4.121.
NMR spectroscopic data for ester 4.121:
iH NMR (400 MHz, CDCI3 , referenced to added TMS): Ô = 7.29-7.11 (lOH, m, Ph), 5.88 (IH, s, 
CH(OAc)Ph), 4.26 (IH, dd, J  10.8, 7.2, HI), 4.16 (IH, dd, J  10.8, 7.2, HI'), 3.04 (IH, sextet, J  7.2, H2), 
2.14 (3H, s, COMe), 1.18 (3H, d, J  6 .8 , C2-Me).
13c NMR (100 MHz, CDCI3): Ô = 170.4 (0, ÇO2 R), 168.9 (0, CO2 R), 142.8 (0, Ph), 133.9 (0, Ph),
129.2 (1, Ph), 128.9 (2C, 1, Ph), 128.6 (2C, 1. Ph), 127.6 (2C, 1, Ph), 127.4 (2C, 1, Ph), 126.8 (1, Ph),
74.6 ( 1 , Ph£H(0 R)C0 2 R), 70.4 (2 , OÇH2 ), 39.0 ( 1 , CH(Me)Ph), 20.8 (3, C(O)Mê), 17.9 (3, CH(Me)Ph).
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